Page last updated: 2024-11-13

tetracycline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetracycline: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetracycline : A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID54675776
CHEBI ID27902
SCHEMBL ID2116661
SCHEMBL ID2116649
SCHEMBL ID3098
SCHEMBL ID537050
SCHEMBL ID21271987
MeSH IDM0021216

Synonyms (180)

Synonym
BIDD:GT0653
AB00053550-04
CHEBI:27902 ,
tetrazyklin
(4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
tetracyclin
tetracyclinum
(4s,4as,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
liquamycin
DIVK1C_000827
KBIO1_000827
tetracycline hcl
supramycin
einecs 200-481-9
achromycin v
tetraciclina [inn-spanish]
tetracycline (internal use)
2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
tetracyclinum [inn-latin]
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,1 0,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
tetracycline (jan/usp/inn)
D00201
sumycin (tn)
SPECTRUM_001034
PRESTWICK2_000140
BSPBIO_001950
SPECTRUM5_001112
IDI1_000827
BSPBIO_000220
agromicina
tsiklomitsin
deschlorobiomycin
tetraverine
tetracyn
t-125
roviciclina
ambramicina
piracaps (base)
6-methyl-1,11-dioxy-2-naphthacenecarboxamide
tetrafil
vetacyclinum
criseociclina
cefracycline
omegamycin
hostacyclin
tetra-co
tetracycline
mericycline
copharlan
vetquamycin-324 (free base)
purocyclina
ambramycin
achromycin
tetracycline i
nsc-108579
tetradecin
centet (base)
ciclibion
veracin
biocycline
tetracycline ii
sk-tetracycline
cyclomycin
nsc108579
60-54-8
panmycin
tetrabon
orlycycline
abramycin
lexacycline
(4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s,4as,5as,6s,12as)-
abricycline
amycin
solvocin
2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-
tsiklomistsin
cyclopar
hsdb 3188
cefracycline suspension
democracin
tetracycl
bio-tetra
limecycline
achromycin (naphthacene derivative)
micycline
liquamycin (veterinary)
C06570
tetracycline, >=88.0% (hplc)
DB00759
KBIOSS_001514
KBIO2_004082
KBIOGR_000783
KBIO3_001450
KBIO2_006650
KBIO2_001514
PRESTWICK1_000140
PRESTWICK0_000140
NINDS_000827
SPECTRUM3_000565
SPECTRUM2_001329
SPBIO_001457
SPECTRUM4_000352
SPBIO_002159
PRESTWICK3_000140
BPBIO1_000242
tetracycline, >=98.0% (nt)
HMS2090B04
e701
NCGC00142507-02
tox21_300150
NCGC00254063-01
dtxcid703645
cas-60-54-8
dtxsid7023645 ,
SCHEMBL2116661
SCHEMBL2116649
tetraciclina
S4490
NCGC00017323-05
NCGC00017323-03
NCGC00017323-04
tetracycline [usp:inn:ban:jan]
ccris 9483
unii-f8vb5m810t
ec 200-481-9
f8vb5m810t ,
NCGC00017323-07
tetracycline [who-dd]
tetracycline [hsdb]
tetracycline [vandf]
tetracycline [inn]
tetracycline [green book]
tetracycline [orange book]
tetracycline [usp monograph]
tetracycline [jan]
tetracycline [ep monograph]
tetracycline [usp impurity]
(4r,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
oxytetracycline hydrochloride impurity b [ep impurity]
2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
lymecycline impurity h [ep impurity]
tetracycline component of pylera
tetracycline [mi]
tetracycline [mart.]
pylera component tetracycline
T3971
SCHEMBL3098
SCHEMBL537050
OFVLGDICTFRJMM-WESIUVDSSA-N
AKOS024277860
AB00053550_06
AB00053550_05
vetquamycin
economycin
bdbm50237605
tetrabid organon
tetracycline base
mfcd00151232
AKOS026749977
SR-01000000212-3
sr-01000000212
EN300-374118
SBI-0051530.P003
rkl10088
Z2144222809
CS-8188
NCGC00017323-15
60-54-8 (free base)
NWXMGUDVXFXRIG-WESIUVDSSA-N
HY-A0107
Q193045
SCHEMBL21271987
gtpl10927
brodspec
ala-tet
(4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
tetracyclinehydrate
BT166207
tetracycline dried down 2.5 microg/ml

Research Excerpts

Overview

Tetracycline (TC) is a widely used antibiotic suffering from poor water solubility and low bioavailability. Tetracy Cline pollution is an emerging threat in aquatic and terrestrial environments because of its widespread applications in human disease, livestock, and aquaculture.

ExcerptReferenceRelevance
"Tetracycline (TC) is a commonly used antibiotic that has gained wide spread notoriety owing to its high environmental risks. "( Insights into the mechanism of enhanced peroxymonosulfate degraded tetracycline using metal organic framework derived carbonyl modified carbon-coated Fe
Bi, F; Chen, H; Ji, W; Li, X; Lin, H; Xu, J; Yang, Y; Zhang, X; Zheng, Z, 2022
)
2.4
"Tetracycline (TC) is a typical ecotoxic antibiotic, which easily causes bacterial resistance. "( Oxidative degradation of tetracycline using peroxymonosulfate activated by cobalt-doped pomelo peel carbon composite.
An, L; Han, S; Wu, D; Xiao, P, 2022
)
2.47
"Tetracycline is a widely used antibiotic suffering from poor water solubility and low bioavailability. "( Antibacterial nanofibers of pullulan/tetracycline-cyclodextrin inclusion complexes for Fast-Disintegrating oral drug delivery.
Altier, C; Celebioglu, A; Chowdhury, R; Durgun, E; Hsiung, E; Kilic, ME; Uyar, T, 2022
)
2.44
"Tetracycline is a common antibiotic and is often carelessly released into the natural environment, thus constantly posing potential threats to the environment. "( Degradation of tetracycline by atmospheric-pressure non-thermal plasma: Enhanced performance, degradation mechanism, and toxicity evaluation.
Fang, C; Huang, Q; Wang, S; Xu, H, 2022
)
2.52
"Tetracyclines are a broad-spectrum class of antibiotics that have unclear actions with potentially lasting effects on bone metabolism. "( Tetracyclines and bone: Unclear actions with potentially lasting effects.
Davies, C; Hathaway-Schrader, JD; Lubker, R; Novince, CM; Warner, AJ, 2022
)
3.61
"Tetracycline pollution is an emerging threat in aquatic and terrestrial environments because of its widespread applications in human disease, livestock, and aquaculture. "( Tetracycline bioremediation using the novel Serratia marcescens strain WW1 isolated from a wastewater treatment plant.
Bhatt, P; Jeon, CH; Kim, W, 2022
)
3.61
"Tetracycline (TC) is a bacteriostatic agent that has a wide spectrum of antibacterial activity."( Tetracycline-loaded magnesium oxide nanoparticles with a potential bactericidal action against multidrug-resistant bacteria: In vitro and in vivo evidence.
Banerjee, S; Das, S; Ganguli, A; Nag, D; Vishakha, K, 2022
)
2.89
"Tetracyclines are a widely used group of antibiotics, many of which are currently only used in veterinary medicine and animal husbandry due to their adverse side effects. "( Metal and pH-Dependent Aptamer Binding of Tetracyclines Enabling Highly Sensitive Fluorescence Sensing.
Gao, B; Liu, J; Sun, P; Zhao, Y, 2022
)
2.43
"Tetracycline (TC) is an antibiotic that has been widely used in the animal husbandry. "( Zinc Ion-Based Switch-on Fluorescence-Sensing Probes for the Detection of Tetracycline.
Chen, YC; Tsai, JJ; Zhan, YC, 2022
)
2.39
"Tetracyclines are a class of broad-spectrum bacteriostatic antibiotics used to treat many infections, including methicillin-resistant Staphylococcus aureus (MRSA), acne, pelvic inflammatory disease, chlamydial infections, and a host of zoonotic infections. "( Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation.
Ahmadzadeh, S; Angelette, AL; Barras, AA; Cornett, EM; Delacroix, BM; Kaye, AD; Kaye, AM; Rando, LL; Shekoohi, S; Talbot, NC; Wadhwa, RD, 2023
)
3.8
"Tetracycline (TC) is a widely used antibiotic with a complex aromatic chemical structure and is highly resistant to biodegradation. "( Biological degradation and mineralization of tetracycline antibiotic using SBR equipped with a vertical axially rotating biological bed (SBR-VARB).
Aghapour, AA; Alizadeh, N; Khorsandi, H, 2023
)
2.61
"Tetracycline (TC) is an antibiotic that is recently found as an emerging pollutant with low biodegradability. "( Enrichment of tetracycline-degrading bacterial consortia: Microbial community succession and degradation characteristics and mechanism.
Chen, C; Chen, X; Ke, Y; Xie, S; Xu, M; Zhu, Y, 2023
)
2.71
"Tetracyclines (TCs) are an important class of antibiotics threatened by an emerging new resistance mechanism─enzymatic inactivation. "( Structure-Based Design of Bisubstrate Tetracycline Destructase Inhibitors That Block Flavin Redox Cycling.
Blake, KS; Dantas, G; DeAngelo, CM; Jones, KV; Kumar, H; Lam, KK; Tolia, NH; Wencewicz, TA; Williford, EE, 2023
)
2.62
"Tetracyclines are a class of antibiotics with a similar four-ringed structure. "( An aptamer array for discriminating tetracycline antibiotics based on binding-enhanced intrinsic fluorescence.
Chen, Y; Gao, B; Liu, J; Zhao, Y, 2023
)
2.63
"Tetracyclines are a potential alternative to quinolones as they have been used to treat acute otitis externa and are thought to be nontoxic to the inner ear."( Cytotoxicity of Tetracyclines in Human Tympanic Membrane Fibroblasts.
Antonelli, PJ; Dirain, CO, 2023
)
1.98
"Tetracyclines (TC) is a typical broad-spectrum antimicrobial agent, and excessive use of TC can lead to a large accumulation of residual tetracycline in water. "( The enhance mechanism of DOM on tetracyclines degradation by electrochemical technology: A improvement of treatment processes.
Cao, P; Fang, S; Li, D; Liu, H; Luo, M; Wang, Z; Zhang, C, 2023
)
2.64
"Tetracycline is an antibiotic that has been prescribed for COVID-19 treatment, raising concerns about antibiotic resistance after long-term use. "( Polyvinylpyrrolidone-passivated fluorescent iron oxide quantum dots for turn-off detection of tetracycline in biological fluids.
Chabib, L; Gedda, G; Huang, GG; Sudewi, S; Zulfajri, M, 2023
)
2.57
"Tetracycline (TC) is a broad-spectrum antibiotic and has been added to animal feeds to grow livestock under healthy conditions, making it important to have effective methods for rapidly detecting TC in complex samples. "( Using lanthanide ions as magnetic and sensing probes for the detection of tetracycline from complex samples.
Chen, YC; Chiu, CP; Zhan, YC, 2023
)
2.58
"Tetracycline (TC) is a widely used antibiotic that adversely affects ecosystems and, therefore, must be removed from the environment. "( Activation of peroxymonosulphate using a highly efficient and stable ZnFe
Gao, J; Li, C; Li, W; Liu, X; Song, D; Xiao, Y; Zhang, J; Zhao, X, 2023
)
2.35
"Tetracycline (TC) is a commonly used antibiotic that affects various physiological processes in plants. "( The toxic mechanism of tetracycline on root tips in hulless barley (Hordeum vulgare L. var. nudum).
Cao, X; Cui, X; Cui, Z; Li, T; Liu, J; Liu, W; Luan, X; Ma, R; Ni, S; Shan, S; Wang, X; Xue, W; Yu, X; Zhang, C; Zhang, S, 2023
)
2.66
"Tetracyclines (TCs) are a class of broad-spectrum antibiotics with diverse pharmacotherapeutic properties due to their various functional groups being attached to a common core structure. "( Unveiling the Osteogenic Potential of Tetracyclines: A Comparative Study in Human Mesenchymal Stem Cells.
Bettencourt, AF; Fernandes, MH; Gomes, PS; Martin, V; Santos, C, 2023
)
2.62
"Tetracycline (TTC) is an antibiotic that can be absorbed by MPs and have a harmful effect on human health."( Adsorption of tetracycline on polyvinyl chloride microplastics in aqueous environments.
Barikbin, B; Bonyadi, Z; Najafpoor, A; Zahmatkesh Anbarani, M, 2023
)
1.99
"Tetracycline is a widely used antibiotic and may thus also be an environmental contaminant with an influence on plant growth. "( Tetracycline inhibits the nitrogen fixation ability of soybean (Glycine max (L.) Merr.) nodules in black soil by altering the root and rhizosphere bacterial communities.
Chen, Y; Feng, C; Han, W; Jiang, Q; Liu, T; Zhang, B; Zhang, S; Zhang, Y, 2024
)
4.33
"Tetracycline is a type of broad-spectrum, naturally occurring antibiotic that leads to several side effects, such as affecting intestinal flora and increase in bacterial resistance. "( Investigation of the deprotonation of tetracycline using differential absorbance spectra: A comparative experimental and DFT/TD-DFT study.
Chen, B; Li, N; Li, Q; Yan, M; Zhang, C; Zuo, W, 2020
)
2.27
"Tetracycline (TC) is a commonly used human and veterinary antibiotic that is mostly discharged into wastewater in the form of the parent compounds. "( Interaction between tetracycline and microorganisms during wastewater treatment: A review.
Chu, Z; Liao, Q; Luo, H; Rong, H; Wang, R; Zhao, M, 2021
)
2.39
"Tetracycline (TET) is a broad-spectrum antibiotic, which is frequently used in the prevention and treatment of animal diseases, feed additives, and so on. "( Aptamer-Pendant DNA Tetrahedron Nanostructure Probe for Ultrasensitive Detection of Tetracycline by Coupling Target-Triggered Rolling Circle Amplification.
Cai, R; Hong, C; Huang, Z; Tan, W; Yang, D; Yang, H; Ye, S; Zhang, X, 2021
)
2.29
"Tetracyclines (TC) are a common antibiotic for using in livestock breeding and healthcare; however, due to the inappropriate application of TCs, more than 75% of TCs are excreted and released into the environment in an active form through human and animal urine and feces, which results in high levels of TCs in the ecological system, causing adverse effects on the food safety and human health. "( Graphene oxide-regulated low-background aptasensor for the "turn on" detection of tetracycline.
Feng, B; Jiang, Z; Qing, T; Xu, J; Zhang, P, 2021
)
2.29
"Tetracyclines are a major broad-spectrum antibiotic class, active against a wide range of Gram-positive and Gram-negative bacteria, and they are the leading choice for the treatment of many conditions in veterinary medicine in recent years."( Emerging Electrochemical Sensors for Real-Time Detection of Tetracyclines in Milk.
Corrigan, DK; Henriquez, FL; Holdsworth, M; Raykova, MR; Ward, AC, 2021
)
1.58
"The tetracycline destructases are a recently discovered family of tetracycline-inactivating flavoenzymes from pathogens and soil metagenomes that have a high potential for broad dissemination."( Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes.
Dantas, G; Elliott, JL; Gasparrini, AJ; Park, J; Reck, MR; Symister, CT; Tolia, NH; Vogel, JP; Wencewicz, TA, 2017
)
1.19
"Tetracycline is a photosensitising medication that increases skin vulnerability to UV-related damage."( Tetracycline use and risk of incident skin cancer: a prospective study.
Cho, E; Drucker, AM; Laden, F; Li, S; Li, WQ; Qureshi, AA; VoPham, T; Weinstock, MA, 2018
)
3.37
"Tetracycline (TC) is an inexpensive broad-spectrum antibiotic used to treat infectious diseases and to promote growth in animals. "( Test strips based on iron(iii)-impregnated alginate/polyacrylonitrile nanofibers for naked eye screening of tetracycline.
Li, Y; Mohammed, A; Wang, L, 2018
)
2.14
"Tetracyclines are a class of antimicrobials frequently found in the environment, and have promoted the proliferation of antibiotic resistance. "( Bioavailability of tetracycline to antibiotic resistant Escherichia coli in water-clay systems.
Boyd, SA; Li, H; Teppen, BJ; Tiedje, JM; Zhang, W; Zhang, Y; Zhu, D, 2018
)
2.25
"Tetracycline (TC) is a veterinary drug, wildly prescribed for prophylactic and therapeutic purposes. "( Development and application of a novel electrochemical immunosensor for tetracycline screening in honey using a fully integrated electrochemical Bio-MEMS.
Baraket, A; Bausells, J; Bouchikhi, B; Boudjaoui, S; El Alami El Hassani, N; El Bari, N; Elaissari, A; Errachid, A; Taveira Tenório Neto, E; Zine, N, 2019
)
2.19
"Tetracycline (TC) is a frequently used antibiotic in human therapy, veterinary industry, and agricultural sectors."( Enhanced tetracycline removal by in-situ NiFe nanoparticles coated sand in column reactor.
Das, B; Gopal, G; Mrudula, P; Mukherjee, A; Natarajan, C; Ravikumar, KVG; Sikarwar, D; Singh, AS, 2019
)
1.65
"Tetracycline (TC) is an antibiotic produced on the largest scale in the world and used for the treatment of both humans and animals. "( Influence of light and Fe(III) ions on tetracycline degradation.
Grajek, H; Margas, M; Piotrowicz-Cieślak, AI; Rydzyński, D; Smyk, B; Wasilewski, J, 2019
)
2.23
"Tetracycline is an antibiotic that frequently contaminates the environment. "( Effects of tetracycline on growth, oxidative stress response, and metabolite pattern of ryegrass.
Chen, X; Ge, S; Guo, W; Han, T; Huang, H; Jiang, L; Li, Q; Li, X; Li, Y; Liang, Y; Liu, Z; Mi, Z; Pan, F; Tang, Y; Wang, J; Wu, M; Wu, Z; Yang, L; Zhang, L; Zhang, Z; Zhou, J, 2019
)
2.35
"Tetracycline (TC) is a broad-spectrum antibiotic produced, indicated for use against many bacterial infections."( Adsorption properties of tetracycline onto graphene oxide: equilibrium, kinetic and thermodynamic studies.
Ghadim, EE; Hosseini, H; Kimiagar, S; Manouchehri, F; Nafisi, S; Soleimani, G, 2013
)
1.41
"Tetracycline is a broad-spectrum antibiotic used to treat infections in swine. "( Tetracycline residues in porcine stomach after administration via drinking water on a swine farm.
Barlow, B; Baynes, R; Brooks, J; Lindquist, D; Mason, S; Schill, K; Wu, H; Yeatts, J, 2014
)
3.29
"Tetracyclines are a large class of antimicrobials used most extensively in livestock feeding operations. "( Organic acids enhance bioavailability of tetracycline in water to Escherichia coli for uptake and expression of antibiotic resistance.
Boyd, SA; Li, H; Teppen, BJ; Tiedje, JM; Zhang, Y, 2014
)
2.11
"Tetracycline (TC) is a common antibacterial agent used for prevention and control of animal diseases. "( A direct competitive assay-based aptasensor for sensitive determination of tetracycline residue in honey.
Chen, Q; Dong, Y; Liu, J; Su, H; Tan, T; Wang, S; Yong, W; Zhang, L, 2015
)
2.09
"Tetracycline (TC) is a widely used veterinary drug in animal breeding and fishery. "( Binding of the veterinary drug tetracycline to bovine hemoglobin and toxicological implications.
Chi, Z; Liu, R; Wang, D; You, H, 2014
)
2.13
"Tetracycline is a type of antibiotic and its potential toxicity is causing environmental concern."( Effects of tetracycline on developmental toxicity and molecular responses in zebrafish (Danio rerio) embryos.
Cheng, J; Xin, Q; Zhang, Q, 2015
)
1.53
"Tetracycline is a semisynthetic antibiotic and is used in several types of infections against both gram-positive and gram-negative bacteria. "( Effect of tetracycline and UV radiation on melanization and antioxidant status of melanocytes.
Beberok, A; Buszman, E; Delijewski, M; Otręba, M; Rok, J; Wrześniok, D, 2015
)
2.26
"Tetracycline (TET) is a broad-spectrum antibiotic with activity against several protozoan parasites, but the mode of action of TET in parasites remains poorly understood."( Novel insights into the molecular events linking to cell death induced by tetracycline in the amitochondriate protozoan Trichomonas vaginalis.
Cheng, CC; Cheng, WH; Chu, LJ; Fang, YK; Huang, KY; Huang, PJ; Ku, FM; Lee, CC; Tang, P; Wu, HH, 2015
)
1.37
"Tetracycline (TC) is a well-known broad spectrum antibiotic, which is effective against many Gram positive and Gram negative bacteria. "( Tetracycline-Containing MCM-41 Mesoporous Silica Nanoparticles for the Treatment of Escherichia coli.
Chavala, SH; Conson, M; Di Pasqua, AJ; Holbert, B; Koneru, B; Miller, ML; Ni, A; Shi, Y; Wang, YC, 2015
)
3.3
"Tetracycline, which is a type of broad-spectrum antibiotic, was selected as the template."( Fluorescence Probe Based on Hybrid Mesoporous Silica/Quantum Dot/Molecularly Imprinted Polymer for Detection of Tetracycline.
Chen, L; Zhang, L, 2016
)
1.37
"The tetracycline aptamer is an in vitro selected RNA that binds to the antibiotic with the highest known affinity of an artificial RNA for a small molecule (Kd approximately 0.8 nM). "( Structural basis for specific, high-affinity tetracycline binding by an in vitro evolved aptamer and artificial riboswitch.
Edwards, TE; Ferré-D'Amaré, AR; Xiao, H, 2008
)
1.16
"Tetracycline (Tc) is a broad-spectrum antibiotic that kills bacteria by interrupting protein biosynthesis. "( Binding of tetracyclines to elongation factor Tu, the Tet repressor, and the ribosome: a molecular dynamics simulation study.
Aleksandrov, A; Simonson, T, 2008
)
2.18
"Tetracycline is a well-tolerated topical agent and is particularly effective in the treatment of inflammatory lesions in acne."( Topical tetracycline in the treatment of acne vulgaris.
Adişen, E; Durukan, E; Gurer, MA; Kaymak, Y, 2008
)
2.22
"Tetracycline (TC) is a group of broad spectrum antibiotics used extensively in human and veterinary medicine."( Adsorption of tetracycline on kaolinite with pH-dependent surface charges.
Ackley, C; Fenske, N; Li, Z; Schulz, L, 2010
)
1.44
"Tetracyclines (TCs) are a group of widely used antibiotics that have been frequently found in the aquatic environment. "( Reactions of tetracycline antibiotics with chlorine dioxide and free chlorine.
He, YL; Huang, CH; Wang, P, 2011
)
2.18
"The tetracycline operon is a self-regulated system. "( Stochastic simulations of the tetracycline operon.
Biliouris, K; Daoutidis, P; Kaznessis, YN, 2011
)
1.22
"Tetracycline is a commonly used drug for rosacea and subantimicrobial doses may resolve the disease in many cases. "( Letter: Tetracycline-induced hepatotoxicity.
Feldman, SR; Glenn, C, 2011
)
2.25
"Tetracycline (TC) is a veterinary antibiotic that is frequently detected as pollutant in the environment. "( Sorption of tetracycline on organo-montmorillonites.
Koopal, LK; Liu, F; Liu, MM; Liu, N; Tan, WF; Wang, MX; Weng, L, 2012
)
2.2
"Tetracycline is a widely used broad spectrum antibiotic. "( Synthesis and analysis of a methyl ether derivative of tetracycline which inhibits growth of Escherichia coli.
Bartzatt, R; Benish, T; Koziol, K; Stoddard, J, 2002
)
2
"Tetracycline (Tc) is an important antibiotic, which binds specifically to the ribosome and several proteins, in the form of a Tc-:Mg2+ complex. "( The tetracycline: Mg2+ complex: a molecular mechanics force field.
Aleksandrov, A; Simonson, T, 2006
)
2.33
"Tetracycline (TC) is a broad-spectrum antibiotic used increasingly in animal husbandry to treat diseases or to promote growth as feed additives. "( Preparation of anti-tetracycline antibodies and development of an indirect heterologous competitive enzyme-linked immunosorbent assay to detect residues of tetracycline in milk.
Liu, W; Lu, S; Xi, R; Zhang, Y; Zhao, C, 2007
)
2.11
"Tetracyclines are a common acne treatment."( Minocycline- and tetracycline-induced hypertriglyceridemia in an HIV-seropositive patient receiving combination antiretroviral therapy.
Bondy, G; Crawford, RI; Somani, N,
)
1.19
"Oxytetracycline (OXY) is a broad-range antimicrobial routinely used in pig production, at doses in the range of few g/kg of medicated feed, during the weaning period. "( Oxytetracycline as environmental contaminant in arable lands.
Barchi, D; Bonazzi, G; Brambilla, G; De Filippis, SP; Mantovi, P; Migliore, L; Patrizii, M, 2007
)
1.58
"Tetracycline acts as an inducer of the system and restores the level of beta-galactosidase activity measured in transformants containing pTB-1 alone."( Plasmid vectors based on Tn10 DNA: gene expression regulated by tetracycline.
Allet, B; Bertrand, KP; Davies, J; de la Torre, JC; Delamarter, J; Domingo, E; Ortín, J; Reznikoff, WS; Wray, LV, 1984
)
1.23
"Tetracycline functions as an inducer in these experiments."( Control of expression of the Tn10-encoded tetracycline resistance operon. II. Interaction of RNA polymerase and TET repressor with the tet operon regulatory region.
Gatz, C; Hillen, W; Schollmeier, K, 1984
)
1.25
"The tetracyclines are a group of widely used antibiotics that have been incriminated in causing adverse hematologic problems, including hemolytic anemia. "( Tetracycline-induced hemolytic anemia.
Kryda, MD; Mazza, JJ, 1980
)
2.26
"Tetracycline sclerotherapy is a safe, effective, and economical form of out-patient therapy that can be recommended as primary treatment for hydroceles in patients who have undergone renal transplantation."( Tetracycline sclerotherapy for testicular hydroceles in renal transplant recipients.
Eraky, I; Ghoneim, MA; Hassan, N; Mohsen, T; Shokeir, AA; Wafa, EW, 1994
)
3.17
"Tetracycline pleurodesis is an effective and well-tolerated paliative treatment for MPE. "( [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Aparicio Urtasun, J; Fullana Monllor, J; Marco Martínez, V; Martínez Moragón, E; Montalar Salcedo, J; Sanchis Aldás, J; Sanchis Moret, F, 1993
)
2.64
"Tetracycline is an antibiotic which has been proven beneficial as an immunomodulating drug in the treatment of autoimmune bullous diseases."( Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999
)
2.03
"Tetracycline is an important component of combination therapies for Helicobacter pylori eradication. "( Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.
El-Zaatari, FA; Graham, DY; Kato, M; Kim, JJ; Kwon, DH; Lee, M; Osato, MS; Yamaoka, Y, 2000
)
2.03
"Tetracycline (TET) is a front-line antibiotic for the treatment of chlamydial infections in both humans and animals, and the emergence of TET-resistant (Tet(r)) Chlamydia is of significant clinical importance. "( Growth and development of tetracycline-resistant Chlamydia suis.
Andersen, AA; Lenart, J; Rockey, DD, 2001
)
2.05
"Tetracycline is an effective drug for management of childhood brucellosis."( Brucellosis in children in Iraq.
Al-Dubooni, HM; Al-Shirkat, SA; Nagi, NA, 1986
)
0.99
"Tetracycline is an effective antimicrobial medicine for treatment of cervical Chlamydia trachomatis infection."( [The importance of tetracycline treatment of cervical Chlamydia trachomatis infections: control with cervical smears].
Demirezen, S; Ozcan, M, 1988
)
1.32
"Tetracycline sclerotherapy is a safe and effective alternative to surgery for hydroceles and epididymal cysts in older patients."( Tetracycline sclerotherapy for hydroceles and epididymal cysts.
Bullock, N; Thurston, AV, 1987
)
2.44
"Tetracycline is an antibiotic that absorbs ultraviolet light at 355 nm and preferentially binds to atherosclerotic plaque both in vitro and in vivo. "( Selective absorption of ultraviolet laser energy by human atherosclerotic plaque treated with tetracycline.
Ginsburg, R; Huestis, W; Kosek, J; Mehigan, J; Mok, W; Murphy-Chutorian, D; Profitt, D; Quay, S, 1985
)
1.93
"Tetracycline continues to be an effective antimicrobial agent in the clinical control of cholera but because of its high cost, relatively short shelf-life and recent reports of increased resistance of vibrios to tetracycline in vitro, alternative antimicrobial agents have been tested. "( Furazolidone in paediatric cholera.
Curlin, GT; Hirschhorn, N; Huq, MI; Karchmer, AW, 1970
)
1.69

Effects

Tetracycline (TC) residues have been noted as an important class of emerging contaminants in the environment, thus fast, straightforward, highly sensitive detection method is becoming an issue that must be addressed. Tetracy Cline has been frequently detected in municipal wastewater due to its extended use for various purposes.

ExcerptReferenceRelevance
"Tetracycline has an established track record for safety."( Studies of quinacrine and of tetracycline for non-surgical female sterilization.
Kessel, E; Mullick, B; Mumford, SD, 1987
)
1.29
"Tetracyclines (TCs) have been extensively used for humans and animal diseases treatment and livestock growth promotion. "( An insight into tetracycline photocatalytic degradation by MOFs using the artificial intelligence technique.
Abida, O; Baghban, A; Esmaeili, A; Gheytanzadeh, M; Habibzadeh, S; Jabbour, K; Mohaddespour, A, 2022
)
2.51
"Tetracycline (TC) has been frequently detected in various environments, thus promoting the occurrence of resistance in bacterial populations. "( Soybean straw biochar activating peroxydisulfate to simultaneously eliminate tetracycline and tetracycline resistance bacteria: Insights on the mechanism.
Duan, R; Fu, H; He, M; Li, G; Ma, S; Wang, B; Xu, S; Zhao, P, 2022
)
2.39
"Tetracycline-class drugs have been used for first-line treatment of moderate-to-severe acne and rosacea for decades. "( Sarecycline: A Narrow-Spectrum Antibiotic.
Adjei, S; Miller, AC; Temiz, LA; Tyring, SK, 2022
)
2.16
"Tetracycline (TC) residues have been noted as an important class of emerging contaminants in the environment, thus fast, straightforward, highly sensitive detection method is becoming an issue that must be addressed. "( Dual-functional CDs@ZIF-8/chitosan luminescent film sensors for simultaneous detection and adsorption of tetracycline.
Cao, S; Feng, X; Miao, M; Mu, L; Yang, Y, 2022
)
2.38
"Tetracycline has been frequently detected in municipal wastewater due to its extended use for various purposes. "( Tetracycline-induced decoupling of symbiosis in microalgal-bacterial granular sludge.
Gu, J; Ji, B; Liu, Y; Ma, Y; Wang, S; Zhang, M, 2021
)
3.51
"Many tetracycline analogs have been accessed through both total synthesis and semisynthesis, but key C-ring tetracycline analogs remain inaccessible."( Heterologous Catalysis of the Final Steps of Tetracycline Biosynthesis by
Cornish, VW; Herbst, E; Lee, A; Snyder, SA; Tang, Y, 2021
)
1.34
"Tetracycline (TC) has been widely used in veterinary medicines and disease treatments, and has been discharged into nature system due to manure application. "( [Natural attenuation of tetracycline in the water of Taihu Lake under different environmental conditions].
Duan, LC; Ji, YX; Wang, FH; Wang, GX; Zhang, F; Zhao, B, 2014
)
2.15
"Tetracycline hydrochloride has been shown to produce changes on periodontally involved root surfaces that can potentially enhance periodontal regeneration. "( Comparative evaluation of root surface morphology after planing and root conditioning with tetracycline hydrochloride--an in vitro SEM study.
Arora, S; Chaubey, KK; Dwivedi, S; Mittal, M; Vashisth, P,
)
1.79
"Tetracycline (TC) has been used as a broad spectrum antibiotic with low risk of CDI and a photosensitizer (PS) in PDT."( In vitro augmented photodynamic bactericidal activity of tetracycline and chitosan against Clostridium difficile KCTC5009 in the planktonic cultures.
Chae, H; Choi, S; Lee, H; Yu, J, 2015
)
1.38
"Tetracycline antibiotics have been increasingly used in medical applications and have been found in wastewater treatment plants as a result of human and industrial activities. "( Effect of Tetracycline Antibiotics on Performance and Microbial Community of Algal Photo-Bioreactor.
Taşkan, E, 2016
)
2.28
"Tetracyclines have been important agents in combating infectious disease since their discovery in the mid-20th century. "( Decoding and engineering tetracycline biosynthesis.
Pickens, LB; Tang, Y, 2009
)
2.1
"Tetracycline has been widely used for decades in human and veterinary medicines, with incremental residues in the environment and adverse influences on living organisms."( Genotoxicity of tetracycline as an emerging pollutant on root meristem cells of wheat (Triticum aestivum L.).
Bao, Q; Bao, Y; He, Z; Xie, X; Zhou, Q, 2011
)
1.44
"Tetracyclines have been proposed for AD therapy, although their effects on the aggregation of Aβ protein, particularly their ability to interact in vivo with the Aβ oligomers and/or aggregates, remain to be understood."( Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers.
Ami, D; Cassata, G; De Luigi, A; Diomede, L; Doglia, SM; Fiordaliso, F; Natalello, A; Salio, M; Salmona, M, 2010
)
2.52
"Oral tetracyclines have been considered the first line treatment for years."( Evidence based review of perioral dermatitis therapy.
Hall, CS; Reichenberg, J, 2010
)
0.82
"Tetracyclines have been used for treatment of a wide variety of gram-positive and gram-negative bacterial infections since the 1950s. "( Tetracycline therapy: update.
Roberts, MC, 2003
)
3.2
"Tetracycline has been used to cure filariae of Wolbachia, as a novel means of chemotherapeutic treatment for both ocular and lymphatic filariasis."( Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment.
Chirgwin, SR; Coleman, SU; Klei, TR; Nowling, JM,
)
1.06
"Tetracyclines have been extensively used as adjunctives to conventional periodontal therapy. "( Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
Colombo, AP; Feres-Filho, EJ; Gonçalves, C; Rodrigues, RM; Souto, R; Uzeda, M, 2004
)
1.99
"Tetracycline (TCN) has been considered the agent of choice for pleurodesis in patients with symptomatic malignant pleural effusions and recurrent pneumothoraces. "( Effects of erythromycin on the rabbit pleura: its potential role as a pleural sclerosant.
Carvalho, P; Charan, NB; Crowley, JJ; Hawk, PA; Knight, LL; Olson, RD, 1995
)
1.73
"Tetracycline pleurodesis has been shown to be a good alternative for the prevention of recurrence of SP."( Spontaneous pneumothorax. Long-term results with tetracycline pleurodesis.
Alfageme, I; Beiztegui, A; Hernandez, J; Huertas, C; Moreno, L; Vargas, A, 1994
)
1.26
"Tetracyclines have been widely used as adjuncts in periodontal therapy due to the antimicrobial efficacy of these drugs. "( Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism.
Chang, KM; Evans, RT; Golub, LM; Klausen, B; McNamara, TF; Murray, PA; Ramamurthy, NS, 1994
)
3.17
"Tetracycline has been one of the most commonly used agents for producing a pleurodesis. "( Corynebacterium parvum versus tetracycline as pleural sclerosing agents in rabbits.
Carmo, AO; Light, RW; Silva, LM; Teixeira, LR; Vargas, FS; Wang, NS, 1995
)
2.02
"Tetracyclines have been used extensively as antibiotics and growth promoters in the poultry industry. "( Tetracycline derivatives inhibit cartilage degradation in cultured embryonic chick tibiae.
Chlebek, KA; Cole, AA; Orth, MW; Schmid, TM,
)
3.02
"Both tetracycline and bleomycin have been shown to be effective for intrapleural instillation, although neither agent has definitively proved advantages over the other."( Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin.
Aparicio, J; Gil-Suay, V; Martínez-Moragón, E; Rogado, MC; Sanchis, F; Sanchis, J, 1997
)
0.99
"Tetracycline antibiotics have been reported to possess anti-resorptive properties in addition to their anti-microbial actions."( The effect of systemic tetracycline on resorption of dried replanted dogs' teeth.
Choi, GW; Sae-Lim, V; Trope, M; Wang, CY, 1998
)
1.33
"Tetracycline has been determined in human serum samples by a combination of: (1) synchronous fluorescence spectra of whole sera treated with Mg2+, and (2) the multivariate calibration methods of partial least-squares (PLS-1) and a variant of the recently introduced hybrid linear analysis (HLA), which does not require the knowledge of pure-component spectra. "( Enhanced synchronous spectrofluorometric determination of tetracycline in blood serum by chemometric analysis. Comparison of partial least-squares and hybrid linear analysis calibrations.
Goicoechea, HC; Olivieri, AC, 1999
)
1.99
"Tetracyclines (TTC) have been used both systemically and locally during periodontal bone grafting procedures, but previous work regarding the effect of TTC on new bone formation has been contradictory. "( Histologic evaluation of combining tetracycline and allogeneic freeze-dried bone on bone regeneration in experimental defects in baboons.
Drury, GI; Yukna, RA, 1991
)
2
"Tetracycline has been shown to collect selectively in atherosclerotic plaque and is a known photosensitizing agent. "( Plaque modification with tetracycline: enhanced tissue ablation with the excimer laser.
Berbaum, KS; Cragg, AH; Landas, SK; Smith, TP, 1990
)
2.03
"Tetracycline has been shown in both animal and human studies to be effective in preventing the recurrence of a pleural effusion while producing only minor side effects, such as fever and pleuritic pain."( Pleural effusions: pathophysiology and management with intrapleural tetracycline.
Oszko, MA, 1988
)
1.23
"Tetracycline sclerotherapy has been described for treatment of intrathoracic and other intracavitary fluid collections."( Tetracycline sclerotherapy for chylous fistula following neck dissection.
Alessi, D; Calcaterra, TC; Metson, R, 1986
)
2.44

Actions

Tetracyclines inhibit not only bacterial but also mitochondrial translation, thus imposing a low level of mitochondrial stress on eukaryotic cells. Tetracy Cline remains the treatment of choice for chronic maintenance of uncomplicated acne.

ExcerptReferenceRelevance
"Tetracyclines inhibit not only bacterial but also mitochondrial translation, thus imposing a low level of mitochondrial stress on eukaryotic cells."( Tetracycline-induced mitohormesis mediates disease tolerance against influenza.
Auwerx, J; D'Amico, D; El Alam, G; Grier, MC; Harris, NL; Katsyuba, E; Li, TY; Liaskos, D; Mottis, A; Mouchiroud, L; Nelson, ML; Rapin, A, 2022
)
2.89
"Tetracycline can cause hepatic steatosis, and ER stress may be involved in tetracycline-induced fatty liver."( Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice.
Cheng, XY; Li, HW; Li, Y; Lin, AB; Qu, JG; Yao, XM, 2016
)
1.48
"Tetracycline did not inhibit hyphal formation at sublethal concentrations."( Tetracycline effects on Candida albicans virulence factors.
Essmann, M; Larsen, B; Mai, H; McCool, L, 2008
)
2.51
"Tetracyclines (TTCs) inhibit the catalytic activities of human metalloproteinases."( Effect of systemic tetracycline on the degradation of tetracycline-impregnated bilayered collagen membranes: an animal study.
Bornstein, MM; Frenkel, T; Moses, O; Nemcovsky, CE; Tal, H; Weinreb, M, 2010
)
1.41
"Tetracyclines may cause esophageal injury."( Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury.
Avsar, E; Gencosmanoglu, R; Kurtkaya-Yapicier, O; Oran, ES; Tiftikci, A; Tozun, N, 2004
)
1.98
"Tetracycline, because of its effectiveness, safety, and economy, remains the treatment of choice for chronic maintenance of uncomplicated acne. "( Clindamycin for tetracycline-resistant acne.
Basler, RS, 1980
)
2.05
"Tetracycline failed to inhibit the adriamycin-induced increase in serum CPK."( Effect of tetracycline on adriamycin cardiotoxicity.
Cady, W; Modrak, J; Pour, A, 1981
)
1.39
"Chlortetracycline did not inhibit cartilage degradation at concentrations tested."( Tetracycline derivatives inhibit cartilage degradation in cultured embryonic chick tibiae.
Chlebek, KA; Cole, AA; Orth, MW; Schmid, TM,
)
2.03
"Tetracycline inhibited the increase in isolation of Gram negative organisms in six subjects, enhanced it in three and had no effect on one subject."( Physiological and environmental control of Gram negative bacteria on skin.
Duncan, WC; Knox, JM; McBride, ME, 1975
)
0.98
"Tetracyclines did not inhibit enzymatic activity of carbonic anhydrase."( Binding of antibiotics to the human intracellular erythrocyte proteins hemoglobin and carbonic anhydase.
Kornguth, ML; Kunin, CM, 1976
)
0.98
"Tetracycline is known to cause hepatic dysfunction in humans by inducing steatosis. "( Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes.
Deboyser, D; Goethals, F; Krack, G; Roberfroid, M, 1989
)
1.99
"Tetracyclines inhibit the binding of catecholamines to collagen and elastin."( Binding of catecholamines to connective tissue and the effect upon the responses of blood vessels to noradrenaline and to nerve stimulation.
Powis, G, 1973
)
0.97

Treatment

Treatment with tetracycline or rifampin for two weeks usually results in cure. Treatment with TMP-SMZ alone (four to eight weeks) or in combination with streptomycin (two to four weeks) resulted in a relapse rate of 16.6%.

ExcerptReferenceRelevance
"Tetracycline treatment also increased the levels of oxoglutaric acid, L-glutamic acid, gamma-aminobutyric acid, and gamma-glutamylalanine and enzymes involved in their production; and decreased the levels of L-isoleucine, L-valine, and L-leucine and enzymes involved in their production."( Integrated transcriptomic, proteomic and metabolomic analysis provides new insights into tetracycline stress tolerance in pumpkin.
Ge, S; Han, T; Hou, Y; Wang, X; Yu, J; Zhang, H; Zhao, J, 2024
)
2.39
"Tetracycline treatment of either the tick or the vertebrate host reduced levels of bacteria in progeny in 74% for eggs and 90% for larvae without major impact neither on the reproductive fitness of the adult female or on embryo development."( A Coxiella mutualist symbiont is essential to the development of Rhipicephalus microplus.
Albano, RM; Farber, M; Gonzales, SA; Guizzo, MG; Leite, MS; Martins, O; Nunes, RD; Oldiges, DP; Oliveira, PL; Oliveira, WHC; Parizi, LF; Schama, R; Tirloni, L; Vaz, IDS; Vieira, RP, 2017
)
1.18
"Tetracycline treatment significantly delayed oviposition of I."( Ixodes pacificus ticks maintain embryogenesis and egg hatching after antibiotic treatment of Rickettsia endosymbiont.
Cheng, D; Kurlovs, AH; Li, J; Zhong, J, 2014
)
1.12
"Tetracycline treatments were used to cure M."( Wolbachia induces strong cytoplasmic incompatibility in the predatory bug Macrolophus pygmaeus.
De Clercq, P; Dermauw, W; Gehesquière, B; Gheysen, G; Machtelinckx, T; Van Leeuwen, T; Vandekerkhove, B; Vanholme, B, 2009
)
1.07
"Tetracycline treatment concomitantly promotes loss of recycling endosome-associated GFP-Rabs and acquisition of GFP-Rab5, GFP-Rab7, and the lysosomal marker, LAMP-1."( The Anaplasma phagocytophilum-occupied vacuole selectively recruits Rab-GTPases that are predominantly associated with recycling endosomes.
Carlyon, JA; Huang, B; Hubber, A; McDonough, JA; Roy, CR; Scidmore, MA, 2010
)
1.08
"Tetracycline treatment significantly increased the expression of BMPRII-Flag mRNA and protein in FT293-BMPRII cells, but induced no significant changes in expression of Id1, Id2, Id3, Smad6, or Smad7 mRNA."( Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
Asano, M; Hayashi, H; Kanetaka, H; Kano, M; Kudo, TA; Okumoto, A; Shimizu, Y; Tamura, S; Watanabe, A; Zhang, Y; Zhao, F, 2010
)
1.08
"Tetracycline treatment induced CD24 expression in a dose- and time-dependent fashion, which was abrogated following treatment with anti-CD24 monoclonal antibodies (mAbs)."( The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
Arber, N; Kazanov, D; Kraus, S; Shapira, S; Starr, A; Weisblatt, S, 2011
)
1.09
"Tetracycline treatment of L4 or adult Brugia pahangi in vivo resulted in Wolbachia clearance."( Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment.
Chirgwin, SR; Coleman, SU; Klei, TR; Nowling, JM,
)
1.06
"Tetracycline treatment of RII transfectants led to the suppression of p21/waf1/cip1and p27/kip expression, thus, directly demonstrating induction of CDK inhibitors by autocrine TGF-beta leading to growth control of ER(+) breast cancer cells."( Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
Ammanamanchi, S; Brattain, MG; Ko, TC; Tillekeratne, MP, 2004
)
1.04
"Tetracycline treatment generally leads to clinical and biological recovery."( [Human granulocytic ehrlichiosis in Europe].
Abadia, G; Amiel, C; Choudat, D, 2004
)
1.04
"Tetracycline-treated females produced many male progeny even though untreated females produced only female progeny."( Detection of 'candidatus Cardinium' bacteria from the haploid host Brevipalpus californicus (Acari: Tenuipalpidae) and effect on the host.
Chigira, A; Miura, K, 2005
)
1.05
"Tetracycline treatments effected a 7-fold decrease in streptococci, but the difference was not significant (P = .07)."( Osseous coagulum collected in bone traps: potential for bacterial contamination and methods for decontamination.
Etcheson, AW; Gillespie, MJ; Miley, DD, 2007
)
1.06
"The tetracycline-treated tet-ERG9aus1 strain failed to grow in the presence of serum, whereas the parental tet-ERG9AUS1 strain grew by incorporating sterol from exogenously supplied serum. "( The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum.
Aoyama, T; Bard, M; Chibana, H; Hodgson, W; Kumaraswami, NS; Metzler, L; Nakayama, H; Niimi, M; Takano, Y; Takemori, D; Tanabe, K; Wu, S, 2007
)
0.9
"Tetracycline hydrochloride treatment of cementum and dentin surfaces derived from human teeth not affected by periodontitis resulted in the removal of the smear layer and uncovered a fibrillar collagen substrate. "( Nondiseased cementum and dentin root surface following tetracycline hydrochloride conditioning: SEM study of the effects of solution concentration and application time.
Calura, G; Scabbia, A; Trombelli, L, 1994
)
1.98
"A tetracycline treatment that eradicates bacterial parasites from insects, abolishes the dnaA sequences from Drosophila and Nasonia DNA."( A prokaryotic dnaA sequence in Drosophila melanogaster: Wolbachia infection and cytoplasmic incompatibility among laboratory strains.
Bourtzis, K; Nirgianaki, A; Onyango, P; Savakis, C, 1994
)
0.85
"A tetracycline-treated group (60 mg/kg per day) and an untreated control group were included for comparisons."( Efficacy of various therapeutic regimens in eliminating Pasteurella pneumotropica from the mouse.
Forsythe, DB; Goelz, MF; Locklear, J; Mahler, J; Rogers, WP; Thigpen, JE; Weigler, BJ, 1996
)
0.85
"Tetracycline is the treatment of choice."( Rickettsialpox.
Boyd, AS, 1997
)
1.02
"The tetracycline treatment led no reduction in HSV-1 synthesis in cells transfected with infectious HSV-1 DNA alone."( A novel tetracycline-inducible viral replication switch.
Eriksson, E; Yao, F, 1999
)
1.22
"Tetracycline-treated animals demonstrated significantly less resorption of the buccal alveolar bone."( Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat.
Bissada, NF; DeMarco, TJ; Weiner, GS, 1979
)
1.27
"Tetracycline-treated surfaces had greater numbers of attached cells at both time points compared to untreated controls."( Tissue interactions with dentin specimens after demineralization using tetracycline.
Frantz, B; Polson, A, 1988
)
1.23
"The tetracycline and SC/RP treatment modalities resulted in statistically significant clinical and microbiological improvements when compared with the control."( Clinical and microbiologic effects of local tetracycline irrigation on periodontitis.
Bissada, N; Greenwell, H; Manouchehr-Pour, M; Silverstein, L, 1988
)
1.02
"Tetracycline-treated conventional nu/nu, but not nu/+, mice were also colonized with C."( Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice.
Balish, E; Balish, MJ; Bartizal, KF; Salkowski, CA, 1987
)
0.99
"Tetracycline-treated human cadaveric aorta was compared with untreated aorta using several techniques: absorptive spectrophotometry, which demonstrated a distinct absorptive peak at 355 nm in tetracycline-treated plaque that was absent in treated normal vessel; ultraviolet microscopy, which showed that treated atheroma acquired the characteristic fluorescence of tetracycline under ultraviolet light; and tissue uptake of radiolabeled tetracycline, which showed 4-fold greater uptake by atheroma than by normal vessel."( Selective absorption of ultraviolet laser energy by human atherosclerotic plaque treated with tetracycline.
Ginsburg, R; Huestis, W; Kosek, J; Mehigan, J; Mok, W; Murphy-Chutorian, D; Profitt, D; Quay, S, 1985
)
1.21
"Treatment with tetracycline or doxycycline drove the emergence of enhanced resistance through mutations in an RluD-like protein-encoding gene and duplications of"( Antibiotics Limit Adaptation of Drug-Resistant Staphylococcus aureus to Hypoxia.
Brockhurst, MA; Condliffe, AM; Foster, SJ; Hull, RC; Rzaska, J; Sayers, JR; Sutton, JAF; Wright, RCT, 2022
)
1.06
"Treatment with tetracycline of the SCID mice for 8 hours proves the tetracycline impact on bacteria viability in vivo, rising the necrotic bacteria releasing GFP fragments."( Induced death of Escherichia coli encapsulated in a hollow fiber membrane as observed in vitro or after subcutaneous implantation.
Granicka, LH; Kawiak, J; Wasilewska, D; Weryn, A; Zolnierowicz, J, 2010
)
0.7
"Treatment with tetracycline or doxycycline resulted in a significant decline in cytokine levels."( Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever.
Castro, JE; Fredeking, TM; Perez-Osorio, C; Vado-Solis, I, 2011
)
0.93
"coli treated with tetracycline was 40% lower when inactivation by UV light or chlorination reached 3-log but was 1.18 times greater when inactivation by chlorination reached 4.3-log."( Effect of chlorination and ultraviolet disinfection on tetA-mediated tetracycline resistance of Escherichia coli.
Hu, HY; Huang, JJ; Lu, Y; Wei, B; Wu, YH, 2013
)
0.95
"Pretreatment with tetracycline inhibited the mRNA and protein expressions of tumor necrosis factor α and interleukin 6 and decreased the numbers of activated and phagocytotic microglia."( Tetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy.
Dai, J; Jiang, Y; Liu, X; Wu, L; Xu, G; Zhu, J, 2012
)
2.15
"The treated tetracycline (TTC) allowed maturation of the cement towards hydroxyapatite."( Behaviour of an injectable calcium phosphate cement with added tetracycline.
Freche, M; Lacout, JL; Ratier, A; Rodriguez, F, 2004
)
0.92
"Treatment with tetracycline and folate is effective in some patients, although relapses after treatment are common."( Tropical sprue.
Nath, SK, 2005
)
0.67
"Treatment with tetracycline in this instance only reduced bacterial counts moderately."( [Antibiotic therapy in the compromised host--presented as a model for listeriosis in the mouse. II. Effect of tetracycline].
Hof, H; Kuhn, B, 1983
)
0.82
"Oral treatment with tetracycline resulted in bacteriologic cure in 23 of 25 (92%) dogs with urinary tract infection caused by Pseudomonas aeruginosa. "( Tetracycline for oral treatment of canine urinary tract infection caused by Pseudomonas aeruginosa.
Creighton, SR; Ling, GV; Ruby, AL, 1981
)
2.03
"Treatment with tetracycline was followed by only mild modifications, such as a reduction of the fraction of phase 2 occupied by multiple-clustered contractions."( Abnormalities in proximal small bowel motility in patients with cirrhosis.
Chesta, J; Defilippi, C, 1993
)
0.63
"Treatment with tetracycline seems to be slightly superior and safer than the treatment with PVP-iodine."( [Effectiveness of local treatment using a PVP-iodine compound for retained placenta in cows].
Geiser, S; Martig, J; Siegenthaler, HP, 1995
)
0.63
"Treatment with tetracycline led to rapid remission of the fever and normalization of the liver tests and hepatic images."( [Hepatic psittacosis: a case of liver abnormality diagnosed by ultrasonography].
Carella, G; Marra, L; Vallot, T, 1996
)
0.63
"Treatment with tetracycline, melphalan, and prednisone resulted in a rapid clinical improvement that persisted for at least 3 years."( Thrombocytopathia and light-chain proteinuria in a dog naturally infected with Ehrlichia canis.
Alberola, J; Font, X; Valladares, JE; Varela, F,
)
0.47
"Treatment with tetracycline in operational doses does not affect the differentiation of RCJ cells with respect to the markers tested."( A versatile chondrogenic rat calvaria cell line R-tTA-24 that permits tetracycline-regulated gene expression.
Bergwitz, C; Brabant, G; Glomb, I; Gras, K; Pötter, E; von zur Mühlen, A; Wendlandt, T, 2000
)
0.88
"When treated with tetracycline, adult females of the thelygenic line produced male progeny only."( Feminization of genetic males by a symbiotic bacterium in a butterfly, Eurema hecabe (Lepidoptera: Pieridae).
Hiroki, M; Kamito, T; Kato, Y; Miura, K, 2002
)
0.64
"Treatment with tetracycline eradicated the organism in 88% of the infected women."( Ureaplasma urealyticum (T-mycoplasma) in vaginal fluid and cervical mucus from fertile and infertile women.
Brown, WJ; Hafez, ES; Jaszczak, S; Rehewy, MS; Thomas, A, 1978
)
0.6
"Oral treatment with tetracycline (66 mg/kg of body weight daily for 14 days) effected remission of signs of disease in 60 of 62 clinically affected dogs and resulted in disappearance of serum antibody in 119 (60%) of 198 seropositive dogs treated during the 2-year study period."( Prophylactic and therapeutic use of tetracycline during an epizootic of ehrlichiosis among military dogs.
Davidson, DE; Dill, GS; Nguen, PL; Premabutra, S; Ristic, M; Stephenson, EH; Tingpalapong, M, 1978
)
0.85
"Heat-treated tetracycline produces greater changes than does the native drug."( [Effect of tetracycline on rat liver mitochondrial oxidative phosphorylation in vivo and in vitro under a varying body allowance of protein].
Mal'tsev, GIu; Nesterin, MF,
)
0.87
"Treatment with tetracycline did result in peptidoglycan accumulation and wall thickening in a manner very similar to that observed previously for inhibition of protein synthesis in S."( Unbalanced growth and macromolecular synthesis in Streptococcus mutans FA-1.
Dipersio, JR; Higgins, ML; Mattingly, SJ; Shockman, GD, 1976
)
0.6
"On treatment with tetracycline in vitro, a marked decrease in the percentage of parasites with Rh123 fluorescence in the mitochondria was observed in parallel with an increase in the percentage of parasites with abnormal morphology during onset of decrease in parasitemia."( Mitochondria as the site of action of tetracycline on Plasmodium falciparum.
Kiatfuengfoo, R; Prapunwattana, P; Suthiphongchai, T; Yuthavong, Y, 1989
)
0.87
"Treatment with tetracycline or rifampin for two weeks usually results in cure."( Q fever pneumonia.
Marrie, TJ, 1989
)
0.62
"Treatment with tetracycline, to which the isolate was susceptible, brought prompt recovery; the stool cultures became negative and the serum antibody titer against P."( Case report of Plesiomonas shigelloides-associated persistent dysentery and pseudomembranous colitis.
Chowdhury, KA; Kay, BA; Rahim, Z; Rahman, SA; van Loon, FP, 1989
)
0.62
"Treatment with tetracycline or trimethoprim-sulfamethoxazole (TMP-SMZ) alone (four to eight weeks) or in combination with streptomycin (two to four weeks) resulted in a relapse rate of 16.6%."( Osteoarticular complications of brucellosis: a study of 169 cases.
Almudallal, DS; Khodeir, SM; Marafie, AA; Mousa, AR; Muhtaseb, SA,
)
0.47
"Treatment with tetracycline produced only temporary remission."( Alpha-chain disease with clinical, immunological, and histological recovery.
Doe, WF; Economidou, JC; Georgiadou, DE; Hadziyannis, SJ; Henry, K; Manousos, ON; Merikas, GE; Pratsika-Ougourloglou, KG, 1974
)
0.59

Toxicity

Tetracycline has been widely used for decades in human and veterinary medicines. The aim of this study was to evaluate the compliance, adverse effects and effectiveness of this treatment with a new galenic three-in-one capsule formulation containing bismuth.

ExcerptReferenceRelevance
"Some LD50 determinations for tetracycline hydrochloride in mice were carried out over a range of pH values, using both the intraperitoneal and the subcutaneous routes of injection."( Influence of pH and route of injection on acute toxicity of tetracycline in mice.
Colaizzi, JL; Jaffe, JM; Wivagg, RT, 1976
)
0.79
" All of the toxic manifestations were reversed upon withdrawal of the drug."( Tetracycline toxicity presenting as generalized vasculitis.
Andolsek, K; Kelly, JR, 1978
)
1.7
"The toxic effect of tetracycline and its epi- and anhydro-derivatives on growing chick embryos and the spleen cells of immunized mice was studied."( [Embryotoxicity and the immunodepressive action of tetracycline and its epi- and anhydro- derivatives].
Ermolova, OB; Klimova, NE, 1976
)
0.83
" The experimental conditions provide a technically simple method which is sensitive enough to examine antiresorptive properties in a healthy animal and to detect adverse effects on the kidney."( Measurement of serum [3H]tetracycline kinetics and indices of kidney function facilitate study of the activity and toxic effects of bisphosphonates in bone resorption.
Eitan, Y; Golomb, G; Hoffman, A, 1992
)
0.59
"Fourteen patients suffering from rosacea treated by prolonged topical applications of fluorinated steroids showed adverse effects."( Adverse effect of topical fluorinated corticosteroids in rosacea.
Sneddon, I, 1969
)
0.25
" Pretreatment of animals with tetracycline protects completely against the toxic effects of washed suspensions of mycoplasmas, while tetracycline affords no protection against the exotoxin."( Studies of PPLO infection. IV. The neurotoxicity of intact mycoplasmas, and their production of toxin in vivo and in vitro.
Bitensky, MW; Thomas, L, 1966
)
0.53
" This report concerns a patient with a toxic reaction to lithium carbonate."( Lithium carbonate toxicity. Acneform eruption and other manifestation.
Heng, MC, 1982
)
0.26
"To evaluate two triple-therapy (TT) regimens of colloidal bismuth subcitrate (CBS), metronidazole, and tetracycline HCl in eradicating Helicobacter pylori, with particular attention to the frequency of resulting adverse effects of the two therapies."( Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Andrews, P; Borody, TJ; Brandl, S; Ferch, N; Hyland, L; Jankiewicz, E, 1994
)
0.5
" pylori is equally efficacious to the standard 4 x/day therapy, but is accompanied by fewer and milder adverse effects."( Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Andrews, P; Borody, TJ; Brandl, S; Ferch, N; Hyland, L; Jankiewicz, E, 1994
)
0.29
"Because minocycline can cause serious adverse events including hypersensitivity syndrome reaction (HSR), serum sicknesslike reaction (SSLR), and drug-induced lupus, a follow-up study based on a retrospective review of our Drug Safety Clinic and the Health Protection Branch databases and a literature review was conducted to determine if similar rare events are associated with tetracycline and doxycycline."( Comparative safety of tetracycline, minocycline, and doxycycline.
Knowles, SR; Shapiro, LE; Shear, NH, 1997
)
0.78
" We theorize that minocycline metabolism may account for the increased frequency of serious adverse events with this drug."( Comparative safety of tetracycline, minocycline, and doxycycline.
Knowles, SR; Shapiro, LE; Shear, NH, 1997
)
0.61
"Since its introduction into dentistry in 1989, nightguard vital bleaching has been proven to be a simple and safe procedure to whiten discolored teeth."( Efficacy, longevity, side effects, and patient perceptions of nightguard vital bleaching.
Leonard, RH, 1998
)
0.3
"Although potentially significant adverse reactions and drug interactions have been reported in association with erythromycin, oral tetracyclines, and trimethoprim-sulfamethoxazole, overall these agents are associated with excellent safety profiles, especially considering their widespread use over many years."( Systemic therapy for rosacea: focus on oral antibiotic therapy and safety.
Del Rosso, JQ, 2000
)
0.51
" We investigated whether minocycline would protect against toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxin that selectively destroys nigrostriatal dopaminergic (DA) neurons and produces a clinical state similar to Parkinson's disease (PD) in rodents and primates."( Minocycline enhances MPTP toxicity to dopaminergic neurons.
Albers, DS; Beal, MF; Browne, SE; Chirichigno, JW; Gregorio, J; Joh, TH; Lorenzl, S; Shimizu, Y; Shin, DH; Sugama, S; Yang, L, 2003
)
0.32
"The effects of toxic and nontoxic compound treatments were investigated by high resolution custom developed 2-11 pH gradient NEPHGE (non equilibrium pH gradient electrophoresis) two-dimensional electrophoresis."( Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats.
Bonk, I; Bryant, S; Klatt, M; Köpke, A; Nebrich, G; Taufmann, M; Thome-Kromer, B; Wacker, U, 2003
)
0.32
" Adherence and adverse events for quadruple therapy were similar to currently recommended triple therapies."( Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Dickason, J; Fischbach, LA; van Zanten, S, 2004
)
0.32
" These data suggest that antioxidants may serve as 'Abeta targeting' therapies that suppress toxic protein aggregation rather than simply acting as downstream radical scavengers."( Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity.
Maezawa, I; Milatovic, D; Montine, KS; Montine, TJ; Nghiem, W; Vaisar, T; Woltjer, RL, 2005
)
0.33
"5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects."( Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004
)
0.32
" The antibiotic itself did not show a toxic effect, and the cell viability in its presence even increased."( [Cytotoxicity of amyloid fibrils of X-protein].
Marsagishvili, LG; Naumov, AA; Podlubnaia, ZA; Potselueva, MM; Shatalin, IuV; Shpagina, MD; Shubina, VS,
)
0.13
" Male rats were treated with acetaminophen (APAP), carbon tetrachloride (CCL), amiodarone (AD) or tetracycline (TC) at toxic doses."( Genomic cluster and network analysis for predictive screening for hepatotoxicity.
Fukushima, T; Hamada, Y; Horii, I; Kikkawa, R, 2006
)
0.55
"An FDA Working Group, along with representatives of PhRMA and the American Association for the Study of Liver Diseases, as well as the Institute of Medicine Report 'To Err is Human: Building a Safer Health Care System' have suggested that post-marketing drug surveillance is a important method to decrease adverse drug events."( Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study.
Brewer, DE; Fenwick, SR; Heaton, PC, 2007
)
0.66
" Doxycycline could potentially be a safe substitute for tetracycline, when appropriate."( Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study.
Brewer, DE; Fenwick, SR; Heaton, PC, 2007
)
0.91
" Administration of tetracycline caused a reduction in the epididymal sperm motility, percentage of live spermatozoa, sperm count, and an increase in abnormal sperm morphology, as well as induction of adverse histopathologic changes in the testes."( Tetracycline-induced reproductive toxicity in male rats: effects of vitamin C and N-acetylcysteine.
Ekor, M; Ezenwadu, TT; Farombi, EO; Oyeyemi, MO; Ugwuezunmba, MC, 2008
)
2.12
" The toxic responses of hepatocytes were systematically evaluated by measuring cell viability, liver-specific function, lipid accumulation, oxidative stress, adenosine triphosphate content and mitochondrial membrane potential."( Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity.
Bader, A; Meng, Q; Schmelzer, E; Shen, C, 2009
)
0.59
" Tetracycline has been widely used for decades in human and veterinary medicines, with incremental residues in the environment and adverse influences on living organisms."( Genotoxicity of tetracycline as an emerging pollutant on root meristem cells of wheat (Triticum aestivum L.).
Bao, Q; Bao, Y; He, Z; Xie, X; Zhou, Q, 2011
)
1.63
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
" Some animal studies indicate that such nanomaterials may have some toxicity, but their synergistic actions on the adverse effects of drugs are not well understood."( Effect of 70-nm silica particles on the toxicity of acetaminophen, tetracycline, trazodone, and 5-aminosalicylic acid in mice.
Hasezaki, T; Isoda, K; Kondoh, M; Li, X; Tsutsumi, Y; Watari, A; Yagi, K, 2011
)
0.61
"Historically, skin toxicity has been assessed in prospective clinical trials using the clinician-reported National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)."( Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
Atherton, PJ; Burger, KN; Jatoi, A; Loprinzi, CL; Miller, RC; Neben Wittich, MA; Sloan, JA, 2012
)
0.38
" Statistical procedures, including Pearson correlations, were utilized to determine relationships between adverse event (AE) grades and Skindex-16 scores."( Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
Atherton, PJ; Burger, KN; Jatoi, A; Loprinzi, CL; Miller, RC; Neben Wittich, MA; Sloan, JA, 2012
)
0.38
" Seventeen patients experienced mild adverse events."( Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
Choi, JH; Hyun, JJ; Jung, SW; Kim, JH; Kim, SY; Koo, JS; Kwon, BS; Lee, SK; Lee, SW; Park, JY; Yim, HJ, 2011
)
0.37
"A retrial of quadruple therapy before use of a third-line therapy may be safe and effective for patients who fail to respond to second-line quadruple therapy."( Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
Choi, JH; Hyun, JJ; Jung, SW; Kim, JH; Kim, SY; Koo, JS; Kwon, BS; Lee, SK; Lee, SW; Park, JY; Yim, HJ, 2011
)
0.37
" Although this class of antibiotics has been linked to adverse effects, tetracycline is considered a safe drug."( Letter: Tetracycline-induced hepatotoxicity.
Feldman, SR; Glenn, C, 2011
)
1.04
" The cyanobacterium was more sensitive than the green alga to the toxic effect of antibiotics."( Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment.
Boltes, K; Fernández-Piñas, F; González-Pleiter, M; Gonzalo, S; Leganés, F; Marco, E; Rodea-Palomares, I; Rosal, R, 2013
)
0.39
" pylori) is complex; full effectiveness is rarely achieved and it has many adverse effects."( Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Barbuti, RC; Bogsan, CS; Chinzon, D; de Oliveira, MN; Eisig, JN; Mattar, R; Moraes-Filho, JP; Navarro-Rodriguez, T; Silva, FM, 2013
)
0.39
" The rate of adverse effects at 7 days with the active probiotic was 59."( Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Barbuti, RC; Bogsan, CS; Chinzon, D; de Oliveira, MN; Eisig, JN; Mattar, R; Moraes-Filho, JP; Navarro-Rodriguez, T; Silva, FM, 2013
)
0.39
"The use of this probiotic compound compared to placebo in the proposed regimen in Brazilian patients with peptic ulcer or functional dyspepsia showed no significant difference in efficacy or adverse effects."( Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Barbuti, RC; Bogsan, CS; Chinzon, D; de Oliveira, MN; Eisig, JN; Mattar, R; Moraes-Filho, JP; Navarro-Rodriguez, T; Silva, FM, 2013
)
0.39
" sakei Al-143 strains possess the best properties to be selected as adequate and safe meat starter cultures."( Technological and safety properties of lactic acid bacteria isolated from Spanish dry-cured sausages.
Carrascosa, AV; Curiel, JA; de las Rivas, B; Landeta, G; Muñoz, R, 2013
)
0.39
" The study will be useful in promoting effective residue monitoring and ensuring safe use of these antibiotics in managing bacterial diseases of pomegranate."( Validation of a residue analysis method for streptomycin and tetracycline and their food safety evaluation in pomegranate (Punica granatum L.).
Banerjee, K; Jadhav, MR; Oulkar, DP; Sabale, R; Shabeer T P, A; Utture, SC, 2013
)
0.63
" In an effort to develop safe and highly effective replication-competent VACV vectors, we established a system to inducibly express IFN-γ."( Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics.
Grigg, P; Jones, LA; Titong, A; Verardi, PH; Yilma, TD, 2013
)
0.65
" This results in protein aggregation and generation of toxic oligomers and fibrils."( Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
Bonanomi, M; Colombo, G; Cornelli, G; Doglia, SM; Malabarba, MG; Natalello, A; Pastori, V; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Visentin, C, 2014
)
0.69
" The toxic chemicals tested were acetaminophen (APAP), 5-aminosalicylic acid (5-ASA), tetracycline (TC), and sodium valproate (VPA)."( Toxicity of 50-nm polystyrene particles co-administered to mice with acetaminophen, 5-aminosalicylic acid or tetracycline.
Ishida, I; Isoda, K; Nozawa, T; Tezuka, M, 2014
)
0.84
" fischeri and the joint toxicity is determined by the sum of toxic unit of free metal-ions and free organic ligands."( Joint toxicity of tetracycline with copper(II) and cadmium(II) to Vibrio fischeri: effect of complexation reaction.
Gu, C; Gu, X; Lee, CC; Tong, F; Zhao, Y, 2015
)
0.75
" Due to its ubiquitous presence, chemical nature, and practical purpose, this type of contaminant can exert toxic effects in nontarget organisms."( Acute effects of tetracycline exposure in the freshwater fish Gambusia holbrooki: antioxidant effects, neurotoxicity and histological alterations.
Antunes, SC; Braga, MR; Campos, JC; Correia, AT; Gomes, R; Nunes, B; Ramos, AS, 2015
)
0.76
" Pleurodesis effectiveness was evaluated according to Paladine's criteria and adverse events were recorded."( Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion.
Keeratichananont, S; Keeratichananont, W; Limthon, T, 2015
)
0.66
"Saccharomyces cerevisiae is the simplest and a favorite eukaryotic system that contains lysosome and thus, is a suitable organism for monitoring some toxic effects in environmental pollution."( Toxicity detection using lysosomal enzymes, glycoamylase and thioredoxin fused with fluorescent protein in Saccharomyces cerevisiae.
Kim, YH; Min, J; Nguyen, NT; Shin, HY, 2015
)
0.42
"Many adverse drug reactions are caused by the cytochrome P450 (CYP)-dependent activation of drugs into reactive metabolites."( Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Jones, LH; Nadanaciva, S; Rana, P; Will, Y, 2016
)
0.43
" Res, a natural antioxidant, and TC, an antibiotic with its antimicrobial and anti-inflammatory properties, offered significant protection from severe oxidative stress and inflammation and ameliorated the general well-being of mice against the toxic outcome of PQ."( Effect of resveratrol and tetracycline on the subacute paraquat toxicity in mice.
Ambhore, PD; Pawar, PP; Puttewar, S; Satpute, RM; Sawale, SD, 2017
)
0.76
" Safety assessments included adverse events (AEs), clinical laboratories, vital signs, electrocardiograms, and physical examinations."( Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Berk, DR; Kaoukhov, A; Leyden, JJ; Sniukiene, V, 2018
)
0.48
" Sarecycline was safe and well tolerated, with similar gastrointestinal AE rates in sarecycline and placebo groups."( Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Berk, DR; Kaoukhov, A; Leyden, JJ; Sniukiene, V, 2018
)
0.48
"5 mg/kg significantly reduced inflammatory lesions versus placebo and was safe and well tolerated with low rates of AEs, including gastrointestinal AEs."( Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Berk, DR; Kaoukhov, A; Leyden, JJ; Sniukiene, V, 2018
)
0.48
" Adverse events occurred in 55 patients (15."( Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study.
Allegretta, L; Baldassarre, G; Brandimarte, G; Cassieri, C; De Bastiani, R; Di Mario, F; Elisei, W; Ferronato, A; Franceschi, M; Licci, C; Miraglia, C; Penna, A; Picchio, M; Pranzo, G; Rizzo, GL; Savarino, E; Scida, S; Tursi, A, 2018
)
0.48
" Adverse events were reported by 32."( The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
Bazzoli, F; Conigliaro, R; Eusebi, LH; Farinati, F; Grande, G; Gravina, AG; Ierardi, E; Maconi, G; Panarese, A; Romano, M; Romiti, A; Savarino, E; Stasi, E; Zagari, RM, 2018
)
0.48
" Adverse events, all mild and transient, were recorded in 571 (2·6%) of the entire study population and 58 (4·1%) of participants in the ten sentinel villages."( Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.
Engelman, D; Kaldor, JM; Kamoriki, B; Marks, M; Nasi, T; Romani, L; Sokana, O; Solomon, AW; Steer, AC; Wand, H; Whitfeld, MJ, 2018
)
0.48
"In the largest trial so far involving coadministration of regimens based on ivermectin and azithromycin, the combination was safe and feasible in a population of more than 26 000 people."( Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.
Engelman, D; Kaldor, JM; Kamoriki, B; Marks, M; Nasi, T; Romani, L; Sokana, O; Solomon, AW; Steer, AC; Wand, H; Whitfeld, MJ, 2018
)
0.48
" The aim of this study was to evaluate the compliance, adverse effects and effectiveness of this treatment with the new galenic three-in-one capsule formulation containing bismuth subcitrate, metronidazole and tetracycline (Pylera®)."( Compliance, adverse effects and effectiveness of first line bismuth-containing quadruple treatment (Pylera®) to eradicate Helicobacter pylori infection in 200 patients.
Castro Fernández, M; Grande Santamaría, L; Keco Huerga, A; Lamas Rojas, E; Llorca Fernández, R; Pabón Jaén, M; Rojas Feria, M; Romero García, T, 2019
)
0.7
" The compliance and adverse effects of the treatment were evaluated via telephone contact and via an interview during the clinical revision."( Compliance, adverse effects and effectiveness of first line bismuth-containing quadruple treatment (Pylera®) to eradicate Helicobacter pylori infection in 200 patients.
Castro Fernández, M; Grande Santamaría, L; Keco Huerga, A; Lamas Rojas, E; Llorca Fernández, R; Pabón Jaén, M; Rojas Feria, M; Romero García, T, 2019
)
0.51
"5% (57/200) of the patients experienced adverse effects, which led to abandoning the treatment in only seven subjects."( Compliance, adverse effects and effectiveness of first line bismuth-containing quadruple treatment (Pylera®) to eradicate Helicobacter pylori infection in 200 patients.
Castro Fernández, M; Grande Santamaría, L; Keco Huerga, A; Lamas Rojas, E; Llorca Fernández, R; Pabón Jaén, M; Rojas Feria, M; Romero García, T, 2019
)
0.51
" It may seem comforting that TC concentrations in the edible parts of pak choi are often found to be below safe limits."( Tetracycline uptake by pak choi grown on contaminated soils and its toxicity in human liver cell line HL-7702.
Hussain, B; Liu, D; Lu, L; Luo, W; Tian, S; Wang, M; Yang, X; Zhou, J, 2019
)
1.96
" The more toxic transformation products of TC, 4-epitetracycline (ETC), anhydrotetracycline (ATC) and 4-epianhydrotetracycline (EATC) are also widely detected."( Toxicity of tetracycline and its transformation products to a phosphorus removing Shewanella strain.
Li, N; Long, S; Pavlostathis, SG; Sun, P; Xiang, F; Yang, Y; Zhao, L, 2020
)
1.19
" Adverse drug effects were found in 36 patients from the twice a day group and 50 patients from the four times a day group (P = ."( Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication.
Kim, JH; Kim, JY; Lee, SY; Park, HS; Sung, IK, 2020
)
0.78
"5 g/d of metronidazole, and 600 mg/d of bismuth subcitrate for one week is effective and safe as the conventional four times a day therapy."( Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication.
Kim, JH; Kim, JY; Lee, SY; Park, HS; Sung, IK, 2020
)
0.78
"Tetracycline antibiotics (TA) used in veterinary medicine reach terrestrial ecosystems mostly via the repeated applications of animal manures and slurries on agricultural soils, where they may cause toxic effects on bacterial communities."( Use of biomass ash to reduce toxicity affecting soil bacterial community growth due to tetracycline antibiotics.
Álvarez-Rodríguez, E; Arias-Estévez, M; Díaz-Raviña, M; Fernández-Calviño, D; Fernández-Sanjurjo, MJ; Núñez-Delgado, A; Santás-Miguel, V, 2020
)
2.22
" The adverse events were predictable and reported as frequent adverse events during triple-antibiotic therapy."( Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS, 2021
)
0.86
" Adverse events were recorded during follow-up by telephone interview."( Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.
Cao, Y; He, W; Li, X; Wang, J, 2021
)
0.86
" The secondary endpoints were adverse effects, symptom improvement rates, and patient compliance."( Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
Bi, H; Chen, X; Chen, Y; Han, S; Li, M; Lin, T; Liu, J; Lyu, T; Shi, Y; Wang, J; Wang, S; Yuan, D; Zhao, X, 2022
)
0.72
" The incidence of adverse events in the HDDT group was significantly lower than that in the TFEB group (11."( Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
Bi, H; Chen, X; Chen, Y; Han, S; Li, M; Lin, T; Liu, J; Lyu, T; Shi, Y; Wang, J; Wang, S; Yuan, D; Zhao, X, 2022
)
0.72
" Cadmium (Cd) is a common heavy metal contaminant and has highly toxic to organisms, plants and humans even at low doses."( Toxicity of single and combined 4-epianhydrotetracycline and cadmium at environmentally relevant concentrations on the zebrafish embryos (Danio rerio).
Lin, Y; Wang, M; Wu, L; Yu, J, 2023
)
1.17
" Thus, such combine pollution should be avoided in safe agricultural product."( Toxicity of emerging contaminant antibiotics in soil to Capsicum annuum L. growth and their effects on it accumulating copper.
Dai, H; Jia, J; Li, R; Skuza, L; Sun, Q; Wei, S; Xue, J, 2023
)
0.91
" There were many similar toxic pathways between MPs and additives, indicating that part of the toxicity risk of MPs was caused by the release of additives."( UV-induced microplastics (MPs) aging leads to comprehensive toxicity.
Bao, D; Cao, X; Guo, M; Li, X; Yang, H; Zheng, X, 2023
)
0.91
" Cell culture studies have shown quinolones to be highly toxic to TM fibroblasts."( Cytotoxicity of Tetracyclines in Human Tympanic Membrane Fibroblasts.
Antonelli, PJ; Dirain, CO, 2023
)
1.26
"Tetracyclines are less toxic to cultured TM fibroblasts than ciprofloxacin."( Cytotoxicity of Tetracyclines in Human Tympanic Membrane Fibroblasts.
Antonelli, PJ; Dirain, CO, 2023
)
2.7
" pylori eradication and adverse events (AEs)."( Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta-analysis of RCTs.
Gao, W; Wang, L; Yin, Y; Zhang, X; Zhu, M, 2023
)
0.91

Pharmacokinetics

The goal of this study was to evaluate the pharmacokinetic interaction between tegoprazan and triple-antibiotic therapy containing metronidazole, tetracycline, and bismuth. IPC had no pharmacokinetics effect on the rate of absorption of tetr Tracycline.

ExcerptReferenceRelevance
" Half-life was calculated as 15."( [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
Grahmann, H; Malerczyk, V; Preuss, I; Schmidt, K; Simon, C, 1976
)
0.26
"A digital computer curve-fitting method, designed to estimate pharmacokinetic model constants by utilizing all drug concentration-time data collected during repetitive dosing studies, was applied to data manifesting systematic dose-to-dose variability in one or another of the pharmacokinetic parameters."( Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration.
Colburn, WA; Gibaldi, M, 1977
)
0.26
"ml-1), as well as a significantly reduced terminal half-life (14."( Effect of tetracycline on mefloquine pharmacokinetics in Thai males.
Back, DJ; Bunnag, D; Karbwang, J; Na Bangchang, K; Rooney, W, 1992
)
0.69
"This report presents a pharmacokinetic model in the rat and rabbit of the direct quantification of mature bone resorption in vivo."( A pharmacokinetic model in the rat and rabbit of the direct measurement of mature bone resorption in vivo with [3H]tetracycline.
Donovan, CA; Klein, L; Li, XQ, 1989
)
0.49
"A physiologic pharmacokinetic model describing drug disposition in the isolated perfused porcine skin flap (IPPSF) is derived."( Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap.
Riviere, JE; Williams, PL, 1989
)
0.28
" The drug had a rapid distribution phase followed by a relatively slow elimination phase, with half-life of 16 hours."( Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine.
Bane, DP; Bevill, RF; Hall, WF; Kniffen, TS; Koritz, GD, 1989
)
0.52
"Two interactive computer programs, INTRAV and ORAL, were written to permit pharmacokinetic modeling of experimental data and to obtain pertinent values based on derived estimates."( INTRAV and ORAL: BASIC interactive computer programs for estimating pharmacokinetic parameters.
Hunter, S; Valentine, JL, 1985
)
0.27
" Pharmacokinetic parameters were determined for intravenous (10 mg/kg) and oral (150 mg/kg) administration."( Pharmacokinetics of tetracycline in the domestic rabbit following intravenous or oral administration.
Black, WD; Percy, DH, 1988
)
0.6
" The program enables the analysis of pharmacokinetic drug level profiles with a high degree of precision."( STRITERFIT, a least-squares pharmacokinetic curve-fitting package using a programmable calculator.
Schwerzel, E; Thornhill, DP, 1985
)
0.27
" Carrier erythrocytes containing tetracycline reinjected in calves were studied for their pharmacokinetic constants."( Pharmacokinetics of tetracycline encapsulated in bovine carrier erythrocytes.
DeLoach, JR; Wagner, GG, 1984
)
0.87
" The pharmacokinetic theory of drug diffusion into the prostate is reviewed."( The pharmacokinetics of antibiotic diffusion in chronic bacterial prostatitis.
Fair, WR; Sharer, WC, 1982
)
0.26
" A flow-limited pharmacokinetic model was constructed to simulate the distribution of tetracycline, delivered at a constant rate from the trilaminate device, in the pregnant rats."( Controlled release of tetracycline--III: A physiological pharmacokinetic model of the pregnant rat.
Anderson, JM; Olanoff, LS, 1980
)
0.8
" The pharmacokinetic parameters were compared with the control data reported previously from this laboratory."( Pharmacokinetic interaction of tetracycline with centchroman in healthy female volunteers.
Gupta, RC; Kamboj, VP; Khurana, M; Lal, J; Nityanand, S, 2003
)
0.6
"05) in the maximum plasma concentration (C(max)), total area under the concentration-time curve (AUC), and terminal elimination half-life (t(1/2,z)), compared with halofantrine alone."( Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers.
Bassi, PU; Onyeji, CO; Ukponmwan, OE, 2004
)
0.71
"The present study aims to investigate the pharmacokinetic interaction between non-steroidal anti-inflammatory drugs and tetracycline in rats."( Pharmacokinetic interaction of tetracycline with non-steroidal anti-inflammatory drugs via organic anion transporters in rats.
Han, HK; Oh, YH, 2006
)
0.83
" IPC had no pharmacokinetic effect on the rate of absorption of tetracycline."( Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia.
Geisser, P; Jacobs, YL; Potgieter, MA; Pretorius, SG; Venter, C; Venter, JL, 2007
)
0.82
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
" The sigmoid maximum-threshold-of-efficacy (E(max)) model fit the survival data, in which the free-drug area under the concentration-time curve (fAUC)/MIC ratio, the maximum concentration of free drug in plasma (fC(max))/MIC ratio, and the cumulative percentage of a 24-h period that the free-drug concentration exceeds the MIC under steady-state pharmacokinetic conditions (f %T(MIC)) were each evaluated."( Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
Ambrose, PG; Bassett, J; Beaudry, A; Bhavnani, SM; Critchley, I; Gill, SC; Heine, HS; Janjic, N; Li, J; Miller, L; Rubino, CM; Stone, KC, 2010
)
0.36
" In vitro pharmacodynamic and target animal pharmacokinetic data were analyzed by Monte Carlo simulation (MCS) for the development of MIC interpretive criteria."( Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
Guardabassi, L; Maaland, MG; Papich, MG; Turnidge, J, 2013
)
0.66
" The observed net growth rates were used to describe the in vitro pharmacodynamic relationship between drug concentration and net growth rate based on E max model with three parameters: maximum net growth rate (amax); concentration for a half-maximal response (E max); and the Hill coefficient (γ)."( Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.
Agersø, Y; Ahmad, A; Christiansen, LE; Damborg, P; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C, 2015
)
0.67
" The pharmacodynamic parameters confirmed that the αmax between susceptible and resistant strains in the absence of a drug was not different."( Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.
Agersø, Y; Ahmad, A; Christiansen, LE; Damborg, P; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C, 2015
)
0.67
" These parameters, along with in vivo pharmacokinetic data, may be useful in mathematical models to predict in vivo competitive growth of many different strains and for development of optimal dosing regimens for preventing selection of resistance."( Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.
Agersø, Y; Ahmad, A; Christiansen, LE; Damborg, P; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C, 2015
)
0.67
" Pharmacodynamic models describing the relationship between the concentration of antimicrobials and the minimum growth rate of the bacteria provide more detailed information than the MIC only."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
" The experimental time-kill curves were analysed and quantified with a previously established pharmacodynamic model."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
" gonorrhoeae time-kill curve experiments analysed with a pharmacodynamic model have potential for in vitro evaluation of new and existing antimicrobials."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
"The present study was carried out to demonstrate novel use of pharmacokinetic approaches to characterize drug behaviors/movements in the vegetables with implications to food safety."( Assessment of veterinary drugs in plants using pharmacokinetic approaches: The absorption, distribution and elimination of tetracycline and sulfamethoxazole in ephemeral vegetables.
Chen, HR; Chou, CC; Loh, SH; Rairat, T; Vickroy, TW; Wu, YC, 2017
)
0.66
" The goal of this study was to evaluate the pharmacokinetic interaction between tegoprazan and triple-antibiotic therapy containing metronidazole, tetracycline, and bismuth."( Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS, 2021
)
1.06
" Pharmacokinetic blood samples were collected within 24 h after the last dose."( Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS, 2021
)
0.86
"Eleven cohort 1 subjects and ten cohort 2 subjects were included in the pharmacokinetic analysis."( Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS, 2021
)
0.86
"Changes in the tegoprazan, tetracycline, and bismuth pharmacokinetic parameters were detected after concurrent administration."( Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS, 2021
)
1.16

Compound-Compound Interactions

The antimicrobial activities of tetracycline, mupirocin, and fusidic acid are tested in combination with Epicatechin Gallate (ECG), and Ethyl Gallate. Dose-dependent inhibition of Salmonella typhimurium DT104 growth is observed. We have compared plasma quinine levels on day 2, day 5 and day 7 in twenty-one patient.

ExcerptReferenceRelevance
" We have compared plasma quinine levels on day 2, day 5 and day 7 (before and at 2 hours after dosing) in twenty-one patients with acute falciparum malaria who were treated with quinine alone (8 patients) or quinine in combination with tetracycline (8 patients) or quinine with tetracycline and primaquine (5 patients)."( Plasma quinine levels in patients with falciparum malaria when given alone or in combination with tetracycline with or without primaquine.
Bunnag, D; Harinasuta, T; Karbwang, J; Molunto, P, 1991
)
0.68
"The efficacy and toxicity of oral quinine combined with oral chloroquine were studied in 50 Thai men with uncomplicated falciparum malaria."( Therapeutic effects of chloroquine in combination with quinine in uncomplicated falciparum malaria.
Chantra, A; Chindanond, D; Clemens, R; Phophak, N; Pukrittayakamee, S; Vanijanonta, S, 1996
)
0.29
"The influence of a 50 Hz magnetic field (MF) on avian and mammalian embryogenesis, the MF level and vector, as well as the effect of exposure to MF (50 Hz, 10 mT) in combination with X-rays has been recently reported [2,3]."( Developmental effects of magnetic field (50 Hz) in combination with ionizing radiation and chemical teratogens.
Bednár, V; Jerábek, J; Pafková, H; Tejnorová, I, 1996
)
0.29
" This article aims to review the "additional" effect of a subgingival irrigation with chlorhexidine, or a local or systemic application of tetracycline or metronidazole, performed in combination with a single course of scaling and root planing in patients with chronic adult periodontitis."( Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature.
Bollen, CM; Quirynen, M, 1996
)
0.5
" The technique combined tetracycline treatment of a root planed root, grafting of the osseous defect with a demineralized freeze-dried bone allograft combined with tetracycline and the placement of a bioabsorbable matrix membrane, made of polylactic acid softened with citric acid ester."( A clinical evaluation of guided tissue regeneration with a bioabsorbable matrix membrane combined with an allograft bone graft. A series of case reports.
Harris, RJ, 1997
)
0.6
"The purpose of this study was to histologically evaluate furcation defects in humans treated with an allograft-alloplast-tetracycline composite graft combined with an absorbable membrane for guided tissue regeneration (GTR)."( Treatment of furcation defects with an allograft-alloplast-tetracycline composite bone graft combined with GTR: human histologic evaluation of a case report.
Harris, RJ, 2002
)
0.77
" pylori eradication rate in both metronidazole-sensitive and -resistant strains following quadruple therapy using single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole."( Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.
Borody, T; Dallaire, C; De Boer, WA; Fallone, CA; Farley, A; Mégraud, F; O'Morain, C; Piotrowski, J; Schuman, R; Spénard, J; Tytgat, G, 2003
)
0.73
"Summary We report a case of protothecosis in an 18-year-old female student caused by Prototheca zopfii successfully treated with amikacin combined with tetracyclines."( Protothecosis successfully treated with amikacin combined with tetracyclines.
Liu, W; Lv, G; Shen, Y; Wu, S; Zhao, J, 2004
)
0.76
"To evaluate the effect of mechanical periodontal treatment combined with tetracycline on periodontal attachment, distances of cementum-enamel junction (CEJ) to the bone defect bottom and to the alveolar crest, and avidity of serum IgG against Porphyromonas gingivalis (Pg) lipopolysaccharide (LPS) in patients with aggressive periodontitis."( [Mechanical periodontal treatment combined with tetracycline for aggressive periodontitis].
Huang, SG; Xie, M; Zhang, HF; Zhang, XQ; Zhang, Y, 2006
)
0.82
"Twenty-six patients with aggressive periodontitis were divided equally into two groups to receive mechanical periodontal treatment combined with tetracycline or exclusive mechanical periodontal treatment, with another 20 periodontally healthy subjects serving as the control group."( [Mechanical periodontal treatment combined with tetracycline for aggressive periodontitis].
Huang, SG; Xie, M; Zhang, HF; Zhang, XQ; Zhang, Y, 2006
)
0.79
"Mechanical periodontal treatment combined with tetracycline produces favorable effects in patients with aggressive periodontitis."( [Mechanical periodontal treatment combined with tetracycline for aggressive periodontitis].
Huang, SG; Xie, M; Zhang, HF; Zhang, XQ; Zhang, Y, 2006
)
0.85
"A molecularly imprinted polymer solid phase extraction (MISPE) method combined with flow-injection chemiluminescence (FI-CL) for the determination of residual tetracycline (TC) in fish samples is presented."( Molecularly imprinted on-line solid-phase extraction combined with flow-injection chemiluminescence for the determination of tetracycline.
He, C; He, D; Xiong, Y; Zhang, Z; Zhou, H, 2006
)
0.74
" Rosacea is most commonly managed with topical metronidazole, sometimes in combination with oral antibiotics."( Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
Balkrishnan, R; Conde, JF; Feldman, SR; Fleischer, AB; Yelverton, CB, 2007
)
0.34
"75% lotion is more effective when used in combination with doxycycline 20 mg dosed twice daily."( Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
Balkrishnan, R; Conde, JF; Feldman, SR; Fleischer, AB; Yelverton, CB, 2007
)
0.34
"The in vitro antibacterial activity against antibiotic-resistant Propionibacterium acnes of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin antibiotics was investigated."( In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
Kim, IH; Lim, YH; Seo, JJ, 2007
)
0.34
" In this study we aimed to determine the in vitro activity of hydrogen peroxide (H2O2; reactive oxygen intermediate) and acidified sodium nitrite (ASN; reactive nitrogen intermediate) alone and in combination with rifampicin (RIF) and tetracycline (TET) against four clinical isolates of Brucella melitensis."( [In vitro effect of reactive nitrogen and oxygen intermediates alone and in combination with some antibiotics against Brucella melitensis clinical isolates].
Coban, AY; Durupinar, B; Tanyel, E; Taşdelen Fişgin, N; Tülek, N, 2009
)
0.54
"The antimicrobial activities of tetracycline, mupirocin, and fusidic acid are tested in combination with Epicatechin Gallate (ECG), and Ethyl Gallate (EG) using 2 Methicillin resistant (MRSA) and 2 Methicillin sensitive (MSSA) strains of Staphylococcus aureus."( In vitro drug interactions of gallates with antibiotics in Staphylococcus Aureus.
Chu Sing Lim, L; Sakharkar, KR; Sakharkar, MK; Soe, WM; Tzer Pin Lin, R, 2010
)
0.64
"The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions."( Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR, 2012
)
0.38
"The in vitro activity of mastoparan-AF, an amphipathic antimicrobial peptide isolated from the hornet venom of Vespa affinis, alone and in combination with various clinically used antibiotics, was investigated against 21 Escherichia coli isolates/strains."( In vitro activity of mastoparan-AF alone and in combination with clinically used antibiotics against multiple-antibiotic-resistant Escherichia coli isolates from animals.
Hou, RF; Lin, CF; Lin, CH; Shia, WY; Shyu, CL; Tu, WC, 2012
)
0.38
"5-4) results against the bacterium in combination with ampicillin, ciprofloxacin, tetracycline or metronidazole."( In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.
Jang, EY; Lee, JY; Moon, JH; Shim, KS, 2015
)
0.64
" In combination with tannins, antibiotics showed increased MICs, suggesting that tannins interfered with antibacterial activity."( Effect of tannic and gallic acids alone or in combination with carbenicillin or tetracycline on Chromobacterium violaceum CV026 growth, motility, and biofilm formation.
Dusane, DH; O'May, C; Tufenkji, N, 2015
)
0.64
" In combination with TH, the gel scaffold exhibited beneficial effects on osteoblast activity, which suggested a promising future for local treatment of pathologies involving bone loss."( Injectable alginate/hydroxyapatite gel scaffold combined with gelatin microspheres for drug delivery and bone tissue engineering.
Chen, Y; Hu, X; Ling, Z; Miao, Y; Tan, H; Xing, X; Yan, J; Zhou, T, 2016
)
0.43
"To assess the efficacy and safety of omeprazole given with the new single capsule of bismuth, metronidazole and tetracycline (OBMT) compared with quadruple treatment consisting of omeprazole, bismuth, amoxicillin and clarithromycin (OBAC) for Helicobacter pylori eradication in duodenal ulcer patients."( New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G, 2018
)
0.95
" However, few researches focused on the mechanism and their contribution of TC removal through microorganisms combined with zero-valent iron (ZVI) in wastewater treatment field."( The enhancement of tetracycline degradation through zero-valent iron combined with microorganisms during wastewater treatment: Mechanism and contribution.
Ding, J; Liu, Y; Su, Z; Yan, M; Zhu, T, 2023
)
1.24

Bioavailability

The bioavailability of a single 250-mg oral dose of tetracycline hydrochloride was studied in seven patients following Billroth-II gastrectomy.

ExcerptReferenceRelevance
" Evaluation of the absorption rate was done by means of urinary excretion measurements."( Effect of magnesium trisilicate and citric acid on the biovailability of tetracycline in man.
Daabis, NA; Khalil, SA; Naggar, VF; Wafik, M,
)
0.36
"The bioavailability of tetracycline in the presence and absence of a porcine gastric mucin dispersion (1% W/V) has been studied by in vivo perfusion of the rat small intestine, the rat everted gut, a diffusion cell technique and the Sartorius Absorption Simulator Apparatus."( The effect of mucin on the bioavailability of tetracycline from the gastrointestinal tract; in vivo, in vitro correlations.
Abbs, ET; Barry, BW; Braybrooks, MP, 1975
)
0.82
" Apparently, the reduction in tetracycline bioavailability previously reported with a kaolin-pectin suspension is not peculiar to kaolin-pectin but can be expected with almost any antidiarrheal whose mechanism of action is adsorptive in nature."( Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture.
Albert, KS; DeSante, KA; DiSanto, AR; Welch, RD, 1979
)
0.95
"Relative bioavailability after oral administration of a single dose and Cmin levels of tetracycline in plasma after multiple doses were determined in groups of well-nourished and under-nourished subjects."( Influence of nutritional status on plasma levels and relative bioavailability of tetracycline.
Krishnaswamy, K; Raghuram, TC, 1977
)
0.71
" However, the rate of absorption appeared to be more rapid in the exercise than in the rest period."( Effect of exercise on the serum level and urinary excretion of tetracycline, doxycycline and sulphamethizole.
Hinkka, H; Neuvonen, PJ; Ylitalo, P, 1977
)
0.5
" Concurrent administration of 2 gm of sodium bicarbonate to 2 of the normal subjects resulted in no impairment of either the rate or extent of tetracycline absorption from capsules, suggesting that the effect of elevated gastric pH on tetracycline bioavailability may relate to formulation."( Tetracycline absorption in elderly patients with achlorhydria.
Benson, J; Chapron, DJ; Kramer, PA; Mercik, SA, 1978
)
1.9
"The bioavailability of a single 250-mg oral dose of tetracycline hydrochloride was studied in seven patients following Billroth-II gastrectomy in comparison with seven control subjects matched for age and body weight."( Absorption of oral tetracycline in patients with Billroth-II gastrectomy.
Dengler, HJ; Greenblatt, DJ; Ochs, HR, 1978
)
0.84
"The influence of various test meals and fluid volumes on the relative bioavailability of commercial formulations of doxycycline hyclate and tetracycline hydrochloride was studied in healthy human volunteers."( Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects.
Craig, WA; Koch, PA; Lau, CC; Welling, PG, 1977
)
0.79
" The rate of absorption of from two to six of the amino acids tested was lower in 7 of the patients than in the control subjects."( Malabsorption of essential amino acids in tropical sprue.
Corcino, JJ; Klipstein, FA, 1975
)
0.25
" The bile salts are important surfactants in man, and modify the absorption rate of tetracycline, but not of doxycycline, sulphadimidine and cycloserine."( Drug absorption in patients with T-tube after cholecystectomy.
Aukee, S; Jussila, J; Karjalainen, P; Venho, VM, 1975
)
0.48
"The period of time after administration over which blood level measurements are required to obtain a reliable bioavailability comparison of two or more formulations of the same drug was considered by the analysis of bioavailability data taken from the literature."( Comparative bioavailabilities from truncated blood level curves.
Lovering, EG; McGilveray, IJ; McMillan, I; Tostowaryk, W, 1975
)
0.25
"Difference in the levels of bioavailability of 4 types of tetracycline hydrochloride tablets was shown on rabbits and guinea pigs."( [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
Ermolova, OB; Zak, AF, 1976
)
0.73
" The bioavailability of substandard product as determined from 48 h urinary tetracycline excretion was significantly lower as compared to standard product both in well-nourished and undernourished subjects."( Bioavailability of different brands of tetracycline in undernourished subjects.
Krishnaswamy, K; Raghuram, TC; Santosh, KK, 1992
)
0.78
"The role of bacteria in the bioavailability of protein-bound vitamin B12 was examined in eight elderly subjects who had atrophic gastritis and in eight normal controls."( Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis.
Goldin, BR; Golner, BB; Morrow, FD; Russell, RM; Suter, PM, 1991
)
0.28
"A pilot bioavailability study was carried out to evaluate the drug interaction and influence of dioctyl sodium sulfosuccinate (DS) on the absorption/bioavailability of tetracycline."( Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline.
Fairweather, WR; Hunt, JP; Knapp, G; Prasad, VK; Shah, VP,
)
0.56
" Earlier studies showed that concentrates reduce the bioavailability of tetracyclines more than a conventional milk replacer."( Studies on the bioavailability of tetracycline chloride after oral administration to calves and pigs.
Bengtsson, B; Jacobsson, SO; Korpe, C; Luthman, J, 1989
)
0.79
"A 2 X 2 crossover design trial was conducted in gilts to determine the bioavailability and pharmacokinetics of tetracycline hydrochloride."( Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine.
Bane, DP; Bevill, RF; Hall, WF; Kniffen, TS; Koritz, GD, 1989
)
0.73
" The tissue disposition and bioavailability of 3H-tetracycline were examined in the channel catfish (Ictalurus punctatus) after intravascular (4 mg/kg body weight) and per os (4 and 80 mg/kg) dosing."( Disposition and bioavailability of 3H-tetracycline in the channel catfish (Ictalurus punctatus).
Guarino, AM; McPhearson, RM; Plakas, SM, 1988
)
0.8
" In particular, recent simulation studies based on newly determined complex stability constants have drawn attention to the potential influence of Ca2+ and Mg2+ ions on the bioavailability of various TC derivatives in blood plasma."( Metal ion-tetracycline interactions in biological fluids. Part 8. Potentiometric and spectroscopic studies on the formation of Ca(II) and Mg(II) complexes with 4-dedimethylamino-tetracycline and 6-desoxy-6-demethyl-tetracycline.
Berthon, G; Decock-Le Révérend, B; Kozlowski, H; Lambs, L; Venturini, M, 1988
)
0.68
" Computer simulations run on this occasion showed that the stoichiometry of these species do actually condition the bioavailability of the antibiotics in blood plasma during treatment, the fraction of free base being quite negligible with regard to the metal-bound one."( Metal ion-tetracycline interactions in biological fluids. Part 3. Formation of mixed-metal ternary complexes of tetracycline, oxytetracycline, doxycycline and minocycline with calcium and magnesium, and their involvement in the bioavailability of these an
Berthon, G; Brion, M; Lambs, L, 1984
)
0.67
"The relative bioavailability of lymecycline and tetracycline hydrochloride was compared in 12 healthy volunteers in a double-blind cross-over study using a high performance liquid chromatographic method for plasma and urine analyses."( Comparative bioavailability of tetracycline and lymecycline.
Hermansson, J; Sjölin-Forsberg, G, 1984
)
0.81
" The results were used, together with those previously obtained on the complexation of these tetracyclines with proton and calcium, to assess the influence of the two alkali earth metal ions on the bioavailability of these drugs in blood plasma."( Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibioti
Berthon, G; Brion, M; Lambs, L, 1983
)
0.89
" The biliary excretion and hepatic levels of [3H]tetracycline were decreased whereas bile flow did not vary and plasma bioavailability of radioactivity increased in comparison with control rats."( Incidence of experimental ochratoxicosis on hepatic disposition of [3H]tetracycline and chloramphenicol in rats.
Alvinerie, M; Galtier, P, 1983
)
0.75
" Intramuscularly, tetraolean was well absorbed in the site of application, and, according to the animal species, it developed proper plasmal therapeutic concentrations at the following rates: calves--20 mg/kg body mass at 12-hour intervals; pigs--10 mg/kg at 6-hr intervals, or 20 mg/kg at 12-hr intervals; horses--10 mg/kg at 12-hr intervals or 20 mg/kg at 24-hr intervals."( [Tolerance for tetraolean i.m. and the blood levels in agricultural animals].
Chaleva, E; Dilov, P; Dimitrov, K; Iotsev, M; Panchev, I, 1984
)
0.27
" The program is applicable to any drug in an individual, provided that the drug follows one-compartment pharmacokinetics after oral administration, while the fraction of the oral dose absorbed, the volume of distribution, the absorption rate constant and the elimination rate constant of the drug in this individual are known."( Prediction of multiple-dose blood level curves of drugs administered four times daily at non-uniform dosing intervals.
Ng, PK, 1981
)
0.26
" In four normal volunteers taking digoxin daily for four weeks, urinary excretion of DRPs was greatest after a poorly absorbed tablet was ingested, and least after intravenous administration, Stool cultures from subjects known to make DRPs in vivo ("excretors") converted digoxin to DRPs; cultures from nonexcretors did not."( Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.
Butler, VP; Lindenbaum, J; Rund, DG; Saha, JR; Tse-Eng, D, 1981
)
0.26
" 6 The bioavailability of tetracycline from tablets and suspension was found to be similar (31."( Effect of cimetidine on the absorption of orally administered tetracycline.
Bradbrook, ID; Fisher, P; House, F; Inns, P; Morrison, PJ; Rogers, HJ, 1980
)
0.8
" Antibiotic bioavailability was measured by area under the plasma level-time curve, peak plasma level and urinary elimination."( Effect of cimetidine on absorption of oral tetracycline in mice.
Garty, M; Hurwitz, A, 1980
)
0.52
" Antibiotic bioavailability as measured by area under the serum level-time curve, peak serum level, and urinary elimination was not affected by cimetidine or sodium bicarbonate."( Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline.
Garty, M; Hurwitz, A, 1980
)
0.5
" It was found that tetraolean used intramuscularly in the early postoperative periods was well absorbed into the lymph, reached its maximum level within 2 hours and exceeded that in the blood."( [Tetraolean pharmacokinetics in the lymph and blood in complicated, acute inflammatory diseases of the abdominal cavity organs].
Iarema, IV; Makarenkov, IS; Marshak, AM; Panchenkov, RT; Urtaev, BM, 1980
)
0.26
" Advantages of the tablets with the film coating in the main characteristics, such as bioavailability and levels of tetracycline-like admixtures were shown."( [Quality and stability of tetracycline tablets].
Grakovskaia, LK; Nesterova, LIa; Okhotnikova, VF; Shadyro, LL, 1980
)
0.77
" The bioavailability was in general low for all the three tetracyclines."( Bioavailability of oxytetracycline, tetracycline and chlortetracycline after oral administration to fed and fasted pigs.
Gyrd-Hansen, N; Nielsen, P, 1996
)
0.85
" This study attempts to add to the understanding of the systemic bioavailability of fluoride ingested with milk compared with water, by measuring its uptake into developing incisors of sheep."( Fluoride uptake into the developing enamel and dentine of sheep incisors following daily ingestion of fluoridated milk or water.
Coote, GE; Cutress, TW; Gao, J; Suckling, GW, 1996
)
0.29
"The effect of milk added to coffee or black tea on the bioavailability of tetracycline was evaluated in 12 healthy volunteers according to a crossover design."( The influence of coffee with milk and tea with milk on the bioavailability of tetracycline.
Jung, H; Moreno-Esparza, R; Peregrina, AA; Rodriguez, JM, 1997
)
0.76
"To determine whether the observed decrease in tetracycline bioavailability is due to the active drug bismuth subsalicylate via complexation, or to magnesium aluminum silicate (Veegum), an inactive excipient present only in the liquid formulation of bismuth subsalicylate, which might adsorb the tetracycline, rendering it unavailable for systemic absorption."( Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Clendening, CE; Dansereau, RJ; Deepe, GS; Dunn, AB; Healy, DP; Mounts, AW, 1997
)
0.99
" The hydroxamate peptidomimetic inhibitor batimastat and its orally bioavailable analogue marimastat, which bind covalently to the zinc atom at the MMP-active site, were the first MMP inhibitors to be studied in detail."( Development of matrix metalloproteinase inhibitors in cancer therapy.
Eckhardt, SG; Hidalgo, M, 2001
)
0.31
" Findings suggest that interference with anti-implantation action of ormeloxifene by tetracycline might be due primarily to the almost complete abolition of its estrogen antagonistic activity at the uterine level, effected by decreased bioavailability of ormeloxifene and/or its active metabolite(s) by altered enterohepatic recirculation because of the effect on gut microflora."( Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats.
Ghosh, R; Kamboj, VP; Singh, MM, 2001
)
0.74
"The objective of this study was to determine the impact of omeprazole on bismuth (Bi) bioavailability when given in a three-in-one capsule containing bismuth biskalcitrate, metronidazole, and tetracycline."( Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.
Aumais, C; Lefebvre, M; Massicotte, J; Spénard, J; Tremblay, C, 2004
)
0.71
"Food significantly decreased the relative bioavailability of each drug but formulation was without effect."( Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication.
Aumais, C; Brunet, JS; Grace, M; Lefebvre, M; Massicotte, J; Spénard, J; Tremblay, C, 2005
)
0.54
" IPC had no pharmacokinetic effect on the rate of absorption of tetracycline."( Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia.
Geisser, P; Jacobs, YL; Potgieter, MA; Pretorius, SG; Venter, C; Venter, JL, 2007
)
0.82
" Human oral bioavailability is an important pharmacokinetic property, which is directly related to the amount of drug available in the systemic circulation to exert pharmacological and therapeutic effects."( Hologram QSAR model for the prediction of human oral bioavailability.
Andricopulo, AD; Moda, TL; Montanari, CA, 2007
)
0.34
"The effect on the bioavailability of the antimicrobial agents (ciprofloxacin and tetracycline), which are well known to form chelates with cationic metals such as calcium, was evaluated in 20 healthy male volunteers according to an open, random crossover fashion using a Kampo preparation, byakkokaninjinto (TJ-34) which contains various cationic metals including calcium."( Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline.
Abe, F; Haniuda, M; Hasegawa, T; Hitoshi, K; Katoh, M; Kurono, S; Nadai, M; Ohnishi, M; Saito, H, 2009
)
0.8
" Furthermore, the study showed that tetracycline oral bioavailability is very small."( Pharmacology of tetracycline water medication in swine.
Almond, GW; Baynes, RE; Mason, SE; Riviere, JE; Scheidt, AB, 2009
)
0.97
" These "in combo" PAMPA data were used to predict the human absolute bioavailability of the ampholytes."( The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Avdeef, A; Sun, N; Tam, KY; Tsinman, O, 2010
)
0.36
"Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh)."( Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV, 2010
)
0.36
" Several analogs have also shown promising oral bioavailability in rats and cynomolgus monkey."( Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
Clark, RB; Hunt, DK; Lofland, D; O'Brien, WJ; Plamondon, L; Sun, C; Xiao, XY, 2011
)
0.6
" Two compounds were identified that exhibit both oral bioavailability in rat and clinically relevant bacterial susceptibility profiles against major respiratory pathogens."( Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
Achorn, C; Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hogan, PC; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sutcliffe, JA; Xiao, XY; Zhu, Z, 2012
)
0.38
" The findings of this study have important implications for the risk assessment of engineered nanomaterials - in aquatic environments nano-NiO (and likely other metal oxide nanomaterials) can strongly adsorb tetracycline antibiotics, resulting in the changes of environmental risks of the metal oxide nanomaterials and/or bioavailability of the adsorbed contaminants."( Adsorption of tetracycline to nano-NiO: the effect of co-existing Cu(ii) ions and environmental implications.
Chen, W; Duan, L; Li, L; Xu, Z, 2014
)
0.95
" Tetracyclines form metal-complexes in natural waters, which could reduce their bioavailability for bacterial uptake."( Organic acids enhance bioavailability of tetracycline in water to Escherichia coli for uptake and expression of antibiotic resistance.
Boyd, SA; Li, H; Teppen, BJ; Tiedje, JM; Zhang, Y, 2014
)
1.58
"Complexation of tetracycline with dissolved organic matter (DOM) in aqueous solution could alter the bioavailability of tetracycline to bacteria, thereby alleviating selective pressure for development of antibiotic resistance."( Influence of Dissolved Organic Matter on Tetracycline Bioavailability to an Antibiotic-Resistant Bacterium.
Boyd, SA; Chen, Z; Gao, Y; Li, H; Zhang, Y; Zhu, D, 2015
)
1.03
" The objectives of this study were (a) to assess the tetracycline (Tc) bioavailability in a clay and in a sandy soil, and (b) to evaluate the effects of the Tc and cow manure on the structure and function of soil microbial communities."( Soil microbial response to tetracycline in two different soils amended with cow manure.
Chessa, L; Garau, G; Mangia, NP; Pinna, MV; Pusino, A, 2016
)
0.98
" The bioavailability of antibiotics varies greatly: some antibiotics remain active in soils (florfenicol, β-lactams), whereas others may be rapidly sorbed and thus not bioavailable (tetracycline, macrolides, quinolones)."( Not All Antibiotic Use Practices in Food-Animal Agriculture Afford the Same Risk.
Call, DR; Mitchell, SM; Subbiah, M, 2016
)
0.63
" Therefore, beneficial biological effects were demonstrated both in vitro and in vivo, which indicated that the bone-targeting effects of micelles greatly enhance the bioavailability of SV on the implant-bone interface, and the provision of SV-loaded targeting micelles alone exhibits the potential for extensive application in improving local bone regeneration and osseointegration, especially in osteoporotic subjects."( Study of a new bone-targeting titanium implant-bone interface.
Cai, L; Lai, R; Li, S; Li, Z; Liu, X; Sun, T; Wang, X; Wang, Y; Zhang, Y; Zhou, L,
)
0.13
" This study investigated the bioavailability of tetracycline sorbed on three soils (Webster clay loam, Capac sandy clay loam, and Oshtemo loamy sand) to a fluorescent Escherichia coli bioreporter under unsaturated conditions using agar diffusion assay, microscopic visualization, and model simulation."( Bioavailability of Soil-Sorbed Tetracycline to Escherichia coli under Unsaturated Conditions.
Boyd, SA; Chen, Z; Gao, Y; Li, H; Teppen, BJ; Tiedje, JM; Wang, G; Zhang, W; Zhang, Y; Zhu, D, 2017
)
1
" coli MC4100/pTGM strain was used to probe the bioavailability of tetracycline sorbed by smectite clay, a class of common soil minerals."( Bioavailability of tetracycline to antibiotic resistant Escherichia coli in water-clay systems.
Boyd, SA; Li, H; Teppen, BJ; Tiedje, JM; Zhang, W; Zhang, Y; Zhu, D, 2018
)
1.05
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" To understand the potential bioavailability of tetracycline (TC) in soil environments, this study explored the behaviors of TC adsorbing to six types of soils sampled from different regions of China."( Factors affecting sorption behaviors of tetracycline to soils: Importance of soil organic carbon, pH and Cd contamination.
Chen, Y; Deng, D; Hu, C; Li, Y; Luo, L, 2020
)
1.08
" Specifically, the uptake of hazardous chemicals by plastics particles may affect the distribution and bioavailability of the chemicals."( Adsorption characteristics of tetracycline onto particulate polyethylene in dilute aqueous solutions.
Chen, CW; Dong, CD; Ho, TB; Hsieh, SL; Huang, CP; Nguyen, TB; Tsai, WP, 2021
)
0.91
" The results illuminated that pyrolysis temperature is a crucial factor of fraction and bioavailability of Mn and other heavy metals in the resultant biochar and pyrolysis temperature under 450 °C may be most suitable for reutilization without potential risk."( Reutilization of manganese enriched biochar derived from Phytolacca acinosa Roxb. residue after phytoremediation for lead and tetracycline removal.
Chen, H; Chi, T; Du, C; Liu, B; Wu, H; Yu, G; Zhou, L; Zhu, X, 2022
)
0.93
", NaCl) could influence the bioavailability of antibiotics to bacteria."( NaCl salinity enhances tetracycline bioavailability to Escherichia coli on agar surfaces.
Chen, Z; Li, H; Luo, Y; Peng, A; Sallach, JB; Yin, L; Zhang, W, 2022
)
1.03
"In aquatic environment, engineered materials may inevitably interact with the coexisted organic pollutants, which affect their bioavailability and toxicity."( Combined exposure to titanium dioxide and tetracycline induces neurotoxicity in zebrafish.
Fu, Z; He, Y; Hu, Q; Xu, L; Yang, X, 2023
)
1.17
" In vivo animal studies using a Sprague Dawley rat model showed antibiotic administration using HF-MAP achieved a sustained release profile, in comparison with animals receiving oral gavage and intravenous (IV) injection, with a transdermal bioavailability of 19."( Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride.
Donnelly, RF; Kelly, SA; Larrañeta, E; Li, L; McCarthy, HO; Vora, LK; Zhao, L, 2023
)
1.15
"To investigate how cyclosporine A, a nonspecific efflux-pump blocker, affects the plasma concentrations and oral bioavailability of tigecycline, oxytetracycline, chlortetracycline, doxycycline, minocycline, and tetracycline."( Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker.
Ziółkowski, H, 2023
)
1.44
" Interestingly, the bioavailability of the tetracyclines was around two times higher after orally administering cyclosporine A than after intravenously administering it (P < 0."( Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker.
Ziółkowski, H, 2023
)
1.5
"Copper (Cu) and tetracyclines (TCs) often coexist in agricultural soils because of the use of manures on farmland; however, the influence of Cu on the bioavailability of TCs is still unclear, especially for cases with aging Cu."( Influence of copper and aging on freely dissolved tetracycline concentration in soil.
Guo, R; He, J; Li, L; Li, X; Ma, W; Wang, Y; Zhu, D, 2023
)
1.51

Dosage Studied

Doxycycline half-life significantly shorter in alcoholics than in controls. In some patients the serum concentration of doxycycline decreased below the generally accepted minimum therapeutic concentration when dosed once daily.

ExcerptRelevanceReference
" Administration of EDTA alone, in a neutral dosage form, did not significantly change absorption of the drug, which contradicted previous findings."( Compensation of dietary induced reduction of tetracycline absorption by simultaneous administration of EDTA.
Poiger, H; Schlatter, C, 1978
)
0.52
" It is concluded that minocycline in a dosage of 50 mg twice daily is a safe and effective antibiotic for those patients with tetracycline-recalcitrant acne vulgaris."( Low-dose minocycline therapy in tetracycline-recalcitrant acne vulgaris.
Cullen, SI, 1978
)
0.75
"These recommendations specify appropriate treatment, including dosage of antibiotics for uncomplicated gonococcal infections in adults, infections with penicillinase-producing Neisseria gonorrhoeae, acute salpingitis, acute epididymitis, disseminated gonococcal infections, and gonococcal infections in pediatric patients (including neonatal infections)."( Gonorrhea. Center for Disease Control recommended treatment schedules, 1979.
, 1979
)
0.26
" calcoaceticus in mice, minocycline was, in general, more active than gentamicin or polymyxin on a dosage basis and significantly more active on a blood-level basis."( In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).
Kuck, NA, 1976
)
0.26
" Up to this time, amoxicillin has not been commercially available as an injectable dosage form."( Pneumococcal meningitis-therapeutic studies in mice.
Hirth, RS; Price, KE; Tsai, YH; Williams, EB, 1975
)
0.25
" Tetracycline resistance was shown by a variety of Gram-negative rods isolated from the low dosage group."( Subgingival microflora of periodontal patients on tetracycline therapy.
Jorgensen, J; Osterberg, SK; Williams, BL, 1979
)
1.42
" Further studies are needed to develop means for rapid identification of refractory patients, and to determine the optimal antimicrobial agent, the optimal route of administration, and the optimal dosage regime."( Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy.
Genco, RJ; Levine, MJ; Mashimo, P; Slots, J, 1979
)
0.46
" The higher dosage administered orally had no greater influence on the sputum concentration."( [Tetracycline levels in the sputum in chronic obstructive bronchitis (author's transl)].
Ritzerfeld, W; Ulmer, WT; Zimmermann, I, 1977
)
1.17
" These studies indicate that the dosage regimen should be based both on body weight and on the nutritional status of the individual."( Influence of nutritional status on plasma levels and relative bioavailability of tetracycline.
Krishnaswamy, K; Raghuram, TC, 1977
)
0.48
" Explants treated with higher dosage levels of the drug were more severely affected than those exposed to lower concentrations."( In vitro inhibition of mouse dental development by tetracycline.
Kerley, MA; Kollar, EJ, 1978
)
0.51
" Inhibition by clindamycin demonstrated a gradual dose-response curve, with inhibition first noted at about 20 microgram of antibiotic/ml and maximal inhibition at 1,000 microgram/ml."( Effect ob broad-spectrum antibiotics on in vitro synthesis of DNA in the rabbit colon.
Alpers, DH; Grimme, N, 1978
)
0.26
"6% in mice receiving the combined dosage schedule of 50 microgram amphotericin B with 2 tetracycline, and 50 microgram amphotericin B with 3 mg tetracycline, respectively."( Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis.
Ferrante, A; Rowan-Kelly, B; Shepherd, C; Thong, YH, 1978
)
0.81
"A trial comparing the efficacy of three different tetracyclines, each in two different dosage regimens, in the treatment of non-specific urethritis is described."( Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse.
Alergant, CD; Annels, EH; Arya, OP; Carey, PB; Ghosh, AK; Goddard, AD, 1978
)
0.51
" At repeated administrations daily dosage of 100 mg was too low of 200 mg sufficient to obtain the same serum levels as after the initial dose of 200 mg."( [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
Grahmann, H; Malerczyk, V; Preuss, I; Schmidt, K; Simon, C, 1976
)
0.26
"A special apparatus with continuous dosing of substrates to flasks was used for experiments on the effect of inorganic phosphorus concentrations on the growth process of Act."( [Mathematical model of the effect of inorganic phosphorus on the tetracycline biosynthesis process].
Biriukov, VV; Gerasimova, TM; Makarevich, VG; Tarasova, SS, 1976
)
0.49
"A digital computer curve-fitting method, designed to estimate pharmacokinetic model constants by utilizing all drug concentration-time data collected during repetitive dosing studies, was applied to data manifesting systematic dose-to-dose variability in one or another of the pharmacokinetic parameters."( Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration.
Colburn, WA; Gibaldi, M, 1977
)
0.26
" Sampling 12 hours and 8 hours after dosing showed no significant differences in plasma levels, with each batch."( Sustained action tetracycline preparation--tetrabid-organon blood level study.
Lucas, CR; Mugglestone, CJ; Thomas, DR, 1977
)
0.6
" The half-life of doxycycline but not that of tetracycline was significantly shorter in alcoholics than in controls and in some patients the serum concentration of doxycycline decreased below the generally accepted minimum therapeutic concentration when dosed once daily."( Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in man.
Neuvonen, PJ; Penttilä, O; Roos, M; Tirkkonen, J, 1976
)
0.76
" It has the following advantages: (1) it is administered orally on a twice-daily dosage schedule, which facilitates patient compliance; (2) its toxicity is well defined and is not troublesome during short-term therapy; and (3) it penetrates tissues in therapeutic amounts and yields serum levels that are well above the minimum inhibitory concentrations of most staphylococci."( Minocycline in staphylococcal soft-tissue infections.
Barnwell, PA; Raff, MJ; Rogers, J; Waterman, N, 1975
)
0.25
"Prophylactic (preventive) antibiotic therapy initiated preoperatively, with antibiotics administered in moderately high dosage for short periods, is recommended on the basis of experimental and prospective, randomized clinical trials for patients who require surgery that is likely to expose tissue planes to contamination."( Prophylactic antibiotic therapy in surgery.
MacLean, LD, 1975
)
0.25
" Combination therapy with full-dose quinine and clindamycin for three days cured all four patients so treated who were followed up, and with half dosage three out of five patients were cured."( Falciparum malaria semi-resistant to clindamycin.
Doberstyn, EB; Hall, AP; Nanokorn, A; Sonkom, P, 1975
)
0.25
" This difference is ascribed to reduced intestinal concentrations of bioactive drug with recommended oral dosage for doxycycline."( Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora.
Bartlett, JG; Bustetter, LA; Gorbach, SL; Onderdonk, AB, 1975
)
0.57
" In addition to being simple and easy to control, the technique is rapid, convenient and precise and provides the basis for the direct analysis of pure compounds, stability samples, complex mixtures and dosage forms of all types."( Reverse phase high speed liquid chromatography of antibiotics.
Bender, AD; Carroll, MA; White, ER; Zarembo, JE, 1975
)
0.25
" In the dosage used it was also successful against gonorrhoea in seven patients treated."( Minocycline in the treatment of non-gonococcal urethritis.
Fazluddin, CM; Sparrow, RW; Willcox, RR, 1975
)
0.25
" It appears, therefore, that a faily high proportion fo tetracycline-resistant strains isolated at the present time are resistant of concentrations of minocycline unattainbale in vivo with the recommended dosage forthis antibiotic (Fishk & Tunevall, 1969)."( The genetics of tetracycline resistance in Staphylococcus aureus.
Asheshov, EH, 1975
)
0.85
" In the second patient we saw a marrow depression dependent on Chloramphenicol and its dosage which disappeared rapidly, when the drug was withheld."( [Enterobacter-osteomyelitis in two neonates (author's transl)].
Göbel, U; Kemperdick, H; Petrich, C; Rosin, H; von Voss, H, 1975
)
0.25
"The plasma half life of tetracycline hydrochloride was determined in groups of well-nourished and undernourished subjects employing two dosage schedules and two routes of administration, namely oral and parenteral."( Undernutrition and tetracycline half life.
Krishnaswamy, K; Shastri, RA, 1976
)
0.89
" There was a dose-response relationship since increasing doses of TCN to as much as 1 mg/ml caused increasing production of growth-factor-like activity without mesothelial cell injury as measured by trypan blue exclusion."( Mechanism of tetracycline-hydrochloride-induced pleurodesis. Tetracycline-hydrochloride-stimulated mesothelial cells produce a growth-factor-like activity for fibroblasts.
Antony, VB; Godbey, SW; Hott, JW; Rothfuss, KJ; Sparks, JA, 1992
)
0.65
" One standard and one substandard brand of tetracycline were selected and their bioavailability, after single dose and plasma steady-state levels after multiple dosing in well nourished and undernourished subjects were determined."( Bioavailability of different brands of tetracycline in undernourished subjects.
Krishnaswamy, K; Raghuram, TC; Santosh, KK, 1992
)
0.82
" Successful antibiotic treatment with tetracycline or erythromycin requires high dosage and a prolonged course."( Chlamydia pneumoniae, strain TWAR pneumonia.
Grayston, JT, 1992
)
0.55
" Substitution of doxycycline for tetracycline HCl offers advantages of less frequent dosing and extrarenal excretion."( Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Andrews, P; Borody, TJ; Brandl, S; Devine, M; George, LL; Lenne, J; Moore-Jones, D; Walton, M, 1992
)
0.56
" The procedure is useful in quality control of the dosage forms."( [Spectrophotometric analysis of tetracycline hydrochloride in the presence of thiamine bromide and riboflavin].
Anokhina, TA; Efimovskikh, SV, 1991
)
0.56
" The implications of dose-response curves are discussed on the basis of the receptor site concept for drug action."( Quantification of antibiotic drug potency by a two-compartment radioassay of bacterial growth.
Boonkitticharoen, V; Ehrhardt, JC; Kirchner, PT, 1990
)
0.28
" The indiscriminate use of surface active agents to increase the dissolution rate of solid oral dosage forms in the belief that the resulting increased dissolution improves product bioavailability must be questioned."( Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline.
Fairweather, WR; Hunt, JP; Knapp, G; Prasad, VK; Shah, VP,
)
0.37
" The antibiotic was taken orally one hour before root planing and continued for six days at a dosage of 250 mg six hourly."( Refractory chronic periodontitis: effect of oral tetracycline hydrochloride and root planning.
Lewis, JM; Papli, R, 1989
)
0.53
" High dosage of penicillin or tetracycline for 10-14 days is the appropriate therapy."( [Prognosis of peripheral facial paralysis in Lyme borreliosis (Garin-Bujadoux, Bannwarth meningopolyradiculitis)].
Laubert, A; Malin, JP, 1989
)
0.57
" In contrast, clindamycin was highly effective over a broad dosing range (8."( Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
Laine, BM; Maier, KA; Mitten, JE; Stevens, DL, 1987
)
0.55
"After dosing laying hens orally with tetracycline (TC) through either drinking water (0."( Excretion of tetracycline and chlortetracycline in eggs after oral medication of laying hens.
Boisseau, J; Moretain, JP; Roudaut, B,
)
0.77
" Doubling of erythromycine dosage could not prevent premenstrual exacerbation of acne."( On therapeutic approaches to some special types of acne.
Rajka, G, 1985
)
0.27
" The dose-response data in the range of concentrations where the amount of pheromone became limiting (10(-11)-10(-12) M) were consistent with the notion that as few as one or two molecules per donor cell may be sufficient to induce a mating response."( Structure of cCF10, a peptide sex pheromone which induces conjugative transfer of the Streptococcus faecalis tetracycline resistance plasmid, pCF10.
Adsit, JC; Dunny, GM; Fujino, M; Ishii, Y; Isogai, A; Kitada, C; Mori, M; Sakagami, Y; Suzuki, A, 1988
)
0.49
" If lidocaine is used in a dosage of less than 3 mg/kg, toxic levels of the drug are unlikely to occur."( Systemic absorption of tetracycline and lidocaine following intrapleural instillation.
Barbarash, RA; Sahn, SA; Strange, C; Wooten, SA, 1988
)
0.59
" The dosage of EA was 400 mg tid and that of ES 500 mg tid."( Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis.
Antikainen, R; Gordin, A; Rostila, T; Visa, K, 1988
)
0.27
" Our findings suggest that the use of tetracycline at a dosage of 250 mg, 4 times a day for 10 days, as a treatment for early Lyme disease should be reconsidered."( Failure of tetracycline therapy in early Lyme disease.
Dattwyler, RJ; Halperin, JJ, 1987
)
0.93
" Six males (five nonsmokers) with obstructive ventilatory defects were studied in two phases: control, after receiving sustained-release theophylline in the same dosage regimen for four days, and treatment, after receiving tetracycline 250 mg po qid for five days in addition to theophylline."( Evaluation of tetracycline on theophylline disposition in patients with chronic obstructive airways disease.
Gotz, VP; Ryerson, GG, 1986
)
0.82
" The higher dosage of tetracycline was more effective in preventing ulceration than the lower dosage (9."( Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits.
Buxton, DF; Golub, LM; Guthrie, DS; McNamara, TF; Perry, HD; Seedor, JA, 1987
)
1
" Of course, overall expense for the hospitalized patient includes costs of tests for monitoring for toxicity as well as administration costs, which are affected by the dosing frequency."( Choosing antimicrobials. Factors to consider, available agents.
Pankey, GA; Valainis, GT, 1985
)
0.27
" These guidelines are based on data on antibiotic concentrations attainable in serum following various dosage regimens."( Antibiotic susceptibility of anaerobic bacteria from the human oral cavity.
Baker, PJ; Evans, RT; Genco, RJ; Slots, J, 1985
)
0.27
"Four recently weaned pigs were dosed orally with oxytetracycline."( The effects of oxytetracycline on the intestinal Escherichia coli flora of newly weaned pigs.
Hampson, DJ; Hampson, E; Hinton, M; Linton, AH, 1985
)
0.85
" The effects of 4 antibiotics orally administered in varying dosage schedules were studied."( Antibiotic therapy of cholera.
Greenough, WB; Islam, MR; Lindenbaum, J, 1967
)
0.25
"A controlled comparison of furazolidone and tetracycline in the treatment of cholera indicates that, in either dosage used, furazolidone reduced total stool volume by 50% and duration of diarrhoea by 40%."( Controlled comparison of tetracycline and furazolidone in cholera.
Banwell, JG; Caranasos, GJ; Keimowitz, RI; Mitra, RC; Mondal, A; Pierce, NF; Thomas, J, 1968
)
0.81
" To overcome this degree of resistance it is necessary to give a soluble penicillin preparation intramuscularly in very high dosage (2-8 million units)."( Development of resistance of gonococci to penicillin: an eight-year study.
Amies, CR, 1967
)
0.25
"In this investigation an attempt has been made to determine the relationship between the staining of permanent teeth by tetracycline administered during the period of tooth formation with the dosage of the drug and the duration of therapy."( The incidence of staining of permanent teeth by the tetracyclines.
Anderson, DO; Conchie, JM; Munroe, JD, 1970
)
0.71
" Peritoneal dialysis does not alter these dosage requirements."( The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.
Ruedy, J, 1966
)
0.46
"5:1; the ratio in serum of patients dosed with Panalba) showed a significant retardation of resistance outgrowth compared with subculture in the presence of the antibiotics individually."( Development of resistance to novobiocin, tetracycline, and a novobiocin-tetracycline combination in Staphylococcus aureus populations.
Vavra, JJ, 1967
)
0.51
" Although HPO alone is primarily bacteriostatic, combined therapy with antibiotics and HPO may be useful against bacterial infections because the therapeutic effectiveness of a maximal dosage of antibiotic could be increased."( Enhancement of antibiotic activity against Staphylococcus aureus by exposure to hyperbaric oxygen.
Bornside, GH, 1967
)
0.25
" Cells incubated with autologous serum specimens from these patients demonstrated significant suppression of both random migration and chemotaxis, with the greatest effect seen at a dosage of 1 g daily and a significant effect found at all dosage levels."( Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy.
Esterly, NB; Furey, NL; Koransky, JS; Trevisan, M, 1984
)
0.51
" This feature of Tn1721 has been used to analyze the relationship between gene dosage and Tcr."( Tetracycline resistance transposon Tn1721: recA-dependent gene amplification and expression of tetracycline resistance.
Schmitt, R; Schraml, S; Shales, SW; Wiebauer, K, 1981
)
1.71
" The formation of plasmid multimers increased the resistance to tetracycline at the level of the induction period, presumably as a result of a gene dosage effect."( Molecular cloning in plasmid pBR322 giving altered expression of the tetracycline resistance gene.
Bastin, M, 1981
)
0.74
" The negative gene dosage effect resulted from decreased expression of two mechanisms (1 and 2) consequent on enhanced expression of the third mechanism."( Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon.
Chopra, I; Shales, SW; Wallace, LJ; Ward, JM, 1981
)
0.54
" In agreement with others, we find that Tn10 tet exhibits a negative gene dosage effect."( Multicopy Tn10 tet plasmids confer sensitivity to induction of tet gene expression.
Bertrand, KP; Moyed, HS; Nguyen, TT, 1983
)
0.27
" No evidence was found for toxicity of tetracycline or its analogues for the dosage given."( Effect of intrauterine administration of tetracyclines on cynomolgus monkeys.
Dubin, NH; Ghodgaonkar, RB; King, TM; Parmley, TH; Rosenshein, NB; Strandberg, JD, 1984
)
0.8
" The relative bioavailability of lymecycline was only 70% compared with tetracycline in multiple dosing (19."( Comparative bioavailability of tetracycline and lymecycline.
Hermansson, J; Sjölin-Forsberg, G, 1984
)
0.79
"The present investigation was performed to study the effect of long-term, low dosage tetracycline therapy on advanced periodontal disease in humans."( Effect of long-term tetracycline therapy on human periodontal disease.
Adielsson, B; Liljenberg, B; Lindhe, J, 1983
)
0.81
" Oral erythromycin ethyl succinate in a paediatric dosage form was administered to one group and topical 1% tetracycline ointment to the other group, twice daily, six days a week for three weeks."( Trachoma therapy with topical tetracycline and oral erythromycin: a comparative trial.
Daghfous, T; Dawson, CR; Hoshiwara, I; Kamoun, M; Ramdhane, K; Schachter, J; Yoneda, C, 1982
)
0.77
" These results suggest that changes in disposition of drugs are also influenced by the severity of malnutrition, and demand suitable alterations in dosage regimen."( Pharmacokinetics of tetracycline in nutritional edema.
Krishnaswamy, K; Raghuram, TC, 1982
)
0.59
" Phase II was designed to simulate clinical conditions using multiple dosing for 30 hr and scoring for survival at 96 hr."( Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline.
Bowdre, JH; Cocchetto, DM; Hull, JH, 1983
)
0.5
" The PAE phenomenon may be of clinical importance with regard to dosage regimens in antimicrobial chemotherapy."( [Experimental study of optimal dose interval in antibiotic therapy].
Craig, WA; Gerber, AU, 1982
)
0.26
" These studies indicate that undernourished subjects may require an altered dosage regimen of tetracycline to maintain effective steady-state concentrations of the drug."( Influence of dietary restriction and protein deficiency on plasma half-life and tissue distribution of tetracycline in rats.
Krishnaswamy, K; Raghuram, TC; Rao, KV,
)
0.57
" Doxycycline, whether used for 2 or 4 weeks, at a dosage of 100 mg, twice daily resulted in the same cure rate (79 and 81 per cent, respectively)."( Ureaplasma urealyticum and infertility: the effect of different antibiotic regimens on the semen quality.
Lesser, ML; Toth, A, 1982
)
0.26
" The majority of dogs showed some transient side-effects after administration of imidocarb, while a small proportion of dogs dosed with tetracycline reacted adversely and dosage had to be reduced or stopped."( A comparison of the efficacy of imidocarb dipropionate and tetracycline hydrochloride in the treatment of canine ehrlichiosis.
Dolan, TT; Price, JE, 1980
)
0.71
"Methods that may be used to design rational dosage schedules of antimicrobial agents are reviewed."( Dosage schedules of antimicrobial agents: a historical review.
Kunin, CM,
)
0.13
"This paper describes a program which can predict multiple-dose blood level of drugs administered four times daily at non-uniform dosing intervals."( Prediction of multiple-dose blood level curves of drugs administered four times daily at non-uniform dosing intervals.
Ng, PK, 1981
)
0.26
" It is concluded that due to alterations in kinetics undernourished subjects may require altered dosage regimens to maintain tetracycline concentrations above the recommended minimum inhibitory concentration in both plasma/tissue for effective therapy."( Tetracycline kinetics in undernourished subjects.
Krishnaswamy, K; Raghuram, TC, 1981
)
1.91
" A number of the cows collapsed shortly after the injection was completed, usually when the 10 mg dosage was given in 60 sec."( Cardiovascular effects of intravenous administration of tetracycline in cattle.
Gyrd-Hansen, N; Rasmussen, F; Smith, M, 1981
)
0.51
" 4 Administration of 400 mg cimetidine 8 hourly and at night for 6 days and dosing with 500 mg tetracycline as tablets or suspension on the fifth day produced no alteration in tetracycline kinetics."( Effect of cimetidine on the absorption of orally administered tetracycline.
Bradbrook, ID; Fisher, P; House, F; Inns, P; Morrison, PJ; Rogers, HJ, 1980
)
0.72
" On the basis of these dependences, the compounds were determined both in synthetic mixtures and in some solid dosage forms."( Studies on spectrophotometric determination of tetracycline and its degradation products.
Regosz, A; Zuk, G, 1980
)
0.52
" If confirmed with the solid dosage form in man, the present study suggests that unlike magnesium aluminum hydroxide gel, cimetidine may be used as an effective means of reducing gastric acid in patients who take tetracycline."( Effect of cimetidine on absorption of oral tetracycline in mice.
Garty, M; Hurwitz, A, 1980
)
0.71
" Even these agents have disadvantages, such as the high cost of bleomycin and the possible need for multiple dosing of doxycycline."( Sclerotherapy for malignant pleural effusions: alternatives to tetracycline.
Como, JA; Windsor, KS; Windsor, PG, 1994
)
0.53
" In this group the response was rapid, but acne and musculoskeletal symptoms tended to relapse when the steroid dosage was reduced."( Acne fulminans: report of clinical findings and treatment of twenty-four patients.
Karvonen, SL, 1993
)
0.29
" Relapses occurred most often in the group receiving the lowest dose of penicillin (46%), and decreased with increasing dosage of penicillin; none of the patients treated with TTC had a relapse."( Treatment of louse-borne relapsing fever with low dose penicillin or tetracycline: a clinical trial.
Rahlenbeck, SI; Seboxa, T, 1995
)
0.53
" However amoxicillin to a sufficient dosage is still enough ("Clinical" Resistance < 1 percent in our sample) for the treatment of respiratory infections except when the MIC is at a high level."( [Resistance of Streptococcus pneumoniae to penicillin. "Bacteriological" resistance/"clinical" resistance].
Bignon, J; Defouilloy, C; Fremaux, A; Geslin, P; Mehdaoui, A, 1994
)
0.29
"-azithromycin dosage regime (83%) (95% CI = 52-98%) compared to the 250-mg-b."( Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
al-Assi, MT; Cole, RA; Genta, RM; Graham, DY; Karttunen, TJ, 1995
)
0.52
" The treatment was conducted beginning from ten days post partum with a high antibiotical dosage (4 g Tetracycline) in shape of small-sized pessaries (UT-forte, MSD) and additionally the cows received 20 micrograms GnRH (Receptal, Hoechst) by intramuscular injection."( [The therapy of postpartum secretion retention (lochiometra) in high-yielding cows].
Dieckhoff, HJ; Kölling, S; Schiele, R, 1994
)
0.5
" Antibiotic treatment requires prolonged high dosage and careful monitoring to ensure that bacterial eradication has occurred."( Prostatitis--an increasing clinical problem for diagnosis and management.
Leigh, DA, 1993
)
0.29
"This review provides an updated overview on Helicobacter pylori (HP) trials, focusing on drug dosage and cost:benefit ratio."( The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Treiber, G, 1996
)
0.29
" Preliminary trials of a combination treatment with these two drugs is a new avenue which has shown in preliminary trials to yield synergistic effects which might allow the dosage of tetracycline to be reduced."( Treatment of actinic prurigo in Chimila Indians.
Bernal, J; Durán, MM; Ordoñez, CP; Prieto, JC, 1996
)
0.49
"One hundred and thirty patients with proven H pylori infection (by at least two tests) were treated with low dose triple therapy (DeNol 1 qid, tetracycline 250 mg qid and metronidazole 200 mg qid for 2 weeks; dosing with meals and at night); 83 were given a standard prescription for triple therapy (dispensed in bottles) and 47 were given a medication pack with times of dosing clearly marked."( An audit of low dose triple therapy for eradication of Helicobacter pylori.
Ali, MR; Chua, LE; Fraser, AG; Hollis, B; Little, SV; Moore, L, 1996
)
0.49
" They were dosed orally each day for 22 weeks with fluoride as sodium fluoride in water or bovine milk."( Fluoride uptake into the developing enamel and dentine of sheep incisors following daily ingestion of fluoridated milk or water.
Coote, GE; Cutress, TW; Gao, J; Suckling, GW, 1996
)
0.29
" Apparently, tTA-regulated gene expression in an individual cell functions as an 'on/off' system rather than regulating the level of gene expression in a dose-response manner, as reported previously."( Lack of gradual regulation of tetracycline-controlled gene expression by the tetracyclin-repressor/VP16 transactivator (tTA) in cultured cells.
de Waard, V; Hop, C; Pannekoek, H; van Mourik, JA, 1997
)
0.59
" Dose-response studies show that doxycycline is the most potent-analogue in abolishing tTA activity."( Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues.
A-Mohammadi, S; Alvarez-Vallina, L; Ashworth, LJ; Hawkins, RE, 1997
)
0.57
"Control of gene expression is important to gene therapy for purposes of both dosing and safety."( Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
Bohl, D; Cohen, LK; Danos, O; Donahue, BA; Leff, SE; Mandel, RJ; Otten, GR; Rendahl, KG; Snyder, RO; Spratt, SK; Van Roey, M, 1998
)
0.3
" Reasons for compliance included the desire to be cured and to follow the advice of malaria staff/employer, and the simple dosing regimen."( Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.
Fungladda, W; Honrado, ER; Kamolratanakul, P; Karbwang, J; Kitayaporn, D; Masngammueng, R; Thimasarn, K, 1998
)
0.57
" The average number of days before reduction of the prednisone dosage could begin was 16."( Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999
)
0.59
" Shortly after either bolus or prolonged dosing with angiotensin II, cell surface AT1-R expression recovers, indicating the existence of a significant restorative externalization pathway."( Relationship between internalization and mRNA decay in down-regulation of recombinant type 1 angiotensin II receptor (AT1) expression in smooth muscle cells.
Adams, B; Murphy, TJ; Obertone, TS; Wang, X, 1999
)
0.3
" Data are also presented demonstrating that STAT protein accumulation and adipocyte conversion occurred only during controlled conditions leading to the expression of PPARgamma and that the expression of these three STATs was tightly regulated in a PPARgamma ligand dose-response fashion."( PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis.
Farmer, SR; Morrison, RF; Stephens, JM; Wu, Z, 1999
)
0.3
" Other factors reported to affect compliance included the frequency of dosing and the number of pills."( A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.
Canning, A; Egan, C; Farraye, FA; Kemp, JA; Lee, M; Tataronis, G, 1999
)
0.3
" Hill coefficients of dose-response curves confirm that the synergistic responses generated by each factor alone are additive, obviating the need for feedback loops."( Transcriptional control: rheostat converted to on/off switch.
Blau, HM; Guicherit, OM; Kringstein, AM; Rossi, FM; Spicher, A, 2000
)
0.31
" Tetracycline was capable of inhibiting L3 to L4 molting within a dosage range similar to that reported for susceptible rickettsial organisms."( Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro.
Rajan, TV; Smith, HL, 2000
)
2.66
" This nonsense mutation may cause a dosage difference of normal P0, and is probably underrepresented in the current mutation data bases."( Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene.
Ferrer, X; Lagueny, A; Latour, P; Le Masson, G; Rouanet, M; Vandenberghe, A; Vital, A; Vital, C, 2001
)
0.31
" The dox dosage was varied in vivo and showed a correlation to the level of GFP expression."( Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina.
Coyne, M; Flannery, JG; Ladner, M; Manning, WC; McGee Sanftner, LH; Quiroz, D; Rendahl, KG, 2001
)
0.31
"HCl and its main degradation product, 4-epi-anhydrotetracycline, due to its toxicity, in samples obtained from stability studies of solid dosage forms (tablets)."( A stability study of tetracycline and tetracycline cyclodextrins in tablets using a new HPLC method.
Córdoba-Borrego, M; Córdoba-Díaz, D; Córdoba-Díaz, M; Moreno-Cerezo, JM, 2001
)
0.88
" Because this Tet-On TA is significantly more efficient than previous ones used in Drosophila, it is also possible to modulate gene induction by controlling the dosage of the antibiotic in the food."( Tetracycline-inducible systems for Drosophila.
Bello, B; Byrne, G; Hillen, W; Stebbins, MJ; Urlinger, S; Yin, JC, 2001
)
1.75
"Eighteen patients received COL-3 in dosing cohorts of 25, 50, and 70 mg/m(2)/d."( Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Cianfrocca, M; Cooley, TP; Dezube, BJ; Figg, WD; Krown, SE; Lee, JY; Pluda, JM; Ratner, L; Rudek, MA; Scadden, DT, 2002
)
0.31
" Antibiotic dosed solid CLMs were placed on agar plates streaked with Escherichia coli and incubated."( Local pharmaceutical release from a new hydrogel implant.
Chen, J; Felsen, D; Petratos, PB; Poppas, DP, 2002
)
0.31
"We evaluated the effect of optimized doses and dosing schedules of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline (BMT) triple therapy with only 1 day of dosing on Helicobacter pylori SS1 titers in a mouse model."( Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.
Amsler, KM; Foster, LA; Merrill, JJ; Modzelewski, TC; Quispe, JD; Sizemore, CF; Slee, AM; Stevenson, DA, 2002
)
0.84
" These results establish the proof of principle of neurotrophic factor dosing for neurodegenerative diseases and demonstrate the feasibility of lentiviral-mediated tetracycline-regulated gene transfer in the brain."( Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Aebischer, P; Déglon, N; Pereira de Almeida, L; Régulier, E; Sommer, B, 2002
)
0.74
"Prototype drug-adjustable heterologous transcription control systems designed for gene therapy applications typically show sigmoid dose-response characteristics and enable fine-tuning of therapeutic transgenes only within a narrow inducer concentration range of a few nanograms."( Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells.
Fussenegger, M; Kramer, BP; Weber, W, 2003
)
0.32
" At dosage of 1 mg l(-1), erythromycin affected the growth of both Synechocystis and Lemna with a maximum inhibition of 70 and 20%, respectively."( Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor.
Calamari, D; Neilan, BA; Netting, AG; Pomati, F, 2004
)
0.63
" Established macrolide- and tetracycline-dependent transactivators/trans-silencers bound and activated modified target promoters tailored for optimal siRNA expression in response to clinical antibiotics' dosing regimes and modulated desired target genes in Chinese hamster ovary (CHO-K1) and human fibrosarcoma (HT-1080) cells with high precision."( Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives.
Fussenegger, M; Malphettes, L, 2004
)
0.97
" Positive PA317/Tet-on/TRE-BCRP cells, which showed well dose-response in expression of BCRP with different concentration of Dox induction, were selected by both reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot."( [Expression establishment and functional analysis of breast cancer resistance protein with doxycycline induced tet regulating system in mouse fibroblast cell line PA317].
Chen, ZC; He, ZM; Yu, YH; Yuan, JH, 2004
)
0.32
"5 PA317/Tet-on /TRE-BCRP cell clone showed well dose-response in expression of BCRP with different concentration of Dox induction; its drug-resistance against mitoxantrone has positive correlation with BCRP expression (r=0."( [Expression establishment and functional analysis of breast cancer resistance protein with doxycycline induced tet regulating system in mouse fibroblast cell line PA317].
Chen, ZC; He, ZM; Yu, YH; Yuan, JH, 2004
)
0.32
" Current recommended dosing intervals for mass azithromycin treatment for trachoma are based on a mathematical model."( Mass treatment with single-dose azithromycin for trachoma.
Aguirre, A; Alexander, ND; Bailey, RL; Courtright, P; Foster, A; Holland, MJ; Mabey, DC; Massae, PA; Molina, S; Natividad-Sancho, A; Peeling, RW; Safari, S; Shao, JF; Solomon, AW; West, SK, 2004
)
0.32
" The same dosage of tetracycline dramatically reduced the size of infarct area in murine hearts analyzed by tetrazolium staining."( Tetracycline protects myocardium against ischemic injury.
Atkinson, JB; Hatano, O; Ichihara, K; Inagami, T; Kagawa, N; Nguyen, VQ; Price, E; Saito, T; Satoh, K; Senbonmatsu, TA; Waterman, MR; Yamagata, N, 2005
)
2.09
" Nonetheless, regulation of mouse EPO secretion was maintained during the entire experimental period, both when the vector dosage was reduced and when the tet-dependent transcription factors were put under the control of a muscle-specific promoter."( Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
Ciliberto, G; Giannetti, P; Lena, AM; Savino, R; Sporeno, E, 2005
)
0.63
" The expression of receptor alpha can be regulated in a dose-response manner by addition of tetracycline in the culture medium."( A rat endometrial cell line (R1-49E1) expressing estrogen receptor-alpha regulated by the tet-off system.
Arias, J; Barrón, A; Castro, I; Flores, H,
)
0.35
" The calculated concentrations of TC-HCl and CP in the upper epidermis of the model wound skin were over their minimum inhibitory concentration (MIC) for several hours against various bacteria, suggesting that this dosage system is useful for the treatment of severe burns."( Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics.
Hada, N; Hasegawa, T; Ishibashi, T; Sugibayashi, K; Takahashi, H, 2005
)
0.63
" Piglets in the treatment group were orally dosed with PCE (10(10) cfu/mL) twice within 24 h of birth, at weaning, and 18-24 h post-weaning; control group piglets were dosed with sterile broth as a placebo."( Effect of porcine-derived mucosal competitive exclusion culture on antimicrobial resistance in Escherichia coli from growing piglets.
Bailey, JS; Fedorka-Cray, PJ; Gray, JT; Jones, RD; Kim, LM, 2005
)
0.33
" There were no interference effects from traditional excipients in the dosage forms when the method was applied to pharmaceutical preparations."( Flow injection spectrophotometric determination of tetracycline in a pharmaceutical preparation by complexation with aluminium(III).
Liawruangrath, B; Liawruangrath, S; Ruengsitagoon, W; Watanesk, S, 2006
)
0.59
"To measure urinary concentrations of doxycycline in cats and dogs and tetracycline in dogs 4 h after conventional oral dosing and determine whether these antibiotics were present in sufficient concentrations to be effective against common feline and canine urinary tract pathogens as assessed in vitro by Epsilometer and disc diffusion antimicrobial susceptibility methods."( Susceptibility of bacteria from feline and canine urinary tract infections to doxycycline and tetracycline concentrations attained in urine four hours after oral dosage.
Baral, RM; Govendir, M; Malik, R; Martin, PA; Norris, JM; Wigney, DI; Wilson, BJ,
)
0.58
" dosing of levofloxacin (81%[95% CI: 78%-89%]vs 84%[95% CI: 66%-97%])."( Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P, 2006
)
0.33
" These dosage effects can be studied by conditionally expressing such proteins at different levels."( A gene regulation system with four distinct expression levels.
Berens, C; Danke, C; Gmeiner, P; Hillen, W; Jäck, HM; Krueger, C; Lochner, S; Pfleiderer, K; Schuh, W, 2006
)
0.33
"This system shows that a promoter can be adjusted to different activities and provides an excellent strategy to investigate protein dosage effects."( A gene regulation system with four distinct expression levels.
Berens, C; Danke, C; Gmeiner, P; Hillen, W; Jäck, HM; Krueger, C; Lochner, S; Pfleiderer, K; Schuh, W, 2006
)
0.33
" We verified tetracycline-dependent dose-response using optimised components and applied a straightforward single-step promoter replacement cassette to regulate expression of pheromone response factor, a key transcription factor regulating mating."( Tetracycline-regulated gene expression in the pathogen Ustilago maydis.
Brachmann, A; Feldbrügge, M; Kaffarnik, F; Kämper, J; Ladendorf, O; Maurer, S; Zarnack, K, 2006
)
2.15
"Humans with heterozygous loss-of-function mutations in the hepatocyte nuclear factor-1alpha (HNF1alpha) gene develop beta-cell-deficient diabetes (maturity-onset diabetes of the young type 3), indicating that HNF1alpha gene dosage is critical in beta-cells."( A conditional model reveals that induction of hepatocyte nuclear factor-1alpha in Hnf1alpha-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious.
de la Ossa, PP; del Pozo, N; Ferrer, J; Luco, RF; Maestro, MA; Philbrick, WM, 2006
)
0.33
" The mesocosms were dosed with antibiotic for 10 days, and effects monitored for 52 days."( Effects of tetracycline on antibiotic resistance and removal of fecal indicator bacteria in aerated and unaerated leachfield mesocosms.
Amador, JA; Atoyan, JA; Patenaude, EL; Potts, DA, 2007
)
0.73
"Annual dosing for 3 yr with zoledronic acid 5 mg intravenously resulted in a median 63% (mean, 71%) reduction of bone turnover and preservation of bone structure and mass without any signs of adynamic bone."( Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Boonen, S; Delmas, PD; Eriksen, EF; García-Hernandez, PA; Gasser, J; Halse, J; Hartl, F; Hu, H; Lewiecki, EM; Mesenbrink, P; Miller, P; Ochoa, L; Recker, RR; Reid, IR; Supronik, J, 2008
)
0.35
" Further, tetracycline treatment caused a significant increase in mtDNA density in naturally Wolbachia-uninfected but not in naturally Wolbachia-infected lines suggesting a dosage effect."( Tetracycline treatment influences mitochondrial metabolism and mtDNA density two generations after treatment in Drosophila.
Ballard, JW; Melvin, RG, 2007
)
2.18
" A dose-response curve was established to determine optimal activation of the gene switch by TC."( Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds.
Dickens, S; Hendrickx, B; Van den Berge, S; Vermeulen, P; Vranckx, JJ, 2008
)
0.35
" Likewise, adjustable transcription control is fundamental to adapt therapeutic protein production to the changing daily dosing regimes of a patient, to titrate expression of protein pharmaceuticals into the therapeutic window, and to reverse dosing upon completion of the therapy."( Adenovirus-mediated transduction of auto- and dual-regulated transgene expression in mammalian cells.
Fussenegger, M; Gonzalez-Nicolini, V, 2008
)
0.35
" All mesocosms were dosed every 6 h for 10 d with 3 cm of domestic wastewater amended with 5 mg TET L(-1)."( Effects of tetracycline on water quality, soil and gases in aerated and unaerated leachfield mesocosms.
Amador, JA; Atoyan, JA; Patenaude, EL; Potts, DA, 2008
)
0.74
" The X inactive specific transcript (Xist) is an untranslated RNA that is required for dosage compensation in mammals."( X chromosome inactivation in the absence of Dicer.
Chen, X; Colin, C; Dimitrov, SD; Kanellopoulou, C; Livingston, DM; Muljo, SA; Plath, K, 2009
)
0.35
" Reporter gene expression in the cascade without feedback showed a steep (sigmoidal) dose-response and a wide, nearly bimodal yEGFP distribution, giving rise to a noise peak at intermediate levels of induction."( Negative autoregulation linearizes the dose-response and suppresses the heterogeneity of gene expression.
Adams, RM; Balázsi, G; Josic, K; Murphy, KF; Nevozhay, D, 2009
)
0.35
" A subtherapeutic concentration of tetracycline did not have any significant effect on the number of transconjugants, but transconjugants were observed earlier in animals dosed with this antibiotic."( Intra- and interspecies conjugal transfer of Tn916-like elements from Lactococcus lactis in vitro and in vivo.
Bardowski, J; Boguslawska, J; Wilcks, A; Zycka-Krzesinska, J, 2009
)
0.63
" Although dosing regimens of clarithromycin triple therapy were quite consistent between trials, dosing regimens varied considerably for bismuth quadruple therapy."( Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Chey, WD; Higgins, PD; Luther, J; Moayyedi, P; Schoenfeld, PS; Vakil, N, 2010
)
0.36
" Here we investigate the effects of dosing frequency on label incorporation of various sites when bone turnover was perturbed by ovariectomy."( Bone seeking labels as markers for bone turnover: effect of dosing schedule on labeling various bone sites in rats.
Cheong, JM; Gunaratna, NS; Jackson, GS; McCabe, GP; Weaver, CM, 2009
)
0.35
" The results showed a continuous release of the embedded drugs in relevant dosage over a period of 6 months."( [Drug release of coated dental implant neck region to improve tissue integration].
Behrend, D; Schmitz, KP; Sternberg, K; von Schwanewede, H; Wolf, J, 2009
)
0.35
" A dosage of antibiotics initially increased the heat production rate."( Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
Buchholz, F; Harms, H; Lerchner, J; Maskow, T; Mertens, F; Wolf, A, 2010
)
0.36
" These limitations impeded the use of this system in studying gene dosage effects in pulmonary pathogenesis and repair mechanisms in the diseased lung."( Use of a new-generation reverse tetracycline transactivator system for quantitative control of conditional gene expression in the murine lung.
Bujard, H; Duerr, J; Gruner, M; Haberkorn, U; Mall, MA; Schubert, SC, 2011
)
0.65
" We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts."( FDA-approved drug labeling for the study of drug-induced liver injury.
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011
)
0.37
" A range of antibiotic effectiveness was displayed in this cell association assay, providing data that may be considered in addition to traditional testing when determining therapeutic dosing regimens."( A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.
Bilonick, RA; Kowalski, RP; Ling, Y; Mah, FS; Romanowski, EG; Shanks, RM; Wingard, JB, 2011
)
0.37
" These results provide a precise mechanism of the interaction TJ-34 and TC, suggesting a safe and effective dosage regimen to coadminister TJ-34 and TC in clinical use."( Mechanism of drug interaction between a Kampo medicine, byakkokaninjinto, and tetracycline in rats.
Hasegawa, T; Hitoshi, K; Hotta, K; Katoh, M; Kurono, S; Nadai, M; Saito, H; Tanaka, Y, 2012
)
0.61
"Single-vector Tet-on systems were developed to enable the tight regulation of transgenes in mammalian cells with a low dosage of doxycycline."( Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.
Chang, CL; Chao, CC; Chao, JS; Chiu, YR; Yuan, CJ, 2012
)
0.38
" These effects were magnified with increased exposure time and dosing concentration."( Temporal dynamics of periphyton exposed to tetracycline in stream mesocosms.
Batt, AL; Blocksom, K; Griffiths, R; Klemm, DJ; Lazorchak, JM; Nietch, CT; Quinlan, EL, 2011
)
0.63
" The dosage levels and temporal control of IGF-I release from encapsulated cells meet the requirements of orthopedic wound repair, making this approach an attractive means for the controlled synthesis and delivery of growth factors in situ for wound healing."( Control of the timing and dosage of IGF-I delivery from encapsulated cells.
Chang, A; Lysaght, MJ; Morgan, JR; Patel, RS, 2013
)
0.39
" Tetracycline, trimethoprim and an ineffective concentration of flumequine given 48 h prior to sampling, strongly increased expression of plasmid mobility genes, whereas an effective dosage of flumequine resulted in lower levels of mRNA copies of these genes relative to placebo treatment."( Impact of antibiotic treatments on the expression of the R plasmid tra genes and on the host innate immune activity during pRAS1 bearing Aeromonas hydrophila infection in zebrafish (Danio rerio).
Cantas, L; Midtlyng, PJ; Sørum, H, 2012
)
1.29
" During the course of an on-site investigation, a miscalculation of dosage - 129-168 mg tetracycline per kg body weight - was revealed."( Lameness in weaned pigs associated with tetracycline overdose. A case report.
Gotter, V; Grosse Beilage, E; Kamphues, J; Wolf, P, 2013
)
0.88
" Besides, through photocatalytic-degradation of the mixed solution of TTC and sulfamethoxazole or amoxicillin, the degradation of the two antibiotics showed obvious selectivity when the pH, TiO2 dosage and other conditions were changed."( [Characteristics and selectivity of photocatalytic-degradation of tetracycline hydrochloride].
Song, CY; Yin, DQ, 2014
)
0.64
" These results open up a new vista in therapeutics to use antibiotics (which have otherwise been rendered useless against MAR bacteria) in combination with minimized dosage of nanoparticles for the more effective control of MAR pathogenic bacteria."( Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island.
Chakrabarti, P; Chakraborti, S; Chakraborty, R; Mandal, AK; Sarwar, S; Singh, P, 2014
)
0.4
"Bacillus subtilis can acquire a higher tolerance to tetracycline by increasing the gene dosage of its resistance gene tetB."( Tetracycline tolerance mediated by gene amplification in Bacillus subtilis.
Inaoka, T; Kawamura, F; Masuda, K; Motoyama, S; Wannarat, W, 2014
)
2.1
" This study evaluated how variation in the dosing protocol for intramuscular administration of tetracycline and the composition of bacterial strains in a pig affect the level of resistance in the intestine of a pig."( Pharmacokinetic-pharmacodynamic model to evaluate intramuscular tetracycline treatment protocols to prevent antimicrobial resistance in pigs.
Ahmad, A; Christiansen, LE; Græsbøll, K; Matthews, L; Nielsen, SS; Toft, N, 2015
)
0.87
" At steady-state, the reactor operation was continued with a daily tetracycline dosing of 50 mg/L for more than 40 days, with periodic monitoring of the microbial composition, the nitrifying bacteria abundance, as well as the amoA and 16S rRNA gene activity, using molecular techniques."( Chronic impact of tetracycline on nitrification kinetics and the activity of enriched nitrifying microbial culture.
Katipoglu-Yazan, T; Merlin, C; Orhon, D; Pons, MN; Ubay-Cokgor, E, 2015
)
0.99
" In this study, withdrawal intervals (WDI) were estimated for pigs when dosed with tetracycline and sulfamethazine in water."( Tissue concentrations of sulfamethazine and tetracycline hydrochloride of swine (Sus scrofa domestica) as it relates to withdrawal methods for international export.
Baynes, RE; Mason, SE; Wu, H; Yeatts, JE, 2015
)
0.9
" The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models."( A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.
Chambers, CB; Embalabala, A; Geltz, J; Gershburg, E; Gross, J; Halford, WP; Villamizar, O; Wilber, A, 2015
)
0.42
" pylori treatment or lookalike placebos together with a single dosage of omeprazole and bismuth."( A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Bajbouj, M; Classen, M; Gerhard, M; Guan, WX; Li, M; Liu, RY; Liu, WD; Ma, JL; Pan, KF; Quante, M; Schmid, R; Suchanek, S; Ulm, K; Vieth, M; Wang, JX; Wang, LH; You, WC; Zhang, L; Zhang, LF; Zhang, Y; Zhou, T, 2016
)
0.43
" However, a dose-response relationship between failure rate and smoking or drinking index was found in men (all Ptrend<0."( A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Bajbouj, M; Classen, M; Gerhard, M; Guan, WX; Li, M; Liu, RY; Liu, WD; Ma, JL; Pan, KF; Quante, M; Schmid, R; Suchanek, S; Ulm, K; Vieth, M; Wang, JX; Wang, LH; You, WC; Zhang, L; Zhang, LF; Zhang, Y; Zhou, T, 2016
)
0.43
" In the present study, we examined whether the failure of dosage compensation was responsible for this sex-specific mortality."( Misdirection of dosage compensation underlies bidirectional sex-specific death in Wolbachia-infected Ostrinia scapulalis.
Ishikawa, Y; Kayukawa, T; Shinoda, T; Sugimoto, TN; Tsuchida, T, 2015
)
0.42
" Spray was applied once, at a usual dosage and without any bandage."( Polyurethane dressing, tetracycline and salicylic acid use for treatment of digital dermatitis in cattle. A comparative study.
Fiedler, A; Maierl, J; Sauter-Louis, C, 2015
)
0.73
" These parameters, along with in vivo pharmacokinetic data, may be useful in mathematical models to predict in vivo competitive growth of many different strains and for development of optimal dosing regimens for preventing selection of resistance."( Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli.
Agersø, Y; Ahmad, A; Christiansen, LE; Damborg, P; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C, 2015
)
0.67
" Predictions made from the study could be used to redesign multidrug treatment strategies not only for intramuscular treatment in pigs, but also for other dosing routes."( Multistrain models predict sequential multidrug treatment strategies to result in less antimicrobial resistance than combination treatment.
Ahmad, A; Christiansen, LE; Græsbøll, K; Matthews, L; Nielsen, SS; Olsen, JE; Toft, N; Zachariasen, C, 2016
)
0.43
" The percentage of isolates with elevated cefixime MICs increased during 2009-2010, then decreased during 2012-2013 after treatment recommendations were changed in 2010 to recommend dual therapy (with a cephalosporin and a second antibiotic) and a higher dosage of ceftriaxone."( Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Del Rio, C; Harvey, A; Holmes, KK; Hook, EW; Kirkcaldy, RD; Kubin, G; Papp, JR; Pettus, K; Riedel, S; Sanders, T; Sharpe, S; Soge, OO; Torrone, E; Zenilman, J, 2016
)
0.43
" The pharmacodynamic parameters based on a wide range of concentrations below and above the MIC provide information that could support improving future dosing strategies to treat gonorrhoea."( Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M, 2016
)
0.43
"03), although there was no obvious dose-response relationship."( The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby, J; Cardwell, CR; Iversen, L; Lee, AJ; Murchie, P; Murray, L; Spence, A; Watson, MC, 2017
)
0.46
" However, the lack of tight control of the inducible system, leading to leakiness and adverse effects caused by undesirable tetracycline dosage requirements, has proven to be a limitation."( Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression.
Almeida, R; Bennett, EP; Coskun, M; David, L; Davidsen, J; Hansen, L; Hintze, J; Larsen, S; Mitchelmore, C; Pinto, R; Troelsen, JT, 2017
)
0.66
" In addition, effects across the dose-response curve showed higher correlative connections among transcriptional, physiological, and individual responses than multigenerational effects."( Multigenerational Effects of the Antibiotic Tetracycline on Transcriptional Responses of Daphnia magna and Its Relationship to Higher Levels of Biological Organizations.
Asselman, J; De Schamphelaere, KAC; Jeong, TY; Kim, HY; Kim, SD; Yu, S, 2017
)
0.72
" Any substance producing sensor bias that exceeded the International Organization for Standardization (ISO) document 15197:2013 limits was then tested using an in vitro dose-response method to determine whether the concentration producing a significant sensor bias was within physiologic/therapeutic concentration ranges."( Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System.
Lorenz, C; Mortellaro, M; Sandoval, W, 2018
)
0.48
" Trials were heterogenous in terms of dosing of interventions and outcome measures."( Antibiotics for treating scrub typhus.
El Sayed, I; Hine, P; Liu, Q; Wee, I, 2018
)
0.48
" Determining potencies of tetracyclines in a physiological medium, such as FBS, is proposed, when the objective is correlation with pharmacokinetic data for dosage determination."( Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
Lees, P; Mead, A; Mitchell, J; Pelligand, L; Rycroft, A; Standing, JF; Toutain, PL, 2019
)
1.1
" Treatment groups consisted of topical applications of tetracycline hydrochloride, in a paste or as a powdered form under a bandage, at 3 different dosing levels (2, 5, and 25 g) on each of the 2 affected feet."( Evaluation of tetracycline in milk following extra-label administration of topical tetracycline for digital dermatitis in dairy cattle.
Cramer, G; Johnson, R; Solano, L, 2019
)
1.12
" A novel Cu-immobilized alginate adsorbent had been synthesized successfully through a facile fabrication way called sol-gel method, and its adsorption performance had been investigated for the tetracycline removal at various conditions, including the pH, temperature, the dosage of adsorbent, concentration and contact time."( Study on adsorption of tetracycline by Cu-immobilized alginate adsorbent from water environment.
Chen, Y; He, Y; Lin, X; Luo, X; Shang, R; Zhang, X, 2019
)
1.01
" This enables the analysis of each compound in a four-point dose-response in isogenic strain pairs along with a no-cell control and 16-point external standard curve, all in triplicate."( Development and Optimization of a Higher-Throughput Bacterial Compound Accumulation Assay.
Krucker, T; Pasutti, WD; Sachdeva, M; Simmons, RL; Six, DA; Tamrakar, P; Widya, M, 2019
)
0.51
" For the treatment options, many conventional dosage forms are available; however, existing limitations of systemic administration of drugs (oral antibiotics), such as adverse events and resistance, led for seek of new formulation options."( Liposome-based combination therapy for acne treatment.
Aslan, M; Çalamak, S; Eroğlu, İ; Gultekinoglu, M; Kart, D; Ulubayram, K; Yaman, Ü, 2020
)
0.56
" Herein, a sequencing batch reactor (SBR) was set up with dosing different concentrations (0-500 μg/L) of tetracycline to investigate its influences on microbial communities and ARG levels in aerobic granular sludge."( Tetracycline exposure shifted microbial communities and enriched antibiotic resistance genes in the aerobic granular sludge.
Li, ZH; Sheng, GP; Yuan, L; Zhang, HC; Zhang, MQ, 2019
)
2.17
" Interestingly, the metabolome showed a highly species-specific pattern with a distinct dose-response relationship."( Low-dose tetracycline exposure alters gut bacterial metabolism and host-immune response: "Personalized" effect?
Dong, W; Fang, M; Keerthisinghe, TP; Wang, M; Zhang, Y, 2019
)
0.93
" We also showed that the system can be finely tuned through dosage of the inducer tetracycline to calibrate the circuit for detection of the desired levels of UPS activation."( Hysteretic Genetic Circuit for Detection of Proteasomal Degradation in Mammalian Cells.
Bhagyashree, B; Nguyen, T; Segatori, L; Zeng, Y; Zhao, W, 2019
)
0.74
" The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown."(
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019
)
0.51
" The IBHC + PS system can remove TC effectively with a relative low IBHC dosage (0."( Enhanced catalytic degradation of tetracycline antibiotic by persulfate activated with modified sludge bio-hydrochar.
Li, J; Liu, Y; Wei, J; Zhu, Y, 2020
)
0.84
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."(
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022
)
0.72
" During the application of TET, their dosage should be effectively considered and controlled."( Recovery of gut microbiota in mice exposed to tetracycline hydrochloride and their correlation with host metabolism.
Hong, H; Wu, B; Yin, J; Zhang, XX; Zhao, F; Zhao, W, 2021
)
0.88
" When the Co-PPCC catalyst dosage was 1 g/L, PMS concentration was 2 g/L, and pH value was 11, the removal efficiency of TC with a concentration of 50 mg/L reached 99% within 60 min."( Oxidative degradation of tetracycline using peroxymonosulfate activated by cobalt-doped pomelo peel carbon composite.
An, L; Han, S; Wu, D; Xiao, P, 2022
)
1.02
" The effect of initial pollutant concentrations, the dosage of iron oxide, pH value, and temperature on the hybrid treatment process was investigated."( Microwave-assisted iron oxide process for efficient removal of tetracycline.
Cheng, F; Hua, Y; Liu, Y; Sun, K; Zhang, Y, 2022
)
0.96
" However, to control dosage and timing, as well as to limit potential side-effects, microRNAs' expression should ideally be under exogenous, inducible control."( Limiting Transactivator Amounts Contribute to Transgene Mosaicism in Tet-On All-in-One Systems.
Duran, AG; Gossen, M; Nazari-Shafti, TZ; Neuber, S; Schwestka, M; Stamm, C, 2022
)
0.72
" The results show that the dosage of 5-10 mg/L TCMP daily effectively inhibited nitrification."( The effect of nitrification inhibitors on the aerobic biodegradation of tetracycline antibiotics in swine wastewater.
Bai, L; Cao, G; Chen, X; Meng, S; Xue, W; Yang, L; Yuan, C, 2023
)
1.14
" With an Fe/SS ratio of 1/2, a sintering temperature of 1050 °C, a sintering time of 30 min, an initial pH of 3, and a filler dosage of 100 g/L, the SMEF demonstrated a high degradation ability for TCH with a removal rate reached 95."( Preparation of sludge-based micro-electrolysis filler and its application in pharmaceutical wastewater treatment by an up-flow aerated filter.
Li, C; Liu, L; Shen, Y; Zhou, YM, 2023
)
0.91
"Although antibiotics are one of the most significant factors contributing to the propagation of antibiotic resistance genes (ARGs), studies on the dose-response relationship at sub-lethal concentrations of antibiotics remain scarce, despite their importance for assessing the risks of antibiotics in the environment."( Differential dose-response patterns of intracellular and extracellular antibiotic resistance genes under sub-lethal antibiotic exposure.
Cheng, Y; Gao, Y; Li, H; Liu, L; Yuan, Q; Zhang, X; Zou, X, 2023
)
0.91
" Also, 1 mM HPO dosage led to 100% antibiotic removal ratios after 10 min of DBD treatment and a TOC removal of 62."( Non-thermal plasma activated peroxide and percarbonate for tetracycline and oxytetracycline degradation: Synergistic performance, degradation pathways, and toxicity evaluation.
Kyere-Yeboah, K; Qiao, XC, 2023
)
1.15
"In a real-world experience, modified tetracycline dosing as part of tetracycline and furazolidone quadruple therapy for 14 d demonstrated high efficacy, comparable to standard tetracycline dose regimens, with a favorable safety profile."( Efficacy and safety of modified tetracycline dosing in a quadruple therapy for
Chen, XQ; Du, Q; Hu, WL; Kim, JJ; Sun, YC; Wang, XJ; Yue, L; Zhao, YR; Zhu, MJ, 2023
)
1.47
" Treatment success is affected by treatment choice, correct dosing of medications, and adherence."( Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Bontems, P; Iliadis, E; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Tetracycline Action Pathway14

Protein Targets (86)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
EWS/FLI fusion proteinHomo sapiens (human)Potency10.76060.001310.157742.8575AID1259252; AID1259253; AID1259255; AID1259256
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency24.54120.000214.376460.0339AID720692
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency38.89520.001019.414170.9645AID743191
Histone H2A.xCricetulus griseus (Chinese hamster)Potency89.76250.039147.5451146.8240AID1224845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)IC50 (µMol)22.44740.17369.803229.2701AID712
estrogen receptor beta isoform 1Homo sapiens (human)IC50 (µMol)50.00001.91098.316518.7976AID1060
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)IC50 (µMol)22.44740.17369.803229.2701AID712
tyrosine-protein phosphatase non-receptor type 7 isoform 2Homo sapiens (human)IC50 (µMol)8.33000.100012.726563.0000AID521
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)133.00000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)133.00000.20005.677410.0000AID1473741
Bile salt export pumpHomo sapiens (human)IC50 (µMol)134.00000.11007.190310.0000AID1443980; AID1473738
30S ribosomal protein S6Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S7Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L15Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
Muscarinic acetylcholine receptor M2Homo sapiens (human)IC50 (µMol)140.00000.00001.23267.7930AID293953
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)220.00000.00001.284810.0000AID293952
Stromelysin-1Homo sapiens (human)IC50 (µMol)140.00000.00001.148410.0000AID293953
50S ribosomal protein L10Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L11Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L7/L12Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L19Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L1Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L20Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L27Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L28Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L29Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L31Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L31 type BEscherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L32Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L33Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L34Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L35Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L36Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S10Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S11Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S12Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S13Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S16Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S18Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S19Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S20Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S2Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S3Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S4Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S5Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S8Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S9Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L13Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L14Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L16Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L23Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S15Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
Multidrug transporter MdfAEscherichia coli K-12IC50 (µMol)13.20002.50002.55002.6000AID71156
50S ribosomal protein L17Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L21Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L30Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L6Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S14Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S17Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S1Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L18Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)IC50 (µMol)140.00000.00021.874210.0000AID293953
Neutrophil collagenaseHomo sapiens (human)IC50 (µMol)180.00000.00000.927210.0000AID293954
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)IC50 (µMol)180.00000.00021.270410.0000AID293954
Alpha-synucleinHomo sapiens (human)IC50 (µMol)6.06000.19003.82049.8000AID1695730
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)IC50 (µMol)180.00000.00001.819410.0000AID293955
Collagenase 3Homo sapiens (human)IC50 (µMol)180.00000.00000.767510.0000AID293955
Cannabinoid receptor 1Mus musculus (house mouse)IC50 (µMol)180.00000.00300.92943.2000AID293954
50S ribosomal protein L2Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L3Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L24Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L4Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L22Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L5Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
30S ribosomal protein S21Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L25Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
50S ribosomal protein L36 2Escherichia coli K-12IC50 (µMol)4.58000.00891.20355.0000AID646205
Integrase Human immunodeficiency virus 1IC50 (µMol)196.00000.00051.544310.0000AID307121; AID307122
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
P2Y purinoceptor 12Homo sapiens (human)Ki10.00000.00202.82209.8300AID375433
Protein-arginine deiminase type-4Homo sapiens (human)IC50 (µMol)780.00002.50004.20005.9000AID320706
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 8Homo sapiens (human)Km566.20000.34501.32173.1000AID681031
Solute carrier family 22 member 11Homo sapiens (human)Km122.70000.15400.62151.0100AID680162
Solute carrier family 22 member 7Homo sapiens (human)Km439.90000.42500.56900.7130AID680772
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (278)

Processvia Protein(s)Taxonomy
phosphatidic acid biosynthetic processDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
synapse assemblyDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
response to nutrientDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
ether lipid biosynthetic processDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
response to xenobiotic stimulusDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
cerebellum morphogenesisDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
paranodal junction assemblyDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
response to starvationDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
membrane organizationDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
response to fatty acidDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
phospholipid biosynthetic processDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
triglyceride biosynthetic processDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
fatty acid metabolic processDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
cytoplasmic translation30S ribosomal protein S6Escherichia coli K-12
translation30S ribosomal protein S6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S7Escherichia coli K-12
translation30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L15Escherichia coli K-12
translation50S ribosomal protein L15Escherichia coli K-12
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of heart contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
response to virusMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M2Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
cytoplasmic translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L10Escherichia coli K-12
regulation of translation50S ribosomal protein L10Escherichia coli K-12
negative regulation of translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
translational termination50S ribosomal protein L11Escherichia coli K-12
stringent response50S ribosomal protein L11Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L11Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L7/L12Escherichia coli K-12
translation50S ribosomal protein L7/L12Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L19Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L19Escherichia coli K-12
translation50S ribosomal protein L19Escherichia coli K-12
negative regulation of translational initiation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L1Escherichia coli K-12
translation50S ribosomal protein L1Escherichia coli K-12
regulation of translation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L20Escherichia coli K-12
translation50S ribosomal protein L20Escherichia coli K-12
negative regulation of translation50S ribosomal protein L20Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L27Escherichia coli K-12
regulation of cell growth50S ribosomal protein L27Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L27Escherichia coli K-12
translation50S ribosomal protein L27Escherichia coli K-12
positive regulation of ribosome biogenesis50S ribosomal protein L27Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L28Escherichia coli K-12
translation50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L29Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
translational initiation50S ribosomal protein L31Escherichia coli K-12
negative regulation of cytoplasmic translational initiation50S ribosomal protein L31Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L31Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
cellular response to zinc ion starvation50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasmic translation50S ribosomal protein L31 type BEscherichia coli K-12
translation50S ribosomal protein L31 type BEscherichia coli K-12
response to reactive oxygen species50S ribosomal protein L32Escherichia coli K-12
response to radiation50S ribosomal protein L32Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L32Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L32Escherichia coli K-12
translation50S ribosomal protein L32Escherichia coli K-12
response to antibiotic50S ribosomal protein L33Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L33Escherichia coli K-12
translation50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L34Escherichia coli K-12
translation50S ribosomal protein L34Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L35Escherichia coli K-12
translation50S ribosomal protein L35Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L36Escherichia coli K-12
translation50S ribosomal protein L36Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S10Escherichia coli K-12
translation30S ribosomal protein S10Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
regulation of DNA-templated transcription elongation30S ribosomal protein S10Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S11Escherichia coli K-12
translation30S ribosomal protein S11Escherichia coli K-12
Group I intron splicing30S ribosomal protein S12Escherichia coli K-12
positive regulation of RNA splicing30S ribosomal protein S12Escherichia coli K-12
RNA folding30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S12Escherichia coli K-12
translation30S ribosomal protein S12Escherichia coli K-12
response to antibiotic30S ribosomal protein S12Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S13Escherichia coli K-12
translation30S ribosomal protein S13Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S16Escherichia coli K-12
DNA metabolic process30S ribosomal protein S16Escherichia coli K-12
translation30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S18Escherichia coli K-12
translation30S ribosomal protein S18Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S19Escherichia coli K-12
translation30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S20Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S20Escherichia coli K-12
translation30S ribosomal protein S20Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S2Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S2Escherichia coli K-12
translation30S ribosomal protein S2Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S3Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S3Escherichia coli K-12
translation30S ribosomal protein S3Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
negative regulation of translational initiation30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S4Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S4Escherichia coli K-12
DNA-templated transcription termination30S ribosomal protein S4Escherichia coli K-12
translation30S ribosomal protein S4Escherichia coli K-12
regulation of translation30S ribosomal protein S4Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S4Escherichia coli K-12
response to antibiotic30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit biogenesis30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S5Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S5Escherichia coli K-12
translation30S ribosomal protein S5Escherichia coli K-12
response to antibiotic30S ribosomal protein S5Escherichia coli K-12
regulation of mRNA stability30S ribosomal protein S8Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S8Escherichia coli K-12
translation30S ribosomal protein S8Escherichia coli K-12
regulation of translation30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S9Escherichia coli K-12
translation30S ribosomal protein S9Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L13Escherichia coli K-12
translation50S ribosomal protein L13Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L14Escherichia coli K-12
translation50S ribosomal protein L14Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L16Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L16Escherichia coli K-12
translation50S ribosomal protein L16Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L23Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L23Escherichia coli K-12
translation50S ribosomal protein L23Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S15Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S15Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
regulation of translation30S ribosomal protein S15Escherichia coli K-12
regulation of cellular pHMultidrug transporter MdfAEscherichia coli K-12
sodium ion transmembrane transportMultidrug transporter MdfAEscherichia coli K-12
response to antibioticMultidrug transporter MdfAEscherichia coli K-12
transmembrane transportMultidrug transporter MdfAEscherichia coli K-12
potassium ion transmembrane transportMultidrug transporter MdfAEscherichia coli K-12
proton transmembrane transportMultidrug transporter MdfAEscherichia coli K-12
xenobiotic detoxification by transmembrane export across the plasma membraneMultidrug transporter MdfAEscherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L17Escherichia coli K-12
translation50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L21Escherichia coli K-12
translation50S ribosomal protein L21Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L30Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L30Escherichia coli K-12
translation50S ribosomal protein L30Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L6Escherichia coli K-12
translation50S ribosomal protein L6Escherichia coli K-12
response to antibiotic50S ribosomal protein L6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S14Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S14Escherichia coli K-12
translation30S ribosomal protein S14Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S17Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S17Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
RNA secondary structure unwinding30S ribosomal protein S1Escherichia coli K-12
negative regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
positive regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L18Escherichia coli K-12
translation50S ribosomal protein L18Escherichia coli K-12
positive regulation of microglial cell activationNeutrophil collagenaseHomo sapiens (human)
proteolysisNeutrophil collagenaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil collagenaseHomo sapiens (human)
collagen catabolic processNeutrophil collagenaseHomo sapiens (human)
positive regulation of tumor necrosis factor productionNeutrophil collagenaseHomo sapiens (human)
endodermal cell differentiationNeutrophil collagenaseHomo sapiens (human)
cellular response to lipopolysaccharideNeutrophil collagenaseHomo sapiens (human)
positive regulation of neuroinflammatory responseNeutrophil collagenaseHomo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayNeutrophil collagenaseHomo sapiens (human)
extracellular matrix organizationNeutrophil collagenaseHomo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
endochondral ossificationCollagenase 3Homo sapiens (human)
growth plate cartilage developmentCollagenase 3Homo sapiens (human)
proteolysisCollagenase 3Homo sapiens (human)
extracellular matrix disassemblyCollagenase 3Homo sapiens (human)
bone mineralizationCollagenase 3Homo sapiens (human)
collagen catabolic processCollagenase 3Homo sapiens (human)
bone morphogenesisCollagenase 3Homo sapiens (human)
response to amyloid-betaCollagenase 3Homo sapiens (human)
extracellular matrix organizationCollagenase 3Homo sapiens (human)
ribosomal large subunit assembly50S ribosomal protein L2Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L2Escherichia coli K-12
translation50S ribosomal protein L2Escherichia coli K-12
negative regulation of DNA-templated DNA replication initiation50S ribosomal protein L2Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L3Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L3Escherichia coli K-12
translation50S ribosomal protein L3Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L24Escherichia coli K-12
translation50S ribosomal protein L24Escherichia coli K-12
transcriptional attenuation50S ribosomal protein L4Escherichia coli K-12
negative regulation of cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
DNA-templated transcription termination50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L4Escherichia coli K-12
regulation of translation50S ribosomal protein L4Escherichia coli K-12
negative regulation of translation50S ribosomal protein L4Escherichia coli K-12
ribosome assembly50S ribosomal protein L4Escherichia coli K-12
negative regulation of DNA-templated transcription50S ribosomal protein L4Escherichia coli K-12
response to antibiotic50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L22Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L22Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
ribosome assembly50S ribosomal protein L22Escherichia coli K-12
response to antibiotic50S ribosomal protein L22Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L5Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L5Escherichia coli K-12
translation50S ribosomal protein L5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S21Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S21Escherichia coli K-12
translation30S ribosomal protein S21Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
response to radiation50S ribosomal protein L25Escherichia coli K-12
negative regulation of translation50S ribosomal protein L25Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L25Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L36 2Escherichia coli K-12
monoatomic ion transportSolute carrier family 22 member 8Homo sapiens (human)
response to toxic substanceSolute carrier family 22 member 8Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 8Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 8Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 8Homo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
monoatomic ion transportP2Y purinoceptor 12Homo sapiens (human)
substrate-dependent cell migration, cell extensionP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
hemostasisP2Y purinoceptor 12Homo sapiens (human)
calcium-mediated signalingP2Y purinoceptor 12Homo sapiens (human)
cerebral cortex radial glia-guided migrationP2Y purinoceptor 12Homo sapiens (human)
cell projection organizationP2Y purinoceptor 12Homo sapiens (human)
lamellipodium assemblyP2Y purinoceptor 12Homo sapiens (human)
platelet activationP2Y purinoceptor 12Homo sapiens (human)
positive regulation of integrin activation by cell surface receptor linked signal transductionP2Y purinoceptor 12Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
positive regulation of monoatomic ion transportP2Y purinoceptor 12Homo sapiens (human)
response to axon injuryP2Y purinoceptor 12Homo sapiens (human)
regulation of chemotaxisP2Y purinoceptor 12Homo sapiens (human)
positive regulation of chemotaxisP2Y purinoceptor 12Homo sapiens (human)
establishment of localization in cellP2Y purinoceptor 12Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionP2Y purinoceptor 12Homo sapiens (human)
platelet aggregationP2Y purinoceptor 12Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 12Homo sapiens (human)
visual system developmentP2Y purinoceptor 12Homo sapiens (human)
positive regulation of ruffle assemblyP2Y purinoceptor 12Homo sapiens (human)
regulation of microglial cell migrationP2Y purinoceptor 12Homo sapiens (human)
positive regulation of microglial cell migrationP2Y purinoceptor 12Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 11Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 11Homo sapiens (human)
organic anion transportSolute carrier family 22 member 11Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 11Homo sapiens (human)
urate metabolic processSolute carrier family 22 member 11Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 11Homo sapiens (human)
chromatin organizationProtein-arginine deiminase type-4Homo sapiens (human)
nucleosome assemblyProtein-arginine deiminase type-4Homo sapiens (human)
chromatin remodelingProtein-arginine deiminase type-4Homo sapiens (human)
stem cell population maintenanceProtein-arginine deiminase type-4Homo sapiens (human)
protein modification processProtein-arginine deiminase type-4Homo sapiens (human)
post-translational protein modificationProtein-arginine deiminase type-4Homo sapiens (human)
innate immune responseProtein-arginine deiminase type-4Homo sapiens (human)
xenobiotic metabolic processSolute carrier family 22 member 7Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 7Homo sapiens (human)
organic anion transportSolute carrier family 22 member 7Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 7Homo sapiens (human)
alpha-ketoglutarate transportSolute carrier family 22 member 7Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (104)

Processvia Protein(s)Taxonomy
glycerone-phosphate O-acyltransferase activityDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
glycerol-3-phosphate O-acyltransferase activityDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
structural constituent of ribosome30S ribosomal protein S6Escherichia coli K-12
protein binding30S ribosomal protein S6Escherichia coli K-12
rRNA binding30S ribosomal protein S6Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S6Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S6Escherichia coli K-12
tRNA binding30S ribosomal protein S7Escherichia coli K-12
RNA binding30S ribosomal protein S7Escherichia coli K-12
mRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S7Escherichia coli K-12
protein binding30S ribosomal protein S7Escherichia coli K-12
rRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L15Escherichia coli K-12
protein binding50S ribosomal protein L15Escherichia coli K-12
rRNA binding50S ribosomal protein L15Escherichia coli K-12
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
arrestin family protein bindingMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
GTPase activity50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L10Escherichia coli K-12
protein binding50S ribosomal protein L10Escherichia coli K-12
rRNA binding50S ribosomal protein L10Escherichia coli K-12
ribosome binding50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L11Escherichia coli K-12
protein binding50S ribosomal protein L11Escherichia coli K-12
rRNA binding50S ribosomal protein L11Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L11Escherichia coli K-12
GTPase activity50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L7/L12Escherichia coli K-12
protein binding50S ribosomal protein L7/L12Escherichia coli K-12
protein homodimerization activity50S ribosomal protein L7/L12Escherichia coli K-12
ribosome binding50S ribosomal protein L7/L12Escherichia coli K-12
mRNA binding50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L19Escherichia coli K-12
rRNA binding50S ribosomal protein L19Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L19Escherichia coli K-12
tRNA binding50S ribosomal protein L1Escherichia coli K-12
RNA binding50S ribosomal protein L1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L1Escherichia coli K-12
protein binding50S ribosomal protein L1Escherichia coli K-12
rRNA binding50S ribosomal protein L1Escherichia coli K-12
mRNA regulatory element binding translation repressor activity50S ribosomal protein L20Escherichia coli K-12
mRNA binding50S ribosomal protein L20Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L20Escherichia coli K-12
rRNA binding50S ribosomal protein L20Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L20Escherichia coli K-12
tRNA binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L27Escherichia coli K-12
protein binding50S ribosomal protein L27Escherichia coli K-12
rRNA binding50S ribosomal protein L27Escherichia coli K-12
ribosome binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L28Escherichia coli K-12
protein binding50S ribosomal protein L28Escherichia coli K-12
rRNA binding50S ribosomal protein L28Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L29Escherichia coli K-12
rRNA binding50S ribosomal protein L29Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31Escherichia coli K-12
zinc ion binding50S ribosomal protein L31Escherichia coli K-12
rRNA binding50S ribosomal protein L31Escherichia coli K-12
metal ion binding50S ribosomal protein L31Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31 type BEscherichia coli K-12
structural constituent of ribosome50S ribosomal protein L32Escherichia coli K-12
protein binding50S ribosomal protein L32Escherichia coli K-12
tRNA binding50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L34Escherichia coli K-12
protein binding50S ribosomal protein L34Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L35Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36Escherichia coli K-12
tRNA binding30S ribosomal protein S10Escherichia coli K-12
transcription antitermination factor activity, RNA binding30S ribosomal protein S10Escherichia coli K-12
RNA binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S10Escherichia coli K-12
protein binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S11Escherichia coli K-12
protein binding30S ribosomal protein S11Escherichia coli K-12
rRNA binding30S ribosomal protein S11Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S11Escherichia coli K-12
tRNA binding30S ribosomal protein S12Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S12Escherichia coli K-12
protein binding30S ribosomal protein S12Escherichia coli K-12
rRNA binding30S ribosomal protein S12Escherichia coli K-12
misfolded RNA binding30S ribosomal protein S12Escherichia coli K-12
tRNA binding30S ribosomal protein S13Escherichia coli K-12
RNA binding30S ribosomal protein S13Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S13Escherichia coli K-12
protein binding30S ribosomal protein S13Escherichia coli K-12
rRNA binding30S ribosomal protein S13Escherichia coli K-12
four-way junction DNA binding30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S16Escherichia coli K-12
endonuclease activity30S ribosomal protein S16Escherichia coli K-12
DNA endonuclease activity30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S18Escherichia coli K-12
protein binding30S ribosomal protein S18Escherichia coli K-12
rRNA binding30S ribosomal protein S18Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S18Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S18Escherichia coli K-12
tRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S19Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S19Escherichia coli K-12
rRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S20Escherichia coli K-12
ornithine decarboxylase inhibitor activity30S ribosomal protein S20Escherichia coli K-12
rRNA binding30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S2Escherichia coli K-12
protein binding30S ribosomal protein S2Escherichia coli K-12
zinc ion binding30S ribosomal protein S2Escherichia coli K-12
RNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA binding30S ribosomal protein S3Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S3Escherichia coli K-12
rRNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA regulatory element binding translation repressor activity30S ribosomal protein S4Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S4Escherichia coli K-12
protein binding30S ribosomal protein S4Escherichia coli K-12
rRNA binding30S ribosomal protein S4Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S4Escherichia coli K-12
RNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S5Escherichia coli K-12
protein binding30S ribosomal protein S5Escherichia coli K-12
rRNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S8Escherichia coli K-12
rRNA binding30S ribosomal protein S8Escherichia coli K-12
tRNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S9Escherichia coli K-12
RNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L13Escherichia coli K-12
zinc ion binding50S ribosomal protein L13Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L13Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L13Escherichia coli K-12
mRNA binding50S ribosomal protein L13Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L14Escherichia coli K-12
protein binding50S ribosomal protein L14Escherichia coli K-12
rRNA binding50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L14Escherichia coli K-12
tRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L16Escherichia coli K-12
rRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L23Escherichia coli K-12
protein binding50S ribosomal protein L23Escherichia coli K-12
rRNA binding50S ribosomal protein L23Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S15Escherichia coli K-12
rRNA binding30S ribosomal protein S15Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S15Escherichia coli K-12
sodium:proton antiporter activityMultidrug transporter MdfAEscherichia coli K-12
potassium:proton antiporter activityMultidrug transporter MdfAEscherichia coli K-12
transmembrane transporter activityMultidrug transporter MdfAEscherichia coli K-12
structural constituent of ribosome50S ribosomal protein L17Escherichia coli K-12
protein binding50S ribosomal protein L17Escherichia coli K-12
RNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L21Escherichia coli K-12
rRNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L30Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L6Escherichia coli K-12
rRNA binding50S ribosomal protein L6Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L6Escherichia coli K-12
tRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S14Escherichia coli K-12
rRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S17Escherichia coli K-12
zinc ion binding30S ribosomal protein S17Escherichia coli K-12
rRNA binding30S ribosomal protein S17Escherichia coli K-12
molecular adaptor activity30S ribosomal protein S17Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S17Escherichia coli K-12
RNA binding30S ribosomal protein S1Escherichia coli K-12
single-stranded RNA binding30S ribosomal protein S1Escherichia coli K-12
mRNA binding30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L18Escherichia coli K-12
5S rRNA binding50S ribosomal protein L18Escherichia coli K-12
rRNA binding50S ribosomal protein L18Escherichia coli K-12
endopeptidase activityNeutrophil collagenaseHomo sapiens (human)
metalloendopeptidase activityNeutrophil collagenaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil collagenaseHomo sapiens (human)
peptidase activityNeutrophil collagenaseHomo sapiens (human)
zinc ion bindingNeutrophil collagenaseHomo sapiens (human)
tumor necrosis factor bindingNeutrophil collagenaseHomo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
endopeptidase activityCollagenase 3Homo sapiens (human)
metalloendopeptidase activityCollagenase 3Homo sapiens (human)
serine-type endopeptidase activityCollagenase 3Homo sapiens (human)
calcium ion bindingCollagenase 3Homo sapiens (human)
collagen bindingCollagenase 3Homo sapiens (human)
zinc ion bindingCollagenase 3Homo sapiens (human)
RNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L2Escherichia coli K-12
protein binding50S ribosomal protein L2Escherichia coli K-12
zinc ion binding50S ribosomal protein L2Escherichia coli K-12
transferase activity50S ribosomal protein L2Escherichia coli K-12
rRNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L3Escherichia coli K-12
protein binding50S ribosomal protein L3Escherichia coli K-12
rRNA binding50S ribosomal protein L3Escherichia coli K-12
RNA binding50S ribosomal protein L24Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L24Escherichia coli K-12
protein binding50S ribosomal protein L24Escherichia coli K-12
rRNA binding50S ribosomal protein L24Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L24Escherichia coli K-12
RNA-binding transcription regulator activity50S ribosomal protein L4Escherichia coli K-12
DNA binding50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L4Escherichia coli K-12
protein binding50S ribosomal protein L4Escherichia coli K-12
rRNA binding50S ribosomal protein L4Escherichia coli K-12
translation repressor activity50S ribosomal protein L4Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L4Escherichia coli K-12
endoribonuclease inhibitor activity50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L22Escherichia coli K-12
protein binding50S ribosomal protein L22Escherichia coli K-12
rRNA binding50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L22Escherichia coli K-12
tRNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L5Escherichia coli K-12
5S rRNA binding50S ribosomal protein L5Escherichia coli K-12
rRNA binding50S ribosomal protein L5Escherichia coli K-12
RNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S21Escherichia coli K-12
rRNA binding30S ribosomal protein S21Escherichia coli K-12
RNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L25Escherichia coli K-12
5S rRNA binding50S ribosomal protein L25Escherichia coli K-12
rRNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36 2Escherichia coli K-12
solute:inorganic anion antiporter activitySolute carrier family 22 member 8Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
G protein-coupled adenosine receptor activityP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled ADP receptor activityP2Y purinoceptor 12Homo sapiens (human)
guanyl-nucleotide exchange factor activityP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 12Homo sapiens (human)
solute:inorganic anion antiporter activitySolute carrier family 22 member 11Homo sapiens (human)
protein bindingSolute carrier family 22 member 11Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
protein-arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
calcium ion bindingProtein-arginine deiminase type-4Homo sapiens (human)
protein bindingProtein-arginine deiminase type-4Homo sapiens (human)
identical protein bindingProtein-arginine deiminase type-4Homo sapiens (human)
histone arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R2 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R8 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R17 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
histone H3R26 arginine deiminase activityProtein-arginine deiminase type-4Homo sapiens (human)
protein bindingSolute carrier family 22 member 7Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 7Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 7Homo sapiens (human)
alpha-ketoglutarate transmembrane transporter activitySolute carrier family 22 member 7Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier family 22 member 7Homo sapiens (human)
transmembrane transporter activitySolute carrier family 22 member 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (68)

Processvia Protein(s)Taxonomy
peroxisomeDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
peroxisomal membraneDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
peroxisomal matrixDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
cytosolDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
membraneDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
peroxisomal membraneDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
mitochondrial membraneDihydroxyacetone phosphate acyltransferaseHomo sapiens (human)
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
cytoplasm30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S6Escherichia coli K-12
ribosome30S ribosomal protein S6Escherichia coli K-12
intracellular organelle30S ribosomal protein S6Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S6Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
membrane30S ribosomal protein S7Escherichia coli K-12
cytoplasm30S ribosomal protein S7Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
ribosome50S ribosomal protein L15Escherichia coli K-12
cytoplasm50S ribosomal protein L15Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L15Escherichia coli K-12
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
clathrin-coated endocytic vesicle membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
asymmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
symmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
neuronal cell bodyMuscarinic acetylcholine receptor M2Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M2Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M2Homo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
cytosol50S ribosomal protein L10Escherichia coli K-12
ribosome50S ribosomal protein L10Escherichia coli K-12
cytoplasm50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L10Escherichia coli K-12
cytosol50S ribosomal protein L11Escherichia coli K-12
ribosome50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L11Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L11Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L7/L12Escherichia coli K-12
ribosome50S ribosomal protein L7/L12Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L19Escherichia coli K-12
ribosome50S ribosomal protein L19Escherichia coli K-12
cytoplasm50S ribosomal protein L19Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L19Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L19Escherichia coli K-12
cytosol50S ribosomal protein L1Escherichia coli K-12
ribosome50S ribosomal protein L1Escherichia coli K-12
cytoplasm50S ribosomal protein L1Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L1Escherichia coli K-12
cytosol50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L20Escherichia coli K-12
cytoplasm50S ribosomal protein L20Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L20Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L27Escherichia coli K-12
cytoplasm50S ribosomal protein L27Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L27Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L27Escherichia coli K-12
cytosol50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L28Escherichia coli K-12
cytoplasm50S ribosomal protein L28Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L28Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L29Escherichia coli K-12
cytoplasm50S ribosomal protein L29Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L29Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L29Escherichia coli K-12
cytosol50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31Escherichia coli K-12
cytoplasm50S ribosomal protein L31Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasm50S ribosomal protein L31 type BEscherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31 type BEscherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31 type BEscherichia coli K-12
cytosol50S ribosomal protein L32Escherichia coli K-12
ribosome50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L32Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L33Escherichia coli K-12
cytosol50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L33Escherichia coli K-12
intracellular organelle50S ribosomal protein L33Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L33Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L34Escherichia coli K-12
cytoplasm50S ribosomal protein L34Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L34Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L34Escherichia coli K-12
ribosome50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L35Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L35Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L36Escherichia coli K-12
ribosome50S ribosomal protein L36Escherichia coli K-12
intracellular organelle50S ribosomal protein L36Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L36Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36Escherichia coli K-12
cytosol30S ribosomal protein S10Escherichia coli K-12
ribosome30S ribosomal protein S10Escherichia coli K-12
cytoplasm30S ribosomal protein S10Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S10Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
cytosol30S ribosomal protein S11Escherichia coli K-12
ribosome30S ribosomal protein S11Escherichia coli K-12
cytoplasm30S ribosomal protein S11Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S11Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S11Escherichia coli K-12
cytosol30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytoplasm30S ribosomal protein S12Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
ribosome30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S13Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S13Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S16Escherichia coli K-12
ribosome30S ribosomal protein S16Escherichia coli K-12
intracellular organelle30S ribosomal protein S16Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S16Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
cytosol30S ribosomal protein S18Escherichia coli K-12
ribosome30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S18Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S18Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S19Escherichia coli K-12
ribosome30S ribosomal protein S19Escherichia coli K-12
intracellular organelle30S ribosomal protein S19Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S20Escherichia coli K-12
cytoplasm30S ribosomal protein S20Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S2Escherichia coli K-12
cytoplasm30S ribosomal protein S2Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S2Escherichia coli K-12
cytosol30S ribosomal protein S3Escherichia coli K-12
ribosome30S ribosomal protein S3Escherichia coli K-12
cytoplasm30S ribosomal protein S3Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S3Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S3Escherichia coli K-12
cytosol30S ribosomal protein S4Escherichia coli K-12
ribosome30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S4Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S5Escherichia coli K-12
cytosol30S ribosomal protein S5Escherichia coli K-12
ribosome30S ribosomal protein S5Escherichia coli K-12
intracellular organelle30S ribosomal protein S5Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S5Escherichia coli K-12
cytoplasm30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S8Escherichia coli K-12
ribosome30S ribosomal protein S8Escherichia coli K-12
intracellular organelle30S ribosomal protein S8Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S8Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S9Escherichia coli K-12
ribosome30S ribosomal protein S9Escherichia coli K-12
intracellular organelle30S ribosomal protein S9Escherichia coli K-12
cytoplasm30S ribosomal protein S9Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S9Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S9Escherichia coli K-12
cytoplasm50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
intracellular organelle50S ribosomal protein L13Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L13Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L14Escherichia coli K-12
cytoplasm50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L16Escherichia coli K-12
cytoplasm50S ribosomal protein L16Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L16Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L16Escherichia coli K-12
ribosome50S ribosomal protein L23Escherichia coli K-12
cytoplasm50S ribosomal protein L23Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L23Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L23Escherichia coli K-12
cytoplasm30S ribosomal protein S15Escherichia coli K-12
cytosol30S ribosomal protein S15Escherichia coli K-12
ribosome30S ribosomal protein S15Escherichia coli K-12
intracellular organelle30S ribosomal protein S15Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S15Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S15Escherichia coli K-12
plasma membraneMultidrug transporter MdfAEscherichia coli K-12
membraneMultidrug transporter MdfAEscherichia coli K-12
plasma membraneMultidrug transporter MdfAEscherichia coli K-12
cytosol50S ribosomal protein L17Escherichia coli K-12
ribosome50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L17Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L17Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L21Escherichia coli K-12
cytosol50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L21Escherichia coli K-12
intracellular organelle50S ribosomal protein L21Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L21Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L30Escherichia coli K-12
cytoplasm50S ribosomal protein L30Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L30Escherichia coli K-12
cytosol50S ribosomal protein L6Escherichia coli K-12
ribosome50S ribosomal protein L6Escherichia coli K-12
cytoplasm50S ribosomal protein L6Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L6Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L6Escherichia coli K-12
cytoplasm30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S14Escherichia coli K-12
intracellular organelle30S ribosomal protein S14Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S14Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S17Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S17Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S1Escherichia coli K-12
ribosome30S ribosomal protein S1Escherichia coli K-12
membrane30S ribosomal protein S1Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S1Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S1Escherichia coli K-12
cytoplasm50S ribosomal protein L18Escherichia coli K-12
cytosol50S ribosomal protein L18Escherichia coli K-12
ribosome50S ribosomal protein L18Escherichia coli K-12
intracellular organelle50S ribosomal protein L18Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L18Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L18Escherichia coli K-12
extracellular regionNeutrophil collagenaseHomo sapiens (human)
extracellular spaceNeutrophil collagenaseHomo sapiens (human)
specific granule lumenNeutrophil collagenaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil collagenaseHomo sapiens (human)
tertiary granule lumenNeutrophil collagenaseHomo sapiens (human)
extracellular spaceNeutrophil collagenaseHomo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
extracellular regionCollagenase 3Homo sapiens (human)
extracellular matrixCollagenase 3Homo sapiens (human)
extracellular spaceCollagenase 3Homo sapiens (human)
cytosol50S ribosomal protein L2Escherichia coli K-12
ribosome50S ribosomal protein L2Escherichia coli K-12
cytoplasm50S ribosomal protein L2Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
DnaA-L2 complex50S ribosomal protein L2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L2Escherichia coli K-12
cytosol50S ribosomal protein L3Escherichia coli K-12
ribosome50S ribosomal protein L3Escherichia coli K-12
cytoplasm50S ribosomal protein L3Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L3Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L3Escherichia coli K-12
cytosol50S ribosomal protein L24Escherichia coli K-12
ribosome50S ribosomal protein L24Escherichia coli K-12
cytoplasm50S ribosomal protein L24Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L24Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L24Escherichia coli K-12
cytosol50S ribosomal protein L4Escherichia coli K-12
ribosome50S ribosomal protein L4Escherichia coli K-12
cytoplasm50S ribosomal protein L4Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L4Escherichia coli K-12
cytosol50S ribosomal protein L22Escherichia coli K-12
ribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasm50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L22Escherichia coli K-12
cytosol50S ribosomal protein L5Escherichia coli K-12
ribosome50S ribosomal protein L5Escherichia coli K-12
cytoplasm50S ribosomal protein L5Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L5Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L5Escherichia coli K-12
cytosol30S ribosomal protein S21Escherichia coli K-12
ribosome30S ribosomal protein S21Escherichia coli K-12
cytoplasm30S ribosomal protein S21Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S21Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S21Escherichia coli K-12
cytosol50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L25Escherichia coli K-12
cytoplasm50S ribosomal protein L25Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L25Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L36 2Escherichia coli K-12
cytosolic ribosome50S ribosomal protein L36 2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36 2Escherichia coli K-12
plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 8Homo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
plasma membraneP2Y purinoceptor 12Homo sapiens (human)
cell surfaceP2Y purinoceptor 12Homo sapiens (human)
membraneP2Y purinoceptor 12Homo sapiens (human)
cell projection membraneP2Y purinoceptor 12Homo sapiens (human)
cell body membraneP2Y purinoceptor 12Homo sapiens (human)
plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
external side of plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 11Homo sapiens (human)
nucleusProtein-arginine deiminase type-4Homo sapiens (human)
nucleoplasmProtein-arginine deiminase type-4Homo sapiens (human)
cytosolProtein-arginine deiminase type-4Homo sapiens (human)
protein-containing complexProtein-arginine deiminase type-4Homo sapiens (human)
nucleusProtein-arginine deiminase type-4Homo sapiens (human)
cytoplasmProtein-arginine deiminase type-4Homo sapiens (human)
cytosolSolute carrier family 22 member 7Homo sapiens (human)
plasma membraneSolute carrier family 22 member 7Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 7Homo sapiens (human)
membraneSolute carrier family 22 member 7Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 7Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2843)

Assay IDTitleYearJournalArticle
AID1347170Vero cells viability counterscreen for qRT-PCR qHTS assay of selected Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347172Secondary qRT-PCR qHTS assay for selected Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID547516Antimicrobial activity against Streptococcus anginosus obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence of 5% defrib2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID543342Antimicrobial activity against Vibrio cholerae non-O1 assessed as percent tetracyclin-resistant isolate at 0.12 to 16 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID308345Antibacterial activity against Staphylococcus aureus MTCCB 962007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID556891Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 3 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID585867Antimicrobial activity against Pseudomonas aeruginosa isolate 14 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1514478Antibacterial activity against Escherichia coli after 24 hrs2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Isolation and structure determination of a new lasso peptide specialicin based on genome mining.
AID565002Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1412152Antibacterial activity against Pseudomonas aeruginosa isolate 1 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID476289Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation.
AID560781Antibacterial activity against Staphylococcus aureus TS10007 harboring ddlA Asp39Asn mutation in fifth-instar silkworm larva infection model assessed as compound concentration per gram of larva causing reduction in survival after 48 hrs post dose at 27 de2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID283169Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5258 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID721792Antibacterial activity against methicillin-sensitive Staphylococcus aureus 8325-4 assessed as growth inhibition after 24 hrs by CLSI broth microdilution method2013European journal of medicinal chemistry, Feb, Volume: 60Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
AID287377Antibacterial activity against Mycobacterium smegmatis after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID556698Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1058229Antibacterial activity against Bacillus cereus by CLSI method2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
AID1906417Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method2022European journal of medicinal chemistry, May-05, Volume: 235Amphiphilic cyclic peptide [W
AID285195Antimicrobial activity against Escherichia coli M073 mutant with AG100 lon2::IS186 acrR::IS5 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID602692Binding affinity to bone mineral hydroxyapatite assessed as binding index after 0.5 hrs by UV-spectrophotometer analysis relative to 5-fluorouracil2011Bioorganic & medicinal chemistry, Jun-15, Volume: 19, Issue:12
Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
AID388003Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microdilution broth method2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Structure-activity relationship of antibacterial chalcones.
AID560223Antibacterial activity against Salmonella enterica serovar Typhimurium R200 expressing Outer membrane protein STM3031 by CLSI M7-A7 agar dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.
AID1442633Antibacterial activity against gram-negative Pseudomonas aeruginosa PA555 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID556878Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 18 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID681044TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, Tetracycline: 50 uM) in OAT3-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID516169Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID477103Antimicrobial activity against Serratia marcescens MTCC 86 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID369445Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID87951Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 2062002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID1698037Antibacterial activity against Bacillus cereus assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID528923Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-14 and CTX-M-27 gene and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID519138Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
AID614080Antibacterial activity against Bacillus brevis ATTC 9999 at 10 mg/ml after 24 to 72 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Synthesis and antimicrobial activity of (E) stilbene derivatives.
AID278270Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID694393Bactericidal activity against Enterococcus faecalis CECT 481 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID325019Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 981 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID460628Antifungal activity against Aspergillus flavus MTCC 2501 at 100 ug/ml after 48 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID1496310Antibacterial activity against vancomycin-resistant Enterococcus faecalis 368 after 24 hrs2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
AID341061Activity of tetracycline efflux transporter TetA(B) Asp190Cys mutant in Escherichia coli DH5alpha membrane vesicles assessed as [3H]tetracycline uptake2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID528724Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID428268Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID1585464Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS-271 measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID521802Antimicrobial activity against Francisella tularensis subsp. tularensis after 48 hrs by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
AID532764Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1231526Antibacterial activity against Salmonella typhi CECT 409 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID447071Antibacterial activity against Escherichia coli ATCC 11230 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID447076Antibacterial activity against Proteus vulgaris ATCC 8427 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1240028Antibacterial activity against Escherichia coli MTCC 724 after 24 hrs by microdilution method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID528708Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID430969Antibacterial activity against tetracycline-susceptible Streptococcus pneumoniae GMRS06 harboring one-nucleotide insertion stop codon in tete(M) gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271.
AID529161FIC index, ratio of MIC for Pseudomonas aeruginosa 100609 in presence of 250 ug/ml polyethylenimine to MIC for Pseudomonas aeruginosa 1006092008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID560776Antibacterial activity against Staphylococcus aureus TS2921 harboring ddlA Asp102Asn mutation and coexpressing pSddlA which complements temperature sensitivity after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID532987Antibacterial activity against Pseudomonas aeruginosa NCIM 5029 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID562239Antimycobacterial activity against Mycobacterium smegmatis by GFP-based fluorescence assay2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
AID544009Antimicrobial activity against Providencia stuartii isolate C167 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID678717Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID325029Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 376 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID406623Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent resistant isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
AID569038Antibacterial activity against Escherichia coli after 24 hrs micro dilution assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.
AID557082Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID646212Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae 1602012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID535769Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID565073Antibacterial activity against CTX-M-14 ESBL producing Morganella morganii assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID323015Antibacterial activity against drug-resistant Propionibacterium acnes P322:2 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID587839Antibacterial activity against Staphylococcus aureus by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID322994Antibacterial activity against drug-resistant Propionibacterium acnes OK8/97 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1821107Antibacterial activity against Enterococcus faecium ATCC 19434 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID396279Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(D), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID535771Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 harboring pTY60H carrying the luxAB gene under the hsp60 promoter agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID557792Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mosaic variant of mef gene by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
AID1055421Antibacterial activity against multidrug and methicillin-resistant Staphylococcus aureus 25697 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID646356Oral bioavailability in human2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID312014Antibacterial activity against Bacillus cereus at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID585427Antimicrobial activity against oqxAB positive Escherichia coli C600 XT11-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID531336Antibacterial activity against MeXAB-OprM deficient Pseudomonas aeruginosa TNP077 by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID575944Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID585862Antimicrobial activity against Pseudomonas aeruginosa isolate 11 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID587841Antibacterial activity against Haemophilus influenzae by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID278593Reduced apicoplast DNA/nuclear DNA ratio in Plasmodium falciparum FCK2 at 100 uM after 72 hrs by competitive PCR2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID587833Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID71156Inhibition of [3H]tetracycline uptake into everted membrane vesicles, prepared from tetracycline resistant Escherichia coli D1-2091993Journal of medicinal chemistry, Feb-05, Volume: 36, Issue:3
Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
AID287376Antibacterial activity against Proteus vulgaris after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID278580Inhibition of Plasmodium falciparum FCK2 second cycle growth in erythrocytes at 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID534340Antimicrobial activity against Burkholderia pseudomallei Bp50 harboring deleted (amrRAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID1585459Antibacterial activity against Staphylococcus aureus Newman measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID250261Susceptibility testing against Pseudomonas aeruginosa PAE_NUH05; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID372895Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID1726840Synergistic antibacterial activity against Staphylococcus aureus assessed as tetracyclin MIC encapsulated by compound2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID671694Oral bioavailability in human2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID548737Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID534344Antimicrobial activity against Burkholderia pseudomallei Bp174 harboring mini-Tn7T-bpeR+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID212903Inhibition of human telomerase before assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID396027Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID574168Antibacterial activity against Escherichia coli MG1655 grown as biofilms after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID564820Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID575058Antibacterial activity against Escherichia coli JM109 harboring plasmid ptac85-vca04212010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
AID212902Inhibition of human telomerase after assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID554648Antimicrobial activity against Ureaplasma urealyticum isolate HPA3 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID1304854Aqueous solubility of compound in media after 16 hrs2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID285845Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate G expressing tnpA, tnpR gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID528722Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID564817Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565315Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1879068Antibacterial activity against NDM-1 positive Escherichia coli ZC-YN3 isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method2022European journal of medicinal chemistry, Mar-05, Volume: 231Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
AID546618Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID585429Antimicrobial activity against Escherichia coli C600 ST2-T transconjugant harboring oqxAB, qnrB6 and aac(6')-Ib-cr genes by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID574178Antibacterial activity against Escherichia coli MG1655 grown as biofilms assessed as inhibition of bacterial biofilms formation at 5 to 500 ug/ml2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID560054Antibacterial activity against Acinetobacter baumannii A9844 infected in Galleria mellonella caterpillar assessed as prolonged survival rate at 50 mg/kg administered as single dose2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
AID323903Antibacterial activity against wild type Staphylococcus aureus RN42202007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID404935Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID556670Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 25 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID587834Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae isolate 160 harboring tet(M) gene by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID534402Antibacterial activity against Escherichia coli EPI300 expressing tet(40) gene assessed as inhibition of bacterial growth at 40 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID278669Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 25142007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID671552Antibacterial activity against tetracycline-resistant Streptococcus pneumoniae isolate 160 expressing tetM gene2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID432804Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 37 degC by population analysis method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
AID717274Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by CLSI protocol based broth microdilution method2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.
AID572060Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID1688649Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID564808Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID559342Antimicrobial activity against Shigella flexneri harboring tetG gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID495752Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow and treated with Cefixime by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID1382191Antibacterial activity against Salmonella typhi after 24 hrs by broth microdilution method2018European journal of medicinal chemistry, Feb-25, Volume: 146Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.
AID571882Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID585852Antimicrobial activity against Pseudomonas aeruginosa isolate 6 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID524651Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID278576Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID396273Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID396503Antibacterial activity against tetracycline-susceptible Escherichia coli clinical isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID556861Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 1 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565012Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285842Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate D expressing tet(M), Xis, tnpA, tnpR gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID530346Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID561513Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID1688647Antifungal activity against Aspergillus brasiliensis ATCC 16404 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 72 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID554865Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 2694 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID531630Antimicrobial activity against Ureaplasma urealyticum by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID572595Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1061189Antimicrobial activity against Klebsiella pneumoniae MTCC 3384 at 50 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID489652Antibacterial activity against Staphylococcus epidermidis ATCC 14990 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID323915Antibacterial activity against Staphylococcus aureus 2A1-7 with rplC G152D, D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID561109Antibacterial activity against Pasteurella multocida BB1043 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID565290Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
AID1231530Antibacterial activity against Escherichia coli CECT 100 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID1061177Antimicrobial activity against Staphylococcus aureus MTCC 96 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID71055Compound was tested for photoinhibition of Escherichia coli (CIP 548T); Sensitive1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
AID1634997Antifungal activity against Candida albicans assessed as reduction in fungal growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID559593Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of Ceftazidime by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID1335593Antibacterial activity against methicillin resistant Staphylococcus aureus MFBF 10682 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID404937Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID445446Oral bioavailability in human2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
AID587243Antimicrobial activity against Klebsiella pneumoniae DSM 681 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID369447Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID554649Antimicrobial activity against Ureaplasma urealyticum isolate HPA6 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID1688657Bactericidal activity against Salmonella typhi ATCC 6539 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID520393Antibacterial activity against mef-positive Streptococcus pneumoniae isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID587847Oral bioavailability in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID529554Antimicrobial activity against Bacillus anthracis MurA1 AS clone 2G2 assessed as growth inhibition in presence of xylose by antisense-induced hypersensitive testing2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
AID417535Antibacterial activity against Staphylococcus aureus after 24 hrs by NLCCS microdilution method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.
AID574547Increase in PSMalpha levels in Staphylococcus aureus USA300 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID444054Oral bioavailability in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID524654Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing tetM mutant gene in combination with variants of other gene loci assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1159086Antimicrobial activity against Klebsiella pneumoniae ATCC 13882 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID544276Antimicrobial activity against Enterococcus faecalis NKH6 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID348889Antibacterial activity against Escherichia coli ATCC 25922 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID516166Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID1067610Inhibition of thioflavin T binding to human amylin assessed as half life2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
A new face for old antibiotics: tetracyclines in treatment of amyloidoses.
AID1431167Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS-271 containing phage type E-MRSA after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID56762Inhibition zone when tested against DAP-AT from Escherichia coli in M9-Minimal agar at concentration 0.3 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID1061187Antimicrobial activity against Klebsiella pneumoniae MTCC 3384 at 100 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID460622Antibacterial activity against Escherichia coli MTCC 1650 at 50 ug/ml after 24 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID369659Antibacterial activity against Campylobacter jejuni 25-45 cmeB:: Kanamycin-resistant mutant by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID1061175Antimicrobial activity against Klebsiella pneumoniae MTCC 3384 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID325446Antibacterial activity against Salmonella enterica serovar Typhimurium LT2 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID1304848Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 incubated for 16 hrs by broth microdilution method in presence of Cu2+2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID541176Antimicrobial activity against multidrug resistant Streptococcus pneumoniae serotype 19F S43 carring erm(B),mef(E) and tet(M) gene2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271.
AID544026Antimicrobial activity against Acinetobacter lwoffii isolate C37 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID404950Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID1304861Dissociation constant, pKa of compound2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID1442632Antibacterial activity against gram-negative Proteus mirabilis PM385 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID613192Antibacterial activity against Streptococcus pyogenes ATCC 19615 after 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
AID1698044Antibacterial activity against Salmonella abony assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID594336Antimicrobial activity against Escherichia coli NCIM 2068/ATCC 11105 at 1000 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID528723Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID1055418Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID554660Antimicrobial activity against Ureaplasma parvum SV9 containing tetM gene2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID1158047Antimicrobial activity against Escherichia coli ATCC 25922 assessed as compound level causing less than 2% growth after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID1514477Antibacterial activity against Micrococcus luteus after 24 hrs2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Isolation and structure determination of a new lasso peptide specialicin based on genome mining.
AID1149695Antimicrobial activity against Escherichia coli assessed as growth inhibition at 0.78 ug/ml after 24 hrs by two-fold serial dilution technique1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Synthesis of 5-chloro-3'-nitro-4'-substituted salicylanilides, a new series of anthelmintic and antimicrobial agents.
AID1335596Antibacterial activity against vancomycin resistant Enterococcus faecalis MFBF 11419 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1348086Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID522669Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis B133 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID565638Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.10 ug/ml (Rvb =757.5 +/- 80.14 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID1412156Bactericidal activity against methicillin-resistant Staphylococcus epidermidis 57 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID564830Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID428267Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID428269Antimicrobial activity against Klebsiella sp. by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID283660Antimicrobial activity against Haemophilus influenzae CDS23 mutant overexpressing Def by broth microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
AID544285Antimicrobial activity against Enterococcus faecalis NKH15 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1131163Antibacterial activity against Staphylococcus aureus MB2865 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID564805Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID560778Antibacterial activity against Staphylococcus aureus RN4220 in fifth-instar silkworm larva infection model assessed as compound concentration per gram of larva causing reduction in survival after 48 hrs post dose at 27 degC2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID1228692Antibacterial activity against tet(B) tetracycline-resistant Acinetobacter baumannii 250 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID65059Concentration required for half maximum rate of enhanced [3H]DHS uptake in Escherichia coli K121987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID212742Inhibition of purified telomerase of Euplotes aediculatus at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID565308Antibacterial activity against Mycoplasma genitalium by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID535636Antimicrobial activity against Group B streptococcus serotype VI R4 harboring Q557E mutation in PBP 2X and T567I, Y262N mutations in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID588216FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID646354AUClast in Sprague-Dawley rat at 10 mg/kg, po by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID396498Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(B), tet(D), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID548522Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID564822Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID445445Permeability at pH 6.5 by PAMPA method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
AID1428626Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by broth microdilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
AID572786Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID520965Antimicrobial activity against Listeria monocytogenes isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID1688651Antibacterial activity against Salmonella typhi ATCC 6539 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID1634996Hemolytic activity in human type RBC after 1 hr2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID524884Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID544274Antimicrobial activity against Enterococcus faecalis NKH4 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID584122Antimicrobial activity against Staphylococcus aureus RN4220 by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID572791Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1058228Antibacterial activity against Escherichia coli ATCC 29522 by CLSI method2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
AID294965Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID1228689Antibacterial activity against Proteus mirabilis 385 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID543354Antimicrobial activity against Salmonella serogroup O9 assessed as percent tetracyclin-resistant isolate at 1 to >128 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID428429Antibacterial activity against Salmonella typhi after 24 hrs by well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis of novel carbazole based macrocyclic amides as potential antimicrobial agents.
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID565069Antibacterial activity against SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID283558Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID543356Antimicrobial activity against Salmonella serotype Typhimurium by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID649517Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID1587192Antibacterial activity against Staphylococcus aureus assessed as diameter of zone inhibition at 100 ppm by disc diffusion method2019European journal of medicinal chemistry, May-15, Volume: 1704(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.
AID1240025Antibacterial activity against Bacillus cereus MTCC 8372 assessed as concentration required to completely destroy test microorganisms after 24 hrs2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID494533Antimicrobial activity against Staphylococcus aureus NCIM 5021 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID494533Antimicrobial activity against Staphylococcus aureus NCIM 5021 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, May-06Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID1577571Antibacterial activity against Clostridium perfringens assessed as inhibition of bacterial growth after 24 hrs by microdilution method
AID388004Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution broth method2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Structure-activity relationship of antibacterial chalcones.
AID448517Antimicrobial activity against Escherichia coli MTCCB 1652 after 24 hrs by serial dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
AID1617789Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by broth microdilution method2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structural Characterization and Anti-infective Activity of 9,10-Seco-29-norcycloartane Glycosides Isolated from the Flowers of the Peruvian Medicinal Plant
AID556700Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid expressing ampC gene by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID278856Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID322991Antibacterial activity against drug-resistant Propionibacterium acnes SW17 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID522824Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis NH by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID544058Antimicrobial activity against Shigella flexneri isolate C506 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID562812Antimicrobial activity against Escherichia coli DH5[alpha]2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID559327Antimicrobial activity against Salmonella enterica serovar Infantis assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID1366158Antibacterial activity against Escherichia coli incubated overnight by two-fold serial dilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID325447Antibacterial activity against Staphylococcus aureus N315 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID563510Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens HMS011 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID237474Percentage of drug bound in bovine plasma albumin2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
AID423156Antibacterial activity against Lactobacillus johnsonii L0077 by Etest2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID561727Antibacterial activity against Enterococcus faecium assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID283172Effect on biofilm formation of Staphylococcus lugdunensis assessed as percent non-biofilm forming isolates2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID531626Antimicrobial activity against Mycoplasma genitalium by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID283161Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2588 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID532219Antibacterial activity against macrolide-lincosamide-streptogramin B-negative, beta-lactamase-positive, methicillin-susceptible Staphylococcus aureus isolate 42010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID535643Antimicrobial activity against Group B streptococcus serotype III N3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID565005Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID585430Antimicrobial activity against oqxAB positive Escherichia coli C600 SP8-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID528703Antibacterial activity against Streptococcus oralis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID649519Antimicrobial activity against Escherichia coli NCTC 10418 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID530585Antimicrobial activity against Mycoplasma pneumoniae isolate 19 by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID565061Antibacterial activity against wild-type Escherichia coli AG100 at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID1681009Antibacterial activity against Staphylococcus aureus assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID629282Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.25 mg/mL after 10 mins by bioluminometry-based acute action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID1127618Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrB/ParE T172A mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID678716Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID529894Antimicrobial activity against Leptospira interrogans serovar Grippotyphosa isolate 2 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID564815Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1428348Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.
AID565060Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID520394Antibacterial activity against mef(E)-positive Streptococcus pneumoniae isolate Spain 9V-3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID548796Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID564833Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID561640Antibacterial activity against Escherichia coli by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID584828Antibacterial activity against Klebsiella pneumoniae2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID541857Antimicrobial activity against Escherichia coli ATCC 29522 carrying Edwardsiella ictaluri pM07-1 by microdilution assay2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
AID1182956Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Trimeric anthracenes from the endophytic fungus Stemphylium globuliferum.
AID285156Antimicrobial activity against Streptococcus pneumoniae ATCC 496192007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
AID585875Antimicrobial activity against Pseudomonas aeruginosa isolate 18 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID528702Antibacterial activity against Streptococcus constellatus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID548795Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID278252Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID529160Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay in presence of 250 ug/ml polyethylenimine2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID530583Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae isolate 2p with A2604G mutation by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID1431162Antibacterial activity against Staphylococcus aureus Newman after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID396031Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID428138Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae isolate P1501016 by agar dilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
AID1496308Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 after 24 hrs2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
AID425601Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax a2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID516167Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID576109Antimicrobial activity against mecA-deficient Staphylococcus sciuri assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID556872Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 12 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID283155Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID467967Antimicrobial activity against Staphylococcus aureus ATCC 12600 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID369443Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID1338322Antibacterial activity against Salmonella bongori PCM 2552 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID1698050Antibacterial activity against Shigella boydii assessed as inhibition of bacterial growth incubated for overnight by CLSI based method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID1428345Antibacterial activity against Staphylococcus haemolyticus MNHN26 after 24 hrs2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.
AID572598Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID572599Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID522644Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis SK57 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1424152Antibacterial activity Bacillus pumilus against by broth dilution assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
AID554871Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 90 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID646208Antibacterial activity against tetracycline-resistant Staphylococcus aureus 1582012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID70764In vitro minimum inhibitory concentration against Escherichia coli UBMS 88-1 (tet B efflux).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID543358Antimicrobial activity against Salmonella serogroup O8 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID460800Antibacterial activity against Acinetobacter baumannii UH8407 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID484676Antibacterial activity against Salmonella typhi2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis of novel beta-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens.
AID556656Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 11 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID556675Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 2 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID324197Antibacterial activity against Escherichia coli K12 mutant JHU313 at 12.5 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID369230Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
AID501865Antifungal activity against Aspergillus fumigatus isolates after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID585856Antimicrobial activity against Pseudomonas aeruginosa isolate 8 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID609168Antifungal activity against Candida glabrata assessed as zone of inhibition at 5 uL and 28 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID646218Antibacterial activity against Klebsiella pneumoniae ATCC 109 138832012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1231523Antibacterial activity against Bacillus cereus CECT 148 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID405455Antibacterial activity against Escherichia coli 1540 isolate by disk diffusion method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
AID1240014Antibacterial activity against Bacillus cereus MTCC 8372 at 100 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID283648Susceptibility of Escherichia coli K12 MG1655 in presence of 10 mM glutathione by agar dilution method relative to control2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID206120In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-1 (tet M ribosomal protection).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID556895Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 7 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1368274Antibacterial activity against Staphylococcus aureus RN4220 over-expressing FabI by microbroth dilution method2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.
AID1551778Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID561514Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID565642Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.12 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =790.8 +/- 90.09 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID528793Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID531629Antimicrobial activity against Ureaplasma parvum by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID556874Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 14 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID456848Antimicrobial activity against Staphylococcus aureus after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives.
AID1592959Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 2697/14 assessed as reduction in microbial growth incubated for 20 hrs2019European journal of medicinal chemistry, Apr-15, Volume: 168Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
AID565072Antibacterial activity against SHV-12 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID564812Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564825Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1230064Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2272 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID557208Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID535641Antimicrobial activity against Group B streptococcus serotype V C1 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID575057Antibacterial activity against Escherichia coli JM109 harboring plasmid ptac852010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
AID489646Antibacterial activity against Citrobacter freundii ATCC 27853 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID454479Antimicrobial activity against Aspergillus flavus MTCC 2501 at 10 ug/ml after 48 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID572817Antimicrobial activity against ramR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID564832Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID278237Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID543357Antimicrobial activity against Salmonella serogroup O7 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID541148Antimicrobial activity against acrB::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID559596Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of tobramycin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID1431164Antibacterial activity against erythromycin-resistant Staphylococcus aureus NRS-70 after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID1695730Inhibition of alpha-synuclein fibril formation (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.
AID1392014Antistaphylococcal activity against linezolid-resistant Staphylococcus aureus NRS-271 containing phage type E-MRSA 15 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID554857Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2918 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID278261Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID491945Antibacterial activity against Brevibacterium epidermidis DSM 20660 after 48 hrs by microtiter plate assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea.
AID556898Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 10 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID516168Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID575167Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in marR mutant containing Escherichia coli K-12 3-AG102 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric 2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID443282Antimicrobial activity against Escherichia coli after 24 hrs by agar dilution technique2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Anti-oxidant and anti-bacterial activities of novel N'-arylmethylidene-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl) acetohydrazides.
AID405081Antimicrobial activity against Escherichia coli CAG12177 by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID556650Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 5 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1225257Antimicrobial activity against Acinetobacter baumannii ATCC 19606 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
A potent antimicrobial compound isolated from Clathria cervicornis.
AID557081Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pACM204 plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1382189Antibacterial activity against Staphylococcus aureus after 24 hrs by broth microdilution method2018European journal of medicinal chemistry, Feb-25, Volume: 146Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.
AID562238Antimycobacterial activity against Mycobacterium smegmatis assessed as growth inhibition in mid-logarithmic phase by spectrophotometry2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
AID601190Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 by CLSI dilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID629286Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.25 mg/mL after 10 mins by bioluminometry-based chronic action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID520961Antimicrobial activity against Corynebacterium urealyticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID564811Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1061178Antimicrobial activity against Bacillus cereus MTCC 8372 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID522652Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 02AS-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID528922Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-14 and CTX-M-27 gene and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID556868Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 8 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID429057Antimicrobial activity against tetracycline-resistant Mycoplasma hominis isolate overexpressing tet(M) gene2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines.
AID533660Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid VGA2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID540928Antimicrobial activity against streptomycin-resistant Streptomyces coelicolor KO-178 harboring rpsL K88E mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID524871Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID572597Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID522367Antimicrobial activity against PpmrI knockout mutant Proteus mirabilis dIpc complemented with PPmrI gene after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID567567Antimicrobial activity against Bacillus sp. BS-01 expressing multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID565639Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.12 ug/ml (Rvb =757.5 +/- 80.14 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID501851Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID404948Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate assessed as susceptible resistant isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID573967Antibacterial activity against Cj1211-negative Campylobacter jejuni harboring aphA3 and tet(O) genes2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni.
AID587842Antibacterial activity against Escherichia coli by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID1689769Antibacterial activity against Pseudomonas aeruginosa ATCC 278532020European journal of medicinal chemistry, Mar-01, Volume: 189Simple amphiphilic α-hydrazido acids: Rational design, synthesis, and in vitro bioactivity profile of a novel class of potential antimicrobial compounds.
AID535774Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 harboring pTY60H containing pCK0601 carrying the luxAB gene under the hsp60 promoter after 14 days determined according to RLU count by real-time luminescence method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID575169Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID1225387Antibacterial activity against Escherichia coli AG102 overexpressing AcrAB-TolC by p-iodonitrotetrazolium chloride colorimetric assay2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
AID524661Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID533665Antimicrobial activity against Staphylococcus aureus ATCC 292132008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID544022Antimicrobial activity against Psychrobacter frigidicola isolate C712 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID548528Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID278674Antibacterial activity against Enterococcus faecalis isolate 57442007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID585846Antimicrobial activity against Pseudomonas aeruginosa isolate 3 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID522658Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis V770-NP1-R by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID449365Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID564891Antibacterial activity against ompF-deficient Escherichia coli AG100 at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID1566496Binding affinity to miR-21 RNA in human HeLA cells transfected with pmirGLO empty vector incubated for 48 hrs by Dual-Glo luciferase assay2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
AID561342Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID565062Antibacterial activity against wild-type Escherichia coli AG100 at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID678715Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID528729Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID323916Antibacterial activity against Staphylococcus aureus 2A1-8 with rplC G152D, D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID694395Bactericidal activity against Escherichia coli CECT 405 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID325025Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 838 isolate with erm(B) and mef(E) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID1228685Antibacterial activity against tet(M) tetracycline-resistant Streptococcus pneumoniae 160 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID420020Antibacterial activity against Staphylococcus aureus at 20 mg/mL by agar diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
AID522663Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis SPS 0053 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID543355Antimicrobial activity against Salmonella serotype Choleraesuis by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID575054Antibacterial activity against Vibrio cholerae O1 569B harboring gyrA and parC genes by 2-fold agar dilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
AID308347Antibacterial activity against Escherichia coli2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID348886Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID278259Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID510749Antibacterial activity against Escherichia coli AG102MB harboring pP10-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID561108Antibacterial activity against Pasteurella multocida BB1042 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID342018Antibacterial activity against Klebsiella pneumoniae NK29 by Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1127619Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrB T172A/ParE T172A double mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID1231529Antibacterial activity against Bacillus subtilis CECT 35 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID1888846Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID524825Antibacterial activity against erythromycin susceptible Campylobacter sp. by agar plate dilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID547517Antimicrobial activity against Streptococcus anginosus obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID545057Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate SZ009 from patient pus by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID396030Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID460626Antibacterial activity against Bacillus subtilis MTCC 1789 at 50 ug/ml after 24 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID1551812Antibacterial activity against Bacillus anthracis incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID396499Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID563503Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 79 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID556657Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 12 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID531627Antimicrobial activity against Mycoplasma hominis by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID528785Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli assessed as resistant isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID534401Antibacterial activity against Escherichia coli EPI300 harboring plasmid GEM-T expressing tet(40) gene after 16 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID644021Antimicrobial activity against Staphylococcus aureus at 100 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID1392012Antistaphylococcal activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-100 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID528709Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID563508Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 79 harboring plasmid STV29 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID585426Antimicrobial activity against oqxAB positive Escherichia coli C600 X1B1-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID574175Antibacterial activity against Escherichia coli MG1655 harboring grown as biofilms plasmid pBR322 carrying blaTEM-1 and tetA(C) genes assessed as decrease in bacterial biofilms formation at 5 ug/ml by GFP assay2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID548525Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID278268Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID562792Antimicrobial activity against Chlamydophila caviae GPIC/rifR harboring rpoB gene2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID765061Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis ATCC 19433 by broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
AID556696Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid expressing ampC gene by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID567568Antimicrobial activity against Staphylococcus aureus RN4220 harboring pBS-01multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID323014Antibacterial activity against drug-resistant Propionibacterium acnes QK6/92 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID425403Antibacterial activity Escherichia coli isolate HM419 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID278858Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID1240018Antibacterial activity against Escherichia coli MTCC 724 at 100 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID585865Antimicrobial activity against Pseudomonas aeruginosa isolate 13 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID572798Antimicrobial activity against marR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID565035Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID556692Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pACM204 plasmid by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID559341Antimicrobial activity against Shigella flexneri harboring tetB gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID556686Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 13 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID556863Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 3 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID532982Antibacterial activity against Escherichia coli W3110 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID495513Antibacterial activity against Acinetobacter baumannii BM4467 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID556864Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 4 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1428346Antibacterial activity against Enterococcus faecalis CIP 103014 after 24 hrs2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.
AID380475Antimicrobial activity against TetK multidrug efflux pump possessing Staphylococcus aureus XU-212 by standard microdilution method2006Journal of natural products, Mar, Volume: 69, Issue:3
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
AID536631Antimicrobial activity against Escherichia coli NCTC 10416 at 5 mg/ml after 24 hrs by agar well diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.
AID572801Antimicrobial activity against soxS::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1688642Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID275055Antibacterial activity against Escherichia coli pTMV192006Journal of medicinal chemistry, Dec-14, Volume: 49, Issue:25
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
AID530539Induction of PvraSr::lacZ gene expression in Staphylococcus aureus SH1000 at 2 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID1240024Antibacterial activity against Bacillus cereus MTCC 8372 after 24 hrs by microdilution method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID565009Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID360853Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID447075Antibacterial activity against Micrococcus luteus La 2971 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID565039Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID646233Apparent volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1431165Antibacterial activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-100 after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID1551780Antibacterial activity against Salmonella typhimurium assessed as zone of inhibition2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID693551Antibacterial activity against Staphylococcus aureus after 48 hrs by well diffusion assay2012European journal of medicinal chemistry, Dec, Volume: 58Facile water promoted synthesis of 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids - highly potent antibacterial agents.
AID206303In vitro antibacterial activity against Staphylococcus aureus UBMS 90-1 Tet M1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID283149Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID368423Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1442635Antibacterial activity against gram-positive Staphylococcus aureus SA101 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID565310Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1482267Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
AID489649Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID388085Antifungal activity at Fusarium oxysporum2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID1228682Antibacterial activity against tet(K) tetracycline-resistant Staphylococcus aureus 158 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID396276Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(B), tet(D) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID278246Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID572058Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID1055417Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa B 63230 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID532675Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID278860Antiproliferative effect against HeLa cells after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID323005Antibacterial activity against drug-resistant Propionibacterium acnes P429:1 (BC) after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID348887Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID588219FDA HLAED, gamma-glutamyl transferase (GGT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID348885Antibacterial activity against Micrococcus luteus PTCC 1110 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID250264Susceptibility testing against Pseudomonas aeruginosa PAE_NUH17; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID565312Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID491946Antibacterial activity against Dermabacter hominis DSM 7083 after 48 hrs by microtiter plate assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea.
AID1269980Antimicrobial activity against Staphylococcus aureus RN4220 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID404936Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID544029Antimicrobial activity against Bacillus psychrodurans isolate C328 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID562791Antimicrobial activity against Chlamydia trachomatis F/70/rifR harboring rpoB gene2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID587832Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate 158 harboring tet(K) gene by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID250265Susceptibility testing against Pseudomonas aeruginosa PAE_NUH18; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID576110Antimicrobial activity against mecA-positive Staphylococcus sciuri assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID1124947Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as growth inhibition after 16 to 20 hrs by microbroth dilution method2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
AID1231524Antibacterial activity against Staphylococcus aureus CECT 86 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID496397Antibacterial activity against azide-resistant Escherichia coli J53 SXT2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID283165Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2664 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID423153Antibacterial activity against Bifidobacterium thermophilum B0242 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID501854Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1058230Antimycobacterial activity against Mycobacterium smegmatis2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
AID1131166Antibacterial activity against Escherichia coli MB2884 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID1730998Antibacterial activity against Staphylococcus aureus Newman assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Mar-05, Volume: 213Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
AID528725Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID520963Antimicrobial activity against Arcanobacterium haemolyticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID404902Antimicrobial activity against Enterococcus faecalis ATCC 29212 by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID520964Antimicrobial activity against Rhodococcus equi isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID396271Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(B) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID1131170Antibacterial activity against Streptococcus pyogenes assessed as growth inhibition at 2 to 8 ug/mL1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID404952Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID646216Antibacterial activity against Pseudomonas aeruginosa ATCC 111 278532012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID556873Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 13 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID30706Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Actinomycetes viscosus bacteria1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Substituted 2-(2-hydroxyphenyl)benzimidazoles as potential agents for the control of periodontal diseases.
AID556899Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 11 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565444Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.05 ug/ml (Rvb =310.8 +/- 17.10 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID528731Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID1442634Antibacterial activity against gram-negative Enterobacter cloacae EC1603 harboring tet(A) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID544021Antimicrobial activity against Psychrobacter sp. DY9-2 isolate C711 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID373747Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus by broth microdilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
AID562784Antimicrobial activity against Chlamydia trachomatis J/6276/rifR harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID283162Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2622 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID1269979Antimicrobial activity against Bacillus subtilis 168 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID425603Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM580 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax a2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID1335600Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1514476Antibacterial activity against Bacillus subtilis after 24 hrs2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Isolation and structure determination of a new lasso peptide specialicin based on genome mining.
AID1551808Antibacterial activity against Escherichia coli incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID594331Antimicrobial activity against methicillin-resistant Staphylococcus aureus at 50 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID749312Bactericidal activity against Bacillus cereus CECT 148 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID323036Antibacterial activity against Streptococcus pyogenes after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID565192Antimicrobial activity against Acinetobacter baumannii JVAB01 expressing disrupted open reading frame orf3 mutant deficient in efflux pump CraA by Etest2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
AID565637Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.08 ug/ml (Rvb =757.5 +/- 80.14 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID524650Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID565019Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID295111Antibacterial activity against Bacillus cereus ATCC 7064 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID564807Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID70762In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet D efflux).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID308344Antibacterial activity against Escherichia coli MTCCB 16102007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID575055Antibacterial activity against Vibrio cholerae O1 CIP0.25-1 harboring Ser to Ile mutation at 83 position in gyrA and parC genes by 2-fold agar dilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
AID562790Antimicrobial activity against Chlamydia trachomatis J/6276/tetR harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID534341Antimicrobial activity against Burkholderia pseudomallei Bp227 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID369663Antibacterial activity against wild type Escherichia coli DH5alpha by agar dilution assay2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID283646Susceptibility of Escherichia coli K12 MG1655 by agar dilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID545053Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ372 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1681014Antibacterial activity against Salmonella typhi assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID556681Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 8 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID564829Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID425400Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID532221Antibacterial activity against macrolide-lincosamide-streptogramin B-positive, beta-lactamase-positive, methicillin-resistant Staphylococcus aureus isolate 62010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID278866Decrease in lactate production in MG63 cells at 400 ug/ml by ELISA2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID369227Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
AID404903Antibacterial activity against Streptococcus bovis ATCC 33317 by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID693552Antibacterial activity against Streptococcus pneumoniae after 48 hrs by well diffusion assay2012European journal of medicinal chemistry, Dec, Volume: 58Facile water promoted synthesis of 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids - highly potent antibacterial agents.
AID396268Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(D) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID561637Antibacterial activity against Helicobacter pylori ARHp80 by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID564828Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID428428Antibacterial activity against Staphylococcus aureus after 24 hrs by well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis of novel carbazole based macrocyclic amides as potential antimicrobial agents.
AID285850Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes D-112 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID495515Antibacterial activity against Acinetobacter baumannii CIP70-10 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID70921In vitro antibacterial activity against Escherichia coli J3272 Tet C1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID649516Antimicrobial activity against Staphylococcus aureus SA 1199B over-expressing NorA MDR efflux pump after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID565815Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID239884pKa value of the compound2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
AID544018Antimicrobial activity against Aerococcus viridans isolate PGS21 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID564810Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285848Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes C-105 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID564816Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1240031Antibacterial activity against Klebsiella pneumoniae MTCC 3384 assessed as concentration required to completely destroy test microorganisms after 24 hrs2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID540930Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor 92G harboring rpsL gene with inserted glycine at position 92 after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID562474Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase SHV-12 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID1055420Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID574546Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus Sanger 2522010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID522668Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis B126 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID444053Renal clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID425393Antibacterial activity against mucosa-associated Escherichia coli isolates isolated from patients with Crohn's disease by disk diffusion method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID250284Susceptibility testing against Pseudomonas aeruginosa ATCC 27853; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID556684Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 11 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1112104Antifungal activity against Microbotryum violaceum by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID489650Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID448510Antimicrobial activity against Staphylococcus aureus MTCCB 737 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
AID1127616Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing ParE/GyrB T172A mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID694205Antibacterial activity against methicillin-sensitive Staphylococcus aureus 8325-4 by CLSI broth microdilution method2012Bioorganic & medicinal chemistry letters, Nov-15, Volume: 22, Issue:22
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
AID565328Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID556661Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 16 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID501849Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID671559Oral bioavailability in CD1 mouse at 30 mg/kg2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID396501Antibacterial activity against tetracycline-resistant Escherichia coli with single drug resistance determinant isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID1551781Antibacterial activity against Shigella dysenteriae assessed as zone of inhibition2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID323907Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID449362Antimicrobial activity against Staphylococcus aureus MTCCB 737 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID338053Antibacterial activity against Bacillus subtilis ATCC 6633 after 16 hrs by microdilution assay
AID521803Antimicrobial activity against Francisella tularensis subsp. holarctica after 48 hrs by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
AID378117Antimicrobial activity against Bacillus cereus at 30 ug/disk by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID585842Antimicrobial activity against Pseudomonas aeruginosa isolate 1 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1278315Antibacterial activity against Escherichia coli BL21 by microbroth dilution assay2016European journal of medicinal chemistry, Mar-03, Volume: 110Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
AID528710Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID556889Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 1 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID561110Antibacterial activity against Pasteurella multocida BB1044 harboring plasmid pB1000 bearing blaROB-1 gene, plasmid 1006 bearing tetO gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID320390Antimicrobial activity against Staphylococcus aureus NCIM2122 by broth microdilution method2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.
AID477411Antibacterial activity against MBX-1090-resistant Staphylococcus aureus isolate d20A1 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID405080Antimicrobial activity against Citrobacter freundii 33587 isolate by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID509868Antibacterial activity against Acinetobacter baumannii isolate 2898 isolated from human ankle2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID1634993Antimicrobial activity against Escherichia coli assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID531332Antibacterial activity against Pseudomonas aeruginosa PAO4290 by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID1158054Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID576741Antimicrobial activity against Bacillus anthracis by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oligochlorophens are potent inhibitors of Bacillus anthracis.
AID323033Antibacterial activity against borderline oxacillin-resistant Staphylococcus aureus after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID353044Antimicrobial activity against Proteus mirabilis at 25 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID1182957Antibacterial activity against Pseudomonas aeruginosa B 63230 by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Trimeric anthracenes from the endophytic fungus Stemphylium globuliferum.
AID396266Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(B) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID572147Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1304851Ratio of MIC for methicillin-resistant Staphylococcus aureus clinical isolate 2 in absence and presence of Cu2+2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID544015Antimicrobial activity against Psychrobacter ikaite isolate C410 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID524662Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID341058Activity of tetracycline efflux transporter TetA(B) in Escherichia coli DH5alpha membrane vesicles assessed as [3H]tetracycline uptake per mg of protein2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID340860Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 vraG mutant microdilution assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
AID476288Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation.
AID565291Antimicrobial activity against Mycoplasma hominis by agar dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
AID667268Antibacterial activity against Pseudomonas aeruginosa at 1000 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID406621Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
AID534343Antimicrobial activity against Burkholderia pseudomallei Bp173 harboring mini-Tn7T after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID1688656Bactericidal activity against Escherichia coli ATCC 25922 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID278241Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID560247Antibacterial activity against Staphylococcus aureus RN4220 by CLSI method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID250272Susceptibility testing against Pseudomonas aeruginosa PAE_NUH25; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID556655Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 10 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID559325Antimicrobial activity against Shigella flexneri assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID1325499Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS-2712016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1820915Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID522641Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Ames by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID556879Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 19 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565015Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID523001Cytotoxicity against human 5637 cells assessed as mild induction of cell death by trypan blue exclusion assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID1681021Antibacterial activity against Staphylococcus aureus ATCC 6538 by CLSI method2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID1781498Anti-MDR bacterial activity against Salmonella typhimurium CCARM 8250 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID278867Decrease in lactate production in HeLa cells at 400 ug/ml by ELISA2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID564813Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1061190Antimicrobial activity against Escherichia coli MTCC 724 at 50 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID548526Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1159087Antimicrobial activity against Pseudomonas aeruginosa ATCC 35032 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID548255Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID554873Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 13 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1360040Antimicrobial activity against Escherichia coli after 18 to 20 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID557083Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID694394Bactericidal activity against Salmonella typhi CECT 409 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID1250088Antibacterial activity against mexABCDXY-deficient Pseudomonas aeruginosa PAO12015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID560553Antimicrobial activity against Helicobacter pylori clinical isolate by Etest2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.
AID585854Antimicrobial activity against Pseudomonas aeruginosa isolate 7 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID594340Antimicrobial activity against Proteus vulgaris NCIM 2027/ATCC 13315 at 1000 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID718413Antibacterial activity against log-phase vancomycin-resistant Enterococcus faecalis ATCC 51575 assessed as growth inhibition after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
AID278249Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID544008Antimicrobial activity against Acinetobacter lwoffii isolate C2 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID532029Antimicrobial activity against Escherichia coli TOP10F' transformant harboring beta-lactamase CTX-M-78 by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID565433Antimicrobial activity against Streptococcus intermedius NCTC 11324 biofilm assessed as biofilm bacterial count at 0.10 ug/ml (Rvb =402.9 +/- 26.88 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID323002Antibacterial activity against drug-resistant Propionibacterium acnes P401:5 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID528726Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID320389Antimicrobial activity against Escherichia coli NCIM2574 by broth microdilution method2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID1726826Antibacterial activity against methicillin resistant Staphylococcus aureus incubated for 14 to 16 hrs by micro broth dilution method2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID585861Antimicrobial activity against Pseudomonas aeruginosa isolate 11 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID563501Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 01 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID1243995Antimicrobial activity against Escherichia coli by agar dilution method2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID299672Antibacterial activity against methicillin-resistant Staphylococcus aureus CMAH 0430 by disk diffusion method2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
AID449360Antimicrobial activity against Escherichia coli MTCCB 1652 after 24 hrs by tube dilution technique2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID588215FDA HLAED, alkaline phosphatase increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID644026Antimicrobial activity against Klebsiella pneumoniae at 25 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID534827Antimicrobial activity against Campylobacter fetus subsp. fetus CA75 harboring pCA75 carrying ant(6)-Ib resistant gene of 1516477 in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID556876Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 16 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID556882Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 22 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1585463Antibacterial activity against gentamicin-resistant Staphylococcus aureus NRS-108 measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID725541Potentiation of tetracycline antimicrobial activity against methicillin-resistant Staphylococcus aureus at 10 ug/ml after 20 hrs by liquid microdilution method2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
AID425610Cytotoxicity against mouse J774A1 cells assessed as macrophage number at 1.7 ug/ml after 3 hrs by total cell protein assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID369660Antibacterial activity against Campylobacter jejuni 81-176 carrying tet(O)+ gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID587835Antibacterial activity against Escherichia coli ATCC 25922 by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID524653Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ, penB and mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID428290Antimicrobial activity against Acinetobacter baumannii BM4454 isolated from patient with urinary tract infection by E test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID547528Antimicrobial activity against Streptococcus intermedius obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence of 5% defr2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID572593Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID278673Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 57342007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID559328Antimicrobial activity against Salmonella enterica serovar Typhimurium assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID559344Antimicrobial activity against Shigella sonnei harboring tetB gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID287374Antibacterial activity against Bacillus cereus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID278666Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57392007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID529899Antimicrobial activity against Leptospira weilii isolate 8 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID528730Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID307121Inhibition of HIV1 recombinant integrase 3'-processing activity2007Bioorganic & medicinal chemistry letters, Apr-15, Volume: 17, Issue:8
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
AID554657Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWO10 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID556885Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 25 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1228686Antibacterial activity against Escherichia coli 107 ATCC 25922 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID561341Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1348088Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID532580Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID278251Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID325444Antibacterial activity against Escherichia coli K12 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID542420Antimicrobial activity against Acinetobacter sp. N2 isolate C439 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID1634989Antimicrobial activity against Staphylococcus aureus 6271 assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID467965Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID671551Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolate 1062012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID368419Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID285197Antimicrobial activity against Escherichia coli M083 mutant with AG100 lon4::IS186 acrR::IS1 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID1698039Antibacterial activity against Enterobacter aerogenes assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID557793Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(A) gene by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
AID565040Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID569307Antibacterial activity against Salmonella typhi at 100 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID529301Antimicrobial activity against Enterococcus faecalis expressing rRNA methylase gene erm(A) obtained from pig manure by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Detection of the erythromycin rRNA methylase gene erm(A) in Enterococcus faecalis.
AID532766Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1338315Antibacterial activity against Staphylococcus aureus ATCC 6538 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID325004Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 115 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID501855Antibacterial activity against Bacillus cereus food isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1376894Antimicrobial activity against Pseudomonas aeruginosa DSM 50071 assessed as growth inhibition at 7 ug per disc after 24 to 48 hrs (Rvb = 0 millimeter)
AID520399Antibacterial activity against mef and erm(B) positive Streptococcus pneumoniae isolates assessed as resistance incidence by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID565008Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID554654Antimicrobial activity against Ureaplasma parvum SV6 isolate HPA23 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID556892Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 4 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565230Antimicrobial activity against Mycobacterium chelonae 9917 by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID646217Antibacterial activity against Enterobacter cloacae ATCC 108 130472012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID501852Antibacterial activity against Proteus vulgaris ATCC 8427 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1571236Inhibition of planktonic growth of Streptococcus gordonii at 40 uM by standard optical density assay relative to control
AID646355Oral bioavailability in Sprague-Dawley rat at 10 mg/kg by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID572787Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83F mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID534339Antimicrobial activity against Burkholderia pseudomallei 1026b after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID70765In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-4 (tet M ribosomal protection).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID278262Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1617788Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by broth microdilution method2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structural Characterization and Anti-infective Activity of 9,10-Seco-29-norcycloartane Glycosides Isolated from the Flowers of the Peruvian Medicinal Plant
AID539666Antimicrobial activity against Bacillus subtilis by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID283559Antibacterial activity against Escherichia coli AG102MB after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1688644Antibacterial activity against Escherichia coli ATCC 25922 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID658546Antimycobacterial activity against Salmonella enterica serovar Typhimurium L10 after 24 hrs2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Antibacterial acylphloroglucinols from Hypericum olympicum.
AID477098Antimicrobial activity against Proteus vulgaris MTCC 1771 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID572806Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID564821Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID278668Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 25302007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1335594Antibacterial activity against methicillin resistant Staphylococcus aureus MFBF 10679 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1191416Antimicrobial activity against Pseudomonas aeruginosa PCM 2562 (ATCC9027) after 16 to 20 hrs by broth micro-dilution method2015Bioorganic & medicinal chemistry letters, Feb-01, Volume: 25, Issue:3
In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.
AID404934Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID334153Antimicrobial activity against Staphylococcus aureus at 30 ug by antimicrobial disk assay1997Journal of natural products, Nov, Volume: 60, Issue:11
New phomopsolides from a Penicillium sp.
AID1392013Antistaphylococcal activity against gentamicin-resistant Staphylococcus aureus NRS-108 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID565813Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID562475Antimicrobial activity against rifampicin-resistant Escherichia coli A15 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID749310Bactericidal activity against Enterococcus faecalis CECT 481 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID587844Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID489653Antibacterial activity against Bacillus cereus ATCC 13061 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID324196Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 12.5 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID353050Antimicrobial activity against Staphylococcus aureus at 75 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID1577570Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth after 24 hrs by microdilution method
AID278258Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID717272Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis ATCC 19433 by CLSI protocol based broth microdilution method2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.
AID1820914Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID565635Antimicrobial activity against Streptococcus intermedius NCTC 11324 planktonic cells assessed as bacterial count at 0.10 ug/ml (Rvb =791.7 +/- 44.10 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID278859Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID56758Inhibition zone when tested against DAP-AT from Escherichia coli in L-agar at concentration 0.3 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID592502Antibacterial activity against Legionella pneumophila Corby by microtiter plate assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Diversonol and blennolide derivatives from the endophytic fungus Microdiplodia sp.: absolute configuration of diversonol.
AID341948Antimicrobial activity against Pseudomonas aeruginosa2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
AID554655Antimicrobial activity against Ureaplasma parvum SV14 isolate HPA32 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID524675Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and penB mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1338319Antibacterial activity against Escherichia coli ATCC 8739 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID545045Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ082 from patient bile by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID340859Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 graR mutant microdilution assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID293953Inhibition of human MMP32007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID644023Antimicrobial activity against Pseudomonas aeruginosa at 50 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID565034Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID522111Antimicrobial activity against Escherichia coli isolates producing extended-spectrum beta-lactamases bla(CTX-M-1), bla(CTX-M-32) and bla(SHV-12) assessed as resistant isolates isolated from Italian broiler flocks by agar dilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks.
AID572802Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1551806Antibacterial activity against Micrococcus luteus incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID477105Antimicrobial activity against Aspergillus niger MTCC 1781 at 30 ug/ml after 48 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID585860Antimicrobial activity against Pseudomonas aeruginosa isolate 10 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID324199Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 12.5 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID388084Antifungal activity at Yarrowia lipolytica2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID70931In vitro antibacterial activity against Escherichia coli UBMS 90-5 sensitive1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID594339Antimicrobial activity against Proteus vulgaris NCIM 2027/ATCC 13315 at 50 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID601194Apparent volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID428272Antimicrobial activity against carbapenemase producing Enterobacter sp. by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID278667Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 25132007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID565004Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID341057Antibacterial activity against intact Escherichia coli DH5alpha2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID325016Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 833 isolate with erm(B) resistance gene from patient sinuitis by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID1442637Antibacterial activity against gram-positive Staphylococcus aureus SA158 harboring tet(K) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID535639Antimicrobial activity against Group B streptococcus serotype VI R1 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1726841Synergistic antibacterial activity against Escherichia coli assessed as tetracyclin MIC encapsulated by compound2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID206121In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-3 (sensitive).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID428271Antimicrobial activity against Klebsiella sp. assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID565016Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1725194Antibacterial activity against Porphyromonas gingivalis 381 assessed as bacterial growth inhibition at 2.81 uM treated for 24 hrs by WST1 assay relative to control
AID325021Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 1017 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID530548Induction of PtcaA::lacZ gene expression in Staphylococcus aureus SH1000 at 2 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID533659Antimicrobial activity against Staphylococcus aureus RN42202008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID1347485Antibacterial activity against Klebsiella pneumoniae assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID564806Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID275056Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate2006Journal of medicinal chemistry, Dec-14, Volume: 49, Issue:25
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
AID283659Antimicrobial activity against Haemophilus influenzae CDS01 mutant with acrB insertional inactivation by broth microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
AID425407Antibacterial activity against mucosa-associated Escherichia coli isolate HM456 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID575948Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID311291Antibacterial activity against Proteus vulgaris at pH 72007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles.
AID372900Antibacterial activity against Enterobacter cloacae ATCC 13047 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID544286Antimicrobial activity against Enterococcus faecalis NKH16 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID646205Inhibition of Escherichia coli ribosome-mediated translation after 60 mins by transcription/translation-coupled luciferase reporter gene assay2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID250270Susceptibility testing against Pseudomonas aeruginosa PAE_NUH23; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID693553Antibacterial activity against Pseudomonas aeruginosa after 48 hrs by well diffusion assay2012European journal of medicinal chemistry, Dec, Volume: 58Facile water promoted synthesis of 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids - highly potent antibacterial agents.
AID417534Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by NLCCS microdilution method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID285198Antimicrobial activity against Escherichia coli M084 mutant AG100 lon4::IS186 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID311290Antibacterial activity against Escherichia coli at pH 72007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles.
AID315456Toxicity in human erythrocytes assessed as hemolysis upto 62.5 ug/mL2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID588119Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID565636Antimicrobial activity against Streptococcus intermedius NCTC 11324 planktonic cells assessed as bacterial count at 0.12 ug/ml (Rvb =791.7 +/- 44.10 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID1525329Antibacterial activity against methicillin-resistant Staphylococcus aureus 2011 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID557794Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(E) gene by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
AID544030Antimicrobial activity against Acinetobacter baumannii isolate C442 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID405925Antimicrobial activity against Staphylococcus aureus ATCC 259232008Journal of natural products, Jun, Volume: 71, Issue:6
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
AID556870Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 10 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID278228Antimicrobial activity against Salmonella enterica serovar Typhimurium S212007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID671550Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate SA158 expressing TetK gene2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID1678780Antibacterial activity against Enterococcus faecalis ATCC 51299 using Cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID341056Antibacterial activity against intact Escherichia coli DH5alpha expressing tetracycline efflux transporter TetA(B) Asp190Cys mutant gene2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID1781492Anti-MDR bacterial activity against Staphylococcus aureus CCARM 3090 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID565622Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.15 ug/ml (Rvb =757.5 +/- 80.14 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID678444Antibacterial activity against Salmonella enterica at 12 ug/well after 24 hrs by agar well diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.
AID535632Antimicrobial activity against Group B streptococcus R8 harboring T77I, S353F and A514V in PBP 2X; V80A and G613R in PBP 2B; and L45P, N163K, N723S and G527V in PBP 1A by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID278681Antibacterial activity against Enterococcus faecium isolate 57522007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID323009Antibacterial activity against drug-resistant Propionibacterium acnes FG7E after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID556699Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1158052Antimicrobial activity against Escherichia coli ATCC 25922 after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID1055422Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID556883Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 23 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID576112Antimicrobial activity against mecA-positive Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID569039Antibacterial activity against Pseudomonas aeruginosa after 24 hrs micro dilution assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.
AID1348089Antimicrobial activity against Bacillus subtilis subsp. subtilis ATCC 6051 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID1347491Antibacterial activity against Escherichia coli assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID565064Antibacterial activity against SHV-12 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID528919Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-14 and CTX-M-27 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID285836Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes iMLS-A isolate expressing erm(B)2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID561340Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID369657Antibacterial activity against Campylobacter jejuni 15-21 cmeB:: Kanamycin-resistant mutant by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID543352Antimicrobial activity against Salmonella serogroup O7 assessed as percent tetracyclin-resistant isolate at 1 to >128 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID585431Antimicrobial activity against oqxAB positive Escherichia coli C600 D83-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1634991Antimicrobial activity against Staphylococcus aureus clinical isolates from Liberec regional hospital assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID556674Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 1 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID556904Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 16 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID323020Antibacterial activity against drug-resistant Propionibacterium acnes GE4E after 72 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID369235Antibacterial activity against inducible macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae expressing erm(B) and tet(M) genes assessed as percent resistant isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
AID585848Antimicrobial activity against Pseudomonas aeruginosa isolate 4 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID399616Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 at 0.1 mg/disk by disk diffusion assay
AID67234In vitro minimum inhibitory concentration against Enterococcus faecalis ATCC 29212.1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID1250082Inhibition of transcription-translation process in Escherichia coli2015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID585864Antimicrobial activity against Pseudomonas aeruginosa isolate 12 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID494535Antimicrobial activity against Salmonella typhi NCIM 2501 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID494535Antimicrobial activity against Salmonella typhi NCIM 2501 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, May-06Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID569308Antibacterial activity against Staphylococcus aureus at 25 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID569309Antibacterial activity against Staphylococcus aureus at 50 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID362546Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID565613Antimicrobial activity against Streptococcus intermedius NCTC 11324 planktonic cells assessed as bacterial count at 0.15 ug/ml (Rvb =791.7 +/- 44.10 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID283557Antimicrobial activity against Streptococcus pneumoniae R6 with L4 69GTG71 to TPS mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID87953Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 812002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID544012Antimicrobial activity against Arthrobacter arilaitensis isolate C361 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID287379Antibacterial activity against Pseudomonas aeruginosa after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID404953Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID543351Antimicrobial activity against Salmonella serotype Typhimurium assessed as percent tetracyclin-resistant isolate at 1 to >128 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID739298Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition by CLSI broth microdilution method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
AID1348084Antimicrobial activity against Candida albicans ATCC 10231 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID572061Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC00372009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID396278Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(C), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID642766Antimicrobial activity against Bacillus subtilis at 25 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID1240016Antibacterial activity against Staphylococcus aureus MTCC 96 at 100 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID338054Antibacterial activity against Escherichia coli ATCC 25922 after 16 hrs by microdilution assay
AID1672291Antifungal activity against Candida tropicalis assessed as fungal growth inhibition after 24 hrs by CLSI protocol based broth microdilution assay
AID1237960Inhibition of beta-haematin formation by microplate reader analysis relative to hemin2015Bioorganic & medicinal chemistry, Aug-15, Volume: 23, Issue:16
Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity.
AID230771Range for minimum inhibitory concentration against Staphylococcus aureus 0.5->162004Journal of medicinal chemistry, Mar-11, Volume: 47, Issue:6
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
AID534403Antibacterial activity against Escherichia coli EPI300 expressing tet(40) gene assessed as inhibition of bacterial growth at 60 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID561738Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1238342Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by agar diffusion method2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Antibacterial activity of diketopiperazines isolated from a marine fungus using t-butoxycarbonyl group as a simple tool for purification.
AID565311Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID544284Antimicrobial activity against Enterococcus faecalis NKH14 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID534163Antimicrobial activity against Campylobacter coli assessed as resistant rate2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.
AID285841Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate C expressing tet(M), Xis, tnpA, tnpR gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID521968Antibacterial activity against Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID565057Antibacterial activity against wild-type Escherichia coli AG100 harboring Tn5 insertion in ycgE gene at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID341946Antimicrobial activity against Proteus vulgaris2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
AID561105Antibacterial activity against Pasteurella multocida BB1039 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID380476Antimicrobial activity against NorA multidrug efflux pump overexpressing Staphylococcus aureus 1199B by ethidium efflux assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
AID530769Antimicrobial activity against beta-lactamase producing Staphylococcus aureus SH10002008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID644022Antimicrobial activity against Pseudomonas aeruginosa at 25 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID532989Antibacterial activity against Klebsiella aerogenes NCIM 2281 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID1061176Antimicrobial activity against Escherichia coli MTCC 724 after 24 hrs by microdilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID278240Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID396502Antibacterial activity against tetracycline-resistant Escherichia coli with multiple drug resistance determinant isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID449363Antimicrobial activity against Staphylococcus epidermidis MTCCB 1824 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID749309Bactericidal activity against Salmonella typhi CECT 409 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID532220Antibacterial activity against macrolide-lincosamide-streptogramin B-negative, beta-lactamase-positive, methicillin-susceptible Staphylococcus aureus isolate 52010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID1688648Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID299674Antibacterial activity against methicillin-resistant Staphylococcus aureus CMAH 0515 by disk diffusion method2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
AID1442640Antibacterial activity against gram-positive Streptococcus pneumoniae SP193 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID1678760Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID396277Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(B), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID1228680Antibacterial activity against Staphylococcus aureus 101 ATCC 29213 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID417533Antibacterial activity against Escherichia coli after 24 hrs by NCCLS microdilution method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.
AID533664Antimicrobial activity against Staphylococcus aureus RN1024-tms2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID323017Antibacterial activity against drug-resistant Propionibacterium acnes SW3CD after 72 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1617936Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 48 hrs by resazurin assay
AID563511Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens HMS011 harboring plasmid STV28 expressing sdeB gene by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID584821Effect on Pseudomonas putida PAW340 biofilms assessed as heat production at 3 ug/ml by Chip calorimetry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID509631Antimicrobial activity against Staphylococcus aureus RN4220 transformant carrying plasmid pKKS25 and expressing erm(T), dfrK and tet(L) genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID341949Antimicrobial activity against Salmonella typhi2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
AID534829Antimicrobial activity against Campylobacter fetus subsp. fetus CA80 harboring ciprofloxacin-resistant gene and IMD523-06 pathogenicity island with tet(44) and ant(6)-Ib resistant marker gene in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID532024Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 harboring pTY60H carrying the luxAB gene under the hsp60 promoter determined after 14 days in presence of 2.5 ug/ml ATP-cassette transporter inhibitor reserpine2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID531625Antimicrobial activity against Mycoplasma pneumoniae by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID456847Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives.
AID531628Antimicrobial activity against Mycoplasma fermentans by broth microdilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
AID554674Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 156 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID456846Antimicrobial activity against Escherichia coli after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives.
AID375938Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 24 hrs by broth microdilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
AID565193Antimicrobial activity against efflux pump CraA deficient Acinetobacter baumannii JVAB01 receiving pJV103 harboring open reading frame orf3 encoded efflux pump CraA by Etest2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
AID522364Antimicrobial activity against PpmrI knockout mutant Proteus mirabilis dIp after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID531333Antibacterial activity against Pseudomonas aeruginosa PAO4290 selected after 1.0 ug/ml of azithromycin by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID395369Antibacterial activity against Klebsiella pneumoniae UC57 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID315449Antibacterial activity against Pseudomonas aeruginosa by microbroth dilution assay2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID1243992Antimicrobial activity against Staphylococcus citreus by agar dilution method2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID508593Antibacterial activity against ciprofloxacin-susceptibility revert strain of Salmonella enteritidis 104 harboring gyrA D87Y/S83F mutant, parC D79N mutant, soxR E16G/R20H mutant and soxS E52K mutant gene after 20 passages by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID428426Antibacterial activity against Proteus mirabilis after 24 hrs by well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis of novel carbazole based macrocyclic amides as potential antimicrobial agents.
AID532988Antibacterial activity against Klebsiella aerogenes NCIM 22812010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID572795Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID585418Antimicrobial activity against Escherichia coli C600 by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1304850Ratio of MIC for methicillin-resistant Staphylococcus aureus clinical isolate 2 in absence and presence of tiron2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID568332Antimicrobial activity against wild type Pseudomonas aeruginosa by broth dilution assay2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
AID406842Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.
AID325012Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 547 isolate with erm(B) resistance gene from patient sinuitis by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID520392Antibacterial activity against mef and erm(B) positive Streptococcus pneumoniae isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID558075Cytotoxicity against normal human epidermal keratinocytes at 100 uM after 72 hrs by MTT assay2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID558082Cytotoxicity against normal human epidermal keratinocytes at 5 uM after 72 hrs by MTT assay2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID1240029Antibacterial activity against Escherichia coli MTCC 724 assessed as concentration required to completely destroy test microorganisms after 24 hrs2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID1131169Antibacterial activity against Bordetella bronchiseptica MB905 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID1879067Antibacterial activity against pET28a-NDM-1 positive Escherichia coli BL21(DE3) isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method2022European journal of medicinal chemistry, Mar-05, Volume: 231Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
AID520962Antimicrobial activity against Corynebacterium xerosis isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID297186Antibacterial activity against multidrug resistant Staphylococcus aureus 495892007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
AID556697Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pACM204 plasmid by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1127622Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrA S81Y/ParC S79F double mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID529302Antimicrobial activity against Enterococcus faecalis expressing rRNA methylase gene erm(A) obtained from human by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Detection of the erythromycin rRNA methylase gene erm(A) in Enterococcus faecalis.
AID585843Antimicrobial activity against Pseudomonas aeruginosa isolate 2 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID285524Antibacterial activity against Neisseria gonorrhoeae after 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
AID498360Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52145R assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID325984Antimicrobial activity against Streptococcus pneumoniae spain 23F-12007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci.
AID528727Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID678713Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID1240019Antibacterial activity against Klebsiella pneumoniae MTCC 3384 at 50 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID360380Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake2007The Journal of biological chemistry, Jan-26, Volume: 282, Issue:4
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
AID574169Antibacterial activity against Escherichia coli MG1655 harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes grown as planktonic cells after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID520956Antimicrobial activity against Corynebacterium amycolatum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID495509Antibacterial activity against Acinetobacter baumannii BM4587 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID563509Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 79 harboring plasmid STV29 expressing hasF gene by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID396500Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates without tet(B) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID520396Antibacterial activity against mef(E) and mef(A)-positive Streptococcus pneumoniae isolate CC-6B by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID554869Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 961 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID279193Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
AID396265Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID324193Antibacterial activity against Escherichia coli K12 mutant JHU313 at 50 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID287378Antibacterial activity against Listeria monocytogenes after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID283160Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2554 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID522657Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis V770 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1442641Antibacterial activity against gram-negative Escherichia coli EC107 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID324169Antibacterial activity against Escherichia coli K12 mutant JHU313 at 25 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID425405Antibacterial activity against mucosa-associated Escherichia coli isolate HM428 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID560774Antibacterial activity against Staphylococcus aureus TS5337 harboring ddlA Pro178Ser mutation after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID1348082Antimicrobial activity against Candida tropicalis ATCC 13803 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID522654Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K4539 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID546621Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID325022Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 1022 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID283167Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5254 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID396026Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID1678769Antibacterial activity against Staphylococcus aureus ATCC 43300 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID556862Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 2 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1238341Antibacterial activity against Bacillus subtilis NCTC 2116 after 18 hrs by agar diffusion method2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Antibacterial activity of diketopiperazines isolated from a marine fungus using t-butoxycarbonyl group as a simple tool for purification.
AID572792Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID323920Antibacterial activity against Staphylococcus aureus 2A1-7 fast2 with rplC D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID556671Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 26 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID569310Antibacterial activity against Staphylococcus aureus at 75 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID529896Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 4 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID524676Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ, penB and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID524883Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID588217FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID545049Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ249 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1648087Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as reduction in microbial growth after 24 hrs by two-fold serial dilution method2020Journal of natural products, 02-28, Volume: 83, Issue:2
Absolute Configuration and Antibiotic Activity of Piceamycin.
AID694208Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI broth microdilution method2012Bioorganic & medicinal chemistry letters, Nov-15, Volume: 22, Issue:22
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
AID278244Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID556866Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 6 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID278234Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID353042Antimicrobial activity against Proteus vulgaris at 75 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID565817Antimicrobial activity against Neisseria gonorrhoeae isolates by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID1635004Bacteriostatic activity against Pseudomonas aeruginosa assessed as induction of bacteria killing at 80 uM after 3 hrs by time kill assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID667262Antibacterial activity against Staphylococcus aureus at 500 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID569041Antibacterial activity against Staphylococcus epidermidis after 24 hrs micro dilution assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.
AID1348087Antimicrobial activity against Staphylococcus aureus subsp. aureus ATCC 25923 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID1465956Antibacterial activity against Staphylococcus aureus after 20 hrs by broth microdilution method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Metabolite diversification by cultivation of the endophytic fungus Dothideomycete sp. in halogen containing media: Cultivation of terrestrial fungus in seawater.
AID295120Antibacterial activity against Micrococcus luteus La 2971 at 30 ug by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID405139Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent susceptible isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID542388Antimicrobial activity against Staphylococcus aureus RN4220 transformed with Staphylococcus aureus ST398 plasmid pSCFS3 carrying cfr and fexA genes2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.
AID524887Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing tetM mutant gene in combination with variants of other gene loci assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID565074Antibacterial activity against CTX-M-14 ESBL producing Proteus mirabilis assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID27795AUC (area under curve) after oral dosing by gavage needle at 30 mg/kg in C57BL/6NTac female mice; Not checked2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID560777Antibacterial activity against Staphylococcus aureus TS2921 harboring ddlA Asp102Asn mutation in presence of 100 mM D-Ala-D-Ala, which complements temperature sensitivity after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID1681022Antibacterial activity against Enterobacter aerogenes ATCC 13048 by CLSI method2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID509632Antimicrobial activity against Staphylococcus aureus 25 transformant carrying plasmid pKKS25 and expressing erm(T), dfrKtet(L), tet(K), tet(M), mecA and blaZ genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID564834Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID206304In vitro antibacterial activity against Staphylococcus aureus UBMS 90-3 sensitive1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID396274Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(M) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID449361Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by tube dilution technique2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID1566490Inhibition of Dicer mediated biotinylated pre-miRNA-21 (unknown origin) maturation at 1 mM measured after 15 mins by cat-ELCCA relative to control2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
AID671554Antibacterial activity against Escherichia coli isolate EC155 expressing tetA gene2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID565641Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.10 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =790.8 +/- 90.09 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID548474Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID323918Antibacterial activity against Staphylococcus aureus 2A1-1 fast2 with rplC D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID501856Antibacterial activity against Corynebacterium pyogenes ATCC 19411 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID556897Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 9 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID524827Antibacterial activity against erythromycin susceptible Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID575056Antibacterial activity against Vibrio cholerae O1 mTn-321 harboring Ser to Ile mutation at 83 position in gyrA and parC genes by 2-fold agar dilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
AID565631Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.15 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =790.8 +/- 90.09 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID320706Inhibition of PAD4 by ABPP-based assay2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
AID516165Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID1269975Antimicrobial activity against Escherichia coli K-12 MG1655 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID585876Antimicrobial activity against Pseudomonas aeruginosa isolate 18 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID496400Antibacterial activity against azide-resistant Escherichia coli J53 SXT13-1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 13 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID495749Antimicrobial activity against Salmonella enterica serotype Virchow 3464b by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID547541Antimicrobial activity against invasive Streptococcus constellatus obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID477107Antimicrobial activity against Penicillium chrysogenum MTCC 1996 at 30 ug/ml after 48 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID547529Antimicrobial activity against Streptococcus intermedius obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID547755Antimicrobial activity against invasive Streptococcus intermedius obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence of2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID1726845Cytotoxicity against human HaCaT cells after 24 hrs by MTT assay2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID278265Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID325483Antibacterial activity against Escherichia coli N43 acrA mutant assessed as inhibition of AcrAB efflux pump after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID542585Antimicrobial activity against plasmid encoded beta-lactamase OXA-58 deficient Acinetobacter radioresistens by CLSI method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
AID585869Antimicrobial activity against Pseudomonas aeruginosa isolate 15 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID678712Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID532983Antibacterial activity against Escherichia coli W31102010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID312017Antifungal activity against Beauveria bassiana at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID1525331Antibacterial activity against Escherichia coli 2271 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID516162Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID425582Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID545055Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate CC023 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID532020Antibacterial activity against macrolide-lincosamide-streptogramin B-negative, beta-lactamase-positive, methicillin-susceptible Staphylococcus aureus isolate 32010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID496396Antibacterial activity against azide-resistant Escherichia coli J53 SXT1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID529900Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 9 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID396504Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID425596Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 0.01 to 10 ug/ml after 3 hrs2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID564831Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID548475Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID323919Antibacterial activity against Staphylococcus aureus 2A1-7 fast1 with rplC D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID388087Antibacterial activity at Staphylococcus aureus2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID1688655Bactericidal activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID312018Antifungal activity against Saccharomyces cerevisiae at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID565314Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1368273Antibacterial activity against Staphylococcus aureus RN4220 by microbroth dilution method2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.
AID582763Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID405924Antimicrobial activity against methicillin-resistant Staphylococcus aureus XU2122008Journal of natural products, Jun, Volume: 71, Issue:6
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
AID428273Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID545047Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ088 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID548527Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID561745Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID528706Antibacterial activity against Streptococcus agalactiae group B clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID322259Antibacterial activity against Salmonella typhi by well diffusion method2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Synthesis of novel spiropyrrolizidines as potent antimicrobial agents for human and plant pathogens.
AID545051Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ274 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID564826Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID531334Antibacterial activity against Pseudomonas aeruginosa TNP030 by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID544005Antimicrobial activity against Pseudomonas fluorescens isolate C131 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID467963Antimicrobial activity against Citrobacter freundii ATCC 8090 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID567569Antimicrobial activity against Staphylococcus aureus RN42202010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID323028Antibacterial activity against Corynebacterium amycolatum after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID565228Antimicrobial activity against Mycobacterium chelonae ATCC 35752 by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID544013Antimicrobial activity against Pseudomonas putida isolate C231 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID454161Antimicrobial activity against Proteus vulgaris MTCC 1771 at 10 ug/ml after 24 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID560224Antibacterial activity against Salmonella enterica serovar Typhimurium R200 expressing stm3031 gene deletion mutant by CLSI M7-A7 agar dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.
AID585873Antimicrobial activity against Pseudomonas aeruginosa isolate 17 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID494536Antimicrobial activity against Proteus vulgaris NCIM 2813 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID494536Antimicrobial activity against Proteus vulgaris NCIM 2813 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, May-06Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID442202Antibacterial activity against Escherichia coli at 50 mg/mL after 48 hrs by agar plate disc diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
AID547540Antimicrobial activity against invasive Streptococcus constellatus obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence o2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID325013Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 552 isolate with erm(B) resistance gene from patient sinuitis by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID323029Antibacterial activity against Corynebacterium minutissimum after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID353049Antimicrobial activity against Staphylococcus aureus at 50 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID250271Susceptibility testing against Pseudomonas aeruginosa PAE_NUH24; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID556869Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 9 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID554876Antimicrobial activity against Streptococcus pneumoniae serotype 4 ST 205 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID498362Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrR containing isogenic acrR knockout assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID278247Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID694391Bactericidal activity against Bacillus cereus CECT 148 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID1382190Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method2018European journal of medicinal chemistry, Feb-25, Volume: 146Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.
AID1566497Binding affinity to miR-21 RNA in human HeLA cells transfected with pmir21 vector incubated for 48 hrs by Dual-Glo luciferase assay2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
AID540825Antimicrobial activity against acrB::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID572818Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1325496Antibacterial activity against erythromycin-resistant Staphylococcus aureus NRS-702016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID646209Antibacterial activity against Enterococcus faecalis ATCC 103 292122012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID285191Antimicrobial activity against Escherichia coli M013 mutant with AG100 delta-(lon-hupB-ppiD) dupIS5 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID585859Antimicrobial activity against Pseudomonas aeruginosa isolate 10 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID529892Antimicrobial activity against Leptospira interrogans isolate 7 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID528918Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-14 and CTX-M-27 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID1304847Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 incubated for 16 hrs by broth microdilution method in presence of tiron2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID353041Antimicrobial activity against Proteus vulgaris at 50 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID565318Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1240026Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by microdilution method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID283170Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID565309Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID554875Antimicrobial activity against Streptococcus pneumoniae serotype 18C ST 496 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID558079Inhibition of PAR2 gene expression in normal human epidermal keratinocytes at 10 uM after 48 hrs by quantitative RT-PCR2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID444057Fraction escaping hepatic elimination in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID395367Antibacterial activity against Escherichia coli ATCC 11230 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID1366160Antibacterial activity against Staphylococcus aureus incubated overnight by two-fold serial dilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID671553Antibacterial activity against Escherichia coli ATCC 25922 isolate 1072012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID501858Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID293954Inhibition of human MMP82007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID495750Antimicrobial activity against Escherichia coli J5 by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID341059Activity of tetracycline efflux transporter TetA(B) in Escherichia coli DH5alpha membrane vesicles assessed as [3H]tetracycline uptake2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID324170Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 25 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID520959Antimicrobial activity against Corynebacterium pseudodiphtheriticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID1240020Antibacterial activity against Klebsiella pneumoniae MTCC 3384 at 100 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID1654443Antibacterial activity against Paenibacillus larvae ATCC 9545 assessed as reduction in microbial growth by CLSI based broth microdilution method2020Journal of natural products, 03-27, Volume: 83, Issue:3
Meliponamycins: Antimicrobials from Stingless Bee-Associated
AID429084Antibacterial activity against Clostridium difficile CD5 expressing tet(W) gene2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.
AID543350Antimicrobial activity against Salmonella serotype Choleraesuis assessed as percent tetracyclin-resistant isolate at 1 to >128 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID584829Antibacterial activity against Staphylococcus aureus2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID283159Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2526 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID278269Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID529159Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID429058Antimicrobial activity against tetracycline-resistant Ureaplasma sp. isolate overexpressing tet(M) gene2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines.
AID576111Antimicrobial activity against mecA-deficient Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID694396Bactericidal activity against Escherichia coli CECT 100 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID556678Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 5 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1698036Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID725545Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 hrs by liquid microdilution method2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
AID285204Antimicrobial activity against Escherichia coli AG112 mutant with AG100 marR genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID564809Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID428140Antimicrobial activity against Streptococcus pneumoniae PC13 transformant harboring 136-bp deletion in erm(B) gene by agar dilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
AID561515Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID556685Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 12 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID629285Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.1 mg/mL after 10 mins by bioluminometry-based chronic action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID1360038Antimicrobial activity against Bacillus cereus after 18 to 20 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID556672Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 27 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID285846Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes A-3 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID544282Antimicrobial activity against Enterococcus faecalis NKH12 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID585849Antimicrobial activity against Pseudomonas aeruginosa isolate 5 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1254824Antibacterial activity against Bacillus subtilis ATCC 23857 after 12 hrs by agar diffusion method2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.
AID1061191Antimicrobial activity against Staphylococcus aureus MTCC 96 at 100 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID1243994Antimicrobial activity against Aeromonas hydrophila by agar dilution method2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID1515695Antibacterial activity against Porphyromonas gingivalis 381 assessed as bacterial growth inhibition at 2.25 uM measured after 2 hrs in anaerobic condition by WST1 assay2019MedChemComm, Jun-01, Volume: 10, Issue:6
Novel zafirlukast derivatives exhibit selective antibacterial activity against
AID565640Antimicrobial activity against Streptococcus intermedius SI006 planktonic cells harboring luxS mutant gene assessed as bacterial count at 0.08 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =790.8 +/- 90.09 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID681031TP_TRANSPORTER: uptake in OAT3-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID1412154Bactericidal activity against methicillin-resistant Staphylococcus aureus 15 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID554860Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 143 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID558078Inhibition of PAR2-mediated SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes at 10 uM after 24 hrs by ELISA2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID467968Antimicrobial activity against Staphylococcus epidermidis ATCC 14990 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID543366Antimicrobial activity against tigecycline-intermediate Aeromonas caviae isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID544271Antimicrobial activity against Enterococcus faecalis NKH1 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID613191Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
AID644018Antimicrobial activity against Staphylococcus aureus at 25 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID293955Inhibition of human MMP132007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID323012Antibacterial activity against drug-resistant Propionibacterium acnes SW101CDA after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID541149Antimicrobial activity against soxS::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID1127620Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrB K143A/ParE T172A double mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID285201Antimicrobial activity against Escherichia coli M104 mutant with AG100 dupIS3 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID572799Antimicrobial activity against marA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID548524Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID544272Antimicrobial activity against Enterococcus faecalis NKH2 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1112106Antimicrobial activity against Escherichia coli by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID1230065Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2372 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID373750Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
AID477409Antibacterial activity against Staphylococcus aureus NCTC 8325 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID565320Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID585423Antimicrobial activity against oqxAB positive Escherichia coli C600 G262-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1688650Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID323906Antibacterial activity against Staphylococcus aureus RN4220 with rplC S158L mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID1593384Growth inhibition of Staphylococcus aureus Newman2019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
AID1496320Cytotoxicity against human THP1 cells after 24 hrs by LDH release assay2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
AID520960Antimicrobial activity against Corynebacterium striatum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID428295Antimicrobial activity against Acinetobacter baumannii BM4579 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by agar dilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID532986Antibacterial activity against Pseudomonas aeruginosa NCIM 50292010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID70761In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet C efflux).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID556658Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 13 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID404895Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB10 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID556646Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 1 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID299673Antibacterial activity against methicillin-resistant Staphylococcus aureus CMAH 0504 at 30 ug/ml by disk diffusion method2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
AID532984Antibacterial activity against Escherichia coli MG1655 in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID587244Antimicrobial activity against Pseudomonas aeruginosa DSM 1128 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID1225389Antibacterial activity against Escherichia coli transformed with plasmid carrying MG1655 deltaBC/pXYM by p-iodonitrotetrazolium chloride colorimetric assay2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
AID699539Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID565007Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID531099Inhibition of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa TNP090 mutant harboring las and rhl gene at 0.016 ug/ml by Cat-2,3-diO reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID341950Antimicrobial activity against Staphylococcus aureus2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
AID425583Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID70922In vitro antibacterial activity against Escherichia coli J3272 Tet D1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID477108Antimicrobial activity against Trichoderma viride MTCC 167 at 30 ug/ml after 48 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID295117Antibacterial activity against Listeria monocytogenes ATCC 15313 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID348891Antibacterial activity against Pseudomonas aeruginosa ATCC 85327 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID556901Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 13 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID694206Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by CLSI broth microdilution method2012Bioorganic & medicinal chemistry letters, Nov-15, Volume: 22, Issue:22
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
AID1672292Antifungal activity against Candida albicans assessed as fungal growth inhibition after 24 hrs by CLSI protocol based broth microdilution assay
AID206394Compound was tested for photoinhibition of Staphylococcus aureus(CIP 53156); Sensitive1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
AID206793Minimum inhibitory concentration against Staphylococcus aureus2004Journal of medicinal chemistry, Mar-11, Volume: 47, Issue:6
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
AID388083Antifungal activity at Benjaminiella poitrasii2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID554872Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 3246 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID278582Reduction in Plasmodium falciparum FCK2 in human erythrocyte culture after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID558081Inhibition of PAR2-mediated TNFalpha and SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes at 10 uM by ELISA2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID556871Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 11 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1261214Bacteriostatic activity against Staphylococcus aureus Mu50 after 24 hrs2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
AID1593387Growth inhibition of Escherichia coli DH5[alpha]2019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
AID323001Antibacterial activity against drug-resistant Propionibacterium acnes P95 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID369667Antibacterial activity against Campylobacter jejuni 23-51 assessed as inhibition of CmeABC efflux pump by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID425653Renal clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID609163Antibacterial activity against Escherichia coli assessed as zone of inhibition at 5 uL and 32 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID386623Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
AID533662Antimicrobial activity against Staphylococcus aureus RN4220 harboring vgaAv positive plasmid CU12008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID565032Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID274302Inhibition of protein synthesis in Escherichia coli S30 extracts by coupled transcription-translation assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID749307Bactericidal activity against Erwinia carotovora CECT 225 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID565018Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564824Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID340858Antimicrobial activity against wild type vancomycin-intermediate resistant Staphylococcus aureus Mu50 by microdilution assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
AID325014Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 683 isolate with erm(B) resistance gene from patient sputum by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID405082Antimicrobial activity against Escherichia coli 33587-TC9 by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
AID1698043Antibacterial activity against Shigella boydii assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID556654Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 9 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID546619Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID1821095Antibacterial activity against Enterococcus faecalis ATCC 19433 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID554653Antimicrobial activity against Ureaplasma urealyticum isolate HPA20 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID520958Antimicrobial activity against Corynebacterium minutissimum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID535637Antimicrobial activity against Group B streptococcus serotype Ib R3 harboring Q557E, A400V mutations in PBP 2X and T567I, G539E mutations in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID554658Antimicrobial activity against Ureaplasma parvum isolate UHWP2 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID557797Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID1228688Antibacterial activity against Klebsiella pneumoniae 457 harboring CTX-M-15 gene assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID448516Antimicrobial activity against Staphylococcus aureus MTCCB 737 after 24 hrs by serial dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
AID1056852Antibacterial activity against CTX-15 expressing Stenotrophomonas maltophilia isolate 125 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID541856Antimicrobial activity against florfenicol-resistant Edwardsiella ictaluri M07-1 by microdilution assay2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
AID1335595Antibacterial activity against vancomycin susceptible Enterococcus faecalis ATCC 29212 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID501850Antibacterial activity against Klebsiella pneumoniae clinical isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID588218FDA HLAED, lactate dehydrogenase (LDH) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID460631Antifungal activity against Penicillium chrysogenum MTCC 1996 at 100 ug/ml after 48 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID212744Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID442201Antibacterial activity against Staphylococcus aureus at 50 mg/mL after 48 hrs by agar plate disc diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
AID1820913Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID534823Antimicrobial activity against nalidixic acid-resistant Campylobacter fetus subsp. fetus IMD523-06 bovine isolate harboring tet(44) and ant(6)-Ib resistance gene in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID1338320Antibacterial activity against Enterobacter cloacae PCM 2569 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID283661Antimicrobial activity against Haemophilus influenzae CDS40 mutant with acrB insertional inactivation by broth microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
AID1496311Antibacterial activity against vancomycin-resistant Enterococcus faecalis 725B after 24 hrs2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
AID285847Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes B-83 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID646207Antibacterial activity against tetracycline- and methicillin-resistant Staphylococcus aureus 1612012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID588121Antimicrobial activity against Streptococcus suis UD isolated from cerebrospinal fluid of patient with meningitis by broth microdilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Different genetic elements carrying the tet(W) gene in two human clinical isolates of Streptococcus suis.
AID323021MBC/MIC ratio of Propionibacterium acnes EG7NS2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID285206Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 125 generations in absence of tetracycline2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID428270Antimicrobial activity against Klebsiella sp. assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID572814Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring GyrA G81C, acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID278271Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID544019Antimicrobial activity against Acinetobacter lwoffii isolate C15 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID556888Antimicrobial activity against multidrug resistant Klebsiella pneumoniae ATCC 11296 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID522653Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K9724 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID30552Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Actinobacillus actinomycetemcommitans bacteria1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Substituted 2-(2-hydroxyphenyl)benzimidazoles as potential agents for the control of periodontal diseases.
AID530050Antimicrobial activity against Staphylococcus aureus 286607-R1 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
AID529904Antimicrobial activity against Leptospira interrogans serovar Canicola isolate 11 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID1131168Antibacterial activity against Bordetella bronchiseptica MB3551 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID539667Antimicrobial activity against Streptococcus pneumoniae by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID372898Antibacterial activity against sPseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID358254Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 48 hrs by microplate assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.
AID1376892Antimicrobial activity against Bacillus cereus DSM 4384 assessed as growth inhibition at 7 ug per disc after 24 to 48 hrs (Rvb = 0 millimeter)
AID569305Antibacterial activity against Salmonella typhi at 50 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID307119Cytotoxicity against CEM cells after 5 days by MTT method2007Bioorganic & medicinal chemistry letters, Apr-15, Volume: 17, Issue:8
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
AID1056842Antibacterial activity against TEM-1/SHV-12/CTX-15 expressing Enterobacter intermedius isolate 243 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID539668Antimicrobial activity against Escherichia coli by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID522646Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Ohio by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID585422Antimicrobial activity against oqxAB positive Escherichia coli C600 W245-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID530234Antimicrobial activity against wild-type Mycobacterium bovis BCG by microplate Alamar blue assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID545043Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ068 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID530286Antimicrobial activity against PR-39-resistant Salmonella enterica serovar Typhimurium LT2 DA10899 harboring Q179Stop mutant gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
AID585851Antimicrobial activity against Pseudomonas aeruginosa isolate 6 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID556693Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid expressing ampC gene by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1056834Antibacterial activity against GIM-1 expressing Pseudomonas aeruginosa isolate 197 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID560780Antibacterial activity against Staphylococcus aureus TS5337 harboring ddlA Pro178Ser mutation in fifth-instar silkworm larva infection model assessed as compound concentration per gram of larva causing reduction in survival after 48 hrs post dose at 27 de2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID380474Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard microdilution method2006Journal of natural products, Mar, Volume: 69, Issue:3
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
AID554879Antimicrobial activity against Streptococcus pneumoniae serotype 17 ST 3248 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1269976Antimicrobial activity against Haemophilus influenzae ATCC 51907 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID380477Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 15 by standard microdilution method2006Journal of natural products, Mar, Volume: 69, Issue:3
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
AID285839Antimicrobial activity against Streptococcus pyogenes iMLS-A isolate A expressing tet(M), tndX gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID530587Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae isolate 1006 with A2603G mutation by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID658545Antimycobacterial activity against Salmonella enterica serovar Typhimurium L354 after 24 hrs2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Antibacterial acylphloroglucinols from Hypericum olympicum.
AID1127623Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrA S81F/ParC S79Y double mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID406622Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent susceptible isolates by broth microdilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
AID530287Antimicrobial activity against PR-39-resistant sbmA-deficient Salmonella enterica serovar Typhimurium LT2 DA12088 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
AID594332Antimicrobial activity against methicillin-resistant Staphylococcus aureus at 1000 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID449359Antimicrobial activity against Staphylococcus epidermidis MTCCB 1824 after 24 hrs by tube dilution technique2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID588208Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset2010Molecular pharmaceutics, Oct-04, Volume: 7, Issue:5
Predicting phospholipidosis using machine learning.
AID369448Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID535640Antimicrobial activity against Group B streptococcus serotype Ib C2 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID540931Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP1 harboring rpsL A262G and C271T mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID1360039Antimicrobial activity against Pseudomonas aeruginosa after 18 to 20 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID575168Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in marR mutant containing Escherichia coli K-12 3-AG102 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric a2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID1412153Bactericidal activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID534337Antimicrobial activity against Burkholderia pseudomallei Bp216 harboring mini-Tn7T after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID534405Antibacterial activity against Escherichia coli EPI300 expressing tet(W) gene assessed as inhibition of bacterial growth at 40 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID467966Antimicrobial activity against Enterococcus faecalis ATCC 19433 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID1821094Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID565003Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID557079Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID572062Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID1360044Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 18 to 20 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID460799Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID1228693Antibacterial activity against Stenotrophomonas maltophilia 256 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID250260Susceptibility testing against Pseudomonas aeruginosa PAE_NUH04; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID520957Antimicrobial activity against Corynebacterium jeikeium isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID206122In vitro minimum inhibitory concentration against Staphylococcus aureus smith (sensitive).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID530347Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID646210Antibacterial activity against tetracycline-resistant Enterococcus faecalis 1592012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1412150Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 57 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID556676Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 3 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID278671Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57362007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID572794Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID528728Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID530348Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID373748Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus by broth microdilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
AID717271Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI protocol based broth microdilution method2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.
AID369662Antibacterial activity against Escherichia coli EW1b containing pDOB472007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID561029Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as disruption of plasma membrane permeability at 4 times MIC by ethidium bromide uptake assay2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Antibacterial properties and mode of action of a short acyl-lysyl oligomer.
AID341106Antibacterial activity against metallo-beta-lactamase VIM12 expressing Escherichia coli 28 isolate from decubitus ulcer infection patient by Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
AID373749Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
AID532980Antibacterial activity against Escherichia coli DH5alpha in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID544027Antimicrobial activity against Acinetobacter rhizosphaerae isolate C44 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID644025Antimicrobial activity against Pseudomonas aeruginosa at 100 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID644029Antimicrobial activity against Klebsiella pneumoniae at 100 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID572151Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID540927Antimicrobial activity against Streptomyces coelicolor 1147 after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID285202Antimicrobial activity against Escherichia coli M114 mutant with AG100 lon4::IS186 marR::IS2 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID324171Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 25 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID509865Antibacterial activity against Acinetobacter baumannii ATCC 17978 isolated from human CSF2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID561639Antibacterial activity against HefC-deficient Helicobacter pylori ARHp80 by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID406149Antimicrobial activity against Chlorella fusca by agar diffusion method2008Journal of natural products, Jun, Volume: 71, Issue:6
Bioactive isocoumarins isolated from the endophytic fungus Microdochium bolleyi.
AID429083Antibacterial activity against Clostridium difficile clinical isolate expressing tet(M) gene by Etest2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.
AID530751Induction of PlytR::lacZ gene expression in Staphylococcus aureus SH1000 at 2 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID554880Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 3249 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID556652Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 7 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID250262Susceptibility testing against Pseudomonas aeruginosa PAE_NUH06; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID561101Antibacterial activity against Pasteurella multocida BB1035 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID646232Clearance in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID574167Antibacterial activity against Escherichia coli MG1655 grown as planktonic cells after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID646235Elimination half life in Sprague-Dawley rat at 10 mg/kg, po by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID396497Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(B), tet(D), tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID1781495Anti-MDR bacterial activity against Micrococcus luteus ML01 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID577443Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid expressing tetK gene assessed resistant isolates2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.
AID1254825Antibacterial activity against Mycobacterium smegmatis ATCC 607 after 12 hrs by agar diffusion method2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.
AID680772TP_TRANSPORTER: uptake in OAT2-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID325006Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 237 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID564889Antibacterial activity against ompF-deficient Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID323027Antibacterial activity against Corynebacterium diphtheriae after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID561103Antibacterial activity against Pasteurella multocida BB1037 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID561724Antibacterial activity against Enterococcus faecium assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1056839Antibacterial activity against TEM-1/CTX-M-15 expressing Aeromonas caviae isolate 260 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID565441Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.10 ug/ml (Rvb =310.8 +/- 17.10 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID325018Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 918 isolate with erm(B) resistance gene from patient eye by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID565038Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1412158Bactericidal activity against Pseudomonas aeruginosa isolate 1 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID529898Antimicrobial activity against Leptospira weilii isolate 6 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID528701Antibacterial activity against Streptococcus viridans clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID315451Antibacterial activity against Staphylococcus aureus by microbroth dilution assay2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID572810Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID529893Antimicrobial activity against Leptospira interrogans serovar Bataviae isolate 1 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID585870Antimicrobial activity against Pseudomonas aeruginosa isolate 15 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID510747Antibacterial activity against Escherichia coli AG102MB harboring pSport1-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID423155Antibacterial activity against Bifidobacterium thermophilum B0256 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID454471Antimicrobial activity against Bacillus subtilis MTCC 1789 at 10 ug/ml after 24 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID572059Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID425652Total body clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID1335592Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 25213 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID646234Elimination half life in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1158053Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as compound level causing less than 2% growth after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID1635003Bacteriostatic activity against Pseudomonas aeruginosa assessed as induction of bacteria killing at 80 uM after 60 mins by time kill assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID587840Antibacterial activity against Streptococcus pneumoniae by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID285840Antimicrobial activity against Streptococcus pyogenes cMLS isolate B expressing tet(M), int, Xis gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID322992Antibacterial activity against drug-resistant Propionibacterium acnes SW26 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID564823Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID1225388Antibacterial activity against Escherichia coli transformed with plasmid carrying MG1655 deltaBC/pABM by p-iodonitrotetrazolium chloride colorimetric assay2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
AID1681010Antibacterial activity against Bacillus cereus assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID587830Antibacterial activity against wild type Staphylococcus aureus Smith ATCC 13709 by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID519140Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene assessed as resistant strains by broth microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
AID442199Antimicrobial activity against Bacillus subtilis pretreated 3 hrs before UV photosensitization measured after overnight reincubation under dark condition by agar plate disc diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
AID644024Antimicrobial activity against Pseudomonas aeruginosa at 75 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID554866Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 2917 harboring ERY-resistant erm(B) and mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID307416Antibacterial activity against Staphylococcus aureus isolate2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.
AID548257Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID322990Antibacterial activity against drug-resistant Propionibacterium acnes SW16 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID522642Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Vollum 1B by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID278256Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID678722Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID501866Antifungal activity against Penicillium chrysogenum isolates after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID588214FDA HLAED, liver enzyme composite activity2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID565056Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID460630Antifungal activity against Candida albicans MTCC 227 at 100 ug/ml after 48 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID522666Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Texas 2 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID447078Antibacterial activity against Listeria monocytogenes ATCC 15313 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID532019Antibacterial activity against macrolide-lincosamide-streptogramin B-positive, beta-lactamase-positive, methicillin-resistant Staphylococcus aureus ATCC 433002010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID574553Decrease in PSMbeta1 levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID278683Antibacterial activity against Enterococcus faecalis isolate 57452007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID362545Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1325494Antibacterial activity against Staphylococcus aureus Newman2016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1681013Antibacterial activity against Escherichia coli assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID1442642Antibacterial activity against gram-negative Escherichia coli EC155 harboring tet(A) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID556900Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 12 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565037Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID556689Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 16 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID521966Antibacterial activity against Campylobacter jejuni assessed as resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID572809Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID278577Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID516159Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID501857Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID694397Bactericidal activity against Erwinia carotovora CECT 225 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID565017Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID323917Antibacterial activity against Staphylococcus aureus 2A1-1 fast1 with rplC D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID396272Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(D) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID361087Antibacterial activity against Klebsiella pneumoniae subsp. pneumoniae ATCC 13833 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID325017Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 859 isolate with erm(B) resistance gene from patient bronchoalveolar lavage by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID315448Antibacterial activity against Salmonella typhi by microbroth dilution assay2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID369446Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID278232Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1240013Antibacterial activity against Bacillus cereus MTCC 8372 at 50 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID529895Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 3 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID565011Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID278670Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57352007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1250089Ratio of MIC for Pseudomonas aeruginosa PAO1 to MIC for mexABCDXY-deficient Pseudomonas aeruginosa PAO12015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID1269978Antimicrobial activity against Bacillus cereus ATCC 11778 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID601191Cmax in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID324194Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 50 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID532027Antimicrobial activity against Kluyvera georgiana 14751 expressing beta-lactamase CTX-M-78 obtained from bloodstream of patient by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID560250Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD and tet(L) gene by CLSI method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID454158Antimicrobial activity against Klebsiella pneumoniae NCIM 2957 at 10 ug/ml after 24 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID1127617Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing ParE/GyrB K143I mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID278672Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57332007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID544028Antimicrobial activity against Acinetobacter lwoffii isolate C141 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID295105Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID323910Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G144R mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID362541Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID632689Antibacterial activity against Bacillus subtilis after 24 to 48 hrs by microdilution method2011Journal of medicinal chemistry, Nov-24, Volume: 54, Issue:22
Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.
AID562472Antimicrobial activity against Klebsiella pneumoniae isolate 2641/08 obtained from urine of patient with ischemic cardiomyopathy and several comorbidities by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID561636Antibacterial activity against Helicobacter pylori SS1 by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID425399Antibacterial activity against Escherichia coli isolate HM580 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID1360043Bactericidal activity against Bacillus cereus after 24 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID1124943Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition after 16 to 20 hrs by microbroth dilution method2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
AID369656Antibacterial activity against Campylobacter jejuni 15-21 by agar diffusion method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID323904Antibacterial activity against Staphylococcus aureus RN4220 with rplC D159Y mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID369444Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID501860Antibacterial activity against Sarcina lutea food isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1335598Antibacterial activity against Bacillus cereus ATCC 11778 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1431166Antibacterial activity against gentamicin-resistant Staphylococcus aureus NRS-108 after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID562796Antimicrobial activity against Chlamydia trachomatis J/6276/oflR-rifR2 harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID420022Antibacterial activity against Escherichia coli at 20 mg/mL by agar diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
AID554862Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 671 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID375939Antibacterial activity against methicillin-resistant Staphylococcus aureus 78-13607A after 24 hrs by broth microdilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
AID585841Antimicrobial activity against Pseudomonas aeruginosa isolate 1 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID278254Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID285843Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate E expressing tet(M), tndX gene2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID1685708Antimicrobial activity against Bacillus subtilis assessed as inhibition of bacterial growth incubated for overnight by CLSI method2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.
AID283556Antimicrobial activity against Streptococcus pneumoniae R6 with L4 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID543360Antimicrobial activity against tetracycline-susceptible Aeromonas sp. isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID278857Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID368422Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID556348Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
AID556690Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565323Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID379323Antimicrobial activity against Escherichia coli ATCC 259222000Journal of natural products, Mar, Volume: 63, Issue:3
Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune.
AID561752Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID556679Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 6 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID564890Antibacterial activity against ompF-deficient Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID625505Antimicrobial activity against Escherichia coli after 24 hrs by spectrophotometry2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Green synthesis and antimicrobial evaluation of some new trifluoromethyl-substituted hexahydropyrimidines by grinding.
AID1067611Antiamyloidogenic activity in mouse transfected with human amylin/amyloid polypeptide assessed as increase in survival time relative to control2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
A new face for old antibiotics: tetracyclines in treatment of amyloidoses.
AID636841Antibacterial activity against Staphylococcus aureus at 1 to 10 mg/mL after 24 hrs by agar well diffusion method2012European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
Efficient one-pot preparation of novel fused chromeno[2,3-d]pyrimidine and pyrano[2,3-d]pyrimidine derivatives.
AID667399Antibacterial activity against Bacillus subtilis at 500 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID278581Reduction in Plasmodium falciparum FCK2 in human blood cell culture after 96 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID278255Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID557078Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID369655Antibacterial activity against Campylobacter jejuni 25-19 by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID325443Antibacterial activity against Escherichia coli K10 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID428266Antimicrobial activity against carbapenemase producing Enterobacteriaceae by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID556673Antimicrobial activity against multidrug resistant Klebsiella pneumoniae ATCC 11296 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID308346Antibacterial activity against Bacillus subtilis NCIM 20632007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID56765Inhibition zone when tested against DAP-AT from Escherichia coli in M9-Minimal agar at concentration 300 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID307417Antibacterial activity against Salmonella Typhimurium isolate2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.
AID1240030Antibacterial activity against Klebsiella pneumoniae MTCC 3384 after 24 hrs by microdilution method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID561106Antibacterial activity against Pasteurella multocida BB1040 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID539436Binding affinity to hydroxyapatite at 10 nM by UV-spectroscopy relative to tetracycline2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
3-O-phosphate ester conjugates of 17-β-O-{1-[2-carboxy-(2-hydroxy-4-methoxy-3-carboxamido)anilido]ethyl}1,3,5(10)-estratriene as novel bone-targeting agents.
AID285194Antimicrobial activity against Escherichia coli M064 mutant with AG100 lon1::IS186 acrR::IS genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID70763In vitro minimum inhibitory concentration against Escherichia coli PRP-1 (tet A efflux).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID522649Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Colorado by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID519139Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL gene and mec type IV gene assessed as susceptible strains by broth microdilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
AID65068Estimated rate of [3H]DHS (Dihydrostreptomycin) uptake in Escherichia coli K12 (ATCC 25868) [pmol/min (optical density unit)E-1] at the C50 was determined; NA is not applicable1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID323031Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1888847Antibacterial activity against Staphylococcus aureus 1199 measured after 24 hrs by Muller Hinton broth based MTT assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID556660Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 15 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1634994Antimicrobial activity against Pseudomonas aeruginosa 5482 assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID476286Antibacterial activity against Escherichia coli MTCC 2939 after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation.
AID460627Antifungal activity against Aspergillus niger MTCC 1781 at 100 ug/ml after 48 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID278861Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID565330Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID425604Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM615 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax a2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID556886Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 26 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID547535Antimicrobial activity against invasive Streptococcus anginosus obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID444051Total clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID565313Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID688532Antibacterial activity against vancomycin-resistant Enterococcus faecium VRE12012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID547522Antimicrobial activity against Streptococcus constellatus obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence of 5% def2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID278682Antibacterial activity against Enterococcus faecium isolate 57532007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID534338Antimicrobial activity against Burkholderia pseudomallei Bp250 harboring mini-Tn7T-bpeA+B+ -oprB+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID530237Antimicrobial activity against wild-type Mycobacterium smegmatis SMR5 by microplate Alamar blue assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID532763Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID556647Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 2 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID532985Antibacterial activity against Escherichia coli MG16552010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID561112Antibacterial activity against Pasteurella multocida BB1046 harboring plasmid pB1003 bearing blaROB-1 gene and plasmid pB1002 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID565429Antimicrobial activity against Streptococcus intermedius NCTC 11324 assessed as biofilm formation at 0.05 to 0.10 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID524873Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID539670Antimicrobial activity against Salmonella typhi by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID562783Antimicrobial activity against Chlamydia suis S45/rifR harboring rpoB gene2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID601267Oral bioavailability in Sprague-Dawley rat at 10 mg/kg administered as single dose2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID548740Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID562809Antimicrobial activity against Escherichia coli J532009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID569040Antibacterial activity against Staphylococcus aureus after 24 hrs micro dilution assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.
AID540835Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 104 harboring gyrA D87Y mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID278242Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID562810Antimicrobial activity against Escherichia coli J53 harboring pEK499 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID348890Antibacterial activity against Enterococcus faecalis ATCC 29737 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID405453Antibacterial activity against Pseudomonas aeruginosa PAOdeltamutS by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
AID1593385Growth inhibition of Bacillus subtilis 1682019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
AID409960Inhibition of bovine brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID556691Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID332075Antibacterial activity against Pseudomonas aeruginosa by agar dilution method2008Bioorganic & medicinal chemistry letters, Jun-01, Volume: 18, Issue:11
Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors.
AID323024MBC/MIC ratio of Propionibacterium acnes SW101T2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID448512Antimicrobial activity against Escherichia coli MTCCB 1652 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
AID1182955Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Trimeric anthracenes from the endophytic fungus Stemphylium globuliferum.
AID556682Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 9 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID448511Antimicrobial activity against Staphylococcus epidermidis MTCCB 1824 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
AID460625Antibacterial activity against Staphylococcus aureus MTCC 96 at 50 ug/ml after 24 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID406148Antimicrobial activity against Microbotryum violaceum by agar diffusion method2008Journal of natural products, Jun, Volume: 71, Issue:6
Bioactive isocoumarins isolated from the endophytic fungus Microdochium bolleyi.
AID1906415Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method2022European journal of medicinal chemistry, May-05, Volume: 235Amphiphilic cyclic peptide [W
AID542387Antimicrobial activity against Staphylococcus aureus RN42202009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.
AID554656Antimicrobial activity against Ureaplasma parvum isolate UHWJM after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID278248Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID556648Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 3 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID237416Distribution coeeficient for the compound at pH7.4 (Log D7.4) 2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
AID678446Antibacterial activity against Bacillus subtilis at 12 ug/well after 24 hrs by agar well diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.
AID1525330Antibacterial activity against methicillin-resistant Enterococcus faecium 1092 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID325988Antimicrobial activity against Streptococcus sp.11923/962007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci.
AID508594Antibacterial activity against ciprofloxacin-susceptible Salmonella enteritidis 1A-revertC2 harboring gyrA D87Y/S83F mutant, parC D79N mutant, soxR R133C/R20H mutant, soxS E52K mutant and marA I111N/H115Q mutant gene after 70 passages by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID585866Antimicrobial activity against Pseudomonas aeruginosa isolate 13 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1360037Antimicrobial activity against Staphylococcus aureus after 18 to 20 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID476287Antibacterial activity against Salmonella typhi MTCC 98 after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation.
AID572789Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83Y mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID629283Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.025 mg/mL after 10 mins by bioluminometry-based acute action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID587846Half life in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID556665Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 20 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID368418Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID565068Antibacterial activity against CTX-M-15 and SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID572800Antimicrobial activity against soxR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1412149Antibacterial activity against Staphylococcus epidermidis ATCC 35984 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID323006Antibacterial activity against drug-resistant Propionibacterium acnes SW54EA after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID531331Inhibition of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa TNP090 mutant harboring las and rhl gene at 0.06 ug/ml by Cat-2,3-diO reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID644019Antimicrobial activity against Staphylococcus aureus at 50 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID396032Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID1061193Antimicrobial activity against Bacillus cereus MTCC 8372 at 100 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID1821096Antibacterial activity against Salmonella enterica ATCC 14028 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID543361Antimicrobial activity against tetracycline-nonsusceptible Aeromonas sp. isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID1756236Antibacterial activity against Bacillus subtilis 168 assessed as bacterial growth inhibition measured after 16 hrs by serial dilution method2021Journal of natural products, 02-26, Volume: 84, Issue:2
Hydrated Rubrolides from the New Zealand Tunicate
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID548472Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID561111Antibacterial activity against Pasteurella multocida BB1045 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID565030Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1431163Antibacterial activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-1 after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID575677Antibacterial activity against Listeria monocytogenes isolated from humans harboring tet(M) gene2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.
AID323018Antibacterial activity against drug-resistant Propionibacterium acnes P95 after 72 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID250306Susceptibility testing against Pseudomonas aeruginosa PAE_NUH21; I=Intermediate2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID206119In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 88-7 (tet K efflux).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID1905202Antibacterial activity against MDR-methicillin-resistant Staphylococcus aureus ATCC BAA-44 assessed as reduction in bacterial growth measured after 18 hrs by broth microdilution method2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.
AID1265630Antibacterial activity against Staphylococcus aureus SG511 after 24 hrs by broth microdilution method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Dimeric Octaketide Spiroketals from the Jellyfish-Derived Fungus Paecilomyces variotii J08NF-1.
AID554659Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWQ3 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID1730999Antibacterial activity against Bacillus subtilis168 assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Mar-05, Volume: 213Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
AID587849Antibacterial activity against Escherichia coli ATCC 25922 infected in iv dosed mouse septicemia model assessed as mouse protection after 48 hrs2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID323011Antibacterial activity against drug-resistant Propionibacterium acnes SP64E after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID396028Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID287372Antibacterial activity against Staphylococcus aureus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID543363Antimicrobial activity against tetracycline-nonsusceptible Vibrio sp. Isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID609167Antifungal activity against Yarrowia lipolytica assessed as zone of inhibition at 5 uL and 28 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID521967Antibacterial activity against Campylobacter coli assessed as resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID1231527Antibacterial activity against Escherichia coli CECT 405 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID561102Antibacterial activity against Pasteurella multocida BB1036 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID765060Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
AID278267Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID509869Antibacterial activity against Acinetobacter baumannii isolate 4860 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID548253Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID70928In vitro antibacterial activity against Escherichia coli UBMS 88-1 Tet B1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID1781494Anti-MDR bacterial activity against Enterococcus faecium CCARM 5203 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID456849Antimicrobial activity against Staphylococcus epidermidis after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives.
AID565634Antimicrobial activity against Streptococcus intermedius NCTC 11324 planktonic cells assessed as bacterial count at 0.08 ug/ml (Rvb =791.7 +/- 44.10 10'8 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID739304Antibacterial activity against vancomycin-sensitive Enterococcus faecalis ATCC 19433 assessed as growth inhibition by CLSI broth microdilution method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
AID325987Antimicrobial activity against Streptococcus sp. 782/962007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci.
AID375434Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
AID540816Antimicrobial activity against marA::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID395372Antibacterial activity against Bacillus cereus ATCC 7064 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID496883Inhibition of amyloid beta (1-40) aggregation by thioflavin T based fluorometric assay2010Journal of medicinal chemistry, Aug-26, Volume: 53, Issue:16
Polyamines in drug discovery: from the universal template approach to the multitarget-directed ligand design strategy.
AID601269Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 infected in iv dosed mouse systemic infection model assessed as survival of mouse administered 60 mins post infection measured up to 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID1360042Bactericidal activity against Staphylococcus aureus after 24 hrs by micro broth dilution method2018European journal of medicinal chemistry, Jun-25, Volume: 154Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
AID1304849Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 incubated for 16 hrs by broth microdilution method in presence of Fe2+2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID531098Inhibition of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa TNP090 mutant harboring las and rhl gene at 0.03 ug/ml by Cat-2,3-diO reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID562788Antimicrobial activity against Chlamydia muridarum MoPn/rifRoflR harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID534342Antimicrobial activity against Burkholderia pseudomallei Bp58 harboring deleted bpeR::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID323909Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and G155R mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID1442628Antibacterial activity against gram-negative Burkholderia cenocepacia BC240 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID477109Antimicrobial activity against Candida albicans MTCC 227 at 30 ug/ml after 48 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID477104Antimicrobial activity against Bacillus megaterium MTCC 1684 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID528705Antibacterial activity against Streptococcus mitis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID575146Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS123 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID1820911Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID561638Inhibition of MurI in flaA mutant Helicobacter pylori Hp80.2 overexpressing MurI gene assessed as microbial growth inhibition by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID278239Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID508592Antibacterial activity against ciprofloxacin-resistant Salmonella enteritidis 104 harboring gyrA D87Y/S83F mutant, soxR R20H mutant and soxS E52K mutant gene after 200 passages by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID283158Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID540837Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 5408 harboring gyrA D87Y mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID585433Antimicrobial activity against Escherichia coli DH5[alpha] by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID516161Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID557076Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pACM204 plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID557084Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID325020Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 1016 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID449364Antimicrobial activity against Escherichia coli MTCCB 1652 at 30 ug/mL after 16 to 20 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID678445Antibacterial activity against Micrococcus luteus at 12 ug/well after 24 hrs by agar well diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.
AID353048Antimicrobial activity against Staphylococcus aureus at 25 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID495751Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID250263Susceptibility testing against Pseudomonas aeruginosa PAE_NUH07; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID395374Antibacterial activity against Listeria monocytogenes ATCC 15313 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID565033Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID212743Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID644016Antimicrobial activity against Bacillus subtilis at 75 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID1230066Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2691 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID565036Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID522656Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 17T5 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID560772Antibacterial activity against Staphylococcus aureus RN4220 after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID325026Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 759 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID587845Volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID1551809Antibacterial activity against Listeria innocua incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID1465957Antibacterial activity against Staphylococcus epidermidis after 20 hrs by broth microdilution method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Metabolite diversification by cultivation of the endophytic fungus Dothideomycete sp. in halogen containing media: Cultivation of terrestrial fungus in seawater.
AID477101Antimicrobial activity against Staphylococcus aureus MTCC 96 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID1412155Bactericidal activity against Staphylococcus epidermidis ATCC 35984 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID1585462Antibacterial activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-100 measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID699540Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID561104Antibacterial activity against Pasteurella multocida BB1038 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1005 bearing strA, sul2 genes by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID404951Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID588113Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent resistant isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID1525333Antibacterial activity against Streptococcus pneumoniae 911 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID561726Antibacterial activity against Enterococcus faecalis assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID546209Antimicrobial activity against Staphylococcus aureus 2171 by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.
AID594273Antimicrobial activity against Bacillus subtilis NCIM 2063/ATCC 6633 at 1000 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID278664Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 5952007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID522660Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1086 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID559340Antimicrobial activity against Shigella flexneri harboring tetA gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID1566489Inhibition of biotinylated pre-let-7d microRNA (unknown origin) maturation preincubated for 15 mins followed by Pre-let-7d addition and measured after 5 hrs by cat-ELCCA2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
AID501846Antibacterial activity against Escherichia coli clinical isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID572594Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID556677Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 4 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1072992Bactericidal activity against Porphyromonas gingivalis ATCC 33277 after 3 days2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis.
AID325449Antibacterial activity against Staphylococcus aureus ATCC 3556 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID1442629Antibacterial activity against gram-positive Enterococcus faecalis EFs327 harboring tet(M) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID396270Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(M) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID287375Antibacterial activity against Micrococcus luteus after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID353053Antimicrobial activity against Salmonella typhi at 50 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID1848342Antibiofilm activity against Porphyromonas gingivalis ATCC 33277 assessed as inhibition of biofilm at 100 uM measured after 48 hrs by safranin staining relative to control
AID358253Antibacterial activity against Staphylococcus aureus ATCC 6535 after 48 hrs by microplate assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.
AID587836Antibacterial activity against tetracycline-resistant Escherichia coli isolate 155 harboring tet(A) gene by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID283554Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 69GTG71 to TPS mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID524826Antibacterial activity against erythromycin resistant Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID564827Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID520395Antibacterial activity against erm(B) and mef(E)-positive Streptococcus pneumoniae isolate Sweden 15A-25 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1781493Anti-MDR bacterial activity against Enterococcus faecalis CCARM 5172 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID544277Antimicrobial activity against Enterococcus faecalis NKH7 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID341947Antimicrobial activity against Proteus mirabilis2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
AID559592Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of Ceftazidime by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID613638Antimicrobial activity against Staphylococcus aureus SG 511 after 24 hrs by microtiter plate based MIC assay2011Journal of natural products, Aug-26, Volume: 74, Issue:8
Antibacterial polyketides from the jellyfish-derived fungus Paecilomyces variotii.
AID574543Activity of Quorum sensing agr in community-associated methicillin-resistant Staphylococcus aureus USA300 assessed as PSMalpha expression after 8 hrs by qRT-PCR2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID529456Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone A expressing beta-lactamase Oxa-48, TEM-1, SHV-12 and Oxa-9 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
AID562786Antimicrobial activity against Chlamydia trachomatis L2/oflR-rifR1 harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID353040Antimicrobial activity against Proteus vulgaris at 25 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID323026Antibacterial activity against Corynebacterium jeikeium after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID278229Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID524652Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and penB mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID568329Antimicrobial activity against wild type Escherichia coli by broth dilution assay2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
AID1442626Antibacterial activity against gram-negative Acinetobacter baumannii AB250 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID565006Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1055423Antibacterial activity against Bacillus subtilis 168 trpC2 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID360857Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID501859Antibacterial activity against Staphylococcus aureus food isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1678766Antibacterial activity against Escherichia coli ATCC 25922 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1698049Antibacterial activity against Enterobacter aerogenes assessed as inhibition of bacterial growth incubated for overnight by CLSI based method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID1821097Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID524886Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ, penB and mtrR mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1240017Antibacterial activity against Escherichia coli MTCC 724 at 50 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID556865Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 5 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID322997Antibacterial activity against drug-resistant Propionibacterium granulosum NCTC-11865 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID556884Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 24 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1412147Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID679401TP_TRANSPORTER: inhibition of PAH uptake (PAH: 5 uM, Tetracycline: 1000 uM) in OAT1-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID369654Antibacterial activity against Campylobacter jejuni 25-19 cmeB:: Kanamycin-resistant mutant by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID70766In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-5 (sensitive).1994Journal of medicinal chemistry, Jan-07, Volume: 37, Issue:1
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
AID325448Antibacterial activity against Staphylococcus aureus Mu50 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID405930Antimicrobial activity against multidrug-resistant Staphylococcus aureus over expressing NorA MDR efflux pump2008Journal of natural products, Jun, Volume: 71, Issue:6
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
AID477106Antimicrobial activity against Aspergillus flavus MTCC 2501 at 30 ug/ml after 48 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID353046Antimicrobial activity against Proteus mirabilis at 75 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID564818Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID530052Antimicrobial activity against Staphylococcus aureus RN4220 expressing gyrB D437N mutant gene by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
AID575678Antibacterial activity against Listeria monocytogenes isolated from humans harboring int-tn gene2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.
AID542584Antimicrobial activity against Acinetobacter radioresistens 251-39C expressing beta-lactamase OXA-133 by CLSI method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
AID565452Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.05 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =413.7 +/- 24.47 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID565814Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID575144Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID718416Antibacterial activity against log-phase methicillin-sensitive Staphylococcus aureus 8325-4 assessed as growth inhibition after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
AID1228690Antibacterial activity against Pseudomonas aeruginosa 555 BAA-47 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID477102Antimicrobial activity against Bacillus subtilis MTCC 1789 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID1252237Antimicrobial activity against Staphylococcus aureus ATCC 292132015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Rapid synthesis and antimicrobial activity of novel 4-oxazolidinone heterocycles.
AID739305Antibacterial activity against methicillin-sensitive Staphylococcus aureus 8325-4 assessed as growth inhibition by CLSI broth microdilution method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
AID587837Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID561729Antibacterial activity against Enterococcus faecalis assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID449358Antimicrobial activity against Staphylococcus aureus MTCCB 737 after 24 hrs by tube dilution technique2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.
AID489651Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID530530Induction of Ppbp2::lacZ gene expression in Staphylococcus aureus SH1000 at 2 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID429085Antibacterial activity against Clostridium difficile CD37 harboring tet(M) gene from Clostridium difficile CD52008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.
AID565322Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1335604Antifungal activity against Candida albicans ATCC 90028 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID699541Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID1634990Antimicrobial activity against Staphylococcus epidermidis assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID325005Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 897 isolate with erm(B) resistance gene from patient bronchoalveolar lavage by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID585868Antimicrobial activity against Pseudomonas aeruginosa isolate 14 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID565449Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.10 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =413.7 +/- 24.47 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID528707Antibacterial activity against Streptococcus pyogenes group A clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID532981Antibacterial activity against Escherichia coli DH5alpha2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID1566488Inhibition of Dicer mediated biotinylated pre-miRNA-21 (unknown origin) maturation preincubated for 15 mins followed by pre-miRNA-21 addition and measured after 5 hrs by cat-ELCCA2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
AID557080Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID66587In vitro antibacterial activity against Enterococcus ATCC 292121999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID477100Antimicrobial activity against Klebsiella pneumoniae NCIM 2957 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID528790Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID509866Antibacterial activity against Acinetobacter baumannii isolate 510 isolated from human sputum2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID529903Antimicrobial activity against Leptospira kirschneri serovar Grippotyphosa isolate 13 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID528704Antibacterial activity against Streptococcus intermedius clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID534165Antimicrobial activity against Campylobacter jejuni by disk diffusion method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.
AID1112105Antialgal activity against 'Chlorella' fusca by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID312015Antifungal activity against Colletotrichum acutatum at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID325007Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 415 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID454476Antimicrobial activity against Trichoderma viride MTCC 167 at 10 ug/ml after 48 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID529901Antimicrobial activity against Leptospira interrogans serovar Icterohaemorrhagiae isolate 10 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID323004Antibacterial activity against drug-resistant Propionibacterium acnes P429:1 (SC) after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1347487Antibacterial activity against Staphylococcus epidermidis assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID765063Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 8325-4 by broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
AID206302In vitro antibacterial activity against Staphylococcus aureus UBMS 88-7 Tet K1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID1131161Antibacterial activity against Pseudomonas aeruginosa MB2245 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID528789Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID348883Antibacterial activity against Bacillus subtilis ATCC 465 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID1056850Antibacterial activity against TEM-1/SHV-12 expressing Klebsiella pneumoniae isolate 303 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID353051Antimicrobial activity against Staphylococcus aureus at 100 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID532676Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as susceptible isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID562787Antimicrobial activity against Chlamydia suis R19/tetR harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID1571235Inhibition of planktonic growth of Porphyromonas gingivalis ATCC 33277 at 40 uM by standard optical density assay relative to control
AID600726Antibacterial activity against Xanthomonas campestris pvs. at 10 ug/disc after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials.
AID749311Bactericidal activity against Staphylococcus aureus CECT 86 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID561100Antibacterial activity against Pasteurella multocida BB1034 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB1001 bearing tetB gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID556349Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
AID1124945Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition after 16 to 20 hrs by microbroth dilution method2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
AID323007Antibacterial activity against drug-resistant Propionibacterium acnes SW101T after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1252238Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 335912015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Rapid synthesis and antimicrobial activity of novel 4-oxazolidinone heterocycles.
AID325009Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 427 isolate with erm(B) resistance gene from patient sinuitis by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID1551811Antibacterial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID360846Antibacterial activity against Streptococcus agalactiae ATCC 13813 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID556896Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 8 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1678762Antibacterial activity against Acinetobacter baumannii ATCC 19606 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1338317Antibacterial activity against Pseudomonas aeruginosa PCM 2562 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID287373Antibacterial activity against Klebsiella pneumoniae after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID1412157Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 incubated for 24 hrs followed by replating on Mueller hinton agar plates and measured after 24 hrs2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID206301In vitro antibacterial activity against Staphylococcus aureus Smith sensitive1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID432805Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 42 degC by population analysis method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
AID534824Antimicrobial activity against ciprofloxacin-resistant Campylobacter fetus subsp. fetus 1516477 human isolate harboring tet(44) and ant(6)-Ib resistance gene in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID557210Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent intermediate isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID285158Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent resistant isolates2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
AID600727Antibacterial activity against Xanthomonas oryzae at 10 ug/disc after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials.
AID278233Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID250259Susceptibility testing against Pseudomonas aeruginosa PAE_NUH03; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID594328Antimicrobial activity against Staphylococcus aureus NCIM 2079/ATCC 6538P at 1000 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID323034Antibacterial activity against Streptococcus dysgalactiae subsp. dysgalactiae after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID206642Minimum inhibitory concentration against Staphylococcus aureus2004Journal of medicinal chemistry, Mar-11, Volume: 47, Issue:6
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
AID646215Antibacterial activity against Acinetobacter baumannii ATCC 19606 1102012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1056840Antibacterial activity against CTX-15 expressing Aeromonas caviae isolate 258 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID569302Antibacterial activity against Proteus vulgaris at 75 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID570782Antimicrobial activity against multidrug-resistant Acinetobacter baumannii assessed as resistant isolates by disk diffusion method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
AID667265Antibacterial activity against Staphylococcus aureus at 1000 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID585424Antimicrobial activity against oqxAB positive Escherichia coli C600 G062-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID613458Antibacterial activity against Staphylococcus aureus NCIM 2122 after 24 hrs by NCCLS method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Stereoselective synthesis and antimicrobial activity of steroidal C-20 tertiary alcohols with thiazole/pyridine side chain.
AID496399Antibacterial activity against azide-resistant Escherichia coli J53 TET2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID1636433Drug activation in human Hep3B cells assessed as human CYP2D6-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 65.4 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of N2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
AID556649Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 4 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID1442627Antibacterial activity against gram-negative Stenotrophomonas maltophilia SM256 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID530581Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae isolate 6 with A2604G mutation by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID544010Antimicrobial activity against Enterococcus hirae isolate PGS48 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID404899Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB34 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID295099Antibacterial activity against Staphylococcus aureus ATCC 6538 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID560773Antibacterial activity against Staphylococcus aureus TS2921 harboring ddlA Asp102Asn mutation after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID569303Antibacterial activity against Proteus vulgaris at 100 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID56764Inhibition zone when tested against DAP-AT from Escherichia coli in M9-Minimal agar at concentration 30 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID325011Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 460 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID560779Antibacterial activity against Staphylococcus aureus TS2921 harboring ddlA Asp102Asn mutation in fifth-instar silkworm larva infection model assessed as compound concentration per gram of larva causing reduction in survival after 48 hrs post dose at 27 de2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID1587191Antibacterial activity against Escherichia coli assessed as diameter of zone inhibition at 100 ppm by disc diffusion method2019European journal of medicinal chemistry, May-15, Volume: 1704(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.
AID1906418Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method2022European journal of medicinal chemistry, May-05, Volume: 235Amphiphilic cyclic peptide [W
AID425402Antibacterial activity Escherichia coli isolate HM413 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID1311814Antibacterial activity against Neisseria gonorrhoeae F-18 ATCC 49226 by two fold serial dilution method2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.
AID535634Antimicrobial activity against Group B streptococcus serotype VI R6 harboring F395L, V405A, R433H, H438Y, A374V and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID484673Antibacterial activity against Proteus vulgaris2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis of novel beta-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens.
AID1617790Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by broth microdilution method2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structural Characterization and Anti-infective Activity of 9,10-Seco-29-norcycloartane Glycosides Isolated from the Flowers of the Peruvian Medicinal Plant
AID1159091Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as zone of inhibition at 30 mg by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID1678763Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID495516Antibacterial activity against multidrug-resistant Acinetobacter baumannii AYE by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID531795Antibacterial activity against SCCmec type 4 genotype-positive and methicillin-resistant Staphylococcus aureus by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
AID544287Antimicrobial activity against Enterococcus faecalis NKH17 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1685706Antimicrobial activity against Escherichia coli K-12 assessed as inhibition of bacterial growth incubated for overnight by CLSI method2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.
AID496398Antibacterial activity against azide-resistant Escherichia coli J53 TET1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID516160Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID1820917Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID447072Antibacterial activity against Staphylococcus aureus ATCC 6538 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1056844Antibacterial activity against TEM-1/CTX-M-15 expressing Enterobacter cloacae isolate 62 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID276338Antimicrobial activity against Helicobacter pylori DSMZ 48672006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
In vitro inhibitory activity of boropinic acid against Helicobacter pylori.
AID368424Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1820912Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID1781496Anti-MDR bacterial activity against Pseudomonas aeruginosa 15690 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID658534Antibacterial activity against Staphylococcus aureus XU212 overexpressing TetK tetracycline efflux pump after 24 hrs2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Antibacterial acylphloroglucinols from Hypericum olympicum.
AID460623Antibacterial activity against Proteus vulgaris MTCC 1771 at 50 ug/ml after 24 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID574554Decrease in PSMbeta1 levels in Staphylococcus aureus USA300 at subinhibitory concentration after 24 hrs by RP-HPLC/ESI-MS2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID1647642Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as reduction in microbial growth2020Journal of natural products, 02-28, Volume: 83, Issue:2
Isocadiolides A-H: Polybrominated Aromatics from a
AID1228687Antibacterial activity against tet(A) tetracycline-resistant Escherichia coli 155 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID559599Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of tobramycin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID530429Resistance factor, ratio of MIC for Mycobacterium smegmatis overexpressing rv0194 gene to MIC for wild-type Mycobacterium smegmatis SMR52008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID489648Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID535635Antimicrobial activity against Group B streptococcus serotype VI R5 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID565329Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1250087Antibacterial activity against tolC-deficient Escherichia coli ATCC 259222015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID525125Suppression of drug resistance development in Staphylococcus aureus RN4220 assessed as assessed as prolonged length of subculture to develop Linezolid resistance at 0.25 times MIC2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
AID558080Inhibition of PAR2-mediated IL1-beta and SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes at 10 uM by ELISA2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID572600Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1688654Bactericidal activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID444058Volume of distribution at steady state in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID562799Antimicrobial activity against Chlamydia muridarum MoPn/tetR1 harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID510750Antibacterial activity against Escherichia coli AG102MB harboring pS1328-based acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID1228691Antibacterial activity against tet(A) tetracycline-resistant Enterobacter cloacae 603 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID585871Antimicrobial activity against Pseudomonas aeruginosa isolate 16 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID543344Antimicrobial activity against Aeromonas hydrophila assessed as percent tetracyclin-resistant isolate at 0.25 to >16 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID278250Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID294966Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID535642Antimicrobial activity against Group B streptococcus serotype VI N4 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID569297Antibacterial activity against Proteus mirabilis at 50 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID559597Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of tobramycin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID563504Antimicrobial activity against Serratia marcescens ATCC 13880 harboring plasmid STV29 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID1159081Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID424867Antibacterial activity against bacterial sensory kinase PhoQ deficient Salmonella enterica serovar Typhimurium CS009 by modified twofold broth microdilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.
AID543365Antimicrobial activity against tetracycline-nonsusceptible Salmonella sp. Isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID447079Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID554650Antimicrobial activity against Ureaplasma urealyticum isolate HPA12 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID565058Antibacterial activity against wild-type Escherichia coli AG100 harboring Tn5 insertion in ycgE gene at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID1443980Inhibition of human BSEP expressed in fall armyworm sf9 cell plasma membrane vesicles assessed as reduction in vesicle-associated [3H]-taurocholate transport preincubated for 10 mins prior to ATP addition measured after 15 mins in presence of [3H]-tauroch2010Toxicological sciences : an official journal of the Society of Toxicology, Dec, Volume: 118, Issue:2
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
AID404898Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB33 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID404897Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB30 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID535647Antimicrobial activity against Group B Streptococcus serotype V 2603 V/R harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID564895Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID484675Antibacterial activity against Staphylococcus aureus2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis of novel beta-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens.
AID601193Clearance in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID406146Antimicrobial activity against Escherichia coli by agar diffusion method2008Journal of natural products, Jun, Volume: 71, Issue:6
Bioactive isocoumarins isolated from the endophytic fungus Microdochium bolleyi.
AID501853Antibacterial activity against Salmonella enterica ATCC 13076 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID562800Antimicrobial activity against Chlamydia trachomatis F/70/rifR-tetR harboring rpoB gene and tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID545056Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate DL010 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID443284Antimicrobial activity against Staphylococcus aureus after 24 hrs by agar dilution technique2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Anti-oxidant and anti-bacterial activities of novel N'-arylmethylidene-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl) acetohydrazides.
AID554870Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 3250 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID587848Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in iv dosed mouse septicemia model assessed as mouse protection after 48 hrs2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID1056836Antibacterial activity against CTX-15 expressing Escherichia coli isolate 235 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID294963Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID1061194Antimicrobial activity against Bacillus cereus MTCC 8372 at 50 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID531335Antibacterial activity against Pseudomonas aeruginosa TNP030 selected after 1.0 ug/ml of azithromycin by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID341060Activity of tetracycline efflux transporter TetA(B) Asp190Cys mutant in Escherichia coli DH5alpha membrane vesicles assessed as [3H]tetracycline uptake per mg of protein2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID323022MBC/MIC ratio of Propionibacterium acnes SW3CD2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID569306Antibacterial activity against Salmonella typhi at 75 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID1348085Antimicrobial activity against Klebsiella oxytoca ATCC 8724 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID42828In vitro inhibition of human recombinant IL-1-beta-induced breakdown of bovine cartilage in a cartilage organ culture assay1994Journal of medicinal chemistry, Sep-16, Volume: 37, Issue:19
Heteroaryl-fused 2-phenylisothiazolone inhibitors of cartilage breakdown.
AID644028Antimicrobial activity against Klebsiella pneumoniae at 75 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID1158051Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID1329753Antibacterial activity against Propionibacterium acnes ATCC 6919 after 24 hrs by broth microdilution method
AID565059Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID534345Antimicrobial activity against Burkholderia pseudomallei Bp175 harboring mini-Tn7T-P1-bpeR+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID688531Antibacterial activity against methicillin-resistant Staphylococcus aureus MW22012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID532762Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID671549Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate SA161 expressing TetM gene2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID544011Antimicrobial activity against Pseudomonas borealis isolate C5 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID546620Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID649515Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID494532Antimicrobial activity against Bacillus subtilis NCIM 2718 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID494532Antimicrobial activity against Bacillus subtilis NCIM 2718 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, May-06Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID1197614Inhibition of protein biosynthesis in Escherichia coli ATCC 25922 assessed as incorporation of [35S]methionine into protein at 2.5 ug/300 ul by in-vivo translation assay2015European journal of medicinal chemistry, Mar-06, Volume: 92Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.
AID70927In vitro antibacterial activity against Escherichia coli PRP1 Tet A1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID587242Antimicrobial activity against Staphylococcus aureus DSM 799 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID1906414Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method2022European journal of medicinal chemistry, May-05, Volume: 235Amphiphilic cyclic peptide [W
AID285193Antimicrobial activity against Escherichia coli M044 mutant with AG100 lon4::IS186 marR::IS genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID524639Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID543347Antimicrobial activity against Aeromonas hydrophila by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID70929In vitro antibacterial activity against Escherichia coli UBMS 90-4 Tet M1999Bioorganic & medicinal chemistry letters, May-17, Volume: 9, Issue:10
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
AID644020Antimicrobial activity against Staphylococcus aureus at 75 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID399617Antimicrobial activity against Proteus vulgaris ATCC 13315 at 0.1 mg/disk by disk diffusion assay
AID1820910Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID508591Antibacterial activity against wild type Salmonella enteritidis 104 harboring gyrA D87Y mutant gene by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID544283Antimicrobial activity against Enterococcus faecalis NKH13 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID323913Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and A150T mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID572811Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring GyrA G81C,acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID417536Antibacterial activity against Staphylococcus epidermidis after 24 hrs by NLCCS microdilution method2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.
AID560775Antibacterial activity against Staphylococcus aureus TS10007 harboring ddlA Asp39Asn mutation after 20 hrs2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
AID1442636Antibacterial activity against gram-positive Staphylococcus aureus SA161 harboring tet(M) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID545052Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ363 from patient secretion by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID56760Inhibition zone when tested against DAP-AT from Escherichia coli in L-agar at concentration 30 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID609164Antibacterial activity against Pseudomonas antimicrobica assessed as zone of inhibition at 5 uL and 32 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID554867Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 3245 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1329752Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution method
AID360837Antibacterial activity against Bacillus cereus ATCC 11778 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID1131159Antibacterial activity against Proteus vulgaris MB838 assessed as growth inhibition at 200 ug/mL1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID285837Antimicrobial activity against tetracyclin-resistant Streptococcus pyogenes cMLS isolate expressing erm(B)2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID535645Antimicrobial activity against Group B Streptococcus serotype Ia N1 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1756235Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 16 hrs by serial dilution method2021Journal of natural products, 02-26, Volume: 84, Issue:2
Hydrated Rubrolides from the New Zealand Tunicate
AID1159090Antimicrobial activity against Bacillus cereus ATCC 11778 assessed as zone of inhibition at 30 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID1442639Antibacterial activity against gram-positive Streptococcus pneumoniae SP160 harboring tet(M) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID1681011Antibacterial activity against Bacillus subtilis assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID565331Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1072993Antibacterial activity against Porphyromonas gingivalis ATCC 33277 after 24 hrs by microbroth dilution assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis.
AID342020Antibacterial activity against Escherichia coli J53 by Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
AID1056838Antibacterial activity against CTX-15 expressing Escherichia coli isolate 4024 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1376895Antimicrobial activity against Staphylococcus aureus DSM 25923 assessed as growth inhibition at 7 ug per disc after 24 to 48 hrs (Rvb = 0 millimeter)
AID565010Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565229Antimicrobial activity against Mycobacterium chelonae ATCC 35752 harboring pZS01 carrying mspA gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID1555492Antimycobacterial activity against Staphylococcus aureus FDA 209P by agar diffusion method2019European journal of medicinal chemistry, Aug-15, Volume: 176Salinomycin and its derivatives - A new class of multiple-targeted "magic bullets".
AID554651Antimicrobial activity against Ureaplasma urealyticum isolate HPA17 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID569301Antibacterial activity against Proteus vulgaris at 50 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID565321Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID1338316Antibacterial activity against Enterococcus faecalis PCM 2673 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID279192Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
AID522366Antimicrobial activity against wild type Proteus mirabilis N2 mutant after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID1685705Antimicrobial activity against Escherichia coli DH5alpha assessed as inhibition of bacterial growth incubated for overnight by CLSI method2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.
AID395368Antibacterial activity against Staphylococcus aureus ATCC 6538 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID428291Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeABC adeIJK double mutant isolated from patient with urinary tract infection by E test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID574170Antibacterial activity against Escherichia coli MG1655 grown as biofilms harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID632690Antibacterial activity against Streptococcus agalactiae after 24 to 48 hrs by microdilution method2011Journal of medicinal chemistry, Nov-24, Volume: 54, Issue:22
Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.
AID522655Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1007 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID561747Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID556663Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 18 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID671548Antibacterial activity against tetracycline-susceptible Staphylococcus aureus ATCC 13709 Smith isolate SA1002012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID1250083Antibacterial activity against Acinetobacter baumannii ARC 34952015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID501862Antifungal activity against Saccharomyces cerevisiae ATCC 9763 after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID543362Antimicrobial activity against tetracycline-susceptible Vibrio sp. Isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID545050Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ250 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID585874Antimicrobial activity against Pseudomonas aeruginosa isolate 17 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID498361Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrB containing isogenic acrB knockout assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID1396071Dark toxicity against human MCF7 cells assessed as decrease in cell viability by MTT assay2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
Photoactivated 2,3-distyrylindoles kill multi-drug resistant bacteria.
AID1442625Antibacterial activity against gram-negative Pseudomonas aeruginosa PA169 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID562794Antimicrobial activity against Chlamydia trachomatis J/6276/oflR-rifR1 harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID1269977Antimicrobial activity against Bacillus anthracis 34F2 Sterne after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID1688652Antifungal activity against Candida albicans ATCC 10231 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID554859Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 3247 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID601268Antimicrobial activity against tetracycline-susceptible Staphylococcus aureus Smith isolate 100 infected in po dosed mouse systemic infection model assessed as survival of mouse administered 60 mins post infection measured after 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID642767Antimicrobial activity against Bacillus subtilis at 50 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID495511Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4665 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID543346Antimicrobial activity against Aeromonas sobria assessed as percent tetracyclin-resistant isolate at 0.25 to >16 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID325023Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 1041 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID1159084Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID543065Antibacterial activity against methicillin-resistant Staphylococcus aureus ST3982009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L).
AID1685707Antimicrobial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for overnight by CLSI method2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.
AID559594Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of Ceftazidime by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID1654444Antibacterial activity against Staphylococcus aureus INCAS0039 assessed as reduction in microbial growth by CLSI based broth microdilution method2020Journal of natural products, 03-27, Volume: 83, Issue:3
Meliponamycins: Antimicrobials from Stingless Bee-Associated
AID396269Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(E) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID530350Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID585420Antimicrobial activity against oqxAB positive Escherichia coli C600 W191-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID574551Decrease in delta toxin levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID294964Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID323000Antibacterial activity against drug-resistant Propionibacterium acnes SW3CD after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID530760Induction of PsgtB::lacZ gene expression in Staphylococcus aureus SH1000 at 2 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID572813Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID556887Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 27 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID602693Binding affinity to bone mineral hydroxyapatite assessed as binding index after 24 hrs by UV-spectrophotometer analysis relative to 5-fluorouracil2011Bioorganic & medicinal chemistry, Jun-15, Volume: 19, Issue:12
Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
AID565013Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID646236AUClast in Sprague-Dawley rat at 1 mg/kg, iv by LC/MS-MS analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID563507Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 71 harboring plasmid STV29 expressing hasF gene by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID1617935Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as bacterial growth inhibition measured after 48 hrs by resazurin assay
AID447073Antibacterial activity against Klebsiella pneumoniae UC57 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1325498Antibacterial activity against gentamicin-resistant Staphylococcus aureus NRS-1082016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID613457Antibacterial activity against Escherichia coli NCIM 2574 after 24 hrs by NCCLS method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Stereoselective synthesis and antimicrobial activity of steroidal C-20 tertiary alcohols with thiazole/pyridine side chain.
AID572816Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID278675Antibacterial activity against Enterococcus faecalis isolate 57432007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID544281Antimicrobial activity against Enterococcus faecalis NKH11 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID454164Antimicrobial activity against Staphylococcus aureus MTCC 96 at 10 ug/ml after 24 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID534404Antibacterial activity against Escherichia coli EPI300 expressing tet(40) gene assessed as inhibition of bacterial growth at 80 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID1465955Antibacterial activity against Bacillus cereus after 20 hrs by broth microdilution method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Metabolite diversification by cultivation of the endophytic fungus Dothideomycete sp. in halogen containing media: Cultivation of terrestrial fungus in seawater.
AID278260Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID522645Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Texas by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID278253Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID525143Antimicrobial activity against linezolid-resistant Staphylococcus aureus isolate 004-737X expressing cfr and ermA gene isolated from paraplegic patient by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
AID559356Antimicrobial activity against Salmonella spp. harboring tetB gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID341055Antibacterial activity against intact Escherichia coli DH5alpha expressing wild-type tetracycline efflux transporter TetA(B) gene2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
AID388002Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microdilution broth method2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Structure-activity relationship of antibacterial chalcones.
AID467962Antimicrobial activity against Acinetobacter baumannii ATCC 19606 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID1056843Antibacterial activity against CTX-15 expressing Enterobacter cloacae isolate 51 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID495512Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4666 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID671557Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in CD-1 mouse assessed as increase in survival at 30 mg/kg, po administered as single dose 1 hr post infection measured after 48 hrs post infection2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID423151Antibacterial activity against Bifidobacterium thermophilum B0219 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID625277FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of less concern for DILI2011Drug discovery today, Aug, Volume: 16, Issue:15-16
FDA-approved drug labeling for the study of drug-induced liver injury.
AID564893Antibacterial activity against wild-type Escherichia coli AG100 harboring marR mutant gene at 26 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID1678768Antibacterial activity against Staphylococcus aureus ATCC 43300 using Cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID315450Antibacterial activity against Streptococcus pneumoniae by micro-broth dilution assay2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID278238Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID323908Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and D159Y mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID1442631Antibacterial activity against gram-negative Klebsiella pneumoniae KP457 harboring blacTX-M-15 extended spectrum beta-lactamase gene by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID322257Antibacterial activity against Proteus mirabilis by well diffusion method2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Synthesis of novel spiropyrrolizidines as potent antimicrobial agents for human and plant pathogens.
AID509867Antibacterial activity against Acinetobacter baumannii isolate 2824 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID563512Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 011 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID1158048Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as compound level causing less than 2% growth after 16 hrs by serial dilution method2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.
AID1225259Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
A potent antimicrobial compound isolated from Clathria cervicornis.
AID573966Antibacterial activity against Cj1211-positive Campylobacter jejuni harboring aphA3 and tet(O) genes2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni.
AID278579Decrease in Plasmodium falciparum FCK2 in erythrocytes at 50 uM after 84 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID644027Antimicrobial activity against Klebsiella pneumoniae at 50 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID559355Antimicrobial activity against Salmonella spp. harboring tetA gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID1339206Inhibition of MMP2 in inflamed tissue isolated from chronic periodontitis patient at 500 ug/l after 15 to 30 mins by gelatin zymographic method relative to control2017Bioorganic & medicinal chemistry, 02-15, Volume: 25, Issue:4
3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: Synthesis, biological evaluation and molecular modelling study.
AID283156Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID554673Antimicrobial activity against Streptococcus pneumoniae serotype 9V ST 156 harboring ERY-resistant erm(B) or mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID260687Antibacterial activity against Xanthomonas campestris pvs by disk diffusion method at 10 ug/disk2006Bioorganic & medicinal chemistry letters, Feb-15, Volume: 16, Issue:4
Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies.
AID601192AUC (0 to infinity) in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose measured after 24 to 48 hrs2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID540826Antimicrobial activity against ramA::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID278235Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1252239Antimicrobial activity against Acinetobacter baumannii ATCC 196062015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Rapid synthesis and antimicrobial activity of novel 4-oxazolidinone heterocycles.
AID1131162Antibacterial activity against Staphylococcus aureus MB108 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID41090Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Bacteroides gingivalis bacteria1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Substituted 2-(2-hydroxyphenyl)benzimidazoles as potential agents for the control of periodontal diseases.
AID649518Antimicrobial activity against Enterococcus faecalis NCTC 12697 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID295108Antibacterial activity against Proteus vulgaris ATCC 8427 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID325028Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 326 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID341107Antibacterial activity against Escherichia coli transconjugant carrying pEC28 isolate eby Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
AID388086Antibacterial activity at Escherichia coli2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID584121Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 isolate 11 containing apmA, erm(B), tet(L), tet(M), tet(K), dfrK, aadD, mecA, blaZ resistance genes by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID1338318Antibacterial activity against Klebsiella pneumoniae PCM1 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID646206Antibacterial activity against Staphylococcus aureus ATCC 101 292132012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1424150Antibacterial activity against Pseudomonas aeruginosa by broth dilution assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
AID559357Antimicrobial activity against Salmonella spp. harboring tetG gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID548256Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID312016Antifungal activity against Botrytis cinerea at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID1335603Antibacterial activity against Escherichia coli ATCC 10535 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID559803Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of ciprofloxacin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID285203Antimicrobial activity against Escherichia coli M124 mutant with AG100 lon4::IS186 acrR::IS genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID586086Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID543353Antimicrobial activity against Salmonella serogroup O8 assessed as percent tetracyclin-resistant isolate at 1 to >128 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID307123Antimycobacterial activity against Mycobacterium tuberculosis by agar dilution method2007Bioorganic & medicinal chemistry letters, Apr-15, Volume: 17, Issue:8
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
AID1056837Antibacterial activity against TEM-1/SHV-12 expressing Escherichia coli isolate 237 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID322993Antibacterial activity against drug-resistant Propionibacterium acnes D-04/97 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID322256Antibacterial activity against Proteus vulgaris by well diffusion method2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Synthesis of novel spiropyrrolizidines as potent antimicrobial agents for human and plant pathogens.
AID718415Antibacterial activity against log-phase methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
AID1339205Inhibition of MMP9 in inflamed tissue isolated from chronic periodontitis patient at 500 ug/l after 15 to 30 mins by gelatin zymographic method relative to control2017Bioorganic & medicinal chemistry, 02-15, Volume: 25, Issue:4
3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: Synthesis, biological evaluation and molecular modelling study.
AID584822Effect on Pseudomonas putida PAW340 biofilms assessed as heat production at 250 ug/ml by Chip calorimetry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID585419Antimicrobial activity against oqxAB positive Escherichia coli C600 W281-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1630578Antibacterial activity against Staphylococcus aureus SG 511 after 24 hrs by two fold serial dilution method2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Synthesis and antibacterial evaluation of hamacanthin B analogues.
AID1585461Antibacterial activity against erythromycin-resistant Staphylococcus aureus NRS-70 measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID285200Antimicrobial activity against Escherichia coli M103 mutant with AG100 lon3::IS186 acrR-acrAB genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID592501Antifungal activity against Microbotryum violaceum assessed as zone of inhibition measured as radius at 50 ug by agar diffusion assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Diversonol and blennolide derivatives from the endophytic fungus Microdiplodia sp.: absolute configuration of diversonol.
AID565436Antimicrobial activity against Streptococcus intermedius NCTC 11324 biofilm assessed as biofilm bacterial count at 0.05 ug/ml (Rvb =402.9 +/- 26.88 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID372897Antibacterial activity against Streptococcus faecalis ATCC 9790 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID530586Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae isolate 685 with A2603G mutation by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID1335599Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID532573Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID557077Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID323008Antibacterial activity against drug-resistant Propionibacterium acnes GE46EB after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID524824Antibacterial activity against erythromycin resistant Campylobacter sp. by agar plate dilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID404949Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID1442638Antibacterial activity against gram-positive Enterococcus faecalis EF159 harboring tet(M) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID1678765Antibacterial activity against Escherichia coli ATCC 25922 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID362544Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID322995Antibacterial activity against drug-resistant Propionibacterium acnes EG7NS after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID544024Antimicrobial activity against Acinetobacter calcoaceticus isolate C35 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID1726821Antibacterial activity against Escherichia coli MTCC 1687 incubated for 14 to 16 hrs by micro broth dilution method2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID362543Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID322258Antibacterial activity against Staphylococcus aureus by well diffusion method2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Synthesis of novel spiropyrrolizidines as potent antimicrobial agents for human and plant pathogens.
AID629281Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.025 mg/mL after 10 mins by bioluminometry-based chronic action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID283555Antimicrobial activity against Streptococcus pneumoniae R6 transformants2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID543359Antimicrobial activity against Salmonella serogroup O9 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID360841Antibacterial activity against Staphylococcus aureus ATCC 27853 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID1124946Antibacterial activity against methicillin-resistant Staphylococcus aureus subsp. aureus ATCC 43300 assessed as growth inhibition after 16 to 20 hrs by microbroth dilution method2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
AID556875Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 15 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1577573Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth after 24 hrs by microdilution method
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1231525Antibacterial activity against Enterococcus faecalis CECT 481 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID509870Antibacterial activity against Acinetobacter baumannii isolate 5191 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID1689766Antibacterial activity against Enterococcus faecalis ATCC 292122020European journal of medicinal chemistry, Mar-01, Volume: 189Simple amphiphilic α-hydrazido acids: Rational design, synthesis, and in vitro bioactivity profile of a novel class of potential antimicrobial compounds.
AID369661Antibacterial activity against Campylobacter jejuni 81-176 cmeB: kanamycin-resistant mutant carrying tet(O)+ gene2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID278257Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1159088Antimicrobial activity against Proteus vulgaris ATCC 33420 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID534825Antimicrobial activity against Campylobacter fetus subsp. fetus CA73 harboring pCA73 carrying tet(44) resistance gene of 1516477 in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID1848325Antibacterial activity against Porphyromonas gingivalis ATCC 33277 assessed as growth inhibition at 2.81 uM measured after 24 hrs by WST-1 assay relative to control
AID529885Antibacterial activity against Staphylococcus aureus RN4220 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
AID368421Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID574544Activity of Quorum sensing agr in community-associated methicillin-resistant Staphylococcus aureus USA300 assessed as PSMbeta expression after 8 hrs by qRT-PCR2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID250267Susceptibility testing against Pseudomonas aeruginosa PAE_NUH20; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID520704Antibacterial activity against tetracycline resistant Streptococcus pneumoniae clinical isolate expressing erm(B) and tet(M) gene by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003.
AID338052Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 hrs by microdilution assay
AID554877Antimicrobial activity against Streptococcus pneumoniae serotype 6B ST 138 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID545044Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ078 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1056841Antibacterial activity against TEM-1/SHV-12 expressing Aeromonas hydrophila isolate 268 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID278264Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID278679Antibacterial activity against Enterococcus faecium isolate 57502007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1678761Antibacterial activity against Acinetobacter baumannii ATCC 19606 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1131164Antibacterial activity against Bacillus subtilis MB964 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID565319Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID404896Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB28 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID535644Antimicrobial activity against Group B streptococcus serotype Ib N2 harboring E63K mutation in PBP 2A and L41S mutation in PBP 1B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID530288Antimicrobial activity against PR-39-resistant Salmonella enterica serovar Typhimurium LT2 DA6192 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
AID477099Antimicrobial activity against Pseudomonas aeruginosa MTCC 2488 at 10 ug/ml after 24 hrs by agar diffusion method2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
AID530580Antimicrobial activity against Mycoplasma pneumoniae isolate FH by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID556687Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 14 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID571884Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID646211Antibacterial activity against Streptococcus pneumoniae ATCC 106 496192012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID680162TP_TRANSPORTER: uptake in OAT4-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID369668Antibacterial activity against Campylobacter jejuni 23-51 cme:: Kanamycin-resistant mutant assessed by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID428274Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID1159083Antimicrobial activity against Micrococcus luteus ATCC 9341 assessed as zone of inhibition at 30 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID532025Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 harboring pTY60H assessed as 2-fold increase in reserpine-mediated inhibition of bacterial growth after 14 days2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID524663Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1131167Antibacterial activity against Klebsiella aerogenes MB1503 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID556667Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 22 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID562473Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase KPC-2/TEM-1 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID360363Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake2007The Journal of biological chemistry, Jan-26, Volume: 282, Issue:4
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
AID283157Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID489647Antibacterial activity against Enterobacter cloacae ATCC 49141 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID307414Antibacterial activity against Pseudomonas aeruginosa ATCC 117752007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.
AID323914Antibacterial activity against Staphylococcus aureus 2A1-1 with rplC G152D, D159Y and unmapped mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID323023MBC/MIC ratio of Propionibacterium acnes P952007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID283166Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5204 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID56761Inhibition zone when tested against DAP-AT from Escherichia coli in L-agar at concentration 300 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID585425Antimicrobial activity against oqxAB positive Escherichia coli C600 G375-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1634992Antimicrobial activity against Staphylococcus aureus clinical isolates from university hospital in Motol assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID1335601Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID572788Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID543349Antimicrobial activity against Aeromonas sobria by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID556666Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 21 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID544273Antimicrobial activity against Enterococcus faecalis NKH3 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID561740Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID660265Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID532678Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as resistant isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID565067Antibacterial activity against CTX-M-15 and SHV-27 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID585863Antimicrobial activity against Pseudomonas aeruginosa isolate 12 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1240015Antibacterial activity against Staphylococcus aureus MTCC 96 at 50 ug/ml after 24 hrs by disc diffusion method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID444052Hepatic clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID565445Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.07 ug/ml (Rvb =310.8 +/- 17.10 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID678719Metabolic stability in human liver microsomes assessed as medium signal/noise ratio (S/N of 10 to 100) by measuring GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID283164Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2640 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID1689767Antibacterial activity against Staphylococcus aureus ATCC 292132020European journal of medicinal chemistry, Mar-01, Volume: 189Simple amphiphilic α-hydrazido acids: Rational design, synthesis, and in vitro bioactivity profile of a novel class of potential antimicrobial compounds.
AID87950Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 1152002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID561755Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID562813Antimicrobial activity against Escherichia coli DH5[alpha] harboring pEK516 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID1698042Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID560222Antibacterial activity against Salmonella enterica serovar Typhimurium 01-4 by CLSI M7-A7 agar dilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.
AID529897Antimicrobial activity against Leptospira interrogans serovar Pyrogenes isolate 5 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID636840Antibacterial activity against Pseudomonas aeruginosa at 1 to 10 mg/mL after 24 hrs by agar well diffusion method2012European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
Efficient one-pot preparation of novel fused chromeno[2,3-d]pyrimidine and pyrano[2,3-d]pyrimidine derivatives.
AID667270Antibacterial activity against Escherichia coli at 500 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID508595Antibacterial activity against wild type Salmonella enteritidis 5408 harboring gyrA D87Y mutant gene by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID575946Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
AID283550Antimicrobial activity against Streptococcus pneumoniae BSF-11524 isolate with erm(B) and L4 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID562795Antimicrobial activity against Chlamydia muridarum MoPn/oflR-rifR harboring ompA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID540932Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP2 harboring rpsL K88E mutant gene and inserted glycine at position 92 of the gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID525040Antimicrobial activity against fluoroquinolone-susceptible Escherichia coli PS5 harboring GyrA S83L mutant gene by Etest2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
AID559600Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of ciprofloxacin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID1376891Antimicrobial activity against Escherichia coli DSM 8579 assessed as growth inhibition at 7 ug per disc after 24 to 48 hrs (Rvb = 0 millimeter)
AID362542Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID544275Antimicrobial activity against Enterococcus faecalis NKH5 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID523002Cytotoxicity against human 5637 cells assessed as mild induction of cell death by LDH release assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID1689768Antibacterial activity against Escherichia coli ATCC 259222020European journal of medicinal chemistry, Mar-01, Volume: 189Simple amphiphilic α-hydrazido acids: Rational design, synthesis, and in vitro bioactivity profile of a novel class of potential antimicrobial compounds.
AID404947Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
AID613193Antibacterial activity against Haemophilus influenzae ATCC 10211 after 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
AID667271Antibacterial activity against Escherichia coli at 1000 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID530051Antimicrobial activity against Staphylococcus aureus 286607-R1 harboring wild type gyrB by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
AID323003Antibacterial activity against drug-resistant Propionibacterium acnes P425:1 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID27797Maximum plasma concentration (Cmax) after oral dosing by gavage needle at 30 mg/kg in C57BL/6NTac female mice; Not checked2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID324168Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 25 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID312013Antibacterial activity against Escherichia coli at 10 ug/disc after 48 hrs by disc diffusion assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.
AID323013Antibacterial activity against drug-resistant Propionibacterium acnes P:413 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1335597Antibacterial activity against Bacillus pumilus NCTC 8241 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID396275Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(B), tet(C) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID556902Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 14 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID575170Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID460803Antibacterial activity against multidrug-resistant Acinetobacter baumannii BAA-1605 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID525144Antimicrobial activity against Staphylococcus epidermidis isolate 426-3147L expressing cfr gene by broth microdilution CLSI method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
AID285838Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate expressing erm(B)2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID516163Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID559345Antimicrobial activity against Shigella sonnei harboring tetG gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID460624Antibacterial activity against Klebsiella pneumoniae NCIM 2957 at 50 ug/ml after 24 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID495514Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4668 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID582764Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID285190Antimicrobial activity against Escherichia coli AG100 mutant with argE3 thi-3 rpsL xyl mtl supE44 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID325445Antibacterial activity against Escherichia coli C921-61 after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID556662Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 17 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565453Antimicrobial activity against Streptococcus intermedius SI006 biofilm harboring luxS mutant gene assessed as biofilm bacterial count at 0.07 ug/ml in presence of 0.8 nM autoinducer 4,5-dihydroxy-2,3-pentanedione (Rvb =413.7 +/- 24.47 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID540865Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID559595Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of Ceftazidime by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID588120Antimicrobial activity against Streptococcus suis CA isolated from cerebrospinal fluid of patient with meningitis by broth microdilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Different genetic elements carrying the tet(W) gene in two human clinical isolates of Streptococcus suis.
AID278678Antibacterial activity against Enterococcus faecium isolate 57492007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID561107Antibacterial activity against Pasteurella multocida BB1041 harboring plasmid pB1000 bearing blaROB-1 gene and plasmid pB9956 bearing tetH gene by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID548471Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID574552Decrease in delta toxin levels in Staphylococcus aureus USA300 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID544278Antimicrobial activity against Enterococcus faecalis NKH8 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID562798Antimicrobial activity against Chlamydia muridarum MoPn/tetR14 harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID584123Antimicrobial activity against Staphylococcus aureus RN4220 carrying pAFS11-apmA, erm(B), tet(L), dfrK, aadD resistance genes by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID368420Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID680185TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, Tetracycline: 50 uM) in OAT4-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID556890Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 2 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID557799Antimicrobial activity against Escherichia coli J53 by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID1820916Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID424866Antibacterial activity against wild type Salmonella enterica serovar Typhimurium ATCC 14028 by modified twofold broth microdilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.
AID678447Antibacterial activity against Pseudomonas aeruginosa at 12 ug/well after 24 hrs by agar well diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.
AID609165Antibacterial activity against Staphylococcus equorum assessed as zone of inhibition at 5 uL and 32 degC after 36 hrs at by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1731000Antibacterial activity against Escherichia coli AB1157 assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Mar-05, Volume: 213Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
AID565326Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID532677Antimicrobial activity against ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates assessed as intermediate resistant isolates by agar dilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
AID285192Antimicrobial activity against Escherichia coli M043 mutant with AG100 lon4::IS186 marR::IS2 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID1127615Antibacterial activity against wild type Streptococcus pneumoniae assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID522651Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K5926 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID285849Antimicrobial activity against tetracyclin-resistant Streptococcus pyogenes C-105 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID1131172Antibacterial activity against Corynebacterium pseudodiphtheriticum assessed as growth inhibition at 2 to 8 ug/mL1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID564892Antibacterial activity against ompF-deficient Escherichia coli AG100 at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID348884Antibacterial activity against Bacillus pumilus PTCC 1114 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID278676Antibacterial activity against Enterococcus faecalis isolate 57422007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1442630Antibacterial activity against gram-positive Enterococcus faecium EFm404 harboring tet(M) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID322989Antibacterial activity against drug-resistant Propionibacterium acnes SW10 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID495753Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow and treated with Cefixime-cluvulanic acid by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID1442623Antibacterial activity against gram-negative Klebsiella pneumoniae KP194 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID1392011Antistaphylococcal activity against erythromycin-resistant Staphylococcus aureus NRS-70 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID307118Antiviral activity against HIV1 3B in CEM cells assessed as inhibition of viral-induced cytopathicity2007Bioorganic & medicinal chemistry letters, Apr-15, Volume: 17, Issue:8
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
AID1228681Antibacterial activity against methicillin-resistant, tet(M) tetracycline-resistant Staphylococcus aureus 161 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID285199Antimicrobial activity against Escherichia coli M093 mutant with AG100 lon3::IS186 acrR::IS1 genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID562797Antimicrobial activity against Chlamydia trachomatis L2/tetR1 harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID1287895Antimicrobial activity against Escherichia coli after 24 hrs by serial dilution method2016European journal of medicinal chemistry, May-04, Volume: 113Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
AID1056835Antibacterial activity against SIM-1 expressing Acinetobacter baumannii isolate 170 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1551779Antibacterial activity against Bacillus subtilis assessed as zone of inhibition2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID534406Antibacterial activity against Escherichia coli EPI300 expressing tet(W) gene assessed as inhibition of bacterial growth at 60 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID558077Inhibition of PAR2-mediated SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes at 5 uM after 24 hrs by ELISA2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID564894Antibacterial activity against wild-type Escherichia coli AG100 harboring marR mutant gene at 37 degC by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
AID1067612Antiprion activity at scrapie prion protein in human brain at 1 mM after 1 hr by Western blotting analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
A new face for old antibiotics: tetracyclines in treatment of amyloidoses.
AID525041Antimicrobial activity against fluoroquinolone-resistant Escherichia coli NorE5 harboring GyrA S83L mutant, ParC S80R mutant, truncated SoxR and constitutively active SoxS by Etest2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
AID565071Antibacterial activity against CTX-M-15 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID396496Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(A), tet(B), tet(D) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID565317Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1347489Antibacterial activity against Serratia marcescens assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID404901Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB41 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID325482Antibacterial activity against Escherichia coli W4573 assessed as inhibition of AcrAB efflux pump after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID565325Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID425404Antibacterial activity against Escherichia coli isolate HM95 isolated from ileal mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID1061192Antimicrobial activity against Staphylococcus aureus MTCC 96 at 50 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID447077Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID569300Antibacterial activity against Proteus vulgaris at 25 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID369229Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
AID283658Antimicrobial activity against Haemophilus influenzae NB65044 by broth microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
AID683715Antimalarial activity against Plasmodium vivax assessed as effect on cure rate after 28 days2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Targeting the liver stage of malaria parasites: a yet unmet goal.
AID565066Antibacterial activity against CTX-M-15 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID1688653Antifungal activity against Aspergillus brasiliensis ATCC 16404 assessed as reduction in bacterial growth incubated for 3 days by paper disk diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID1577574Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by microdilution method
AID1698041Antibacterial activity against Salmonella typhi assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID562793Antimicrobial activity against Chlamydia trachomatis L2/oflR-rifR2 harboring ampA and rpoB genes2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID534826Antimicrobial activity against kanamycin-resistant Campylobacter fetus subsp. fetus CA74 harboring deletion in tet(44)::pCA64 resistant gene in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID572150Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID460802Antibacterial activity against Acinetobacter baumannii AB0043 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID524674Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and mtrR mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID560248Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD, tet(L), dfrK and vga(C) gene by CLSI method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID353043Antimicrobial activity against Proteus vulgaris at 100 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1299634Antibiofilm activity against Pseudomonas aeruginosa PAO1 ATCC 47085 after 24 hrs by crystal violet staining-based spectrophotometry2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Antibacterial Diamines Targeting Bacterial Membranes.
AID572790Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID559326Antimicrobial activity against Shigella sonnei assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID494534Antimicrobial activity against Pseudomonas aeruginosa NCIM 5029 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID494534Antimicrobial activity against Pseudomonas aeruginosa NCIM 5029 after 18 hrs by broth microdilution assay2010European journal of medicinal chemistry, May-06Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.
AID667400Antibacterial activity against Bacillus subtilis at 1000 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID311524Oral bioavailability in human2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Hologram QSAR model for the prediction of human oral bioavailability.
AID544023Antimicrobial activity against Psychrobacter ikaite isolate C713 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID556694Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID562782Antimicrobial activity against Chlamydia trachomatis L2/oflR harboring ompA gene2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID522667Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K8091 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID585858Antimicrobial activity against Pseudomonas aeruginosa isolate 9 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID534346Antimicrobial activity against Burkholderia pseudomallei Bp207 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID585847Antimicrobial activity against Pseudomonas aeruginosa isolate 4 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID561099Antibacterial activity against Pasteurella multocida ATCC 43137 by CLSI M31-A3 broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.
AID1672290Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition after 24 hrs by CLSI protocol based broth microdilution assay
AID283552Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with erm(B) mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID522643Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Sterne by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID530235Antimicrobial activity against Mycobacterium bovis BCG ML1034 by microplate Alamar blue assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID278231Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID565633Antimicrobial activity against Streptococcus intermedius NCTC 11324 assessed as growth inhibition at 0.7 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540836Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
AID585421Antimicrobial activity against oqxAB positive Escherichia coli C600 W322-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID554652Antimicrobial activity against Ureaplasma parvum SV1 isolate HPA18 after 48 hrs by modified broth microdilution technique2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
AID250257Susceptibility testing against Pseudomonas aeruginosa PAE_NUH01; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID425589Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease in mouse J774A1 cells assessed as intracellular killing of bacteria at 1.7 ug/ml after 3 h2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID524638Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID554863Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 236 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID554864Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 271 harboring ERY-resistant erm(B) and mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID556669Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 24 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID584820Effect on Pseudomonas putida PAW340 biofilms assessed as heat production at 70 ug/ml by Chip calorimetry2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID671558Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in po dosed CD-1 mouse assessed as increase in survival administered as single dose 1 hr post infection measured after 48 hrs post infection2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID530428Antimicrobial activity against Mycobacterium smegmatis overexpressing rv0194 gene by microplate Alamar blue assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID721791Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 24 hrs by CLSI broth microdilution method2013European journal of medicinal chemistry, Feb, Volume: 60Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
AID307122Inhibition of HIV1 recombinant integrase strand transfer activity2007Bioorganic & medicinal chemistry letters, Apr-15, Volume: 17, Issue:8
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
AID556668Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 23 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID563502Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 71 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID671560Oral bioavailability in rat2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID1250084Antibacterial activity against Klebsiella pneumoniae ATCC 7006032015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID323905Antibacterial activity against Staphylococcus aureus RN4220 with rplC G155R mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID556903Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 15 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1325497Antibacterial activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-1002016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID428292Antimicrobial activity against Acinetobacter baumannii BM4579 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID283168Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5256 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID396033Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID556880Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 20 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565816Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
AID1820909Antibacterial activity against Enterococcus faecium assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID360366Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake2007The Journal of biological chemistry, Jan-26, Volume: 282, Issue:4
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
AID547756Antimicrobial activity against invasive Streptococcus intermedius obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID688533Antibacterial activity against Enterococcus faecalis ATCC 292122012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID522659Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis 003BS by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1756237Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition measured after 16 hrs by serial dilution method2021Journal of natural products, 02-26, Volume: 84, Issue:2
Hydrated Rubrolides from the New Zealand Tunicate
AID377751Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 after 18 hrs by broth dilution assay2006Journal of natural products, Jul, Volume: 69, Issue:7
Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.
AID564814Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID360849Antibacterial activity against Escherichia coli ATCC 25922 at 30 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID565041Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID743656Antibacterial activity against Escherichia coli EB2120 conditional lolA strain with lolA deletion and complementing copy placed at araBAD locus at 1 to 256 ug/mL after 18 hrs in presence of 0.00002 to 0.2% of arabinose2013Bioorganic & medicinal chemistry letters, Apr-15, Volume: 23, Issue:8
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
AID565437Antimicrobial activity against Streptococcus intermedius NCTC 11324 biofilm assessed as biofilm bacterial count at 0.07 ug/ml (Rvb =402.9 +/- 26.88 10'5 CFU/ml)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
AID1325495Antibacterial activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-12016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID323635Antimicrobial activity against group A streptococci assessed as percent resistant isolates by Etest2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance.
AID559329Antimicrobial activity against Salmonella enterica serovar Virchow assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID1159089Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID454155Antimicrobial activity against Escherichia coli MTCC 1650 at 10 ug/ml after 24 hrs by agar diffusion method2009Bioorganic & medicinal chemistry, Dec-15, Volume: 17, Issue:24
Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.
AID501864Antifungal activity against Acremonium chrysogenum isolates after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID646213Antibacterial activity against Escherichia coli ATCC 107 259222012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID1338321Antibacterial activity against Proteus vulgaris PCM 2668 after 20 hrs by microbroth dilution method2016European journal of medicinal chemistry, Nov-29, Volume: 124New family of antimicrobial agents derived from 1,4-naphthoquinone.
AID1821098Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hr by CLSI based broth microdilution method
AID559601Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of ciprofloxacin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID575166Inhibition of acrAB AcrAB-TolC in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as [3H]TMG accumulation at 800 uM by scintillation counter method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID425612Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID587843AUC in Sprague-Dawley rat at 1 mg/kg, iv and 10 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID572803Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID585855Antimicrobial activity against Pseudomonas aeruginosa isolate 8 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1131171Antibacterial activity against Pasteurella multocida MB7 assessed as growth inhibition at 2 to 8 ug/mL1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID545042Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ043 from patient abdominal drainage by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1551807Antibacterial activity against Bacillus subtilis incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID406147Antimicrobial activity against Bacillus megaterium by agar diffusion method2008Journal of natural products, Jun, Volume: 71, Issue:6
Bioactive isocoumarins isolated from the endophytic fungus Microdochium bolleyi.
AID1278314Antibacterial activity against acrAB and acrEF knock-out Escherichia coli BL21 by microbroth dilution assay2016European journal of medicinal chemistry, Mar-03, Volume: 110Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
AID558076Cytotoxicity against normal human epidermal keratinocytes at 10 uM after 72 hrs by MTT assay2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
AID559602Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of ciprofloxacin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID532021Antimicrobial activity against Mycobacterium ulcerans ATCC 19423 harboring pTY60H containing pCK0601 carrying the luxAB gene under the hsp60 promoter after 14 days determined according to CFU counts by bioluminescence method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
AID721789Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 assessed as growth inhibition after 24 hrs by CLSI broth microdilution method2013European journal of medicinal chemistry, Feb, Volume: 60Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
AID667267Antibacterial activity against Pseudomonas aeruginosa at 500 ug/ml after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.
AID543364Antimicrobial activity against tetracycline-susceptible Salmonella sp. Isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID625506Antimicrobial activity against Bacillus thuringiensis after 24 hrs by spectrophotometry2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Green synthesis and antimicrobial evaluation of some new trifluoromethyl-substituted hexahydropyrimidines by grinding.
AID1592957Antibacterial activity against multi-drug resistant Escherichia coli NMI 3548/14 assessed as reduction in microbial growth incubated for 20 hrs2019European journal of medicinal chemistry, Apr-15, Volume: 168Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
AID1698048Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for overnight by CLSI based method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID569298Antibacterial activity against Proteus mirabilis at 75 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID285851Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes E-115 transconjugated with erm(B) and tet(M) genes2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID545048Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ210 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID629284Antibacterial activity against Photobacterium leiognathi Sh1 assessed as inhibition of bacterial luminescence at 0.1 mg/mL after 10 mins by bioluminometry-based acute action test2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
AID283171Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID510559Antibacterial activity against Escherichia coli AG102MB2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID250258Susceptibility testing against Pseudomonas aeruginosa PAE_NUH02; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID524673Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ mutant gene assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID501863Antifungal activity against Aspergillus restrictus isolates after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID1304852Ratio of MIC for methicillin-resistant Staphylococcus aureus clinical isolate 2 in absence and presence of Fe2+2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID1225258Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
A potent antimicrobial compound isolated from Clathria cervicornis.
AID1681015Antibacterial activity against Pseudomonas aeruginosa assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID569299Antibacterial activity against Proteus mirabilis at 100 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID395375Antibacterial activity against Micrococcus luteus La 2971 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID563500Antimicrobial activity against Serratia marcescens ATCC 13880 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID529902Antimicrobial activity against Leptospira interrogans serovar Pomona isolate 12 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID323019Antibacterial activity against drug-resistant Propionibacterium acnes SW101T after 72 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID548473Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID1592960Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 3081/09 assessed as reduction in microbial growth incubated for 20 hrs2019European journal of medicinal chemistry, Apr-15, Volume: 168Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
AID585845Antimicrobial activity against Pseudomonas aeruginosa isolate 3 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID556653Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 8 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID325008Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 426 isolate with erm(B) resistance gene from patient sinuitis by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID377750Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 hrs by broth dilution assay2006Journal of natural products, Jul, Volume: 69, Issue:7
Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.
AID1347488Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID594272Antimicrobial activity against Bacillus subtilis NCIM 2063/ATCC 6633 at 50 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID1329751Antibacterial activity against Salmonella typhimurium ATCC 13311 after 24 hrs by broth microdilution method
AID572596Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID584830Antibacterial activity against Pseudomonas aeruginosa2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID1592958Antibacterial activity against multi-drug resistant Escherichia coli NMI 3898/15 assessed as reduction in microbial growth incubated for 20 hrs2019European journal of medicinal chemistry, Apr-15, Volume: 168Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
AID693554Antibacterial activity against Salmonella typhimurium after 48 hrs by well diffusion assay2012European journal of medicinal chemistry, Dec, Volume: 58Facile water promoted synthesis of 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids - highly potent antibacterial agents.
AID283560Antibacterial activity against Escherichia coli HNCE4 after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID285844Antimicrobial activity against tetracycline-susceptible Streptococcus pyogenes cMLS isolate F2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.
AID554878Antimicrobial activity against Streptococcus pneumoniae serotype 10 ST 461 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID565070Antibacterial activity against CTX-M-14 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID420023Antibacterial activity against Pseudomonas aeruginosa at 20 mg/mL by agar diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID556867Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 7 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID649514Antimicrobial activity against Staphylococcus aureus ATCC 29523 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Efficient synthesis and biological evaluation of proximicins A, B and C.
AID1514479Antibacterial activity against Staphylococcus aureus after 24 hrs2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Isolation and structure determination of a new lasso peptide specialicin based on genome mining.
AID556906Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1254823Antibacterial activity against Staphylococcus aureus ATCC 25923 after 12 hrs by agar diffusion method2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.
AID532018Antibacterial activity against macrolide-lincosamide-streptogramin B-negative, beta-lactamase-positive, methicillin-susceptible Staphylococcus aureus ATCC 292132010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
AID428139Antimicrobial activity against wild-type Streptococcus pneumoniae PC13 by agar dilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
AID562789Antimicrobial activity against Chlamydia trachomatis L2/tetR13 harboring tet(C) allele2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID467964Antimicrobial activity against Escherichia coli ATCC 11775 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID533663Antimicrobial activity against Staphylococcus aureus RN10242008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID547534Antimicrobial activity against invasive Streptococcus anginosus obtained from non-cystic fibrosis patient assessed as non-susceptible isolates grown on mueller-Hinton blood agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method in presence of 52010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID353047Antimicrobial activity against Proteus mirabilis at 100 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID572804Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID425398Antibacterial activity against Escherichia coli isolate HM154 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID425602Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate LF82 in mouse J774A1 cells isolated from chronic ileal lesions of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax after2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID587245Antimicrobial activity against Escherichia coli DSM 682 after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID1348083Antimicrobial activity against Candida parapsilosis ATCC 90018 assessed as zone of inhibition at 50 ug per disc after 48 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID501848Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID293956Reduction of IL1-beta plus AMPA-induced proteoglycan degradation in rabbit articular cartilage at 200 uM relative to control2007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID1061188Antimicrobial activity against Escherichia coli MTCC 724 at 100 ug/ml after 24 hrs by disc diffusion method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.
AID325010Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 443 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID275054Antibacterial activity against Escherichia coli W31102006Journal of medicinal chemistry, Dec-14, Volume: 49, Issue:25
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
AID295096Antibacterial activity against Escherichia coli ATCC 11230 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID353052Antimicrobial activity against Salmonella typhi at 25 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID1231528Antibacterial activity against Erwinia carotovora CECT 225 assessed as inhibition of microbial growth incubated for 18 hrs by 2-fold microtiter broth dilution method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antibacterial activities of cadiolides A, B and C and analogues.
AID574545Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus USA3002010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
AID87952Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 802002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
AID501861Antifungal activity against Candida albicans ATCC 10231 after 48 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID556659Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 14 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1678759Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID534828Antimicrobial activity against kanamycin-resistant Campylobacter fetus subsp. fetus CA76 harboring deletion in ant(6)-Ib::pCA76 in presence of 5% lacked horse blood2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.
AID1131160Antibacterial activity against Pseudomonas aeruginosa MB418 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID278665Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57372007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1376893Antimicrobial activity against Bacillus cereus DSM 4313 assessed as growth inhibition at 7 ug per disc after 24 to 48 hrs (Rvb = 0 millimeter)
AID405427Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
AID522876Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in human 5637 cells assessed as decrease in intracellular bacterial level at 250 to 300 ug/ml after 12 hrs by serial dilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID375433Displacement of [3H]PSB0413 from human platelet P2Y12 receptor2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
AID1056845Antibacterial activity against TEM-1/SHV-12 expressing Enterobacter cloacae isolate 306 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1335591Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 25923 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID495518Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4676 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID522664Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA1024 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID278266Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID520398Antibacterial activity against mef-positive Streptococcus pneumoniae isolates assessed as resistance incidence by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID559343Antimicrobial activity against Shigella sonnei harboring tetA gene assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID299671Antibacterial activity against Staphylococcus aureus by disk diffusion method2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
AID644017Antimicrobial activity against Bacillus subtilis at 100 ug/ml by agar diffusion assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID585432Antimicrobial activity against oqxAB positive Escherichia coli DH5[alpha] harboring pMD18-T::oqxAB by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID311292Antibacterial activity against Proteus mirabilis at pH 72007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles.
AID1412151Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID1055419Antibacterial activity against multidrug and vancomycin-resistant Enterococcus faecalis UW 2689 assessed as growth inhibition by broth microdilution method2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
AID1131165Antibacterial activity against Salmonella schottmuelleri MB2837 assessed as growth inhibition1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.
AID372899Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID428427Antibacterial activity against Proteus vulgaris after 24 hrs by well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis of novel carbazole based macrocyclic amides as potential antimicrobial agents.
AID528915Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID323010Antibacterial activity against drug-resistant Propionibacterium acnes GE4E after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID295114Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID522662Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K7038 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1888848Antibacterial activity against Staphylococcus aureus K1758 measured after 24 hrs by Muller Hinton broth based MTT assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID587831Antibacterial activity against tetracycline-resistant Staphylococcus aureus isolate 161 harboring tet(M) gene by CLSI M07-A8 method2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID342683Antimicrobial activity against CTX-M extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.
AID1681020Antibacterial activity against Salmonella typhi ATCC 9207 by CLSI method2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID569311Antibacterial activity against Staphylococcus aureus at 100 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID1112107Antimicrobial activity against Bacillus megaterium by agar diffusion test2012Fitoterapia, Apr, Volume: 83, Issue:3
Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.
AID322998Antibacterial activity against drug-resistant Propionibacterium acnes SW11 after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID609166Antibacterial activity against Streptococcus entericus assessed as zone of inhibition at 5 uL and 32 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID556877Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 17 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1525332Antibacterial activity against Escherichia coli 121 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID278864Increase in lactate production in primary human osteoblasts at 190 ug/ml by ELISA2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID278243Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1681012Antibacterial activity against Enterobacter aerogenes assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID688530Antibacterial activity against Staphylococcus aureus ATCC 292132012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID1159082Antimicrobial activity against Salmonella typhimurium ATCC 14028 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID283163Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2639 biofilms after 24 hrs assessed as bacterial regrowth2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID495517Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4675 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID1142218Antimicrobial activity against Helicobacter pylori isolated from gastrointestinal disease patient after 72 hrs by Etest method2014Bioorganic & medicinal chemistry letters, Jun-01, Volume: 24, Issue:11
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
AID545046Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ085 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID460629Antifungal activity against Trichoderma viride MTCC 167 at 100 ug/ml after 48 hrs agar diffusion method2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
AID1496309Antibacterial activity against vancomycin-resistant Enterococcus faecalis 342B after 24 hrs2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
AID561736Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as susceptible isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID1442622Antibacterial activity against gram-negative Klebsiella pneumoniae KP153 harboring tet(A) by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID278245Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID559598Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of tobramycin by Etest2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
AID568333Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa by broth dilution assay2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
AID569304Antibacterial activity against Salmonella typhi at 25 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID557394Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent resistant isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID563513Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 011 harboring plasmid STV28 expressing sdeB gene by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID572815Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID524885Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing rpsJ and penB mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID585872Antimicrobial activity against Pseudomonas aeruginosa isolate 16 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1820908Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID322999Antibacterial activity against drug-resistant Propionibacterium acnes EG3NS after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID498788Antimicrobial activity against macrolide-resistant Streptococcus pyogenes emm77/ST399/T28 expressing tetM gene by agar dilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
AID535638Antimicrobial activity against Group B streptococcus serotype VI R2 harboring F395L, V405A, R433H, H438Y, and G648A mutations in PBP 2X and T567I mutation in PBP 2B by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1412148Antibacterial activity against methicillin-resistant Staphylococcus aureus 15 after 24 hrs by microbroth dilution method2018MedChemComm, Jan-01, Volume: 9, Issue:1
Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.
AID556651Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 6 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1636356Drug activation in human Hep3B cells assessed as human CYP2C9-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NA2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
AID565065Antibacterial activity against CTX-M-14 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID250266Susceptibility testing against Pseudomonas aeruginosa PAE_NUH19; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID420021Antibacterial activity against Streptococcus faecalis at 20 mg/mL by agar diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
AID1058231Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
AID542389Antimicrobial activity against Staphylococcus aureus RN4220 transformed with Staphylococcus aureus ST9 plasmid pSCFS3 carrying cfr and fexA genes2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.
AID533661Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid CU12008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID395370Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID358252Antibacterial activity against Cryptococcus neoformans ATCC 90113 after 48 hrs by microplate assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.
AID489645Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 24 hrs by broth microdilution technique2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.
AID554874Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2678 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID290123Inhibition of protein synthesis in Escherichia coli by coupled transcription-translation assay2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Synthesis and SAR of 3,5-diamino-piperidine derivatives: novel antibacterial translation inhibitors as aminoglycoside mimetics.
AID739303Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 assessed as growth inhibition by CLSI broth microdilution method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
AID315457Toxicity in human erythrocytes assessed as hemolysis upto 3.91 ug/mL2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
AID540929Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor KO-347 harboring rpsl P91S mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID609170Antifungal activity against Hyphopichia burtonii assessed as zone of inhibition at 5 uL and 28 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID1127621Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae D39 NCTC 7466 expressing GyrA S81F/ParC S79F double mutant assessed as growth inhibition after 18 to 24 hrs by CLSI broth microdilution method2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
AID1228683Antibacterial activity against tet(M) tetracycline-resistant Enterococcus faecalis 327 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID1681016Antibacterial activity against Shigella boydii assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID323032Antibacterial activity against methicillin-resistant Staphylococcus aureus after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID324198Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 12.5 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID522665Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis BA0018 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID388081Antifungal activity at Candida albicans2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID542385Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 expressing cfr, fexA, erm(A), tet(M) and mecA genes2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.
AID547523Antimicrobial activity against Streptococcus constellatus obtained from patient with cystic fibrosis assessed as non-susceptible isolates grown on brain heart infusion agar at 30 ug/ml after 24 hrs at 37 degC by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
AID1240027Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as concentration required to completely destroy test microorganisms after 24 hrs2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
AID278684Antibacterial activity against Enterococcus faecalis isolate 57462007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID323030Antibacterial activity against Staphylococcus epidermidis after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID374169Antibacterial activity against Streptococcus mutans ATCC 33402 biofilms assessed as log reduction of viable bacteria at 500 ug/ml2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens.
AID308343Antibacterial activity against Pseudomonas aeruginosa MTCCB 7412007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID594335Antimicrobial activity against Escherichia coli NCIM 2068/ATCC 11105 at 50 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID532031Antimicrobial activity against Escherichia coli TOP10F' by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID388001Antibacterial activity against Bacillus cereus ATCC 11778 after 24 hrs by microdilution broth method2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Structure-activity relationship of antibacterial chalcones.
AID601195Elimination half life in Sprague-Dawley rat at 1 mg/kg, iv administered as single dose2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
AID781325pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 20092014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID556680Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 7 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID293952Inhibition of human MMP22007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID447074Antibacterial activity against Bacillus cereus ATCC 7064 at 30 ug after 24 hrs by agar disk diffusion assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1228684Antibacterial activity against tet(M) tetracycline-resistant Enterococcus faecium 404 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID556893Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 5 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID396029Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID409958Inhibition of bovine brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID530582Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae isolate 11 with A2604G mutation by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID556688Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 15 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID565324Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID721790Antibacterial activity against vancomycin-sensitive Enterococcus faecalis ATCC 19433 assessed as growth inhibition after 24 hrs by CLSI broth microdilution method2013European journal of medicinal chemistry, Feb, Volume: 60Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
AID1678767Antibacterial activity against Enterococcus faecalis ATCC 51299 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID572807Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1159092Antimicrobial activity against Bacillus thuringiensis assessed as zone of inhibition at 30 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID324195Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 50 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID1149689Antimicrobial activity against Agrobacterium tumefaciens assessed as growth inhibition after 24 hrs by two-fold serial dilution technique1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Synthesis of 5-chloro-3'-nitro-4'-substituted salicylanilides, a new series of anthelmintic and antimicrobial agents.
AID283551Antimicrobial activity against Streptococcus pneumoniae PC13 transformants2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID1335602Antibacterial activity against multi-drug resistant Pseudomonas aeruginosa MFBF after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1698040Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID522648Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis Africa 33 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID545054Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ390 from patient secretion by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID544280Antimicrobial activity against Enterococcus faecalis NKH10 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID539665Antimicrobial activity against Staphylococcus aureus by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID588114Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent susceptible isolates after 24 hrs by agar dilution method2011Antimicrobial agents and chemotherapy, Feb, Volume: 55, Issue:2
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
AID1525328Antibacterial activity against methicillin-resistant Staphylococcus aureus 757 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID565327Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID428294Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by E test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID278236Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID1124944Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 16 to 20 hrs by microbroth dilution method2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
AID1678764Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID530579Antimicrobial activity against Mycoplasma pneumoniae isolate M129 by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID534164Antimicrobial activity against Campylobacter coli by disk diffusion method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.
AID572797Antimicrobial activity against marR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID369658Antibacterial activity against Campylobacter jejuni 25-45 by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
AID765062Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
AID529553Antimicrobial activity against Bacillus anthracis MurA1 AS clone 2G2 assessed as growth inhibition in absence of xylose by antisense-induced hypersensitive testing2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
AID585428Antimicrobial activity against oqxAB positive Escherichia coli C600 SW8-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID680947TP_TRANSPORTER: inhibition of PGF2alpha uptake (PGF2alpha: 0.005 uM, Tetracycline: 5 uM) in OAT2-expressing S2 cells2002Japanese journal of pharmacology, Jan, Volume: 88, Issue:1
Human organic anion transporters mediate the transport of tetracycline.
AID353055Antimicrobial activity against Salmonella typhi at 100 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID1577572Antibacterial activity against Pseudomonas viridiflava assessed as inhibition of bacterial growth after 24 hrs by microdilution method
AID562785Antimicrobial activity against Chlamydia muridarum MoPn/oflR harboring ompA gene2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
AID565316Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
AID563505Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 01 harboring plasmid STV29 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID325015Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 811 isolate with erm(B) resistance gene from patient blood by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID543343Antimicrobial activity against Vibrio cholerae non-O1 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID548739Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID428293Antimicrobial activity against Acinetobacter baumannii BM4651 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
AID1731001Antibacterial activity against Escherichia coli DH5-alpha assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Mar-05, Volume: 213Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
AID522650Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K7978 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID396267Antibacterial activity against tetracycline-resistant Escherichia coli clinical isolates expressing tet(C) gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
AID561656Induction of morphological changes in Helicobacter pylori by phase contrast microscopy2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID342019Antibacterial activity against plasmid pK29 transconjugant Escherichia coli J53 by Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
AID694392Bactericidal activity against Staphylococcus aureus CECT 86 at 0.2 mg/disk after 24 hrs by agar diffusion assay2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.
AID548254Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID395373Antibacterial activity against Mycobacterium smegmatis CCM 2067 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID348888Antibacterial activity against Streptococcus mutans PTCC 1601 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID694207Antibacterial activity against vancomycin-sensitive Enterococcus faecalis ATCC 19433 by CLSI broth microdilution method2012Bioorganic & medicinal chemistry letters, Nov-15, Volume: 22, Issue:22
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
AID1681017Antibacterial activity against Salmonella enterica subsp. enterica serovar Abony assessed as diameter of inhibition zone at 1 mg/ml incubated for 24 hrs by agar well diffusion assay2020Bioorganic & medicinal chemistry letters, 10-01, Volume: 30, Issue:19
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID323035Antibacterial activity against Streptococcus equi subsp. zooepidemicus after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1347490Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID565014Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID544004Antimicrobial activity against Aerococcus viridans isolate PGS22 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID524677Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing tetM mutant gene in combination with variants of other gene loci assessed as percentage intermediate isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID405929Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 15 containing mecA gene2008Journal of natural products, Jun, Volume: 71, Issue:6
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
AID425401Antibacterial activity against Escherichia coli isolate HM615 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID585850Antimicrobial activity against Pseudomonas aeruginosa isolate 5 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID531103Inhibition of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa TNP090 mutant harboring las and rhl gene at 0.125 ug/ml by Cat-2,3-diO reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID678714Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID561734Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as resistant isolates by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
AID585844Antimicrobial activity against Pseudomonas aeruginosa isolate 2 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID460801Antibacterial activity against Acinetobacter baumannii 3304 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID388082Antifungal activity at Cryptococcus neoformans2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID544279Antimicrobial activity against Enterococcus faecalis NKH9 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID594327Antimicrobial activity against Staphylococcus aureus NCIM 2079/ATCC 6538P at 50 ug/mL after 24 hrs by disc diffusion method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
AID660264Ratio of MIC for wild type Escherichia coli HS414 to MIC for acrB-deficient Escherichia coli HS832 by agar dilution method2012European journal of medicinal chemistry, Jun, Volume: 52Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
AID544025Antimicrobial activity against Acinetobacter calcoaceticus isolate C36 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID718414Antibacterial activity against log-phase vancomycin-sensitive Enterococcus faecalis ATCC 19433 assessed as growth inhibition after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
AID1585460Antibacterial activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-1 measured after 16 hrs2019European journal of medicinal chemistry, Jan-15, Volume: 162Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.
AID556664Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 19 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1228694Antibacterial activity against Burkholderia cenocepacia 240 assessed as bacterial growth inhibition by susceptibility testing assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
AID609169Antifungal activity against Aspergillus niger assessed as zone of inhibition at 5 uL and 28 degC after 36 hrs by disk diffusion method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.
AID285196Antimicrobial activity against Escherichia coli M074 mutant with AG100 lon2::IS186 acrR::IS genotype2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID423154Antibacterial activity against Bifidobacterium thermophilum B0253 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID495510Antibacterial activity against Acinetobacter baumannii BM4454 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID378120Antimicrobial activity against Bacillus subtilis at 30 ug/disk by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID1442624Antibacterial activity against gram-negative Proteus mirabilis PM122 by CLSI method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
AID1688645Antibacterial activity against Salmonella typhi ATCC 6539 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID250269Susceptibility testing against Pseudomonas aeruginosa PAE_NUH22; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID554675Antimicrobial activity against Streptococcus pneumoniae serotype 19F ST 156 by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID586085Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID307415Antibacterial activity against Escherichia coli ATCC 256682007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.
AID584827Antibacterial activity against Escherichia coli2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.
AID1304853Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 incubated for 16 hrs by broth microdilution method2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID554861Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2916 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID572812Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1688643Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID1392010Antistaphylococcal activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-1 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1149694Antimicrobial activity against Salmonella typhi assessed as growth inhibition at 0.78 ug/ml after 24 hrs by two-fold serial dilution technique1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Synthesis of 5-chloro-3'-nitro-4'-substituted salicylanilides, a new series of anthelmintic and antimicrobial agents.
AID283656Increase in ROS levels in Escherichia coli K12 MG1655 assessed as ratio of ROS with antibiotic to ROS without antibiotic2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID404900Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB40 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
AID278230Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID572793Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID444056Fraction escaping gut-wall elimination in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID323912Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and H134N mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID539669Antimicrobial activity against Shigella sp. by well diffusion method2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.
AID444050Fraction unbound in human plasma2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID423152Antibacterial activity against Bifidobacterium thermophilum B0241 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
AID565231Antimicrobial activity against Mycobacterium chelonae 9917 harboring pZS01 carrying mspA gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID556905Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID556695Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID534407Antibacterial activity against Escherichia coli EPI300 expressing tet(W) gene assessed as inhibition of bacterial growth at 80 ug/ml after 18 hrs in presence of 2.5 ug/ml efflux pump inhibitor CCCP2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID311293Antibacterial activity against Pseudomonas aeruginosa at pH 72007Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles.
AID528786Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae assessed as resistant isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID532990Antibacterial activity against Klebsiella pneumoniae NCIM 2883 assessed as growth inhibition in presence of 10 mM N-Acetylcysteine2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
AID565063Antibacterial activity against CTX-M-15 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID559330Antimicrobial activity against Salmonella enterica clinical isolates assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.
AID563506Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 71 harboring plasmid STV29 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID1726825Antibacterial activity against Pseudomonas aeruginosa MTCC 2488 incubated for 14 to 16 hrs by micro broth dilution method2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID1159085Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as zone of inhibition at 30 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID322996Antibacterial activity against drug-resistant Propionibacterium acnes EG13NS after 48 hrs by broth microdilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID341108Antibacterial activity against Escherichia coli 26R793 by Etest2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
AID556894Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 6 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID531337Antibacterial activity against MeXAB-OprM deficient Pseudomonas aeruginosa TNP077 selected after 1.0 ug/ml of azithromycin by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
AID1514480Antibacterial activity against Pseudomonas aeruginosa after 24 hrs2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Isolation and structure determination of a new lasso peptide specialicin based on genome mining.
AID532765Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID560249Antibacterial activity against Staphylococcus aureus RN4220 harboring tet(L), dfrK gene by CLSI method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID360381Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake2007The Journal of biological chemistry, Jan-26, Volume: 282, Issue:4
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
AID508596Antibacterial activity against ciprofloxacin-resistant Salmonella enteritidis 5408 harboring gyrA D87Y mutant, gyrB E466D mutant, parE V461G mutant and ramR G25A mutant gene after 200 passages by CLSI method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
AID557795Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID572796Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID367433Binding affinity to bone mineral hydroxyapatite assessed as binding index2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent.
AID585857Antimicrobial activity against Pseudomonas aeruginosa isolate 9 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID501847Antibacterial activity against Escherichia coli food isolate after 24 hrs by broth microdilution method2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).
AID524872Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing penA mutant gene assessed as incidence of resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID564819Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1551777Antibacterial activity against Escherichia coli assessed as zone of inhibition2019European journal of medicinal chemistry, Jul-01, Volume: 173Antibacterial activity study of 1,2,4-triazole derivatives.
AID495748Antimicrobial activity against Escherichia coli ATCC 25922 by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
AID569296Antibacterial activity against Proteus mirabilis at 25 ug/ml after 24 hrs agar diffusion method2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
AID717273Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 8325-4 by CLSI protocol based broth microdilution method2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.
AID285205Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 250 generations in 5 ug/ml presence of tetracycline2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
AID1392009Antistaphylococcal activity against Staphylococcus aureus Newman after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID323911Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G155R mutation2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
AID335300Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum D6
AID353045Antimicrobial activity against Proteus mirabilis at 50 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID561641Antibacterial activity against Staphylococcus aureus by CLSI M100-S13 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).
AID325024Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 1051 isolate with erm(B) resistance gene from patient ear by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID372896Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID278680Antibacterial activity against Enterococcus faecium isolate 57512007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID484674Antibacterial activity against Proteus mirabilis2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis of novel beta-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens.
AID556881Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 21 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID295102Antibacterial activity against Klebsiella pneumoniae UC57 at 30 ug after 24 hrs by disk diffusion method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID429853Antibacterial activity against Staphylococcus aureus XU-212 overexpressing TetK, mecA after 24 hrs2009Journal of natural products, Jun, Volume: 72, Issue:6
Antibacterial diterpenes from Plectranthus ernstii.
AID425620Cmax in patient with Billroth-II gastrectomy at 250 mg, po2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID572808Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID443283Antimicrobial activity against Bacillus subtilis after 24 hrs by agar dilution technique2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Anti-oxidant and anti-bacterial activities of novel N'-arylmethylidene-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl) acetohydrazides.
AID444055Fraction absorbed in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID509630Antimicrobial activity against Staphylococcus aureus RN4220 by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID91481Binding constant against human serum albumin (HSA)2001Journal of medicinal chemistry, Dec-06, Volume: 44, Issue:25
Cheminformatic models to predict binding affinities to human serum albumin.
AID510748Antibacterial activity against Escherichia coli AG102MB harboring naive acrB gene2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
AID568330Antimicrobial activity against multidrug-resistant Escherichia coli by broth dilution assay2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
AID554858Antimicrobial activity against Streptococcus pneumoniae serotype 14 ST 2306 harboring ERY-resistant erm(B) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID56763Inhibition zone when tested against DAP-AT from Escherichia coli in M9-Minimal agar at concentration 3 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID749306Bactericidal activity against Escherichia coli CECT 100 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID1428344Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.
AID524640Antimicrobial activity against Neisseria gonorrhoeae obtained from patient with uncomplicated gonorrhea expressing mtrR mutant gene assessed as incidence of susceptible isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
AID1525334Antibacterial activity against Haemophilus influenzae 1244 after 20 hrs by CLSI-based microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID543345Antimicrobial activity against Aeromonas caviae assessed as percent tetracyclin-resistant isolate at 0.25 to >16 ug/ml by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID671556Antibacterial activity against Staphylococcus aureus ATCC 13709 infected in CD-1 mouse assessed as increase in survival at 3 mg/kg, iv administered as single dose 1 hr post infection measured after 48 hrs post infection2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID260689Antibacterial activity against Xanthomonas oryzae by disk diffusion method at 10 ug/disk2006Bioorganic & medicinal chemistry letters, Feb-15, Volume: 16, Issue:4
Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies.
AID544017Antimicrobial activity against Enterococcus sulfureus isolate PGS61 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID1781497Anti-MDR bacterial activity against Escherichia coli CCARM 1009 assessed as inhibition of bacterial growth incubated for 18 hrs by microplate reader analysis
AID585853Antimicrobial activity against Pseudomonas aeruginosa isolate 7 obtained from cystic fibrosis patients after 16 to 20 hrs by broth microdilution method in presence of 120 uM carbonyl cyanide m-chlorophenyl-hydrazone2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID557209Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent susceptible isolates by Etest method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
AID1634995Antimicrobial activity against Pseudomonas aeruginosa clinical isolates assessed as reduction in bacterial growth after 20 hrs by drop diffusion test2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.
AID530349Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID283553Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
AID278677Antibacterial activity against Enterococcus faecium isolate 25472007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID335299Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2
AID1726820Antibacterial activity against Staphylococcus aureus MTCC 96 incubated for 14 to 16 hrs by micro broth dilution method2021RSC medicinal chemistry, Jun-23, Volume: 12, Issue:6
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.
AID325027Antimicrobial activity against telithromycin-resistant Streptococcus pneumoniae 837 isolate with mutation in erm(B), mef(E), L4 Ser20Asn mutant gene from patient sputum by disk diffusion test2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Molecular epidemiology of telithromycin-resistant pneumococci in Finland.
AID749308Bactericidal activity against Escherichia coli CECT 405 at 0.2 mg/disk after 24 hrs by paper disk-agar diffusion method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Novel isoquinoline derivatives as antimicrobial agents.
AID529457Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone B expressing beta-lactamase Oxa-48, TEM-1, CTX-M-15 and Oxa-1 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
AID1335590Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by serial microdilution broth assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
AID1250085Antibacterial activity against Escherichia coli ATCC 259222015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID293958Inhibition of IL-1-beta-induced MMP13 production in human SW1353 cells at 50 uM2007Bioorganic & medicinal chemistry, Mar-15, Volume: 15, Issue:6
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
AID543348Antimicrobial activity against Aeromonas caviae by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
AID278263Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
AID541855Antimicrobial activity against Escherichia coli ATCC 29522 by microdilution assay2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
AID287371Antibacterial activity against Escherichia coli after 72 hrs by disk diffusion method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID587838Inhibition of protein synthesis in Escherichia coli S30 extract by coupled transcription/translation assay2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
AID544288Antimicrobial activity against Enterococcus faecalis NKH18 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1593386Growth inhibition of Escherichia coli AB11572019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
AID530584Antimicrobial activity against Mycoplasma pneumoniae isolate 18 by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.
AID323025MBC/MIC ratio of Propionibacterium acnes GE4E2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID572805Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
AID1238340Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by agar diffusion method2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Antibacterial activity of diketopiperazines isolated from a marine fungus using t-butoxycarbonyl group as a simple tool for purification.
AID556683Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 10 by broth dilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID283175Stimulation of Staphylococcus lugdunensis IDRL5256 biofilm formation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
AID1347486Antibacterial activity against Streptococcus pyogenes assessed as zone of inhibition after 24 to 48 hrs by well diffusion method2018European journal of medicinal chemistry, Jan-01, Volume: 143Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
AID646214Antibacterial activity against tetracycline-resistant Escherichia coli 1552012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID520397Antibacterial activity against erm(B) and mef(E)-positive Streptococcus pneumoniae isolate Spain 6B by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).
AID1329754Antibacterial activity against Streptococcus mitis NCIMB 13770 after 24 hrs by broth microdilution method
AID548738Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID523004Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as degradation of preexisting biofilm after 24 hrs by microscopy2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID324192Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 50 ug/ml after 48 hrs by disc diffusion method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
AID353054Antimicrobial activity against Salmonella typhi at 75 ug/ml after 24 hrs by agar diffusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.
AID554868Antimicrobial activity against Streptococcus pneumoniae serotype 23F ST 81 harboring ERY-resistant mef(E) gene by agar plate dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
AID1311818Antibacterial activity against Burkholderia pseudomallei AHS 1 NCTC 8016 by two fold serial dilution method2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.
AID688534Antibacterial activity against Streptococcus pyogenes UWL2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID1348090Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 50 ug per disc after 24 hrs by disc diffusion assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
AID522661Antibacterial activity against beta-lactamase Bla1 and Bla2-producing Bacillus anthracis K1938 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
AID1250086Antibacterial activity against Pseudomonas aeruginosa PAO12015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID369228Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
AID646219Antibacterial activity against tetracycline-resistant Klebsiella pneumoniae 1532012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
AID542386Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ST9 expressing cfr, fexA and erm(C) genes2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.
AID565031Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID535633Antimicrobial activity against Group B streptococcus serotype Ia R7 harboring T77I, F395V and S353F in PBP 2X; V80A and G613R in PBP 2B; and L45P, N163K, N723S and Y470F in PBP 1A by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1688646Antifungal activity against Candida albicans ATCC 10231 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method2020European journal of medicinal chemistry, Feb-15, Volume: 188One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
AID1698038Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
AID562811Antimicrobial activity against Escherichia coli J53 harboring pEK204 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID530236Resistance factor, ratio of MIC for Mycobacterium bovis BCG ML1034 to MIC for wild-type Mycobacterium bovis BCG2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
AID535646Antimicrobial activity against Group B Streptococcus serotype III NEM 316 by broth microdilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
AID1820918Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique2022European journal of medicinal chemistry, Feb-05, Volume: 229An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
AID536632Antimicrobial activity against Staphylococcus aureus NCTC 7447 at 5 mg/ml after 24 hrs by agar well diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.
AID544020Antimicrobial activity against Psychrobacter ikaite isolate C20 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.
AID565191Antimicrobial activity against Acinetobacter baumannii ATCC 19606 expressing open reading frame orf3 encoded efflux pump CraA by Etest2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
AID1243993Antimicrobial activity against Staphylococcus aureus by agar dilution method2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID323016Antibacterial activity against drug-resistant Propionibacterium acnes EG7NS after 72 hrs2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
AID1636376Drug activation in human Hep3B cells assessed as human CYP3A4-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 56.4 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of N2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
AID1672289Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition after 24 hrs by CLSI protocol based broth microdilution assay
AID56759Inhibition zone when tested against DAP-AT from Escherichia coli in L-agar at concentration 3 ug1998Bioorganic & medicinal chemistry letters, Apr-21, Volume: 8, Issue:8
Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.
AID671555Antibacterial activity against Klebsiella pneumoniae ATCC 138832012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
AID325484Antibacterial activity against Escherichia coli N818 delta acrA mutant assessed as inhibition of AcrAB efflux pump after 14 to 16 hrs by broth dilution method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Polyamine effects on antibiotic susceptibility in bacteria.
AID395371Antibacterial activity against Proteus vulgaris ATCC 8427 at 30 ug after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID467969Antimicrobial activity against Bacillus cereus ATCC 14579 after 18 to 24 hrs by liquid broth method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.
AID530345Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347158ZIKV-mCherry secondary qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1347164384 well plate NINDS Rhodamine confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347163384 well plate NINDS AMC confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20,075)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011665 (58.11)18.7374
1990's1990 (9.91)18.2507
2000's2477 (12.34)29.6817
2010's2581 (12.86)24.3611
2020's1362 (6.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 97.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index97.52 (24.57)
Research Supply Index10.02 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index200.41 (26.88)
Search Engine Supply Index2.16 (0.95)

This Compound (97.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials977 (4.54%)5.53%
Reviews983 (4.57%)6.00%
Case Studies1,144 (5.31%)4.05%
Observational12 (0.06%)0.25%
Other18,408 (85.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (105)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Helicobacter Pylori Eradication Using a Bismuth Quadruple Therapy Among Asymptomatically Infected Adults in El Paso, Texas: A Pilot Study. [NCT01335334]Phase 450 participants (Anticipated)Interventional2011-03-31Recruiting
Twice-a-day PPI, Tetracycline, Metronidazolequadruple Therapy With Pylera® or Lactobacillus Reuteri for Treatment naïve or for Retreatment of H. Pylori: Two Randomized Pilot Studies [NCT03925818]99 participants (Actual)Interventional2017-08-29Terminated(stopped due to Lactobacillus reuteri (Gastrus®) was not anymore available in the region)
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [NCT04678492]Phase 4658 participants (Actual)Interventional2020-12-20Completed
Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans [NCT04716426]100 participants (Actual)Interventional2021-01-28Completed
Effect of Topical Tetracycline and Dexamethasone on Periodontal and Pulpal Regeneration of Replanted Avulsed Permanent Teeth: A Long-term Follow-up After 9-16 Years [NCT03611920]33 participants (Actual)Observational2000-08-14Completed
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [NCT03609892]Phase 4658 participants (Actual)Interventional2018-08-01Completed
Antibiotic Susceptibility-based Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy: a Prospective Clinical Trial [NCT03708848]Phase 4112 participants (Actual)Interventional2018-12-05Completed
Comparison of the Efficacy of 14-day Sequential Therapy and 10-day Bismuth Quadruple Therapy in the Second Line Therapy for Helicobacter Pylori Infection: A Multi-center Randomized Trial [NCT03208426]Phase 4240 participants (Anticipated)Interventional2017-10-01Recruiting
Assessment of Tetracycline Pleurodesis in Prevention of Primary Spontaneous Pneumothorax Recurrence in Patients With Normal CT-scan [NCT03634605]50 participants (Actual)Interventional2015-05-05Completed
Effects of Antimicrobials on the Altered Skin Flora in Patients With Palmar Arsenical Keratosis [NCT03632733]Phase 230 participants (Anticipated)Interventional2018-01-21Recruiting
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection-A Randomized Clinical Trial [NCT03658746]Phase 4420 participants (Actual)Interventional2019-01-01Completed
Innovative Technology for Assessing the Periodontal Disease and New Periodontitis Treatment Based on Hyaluronic Acid and Melatonin [NCT03656484]Phase 250 participants (Actual)Interventional2019-01-15Completed
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies. [NCT05431075]Phase 4407 participants (Anticipated)Interventional2022-07-31Not yet recruiting
Visiting Staff, Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan [NCT04853875]Phase 4104 participants (Actual)Interventional2021-04-19Completed
[NCT02057926]Phase 210 participants (Actual)Interventional2009-11-30Completed
Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial [NCT03555526]Phase 4320 participants (Anticipated)Interventional2017-12-15Recruiting
Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics [NCT02099240]Early Phase 111 participants (Actual)Interventional2014-03-06Terminated(stopped due to Not enough patient enrollment and lack of staffing)
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies. [NCT05432115]Phase 4407 participants (Anticipated)Interventional2022-06-25Recruiting
A Prospective, Single-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare the 14-day Bismuth Quadruple Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter as a Rescue 2nd Therapy. [NCT02359331]370 participants (Actual)Interventional2014-08-31Terminated
10-Day Antimicrobial Susceptibility Testing Guided Triple Therapy Versus 14-Day Empirical Tailored Therapy for the First-line Treatment of Helicobacter Pylori Infection-A Randomized Controlled Trail [NCT03571230]Phase 4400 participants (Anticipated)Interventional2018-07-01Not yet recruiting
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized Non-Inferiority Trial of Minocycline or Tetracycline in Bismuth Quadruple Therapy [NCT04531059]Phase 4368 participants (Actual)Interventional2020-10-15Completed
Immunomodulatory and Clinical Effects of Doxycycline on Persistent Symptoms After Treatment of Neuroborreliosis: A Double-blind, Randomised, Crossover Study [NCT01205464]15 participants (Actual)Interventional2005-02-28Completed
Prospective, Randomized Controlled Trial Comparing High Dose Amoxicillin Versus Tetracycline Based Quadruple Therapy as Second-line Treatment for Resistant Helicobacter Pylori Infection [NCT02175927]Phase 4312 participants (Actual)Interventional2014-07-31Completed
Comparison Between Tailored Therapy Guided by a Non-invasive Antibiotic Susceptibility Test and Empiric Treatment for First-line Helicobacter Pylori Eradication in Patients With Dyspepsia: a Randomized Controlled Trial. [NCT04107194]Phase 3362 participants (Anticipated)Interventional2020-01-14Recruiting
Conditioning of Root Surfaces With Citric Acid and Tetracycline for Different Application Times Improves the Outcomes of Root Coverage by Subepithelial Connective Tissue Graft: a Randomized Clinical Trial. [NCT02259543]36 participants (Actual)Interventional2011-08-31Completed
Efficacy and Safety of a 14-day Modified Sequential Therapy for Refractory Helicobacter Pylori Infection: an Open Randomized Pilot Study [NCT03658733]Phase 4120 participants (Anticipated)Interventional2018-12-15Not yet recruiting
Efficacy and Safety of a 14-day Modified Sequential Therapy for Refractory Helicobacter Pylori Infection: a Pilot Study [NCT03616405]Phase 460 participants (Anticipated)Interventional2019-04-01Not yet recruiting
Efficacies of Tetracycline-levofloxacin Quadruple Therapy, Standard Bismuth Quadruple Therapy and Amoxicillin-levofloxacin Quadruple Therapy in the Second-line Treatment of H Pylori Infection [NCT05850117]240 participants (Anticipated)Interventional2020-02-10Recruiting
A Tetracycline Drain Reduces Alveolar Osteitis in Third Molar Surgery [NCT03494972]200 participants (Actual)Interventional2016-01-02Completed
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori: A Pilot Study [NCT04991584]60 participants (Anticipated)Interventional2021-08-04Not yet recruiting
Rifabutin-containing Triple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled Trial [NCT05874544]Phase 4357 participants (Anticipated)Interventional2023-05-16Recruiting
A Phase 3b, Comparative and Randomized Study to Assess the Efficacy and Safety of an Intravaginal Ovule Combination of Ketoconazole and Clindamycin Compared With an Intravaginal Cream Combination of Tetracycline and Amphotericin B for the Treatment of Bac [NCT01293643]Phase 399 participants (Actual)Interventional2010-05-31Completed
Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given X 10 Days With Omeprazole in Eradication of Helicobacter Pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given X 7 Days [NCT00669955]Phase 3440 participants (Actual)Interventional2008-06-30Completed
Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication [NCT02547038]352 participants (Actual)Interventional2015-02-28Completed
Cognitive Effects of Minocycline in Humans [NCT02193269]Phase 110 participants (Actual)Interventional2013-07-08Completed
Efficacy of High-dose Dual Therapy Versus Bismuth-containing Quadruple Therapy for First-line Treatment of Helicobacter Pylori Infection - A Prospective, Randomized, Comparative Study [NCT02483715]Phase 4589 participants (Actual)Interventional2015-07-31Completed
Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992 [NCT01880515]Phase 2107 participants (Actual)Interventional2010-12-31Completed
Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori : A Multicenter Randomized Non-Inferiority Trial [NCT05997433]254 participants (Anticipated)Interventional2023-09-02Recruiting
Evaluation of Root Coverage by Subepithelial Connective Graft Associated to Root Conditioning by Citric Acid Plus Tetracycline and Antimicrobial Photodynamic Therapy: A Randomized Clinical Trial [NCT03095378]14 participants (Actual)Interventional2014-03-10Completed
A Clinico-pathological Phase II Study With Translational Elements to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae With Particular Reference to Chlamydia Species and the Effects of MALT Lymphoma Treatment With Tet [NCT01010295]Phase 254 participants (Actual)Interventional2006-09-30Completed
T4 - Tetracycline Treatment Tolerability Trial A Pilot Study Examining the Feasibility and Tolerability of Tetracycline Therapy in Post-Treatment Lyme Disease (PTLD) [NCT05219929]Phase 260 participants (Anticipated)Interventional2022-11-02Enrolling by invitation
Control of Periodontal Infections [NCT01098448]Phase 3187 participants (Actual)Interventional1999-09-30Completed
Construction and Application of the Treatment of Refractory Helicobacter Pylori Infection Based on the High-throughput Sequencing Technologies [NCT02741414]4,428 participants (Anticipated)Interventional2016-06-30Recruiting
Trial of Antibiotics to Reduce Recurrent Trichiasis (STAR) [NCT00347776]Phase 41,452 participants (Actual)Interventional2001-08-31Completed
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori: A Pilot Study [NCT03726099]Phase 460 participants (Anticipated)Interventional2019-03-15Recruiting
An Open-Label, Randomized, Crossover Study to Evaluate the Pharmacokinetic Interaction After Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers [NCT04066257]Phase 132 participants (Actual)Interventional2019-01-17Completed
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection - A Prospective Randomized, Comparative Study [NCT05332444]Phase 4450 participants (Anticipated)Interventional2022-04-11Recruiting
Comparison of the Effectiveness of Povidone-Iodine Alone to Povidone-Iodine-Tetracycline Combination for Chemical Pleurodesis in Malignant Pleural Effusion [NCT04039126]Phase 162 participants (Anticipated)Interventional2019-06-20Recruiting
Long-Term Bone Quality in Women With Breast Cancer (A Companion Study to S0307) [NCT00873808]0 participants (Actual)Observational2008-10-31Withdrawn(stopped due to lack of accrual)
A Topical Antiseptic Bundle for Decreasing Surgical Site Infection in Head and Neck Cancer Patients: Perioperative Effects on the Oral Microbiome [NCT04721626]25 participants (Actual)Observational2021-01-06Completed
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies. [NCT05802888]Phase 4260 participants (Anticipated)Interventional2023-03-12Recruiting
Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication. [NCT00841854]Phase 4199 participants (Actual)Interventional2008-06-30Completed
Phase III, Open Label, Randomized, Multicenter Study to Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, Compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vagin [NCT00889356]Phase 3160 participants (Anticipated)Interventional2009-09-30Not yet recruiting
The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure [NCT05173493]670 participants (Actual)Observational2021-12-30Completed
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [NCT06168084]Phase 4688 participants (Anticipated)Interventional2023-06-06Recruiting
Director of Research Division [NCT01863823]Phase 1/Phase 2350 participants (Actual)Interventional2011-08-31Completed
Bone Disease in Severely Burned Children [NCT00591162]Phase 2/Phase 3254 participants (Actual)Interventional1992-10-31Terminated(stopped due to terminated due to PI lab/duties affected by natural disaster.)
Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori: A Pilot Study [NCT05126121]60 participants (Anticipated)Interventional2021-11-20Not yet recruiting
MMP-9 Inhibition for Recalcitrant Wet Age-Related Macular Degeneration (AMD) [NCT04504123]Phase 250 participants (Anticipated)Interventional2020-11-04Recruiting
Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa [NCT00336154]Phase 40 participants (Actual)InterventionalWithdrawn
[NCT01481844]Phase 3101 participants (Actual)Interventional2011-11-30Completed
Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital [NCT05061732]Phase 44,447 participants (Anticipated)Interventional2021-09-30Recruiting
Rifabutin-containing Triple Therapy for Rescue Treatment of Helicobacter Pylori: A Randomized Clinical Trial [NCT04879992]413 participants (Actual)Interventional2021-05-07Completed
CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA [NCT00002682]Phase 25 participants (Actual)Interventional1995-08-10Completed
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II [NCT02754583]Phase 3340,000 participants (Anticipated)Interventional2015-12-05Recruiting
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Multicenter Randomized Clinical Trial of 10 and 14 Days [NCT05049902]Phase 41,300 participants (Actual)Interventional2021-09-21Completed
An Exploratory, Placebo-Controlled Trial of Prophylactic Tetracycline for Gefitinib-or Cetuximab-Induced Skin Rash (or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash) [NCT00091247]130 participants (Actual)Interventional2004-12-31Completed
The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment [NCT01318356]Phase 4156 participants (Actual)Interventional2011-04-30Completed
Doxycycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled Trial [NCT05874570]Phase 4368 participants (Anticipated)Interventional2023-06-20Recruiting
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement [NCT02576652]Phase 46 participants (Actual)Interventional2015-12-22Completed
Predictive Factors Affecting the Efficacy of Local Tetracycline Injection for Treatment of Post-mastectomy Seroma. [NCT04730674]18 participants (Actual)Interventional2020-01-01Completed
[NCT01792700]Phase 4648 participants (Actual)Interventional2003-01-31Completed
Clinical Implication of Next Generation Sequencing of Urinary Bacteria in Patients With Low Colony Forming Units of Bacteria in Traditional Urine Culture [NCT05206500]Phase 4100 participants (Anticipated)Interventional2022-05-17Recruiting
A Prospective, Multi-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare 10-day Sequential Therapy and 14-day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea [NCT02159976]390 participants (Actual)Interventional2014-07-31Completed
Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial [NCT02541864]330 participants (Actual)Interventional2013-07-31Completed
Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial [NCT02547012]51 participants (Actual)Interventional2013-11-30Completed
Efficacies of Hybrid, High-dose Dual and Bismuth Quadruple Therapies for the First-line Anti-H Pylori Treatment and Tetracycline-levofloxacin Quadruple Therapy for the Second-line Anti-H Pylori Treatment - a Multicentre Randomized Trial [NCT03779074]Phase 3918 participants (Actual)Interventional2018-09-03Completed
Clinical Efficacy and Health Economic Evaluation of Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment:Multicenter Randomized Controlled Study [NCT05250050]Phase 4388 participants (Anticipated)Interventional2022-03-25Recruiting
Helicobacter Pylori Treatment [NCT01668927]Phase 4424 participants (Actual)Interventional2012-07-31Completed
The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure [NCT04810793]820 participants (Actual)Observational [Patient Registry]2020-07-01Completed
[NCT01742429]Phase 4200 participants (Actual)Interventional2012-11-30Completed
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication: A Single-center, Randomised, Controlled Trial. [NCT06168214]Phase 41,404 participants (Anticipated)Interventional2023-09-04Recruiting
Ten Days Quadruple Versus Sequential Therapy as Empirical First and Second Line Treatment for Helicobacter Pylori Eradication: a Randomized Crossover Trial [NCT01760824]391 participants (Actual)Interventional2011-05-31Completed
Intralesional Tetracycline Injection in the Treatment of Chalazia [NCT01763437]Early Phase 10 participants (Actual)Interventional2014-03-31Withdrawn(stopped due to Investigator left the institution)
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy [NCT01463384]Phase 213 participants (Actual)Interventional2011-09-30Completed
Efficacy of Two Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment [NCT02988089]Phase 4480 participants (Anticipated)Interventional2017-04-20Recruiting
A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment [NCT02978157]102 participants (Actual)Interventional2015-02-28Completed
A Clinical Study on the Treatment of Paronychia Caused by Afatinib With Zanthoxylum Nitidum Tincture [NCT03908892]110 participants (Anticipated)Interventional2019-06-12Recruiting
The Effect of Different Time Intervals on Rescue Treatment of Helicobacter Pylori Infection: a Prospective, Multicenter Observational Study [NCT05620589]626 participants (Anticipated)Observational2022-11-11Not yet recruiting
A Phase II Clinical Trial of Anti-Helicobacter Pylori Treatment in Endoscopically Diagnosed Low-Grade Localized Gastric Lymphoma [NCT00003151]Phase 296 participants (Anticipated)Interventional1997-09-30Completed
A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease [NCT00355459]0 participants (Actual)Interventional2005-08-31Withdrawn(stopped due to The PI has elected to terminate study at this time)
Efficacy and Safety of Helicobacter Pylori Eradication Dual or Triple Regimes Using Vonoprazan as the Antacid [NCT05345210]Phase 4500 participants (Anticipated)Interventional2022-04-25Recruiting
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment [NCT00361257]Phase 2107 participants (Actual)Interventional2007-03-31Terminated(stopped due to This study was terminated early due to futility.)
Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection - a Multi-center Randomized Controlled Trial [NCT03779087]112 participants (Actual)Interventional2018-07-11Completed
Personalized Treatment for Refractory H Pylori Infection [NCT02547025]126 participants (Actual)Interventional2012-08-01Completed
Efficacy of High-dose Dual Therapy Versus Bismuth-containing Quadruple Therapy for Rescue Treatment of Helicobacter Pylori Infection - A Prospective, Randomized, Comparative Study [NCT02490839]Phase 4450 participants (Actual)Interventional2015-07-31Completed
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment [NCT03139253]Phase 4120 participants (Anticipated)Interventional2017-05-30Not yet recruiting
Antibiotic Profile of Pathogenic Bacteria Isolated From Postsurgical Site Infections in Public Hospitals in Northern Jordan [NCT05106803]24 participants (Actual)Observational2019-08-01Completed
The Efficacy of Minocycline in the Treatment of Angelman Syndrome [NCT01531582]25 participants (Actual)Interventional2012-04-30Completed
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis [NCT01753856]Phase 469 participants (Actual)Interventional2013-01-31Completed
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Multicenter Randomized Clinical Trial of 10 and 14 Days [NCT04901117]Phase 41,300 participants (Anticipated)Interventional2021-06-30Not yet recruiting
Bismuth Quadruple Therapy With Tetracycline Versus Doxycycline as Rescue Therapy for Helicobacter Pylori Infection: a Randomized Controlled Trial [NCT05018923]Phase 4242 participants (Anticipated)Interventional2021-08-24Recruiting
Helicobacter Pylori and Body Iron in Adults [NCT03146325]Phase 40 participants (Actual)Interventional2012-11-30Withdrawn(stopped due to Study was not funded and PI has left the institution)
The Studies of Integrating Gastric and Gut Microbiota, F. Prausnitzii Metabolites, Microenvironment, and Epigenetics to Identify the Cancer Risk of H. Pylori-related Precancerous Conditions Through an AI System and Control the Risky by Probiotic Supplemen [NCT04527055]Phase 4312 participants (Anticipated)Interventional2020-05-06Enrolling by invitation
The Effects of Minocycline on Opioid-induced Hyperalgesia in Opioid-Maintained Patients [NCT02359006]27 participants (Actual)Interventional2015-03-12Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00347776 (4) [back to overview]Recurrent Trichiasis in Tetracycline and Azithromycin Groups
NCT00347776 (4) [back to overview]Recurrent Trichiasis Between Two Azithromycin Arms
NCT00347776 (4) [back to overview]Surgical Failure
NCT00347776 (4) [back to overview]Adverse Events
NCT00361257 (24) [back to overview]Changes in Medication Management Test (Modified)
NCT00361257 (24) [back to overview]Changes in Cluster of Differentiation 8 (CD8) Cell Counts (24 Weeks)
NCT00361257 (24) [back to overview]Changes in Cluster of Differentiation 4 (CD4) Cell Counts (24 Weeks)
NCT00361257 (24) [back to overview]Changes in Alternate Verbal Memory Z-Score
NCT00361257 (24) [back to overview]Change in Investigator's Clinical Global Impression Score (ICGIS)
NCT00361257 (24) [back to overview]Changes in Markers of Oxidative Stress and Immune Activation (Unit=pg/mL Only)
NCT00361257 (24) [back to overview]Changes in Instrumental Activities of Daily Living Questionnaire
NCT00361257 (24) [back to overview]Change of HIV Plasma RiboNucleic Acid (RNA) Viral Load
NCT00361257 (24) [back to overview]Change in Fine Motor Function Domain Z-Score
NCT00361257 (24) [back to overview]Change in Cognitive Performance Compared to Baseline
NCT00361257 (24) [back to overview]Change in Cognitive Gross Motor Function Domain Z-Score
NCT00361257 (24) [back to overview]Changes in Alternate Psychomotor Function Z-Score
NCT00361257 (24) [back to overview]Change in Karnofsky Performance Score
NCT00361257 (24) [back to overview]Changes in Alternate Frontal Systems Z-Score
NCT00361257 (24) [back to overview]Change in Verbal Memory Domain Z-Score
NCT00361257 (24) [back to overview]Change in Psychomotor Function Domain Z-Score
NCT00361257 (24) [back to overview]Change in Information Processing Function Domain Z-Score
NCT00361257 (24) [back to overview]Change in Global Deficit Z-Score (GDS)
NCT00361257 (24) [back to overview]Change in Frontal Systems Function Domain Z-Score
NCT00361257 (24) [back to overview]Change in Fine Motor/Nonverbal Function Domain Z-Score
NCT00361257 (24) [back to overview]Number of Participants With Grade 2 or Higher Toxicity and/or Signs and Symptoms
NCT00361257 (24) [back to overview]Changes in Protein Markers of Oxidative Stress (Unit = Counts Per Second Only)
NCT00361257 (24) [back to overview]Changes in Neurotransmitter Levels (Unit = uM Only)
NCT00361257 (24) [back to overview]Changes in Markers of Oxidative Stress (Unit = Pixels/mm2 Only)
NCT00669955 (7) [back to overview]Metronidazole Resistance
NCT00669955 (7) [back to overview]Clarithromycin Resistance
NCT00669955 (7) [back to overview]H. Pylori Eradication and Presence or Past History of Peptic Ulcers
NCT00669955 (7) [back to overview]Helicobacter Pylori Eradication Confirmed by Urea Breath Test
NCT00669955 (7) [back to overview]Number of Patients Experiencing Treatment Emergent Adverse Events.
NCT00669955 (7) [back to overview]Number of Patients With Bismuth Plasma Concentrations Above the Toxic Level
NCT00669955 (7) [back to overview]Overall Compliance to Study Medications
NCT01318356 (3) [back to overview]Symptom Checklist 90 (SCL90)
NCT01318356 (3) [back to overview]Sickness Impact Profile (SIP) Total Score
NCT01318356 (3) [back to overview]Checklist Individual Strength (CIS)
NCT01463384 (3) [back to overview]Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
NCT01463384 (3) [back to overview]Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).
NCT01463384 (3) [back to overview]Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC)
NCT01531582 (5) [back to overview]Bayley Scales of Infant and Toddler Development, 2nd Edition (BSID-II) Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up
NCT01531582 (5) [back to overview]Clinical Global Impressions Severity Scale Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up
NCT01531582 (5) [back to overview]Normalization of the EEG (Electroencephalogram) Signature
NCT01531582 (5) [back to overview]Preschool Language Scale, Fourth Edition (PLS-4)Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up
NCT01531582 (5) [back to overview]Vineland Adaptive Behavior Scale, 4th Edition (Vineland-II)Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up
NCT01753856 (23) [back to overview]Percentage of Osteoid Volume (OV)/Bone Volume (BV) in the CC of the Iliac Crest
NCT01753856 (23) [back to overview]Percentage of Single or Double Tetracycline Labels Per Bone Surface (sLS/BS or dLS/BS) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Wall Thickness (W.Th) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Change From Baseline to 3 Months in Mineralizing Surface (MS) /Bone Surface (BS) in the Cancellous Compartment (CC) of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Activation Frequency (Ac.f) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Adjusted Apposition Rate (Aj.AR) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Average Length of DLs in the CC, EC, IC and PC of the Iliac Crest
NCT01753856 (23) [back to overview]Change From Baseline to 3 Months in Bone Formation Rate/Bone Surface (BFR/BS ) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Change From Baseline to 3 Months in Label Length Within Each Basic Multicellular Unit (BMU) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Change From Baseline to 3 Months in Mineral Apposition Rate (MAR) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Change From Baseline to 3 Months in MS/BS in the Endocortical Compartment (EC), Intracortical Compartment (IC), and Periosteal Compartment (PC) of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]MS/BS in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies 3 Months Post First Dose of Study Drug
NCT01753856 (23) [back to overview]Number of Samples With Single or Double Tetracycline Labels, SL and DL, or No Tetracycline Labels in the CC, Endocortical Compartment (EC), Intracortical Compartment (IC) and Periosteal Compartment (PC) of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Osteoid Thickness (O.Th) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Percentage Change From Baseline to 1, 3, and 6 Months in Intact Parathyroid Hormone (PTH)
NCT01753856 (23) [back to overview]Percentage Change From Baseline to 1, 3, and 6 Months in Serum Carboxyterminal Cross-Linking Telopeptide of Type I Collagen (CTX)
NCT01753856 (23) [back to overview]Percentage Change From Baseline to 1, 3, and 6 Months in Serum Osteocalcin
NCT01753856 (23) [back to overview]Percentage Change From Baseline to 1, 3, and 6 Months in Serum Procollagen Type I N-terminal Propeptide (P1NP)
NCT01753856 (23) [back to overview]Percentage of Bone With Remodeling-Based and Modeling-Based Formations in the CC, EC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Percentage of Eroded Surface/Bone Surface (ES/BS) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Percentage of Mineralizing Surface With Remodeling-Based Formation and Modeling-Based Formation in the CC, EC and PC of the Iliac Crest Bone Biopsies
NCT01753856 (23) [back to overview]Percentage of Osteoid Surface (OS)/Bone Surface (BS) in the CC, EC and IC of the Iliac Crest
NCT01753856 (23) [back to overview]Percentage of Overfilled Remodeling Sites in the CC, EC and PC of the Iliac Crest Bone Biopsies
NCT01880515 (2) [back to overview]Frequency of Participants Who Experienced Any Grade of Rash As Characterized By The Common Toxicity Criteria for Adverse Effects (CTCAE) V4.0
NCT01880515 (2) [back to overview]Progression Free Survival
NCT02159976 (4) [back to overview]Counts of Participants With Successful H. Pylori Eradication
NCT02159976 (4) [back to overview]Functional Dyspepsia Symptom Responses Rate
NCT02159976 (4) [back to overview]Counts of Participants Whose Drug Compliance is More Than 85%
NCT02159976 (4) [back to overview]Counts of Participants With Adverse Event
NCT02359006 (18) [back to overview]Ecological Momentary Assessments (EMA) - Craving
NCT02359006 (18) [back to overview]Ecological Momentary Assessments (EMA) - Pain
NCT02359006 (18) [back to overview]Ecological Momentary Assessments (EMA): SOWS
NCT02359006 (18) [back to overview]Brief Pain Inventory - Short Form: Interference
NCT02359006 (18) [back to overview]Brief Pain Inventory - Short Form: Pain Severity
NCT02359006 (18) [back to overview]Digit Symbol Substitution Test
NCT02359006 (18) [back to overview]Interleukin-1 Beta (IL-1β)
NCT02359006 (18) [back to overview]Interleukin-6 (IL-6)
NCT02359006 (18) [back to overview]Opioid Withdrawal Symptom Checklist (OWSC): Back Pain Item
NCT02359006 (18) [back to overview]Pain Threshold
NCT02359006 (18) [back to overview]Pain Tolerance
NCT02359006 (18) [back to overview]Profile of Mood States (POMS) - Total Mood Disturbance
NCT02359006 (18) [back to overview]Profile of Mood States (POMS) Depression Subscale
NCT02359006 (18) [back to overview]Short-Form McGill Pain Questionnaire (SF-MPQ): Affective Subscale
NCT02359006 (18) [back to overview]Short-Form McGill Pain Questionnaire (SF-MPQ): Sensory Subscale
NCT02359006 (18) [back to overview]Sustained Attention to Response Test (SART): Go Trials: Errors of Omission
NCT02359006 (18) [back to overview]Sustained Attention to Response Test (SART): No-go Trials: Errors of Commission
NCT02359006 (18) [back to overview]Tumor Necrosis Factor Alpha (TNF-α)
NCT02541864 (1) [back to overview]Number of Participants in Which H. Pylori Was Eradicated
NCT02547012 (1) [back to overview]Number of Participants in Which H. Pylori Was Eradicated
NCT02547038 (1) [back to overview]Number of Participants in Which H. Pylori Was Eradicated
NCT02576652 (4) [back to overview]Remodeling-based Formation Units Including Overfilled Units in the Femoral Neck
NCT02576652 (4) [back to overview]Overfilled Remodeling-based Formation Units in the Femoral Neck
NCT02576652 (4) [back to overview]Modeling Based Formation Units in the Femoral Neck
NCT02576652 (4) [back to overview]Percentage of Participants With Modeling Based Bone Formation in the Femoral Neck
NCT02978157 (1) [back to overview]Number of Participants in Which H. Pylori Was Eradicated
NCT04716426 (5) [back to overview]Other Virus or Bacteria Contamination Rate.
NCT04716426 (5) [back to overview]Number of Participants With Adverse Events
NCT04716426 (5) [back to overview]Days Over Which an Adverse Event Was Reported
NCT04716426 (5) [back to overview]COVID-19 Contamination Rate.
NCT04716426 (5) [back to overview]Average Number of Adverse Events

Recurrent Trichiasis in Tetracycline and Azithromycin Groups

Recurrence of trichiasis : Clinical assessment was done by looking for one or more eye lashes touching globe or evidence of epilation. (NCT00347776)
Timeframe: Primary outcome assessed at 2 weeks,1.5 months, 6 months and 12 months post-surgery

InterventionParticipants (Count of Participants)
Control45
Intervention62

[back to top]

Recurrent Trichiasis Between Two Azithromycin Arms

"Recurrence of trichiasis :Clinical assessment for recurrence was done by looking for one or more eye lashes touching globe or evidence of epilation.~If there was evidence of epilation or if one or more eye lashes were touching the globe, it was considered as recurrence of trichiasis." (NCT00347776)
Timeframe: Primary outcome assessed at 2 weeks,1.5 months, 6 months and 12 months post-surgery

InterventionParticipants (Count of Participants)
Intervention126
Intervention236

[back to top]

Surgical Failure

The surgery was considered a failure if one or more eye lashes were touching the globe of the eye of the subject. (NCT00347776)
Timeframe: 6 weeks

InterventionParticipants (Count of Participants)
Control12
Intervention20

[back to top]

Adverse Events

At 6 weeks participants/family members were asked about any hospitalization,death,ocular complaints, gastrointestinal illness or other specific illness or any clinic visit within six weeks of receiving surgery. (NCT00347776)
Timeframe: 6 weeks

,
InterventionParticipants (Count of Participants)
Gastrointestinal complaints/other specific illnessOcular complaints
Control67
Intervention226

[back to top]

Changes in Medication Management Test (Modified)

The medication management test (modified) is designed to assess participants' medication management ability and their own medications and management. It's the number of how many times participants correctly answered 16 questions. The score ranges between 0 and 16, and higher score indicates better medication management. (NCT00361257)
Timeframe: At baseline and weeks 24

Interventionscores on a scale (Mean)
Minocycline0.16
Matching Placebo0.48

[back to top]

Changes in Cluster of Differentiation 8 (CD8) Cell Counts (24 Weeks)

The outcome was the 24 week change of CD8 cell counts (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventioncells/mm^3 (Mean)
Minocycline43.90
Matching Placebo0.00

[back to top]

Changes in Cluster of Differentiation 4 (CD4) Cell Counts (24 Weeks)

The outcome was the 24 week change in CD4 cell count (week 24-baseline). (NCT00361257)
Timeframe: At baseline and weeks 24

Interventioncells/mm^3 (Mean)
Minocycline24.10
Matching Placebo8.24

[back to top]

Changes in Alternate Verbal Memory Z-Score

The alternate verbal memory was defined as a mean of age and education adjusted z score of trials 1 to 3 and delayed recall tests. The outcome is the 24 week change in alternate verbal memory z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.18
Matching Placebo0.02

[back to top]

Change in Investigator's Clinical Global Impression Score (ICGIS)

"Clinicians were asked to rate their overall impression about the clinical improvement or worsening of his/her study participants. They can choose from the following 7 levels: (0) No Change, (1) Mild Improvement, (2) Moderate Improvement, (3) Marked Improvement, (4) Mild Worsening, (5) Moderate Worsening, and (6) Marked Worsening.~For the analysis, we simplified the outcome into the following 3 levels: (0) worsened, (1) No Change, and (2) Improved." (NCT00361257)
Timeframe: At week 24

,
Interventionparticipants (Number)
WorsenedNo ChangeImproved
Matching Placebo23112
Minocycline4289

[back to top]

Changes in Markers of Oxidative Stress and Immune Activation (Unit=pg/mL Only)

Protein markers of oxidative stress (Protein carbonyls) and markers of immune activation (TNF-a, IL-6,CXCL8, Hepatocyte growth factor, Osteopontin, sFAS, sFAS ligand, and CXCL12). For all markers, the outcome is the 24 week change (week 24-baseline). (NCT00361257)
Timeframe: At pre-entry and Week 24

,
Interventionpg/mL (Median)
Protein carbonyls (pg/ml)TNF-α (pg/mL)IL-6 (pg/mL)CXCL8 (pg/mL)Hepatocyte growth factor (pg/mL)Osteopontin (pg/mL)sFAS (pg/mL)sFAS ligand (pg/mL)CXCL12 (pg/mL)
Arm 1: Minocycline4.00.04-0.290.3416.09-5208.940.68-0.27204.39
Arm 2: Matching Placebo13.20.140.95-6.1390.48673.55134.10.111,071.84

[back to top]

Changes in Instrumental Activities of Daily Living Questionnaire

The Instrumental Activities of Daily Living (IADL) questionnaire is designed to learn more about how subjects are able to perform common tasks. There are 16 common tasks. For each task, if the score at the time of evaluation is worse than the best in the past, an indicator of 1 is given. Otherwise, the indicator is 0. The overall IADL score is a sum of 16 indicators divided by 16; therefore, the range is between 0 and 1 and the lower score is better. The 24-week change of IADL score was changed into a categorical variable (no change/worse vs. better) at week 24 compare to baseline. (NCT00361257)
Timeframe: At baseline and week 24

,
Interventionparticipants (Number)
No Change/WorseBetter
Matching Placebo3211
Minocycline3012

[back to top]

Change of HIV Plasma RiboNucleic Acid (RNA) Viral Load

The original scale of HIV RNA viral load is between 30 copies/mL to infinitive. The minimum score of 30 is the lowest detectable value. The summary table categorized this continuous value to a dichotomous variable (<30 copies/mL and >= 30 copies/mL). (NCT00361257)
Timeframe: At baseline and week 24

,
Interventionparticipants (Number)
>= 30 copies/mL at base, >= 30 at week 24>= 30 copies/mL at base, < 30 at week 24< 30 copies/mL at base, >= 30 at week 24< 30 copies/mL at base, < 30 at week 24
Matching Placebo02019
Minocycline10217

[back to top]

Change in Fine Motor Function Domain Z-Score

The fine motor function domain score is an average of age, sex, education, and African-American ethnicity adjusted z scores of Grooved Pegboard Dominant Hand (GPD) and Grooved Pegboard Non-dominant hand (GPN). The outcome is a 24 week change of the fine motor function domain z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.27
Matching Placebo0.05

[back to top]

Change in Cognitive Performance Compared to Baseline

"Th cognitive performance is measured by NPZ-8. NPZ-8 is defined as the average of age and education adjusted z-scores of eight neuropsychological tests subcomponents in the neuropsychological test battery. These eight tests are:~Grooved Pegboard Dominant Hand (GPD)~Grooved Pegboard Non-dominant hand (GPN)~Choice Reaction Time (CRT)~Sequential Reaction Time (QRT)~Timed Gait (TIG)~Trail Making Part A (TMA)~Trail Making Part B (TMB)~Symbol Digit (SYD) The primary outcome is NPZ-8 score at week24 - NPZ-8 score at baseline." (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.12
Matching Placebo0.17

[back to top]

Change in Cognitive Gross Motor Function Domain Z-Score

The cognitive gross motor function is a age and education adjusted z score of Timed Gait (TIG). The outcome is the 24 week change of cognitive gross motor function domain z-scores (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.22
Matching Placebo0.08

[back to top]

Changes in Alternate Psychomotor Function Z-Score

The alternate psychomotor function is defined as the mean of age, sex, education, and African-American ethnicity adjusted z scores of Trail Making Part A (TMA), and age and education adjusted z score of Symbol Digit (SYD). The outcome is the 24 week change in alternate psychomotor function z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline-0.03
Matching Placebo0.05

[back to top]

Change in Karnofsky Performance Score

"The original Karnofsky performance score is 11 level score which ranges between 0 to 100. The score 100 means normal and 0 means death; therefore, higher score means higher ability to perform daily tasks.~For the analysis, a new dichotomous variable (no change/worse vs. better at 24 weeks compared to baseline) was created." (NCT00361257)
Timeframe: At baseline and week 24

,
Interventionparticipants (Number)
No Change/WorseBetter
Matching Placebo423
Minocycline336

[back to top]

Changes in Alternate Frontal Systems Z-Score

The alternate frontal systems was defined as a mean of age and education adjusted z score of Interference task, and age, sex, education, and African-American ethnicity adjusted z score of Trail Making Part B. The outcome was the 24 week change in alternate frontal systems z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.03
Matching Placebo-0.07

[back to top]

Change in Verbal Memory Domain Z-Score

The verbal memory domain score is the average of age and education adjusted z scores of Hopkins Verbal Learning Test- Revised, Learning and Delayed Recall. The outcome is the 24 week change of verbal memory domain z-scores (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.18
Matching Placebo0.02

[back to top]

Change in Psychomotor Function Domain Z-Score

The psychomotor function domain score us the average of age, sex, education, and African-American ethnicity adjusted z scores of Trail Making Part A (TMA) and Trail Making Part B (TMB). The outcome is the 24 week change of psychomotor function domain z-scores (week24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.07
Matching Placebo0.15

[back to top]

Change in Information Processing Function Domain Z-Score

The information processing function domain score is the average of age and education adjusted z scores of simple and sequential reaction time - CalCAP. The outcome is the 24 week change of information processing function domain z-scores (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.14
Matching Placebo0.20

[back to top]

Change in Global Deficit Z-Score (GDS)

GDS on the test battery is the simple average of all 14 individual deficit scores in the test battery, including Time Gait, Grooved Pegboard Test for the dominant and non-dominant hands, Trail Making Test parts A and B, Symbol Digit Test, simple and sequential reaction time - CalCAP, Hopkins Verbal Learning Test (Revised)- Learning, Delayed Recall and Recognition trials, and Stroop Color Interference Test-color, word, and interference tasks. The outcome is the 24 week change of GDS Z-score (24 week-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline0.11
Matching Placebo0.09

[back to top]

Change in Frontal Systems Function Domain Z-Score

The frontal systems function domain score is the average of age and education adjusted z scores of Stroop Color Interference Test (CTP) and interference task (STP). The outcome is the 24 week change of frontal systems function domain z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline-0.04
Matching Placebo0.21

[back to top]

Change in Fine Motor/Nonverbal Function Domain Z-Score

The fine motor/nonverbal function domain score is a age and education adjusted z score of Symbol Digit Test (SYD) The outcome is the 24 change of fine motor/nonverbal function domain z-score (week 24-baseline). (NCT00361257)
Timeframe: At baseline and week 24

Interventionz-score (Mean)
Minocycline-0.15
Matching Placebo-0.07

[back to top]

Number of Participants With Grade 2 or Higher Toxicity and/or Signs and Symptoms

Grade or higher means that adverse events were moderate, severe, or life-threatening, or death. Grade 2 or higher adverse events are lised in the Adverse Event section. (NCT00361257)
Timeframe: Throughout study up to week 48

,
Interventionparticipants with an event (Number)
0 - 4 weeks4.01 - 12 weeks12.01 - 24 weeks24.01 - 48 weeks
Matching Placebo32312
Minocycline29521

[back to top]

Changes in Protein Markers of Oxidative Stress (Unit = Counts Per Second Only)

Protein marker of oxidative stress (Ceramides, Monohexosylceramides, Dihydro Glycosyl Galceramides, and Dihexosylceramides). For all markers, the outcome is the 24 week change (week 24-baseline). (NCT00361257)
Timeframe: At pre-entry and Week 24

,
Interventioncounts per second (Median)
Ceramides (counts per second)Monohexosylceramides (counts per second)Dihydro Glycosyl Galceramides (counts per second)Dihexosylceramides (counts per second)
Arm 1: Minocycline0.00070.00130.02010.0005
Arm 2: Matching Placebo-0.0051-0.0066-0.0048-0.0043

[back to top]

Changes in Neurotransmitter Levels (Unit = uM Only)

Neurotransmitter levels (Glutamate, Tryptophan, Anthranilic Acid, Quinolinic Acid, Kynurenin, and 3-Hydroxykynurenine). The outcome is the 24 week change (week 24-baseline). (NCT00361257)
Timeframe: At pre-entry and Week 24

,
InterventionuM (Median)
Glutamate (uM)Tryptophan (uM)Anthranilic Acid (uM)Quinolinic Acid (uM)Kynurenin (uM)3-Hydroxykynurenine (uM)
Arm 1: Minocycline5.09-0.210.0-0.556.85-4.09
Arm 2: Matching Placebo-1.080.070.00.06.97-0.83

[back to top]

Changes in Markers of Oxidative Stress (Unit = Pixels/mm2 Only)

Protein marker of oxidative stress (Neurofilament heavy polypeptide). The outcome is the 24 week change (week 24-baseline). (NCT00361257)
Timeframe: At pre-entry and Week 24

InterventionPixels/mm^2 (Median)
Arm 1: Minocycline-59.3
Arm 2: Matching Placebo-3.04

[back to top]

Metronidazole Resistance

Eradication rates in subset of patients infected with a bacterial strain confirmed as resistant to metronidazole at baseline. Resistance to metronidazole defined as Minimum Inhibitory Concentration (MIC) above 8 ug/ml (NCT00669955)
Timeframe: Measured at baseline

Interventionparticipants (Number)
Quadruple Therapy (OBMT) 10 Days38
Triple Therapy (OAC) 7 Days28

[back to top]

Clarithromycin Resistance

Eradication rates in subset of patients infected with a bacterial strain confirmed as resistant to clarithromycin at baseline. Resistance to clarithromycin defined as Minimum Inhibitory Concentration (MIC) of 1 ug/ml and above (NCT00669955)
Timeframe: Measured at baseline

Interventionparticipants (Number)
Quadruple Therapy (OBMT) 10 Days30
Triple Therapy (OAC) 7 Days2

[back to top]

H. Pylori Eradication and Presence or Past History of Peptic Ulcers

Eradication rates in the subset of patients with peptic ulcer (current or past history) at baseline are reported based on the per protocol population. Eradication must be confirmed at week 6 and week 10 by a negative Urea Breath Test conducted within the allocated windows. (NCT00669955)
Timeframe: Week 6 and week 10 follow-up visits

InterventionParticipants (Number)
Quadruple Therapy (OBMT) 10 Days18
Triple Therapy (OAC) 7 Days15

[back to top]

Helicobacter Pylori Eradication Confirmed by Urea Breath Test

H. pylori Eradication defined as a negative C13-UBT (urea breath test) result at both Week 6 and Week 10 follow-up visits. (NCT00669955)
Timeframe: Week 6 and week 10 follow-up visits

InterventionParticipants (Number)
Quadruple Therapy (OBMT) 10 Days166
Triple Therapy (OAC) 7 Days112

[back to top]

Number of Patients Experiencing Treatment Emergent Adverse Events.

"A treatment-emergent adverse event is defined as an event not present prior to exposure to the study medication or any event already present that worsens in either intensity or frequency following exposure to study medication up to 30 days after study discontinuation.~All safety analysis based on the safety population." (NCT00669955)
Timeframe: at the end of treatment (day 8-14), week 6 and wek 10 follow-up visits.

InterventionParticipants (Number)
Quadruple Therapy (OBMT) 10 Days101
Triple Therapy (OAC) 7 Days112

[back to top]

Number of Patients With Bismuth Plasma Concentrations Above the Toxic Level

Tolerability of OBMT with respect to plasma bismuth concentrations: number of patients with bismuth concentrations above the toxic level (50 ug per liter) (NCT00669955)
Timeframe: Baseline (both arms), end of treatment (Day 11-14) and end of study (Day 70) OBMT arm only

Interventionparticipants (Number)
Quadruple Therapy (OBMT) 10 Days0

[back to top]

Overall Compliance to Study Medications

Overall compliance: number of capsules dispensed - number of capsules returned/Number of prescribed capsules X 100. Percentages based on safety population (NCT00669955)
Timeframe: At the end of the treatment phase (days 8-14)

Interventionparticipants (Mean)
Quadruple Therapy (OBMT) 10 Days97.58
Triple Therapy (OAC) 7 Days97.47

[back to top]

Symptom Checklist 90 (SCL90)

The total score of the Symptom Checklist 90 (SCL90) measures the level of psychological distress. The SCL90 consists of 90 items scored on a 5-point scale. Scores range from 90 to 450. A low total score reflects high psychological well-being. The SCL-90 is a reliable and valid instrument. (NCT01318356)
Timeframe: 24 weeks after start of treatment

Interventionscore on a scale (Mean)
Cognitive Behavioral Therapy127.1
Doxycycline149.2
Placebo142.6

[back to top]

Sickness Impact Profile (SIP) Total Score

Level of functional impairment measured with the Sickness Impact Profile (SIP). The SIP is an instrument that is used to gauge sickness-related dysfunction. The weighted total score on eight subscales of the SIP8 (SIP8 total score) will be used to assess functional disability in all domains of functioning (range 0-5799). A higher score indicates higher levels of functional impairment. A score of 450 or higher on the SIP is defined as being significant disabled because of fatigue. (NCT01318356)
Timeframe: 24 weeks after start of treatment

Interventionscore on a scale (Mean)
Cognitive Behavioral Therapy786.8
Doxycycline1101.5
Placebo963.8

[back to top]

Checklist Individual Strength (CIS)

The primary outcome measure is the fatigue severity measured by the subscale fatigue severity (8 items, 7-point Likert Scale) of the Checklist Individual Strength (CIS questionnaire) with a severity range from 8-56. High scores indicate a high level of fatigue. Patients with a cut-off score of ≥35 are classified as severely fatigued. (NCT01318356)
Timeframe: 24 weeks after start of treatment

Interventionscore on a scale (Mean)
Cognitive Behavioral Therapy31.6
Doxycycline40.8
Placebo37.8

[back to top]

Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

"RBANS is a brief neurocognitive battery with four alternate forms, measuring immediate and delayed memory, attention, language, and visuospatial skills. RBANS was developed as a stand-alone core battery for the detection and neurocognitive characterization of dementia and as a brief neurocognitive battery for the detection and tracking of neurocognitive deficits in a variety of disorders. (Reference: http://rbans.com/)~Qualitative Description of Index Scores:~Index Score Classification 130 and above Very Superior 120-129 Superior 110-119 High Average 90-109 Average 80-89 Low Average 70-79 Borderline 69 and below Extremely Low~Psychometric range for RBANS:~AD 0 - 77 MCI 78 - 99 Normal > 100~Range of scores: Minimum = 0, Maximum = 130~Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration." (NCT01463384)
Timeframe: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged)

,,
Interventionunits on a scale (Mean)
Baseline ValuesAveraged Values for Months 1-3Averaged Values for Months 4-6
Minocycline AD4932.532.9
Minocycline MCI8158.763.8
Minocycline NC106108.4123.6

[back to top]

Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).

"Using magnetic resonance images acquired, hippocampal volume was measured monthly for 6 months.~Normal range for hippocampal volume in aged-matched controls is 6.6 - 8.8 cm^3.~Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration." (NCT01463384)
Timeframe: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged)

,,
Interventioncm^3 (Mean)
Baseline ValuesAveraged Values for Months 1-3Averaged Values for Months 4-6
Minocycline AD5.495.424.94
Minocycline MCI6.356.307.60
Minocycline NC6.986.926.82

[back to top]

Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC)

"It has been demonstrated in numerous studies over the past decade that magnetic resonance spectroscopy (MRS) can be used for the diagnosis of Alzheimer's disease. By measuring an area within the posterior cingulate gyrus, one can obtain a biochemical signature of that region in AD whereby NAA is reduced and mI is increased.~These two biomarkers, N-acetylaspartate (NAA, a neuronal marker) and myo-inositol (mI, a glial marker) were quantified and then used to calculate NAA/mI (an index currently widely used for AD and MCI diagnosis).~Scale of MRS biomarkers for aged-matched controls: NAA = 1.43, mI = 0.60, NAA/mI = 2.38. Any value lower than NAA/mI of 2.38 are considered not normal.~Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration." (NCT01463384)
Timeframe: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged)

,,
InterventionRatio (Mean)
Baseline ValuesAveraged Values for Months 1-3Averaged Values for Months 4-6
Minocycline AD1.691.781.84
Minocycline MCI1.871.802.08
Minocycline NC2.422.442.47

[back to top]

Bayley Scales of Infant and Toddler Development, 2nd Edition (BSID-II) Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up

"The primary outcome measure consists of improvement in raw and standard scores on the Bayley Scales of Infant and Toddler Development when post Minocycline administration results are compared to baseline results. This is an individually administered test used to asses developmental functioning. The Bayley scales are typically used for ages 1-42 months, and can be utilized to identify developmental delay by evaluating five major areas of development: cognitive, communication, physical, social/emotional, and adaptive.~The score ranges for each subscale are as follows: Cognitive, 0-91; Communication, 0-75; Receptive Language, 0-49; Expressive Language, 0-48; Gross Motor, 0-72; Fine Motor, 0-66; Self-Care, 0-72; and Self-Direction, 0-75.~Fine and Gross Motor scores were summed for the Motor domain; Receptive and Expressive Language were combined for the Language domain.~Increase in raw score indicates improvement in the specific subdomain for each of the listed scales." (NCT01531582)
Timeframe: Baseline, 8 weeks & 16 weeks

,,
InterventionScores on Scale (Mean)
CognitiveCommunicationReceptive LanguageExpressive LanguageGross MotorFine MotorSelf-CareSelf-Direction
16 Weeks-After 8 Week Washout30.723.513.811.242.822.44039.5
8 Weeks After Treatment With Minocycline31.722.813.711.840.519.840.638.1
Baseline Measures26.418.913.410.141.319.437.83.8

[back to top]

Clinical Global Impressions Severity Scale Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up

The CGI is a brief assessment used by the clinician to describe the participants condition before and after the administration of a study medication.It is a research rating tool that physicians use to provide a timely assessment of a clinician's view of a particular patient's global functioning before and after the usage of a study medication. The CGI is used to measure the change since the initiation of treatment; both measures 10 questions on a seven-point Likert-type scale ranging from ranging from 1 to 7 points, equaling 10-70 points total, from which the mean is attained. A decrease in mean score indicates improvement in the specific sub-domain. (NCT01531582)
Timeframe: Baseline, 8 & 16 weeks

InterventionScores on Scale (Mean)
Baseline Measures5.5
8 Weeks After Treatment With Minocycline4.88
16 Weeks-After 8 Week Washout5.08

[back to top]

Normalization of the EEG (Electroencephalogram) Signature

A scoring system was used to evaluate several aspects of the EEG recordings regardless of whether or not they were a part of AS specific EEG patterns. Points were assigned when a particular characteristic was observed. For instance, when evaluating the EEG background, 1 point was assigned if primarily theta waves (mild slowing, >50%) were observed. When a mixture of theta and delta waves (moderate slowing) were observed, 2 points were assigned. When primarily delta waves (severe slowing, >50%) were recorded 3 points were assigned. Other EEG characteristics were also examined including occipital rhythm (normal-1, slow-2 and absent-3), rhythmic theta (present <50% of time-1, present >50% of time-2) rhythmic delta (present-3) and epileptiform abnormalities (present-1, focal-1, multifocal-1, generalized-1, seizure-2). The points were totaled resulting in a total score, ranging from 0 (most normal) to 24 (most abnormal). (NCT01531582)
Timeframe: Baseline, 8 and 16 weeks

InterventionScore (Mean)
Baseline Measures9.16
8 Weeks After Treatment With Minocycline8.76
16 Weeks-After 8 Week Washout8.17

[back to top]

Preschool Language Scale, Fourth Edition (PLS-4)Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up

This test is used to evaluate the development of expressive and receptive language development. It also can be used to assess behaviors considered to be language precursors. The PLS use a play-based assessment to provide a comprehensive developmental language appraisal. These scales assess auditory and expressive comprehension. The score ranges for the two subdomains of this measure depend on 16 chronological age ranges from birth - 7 years, with a score range of 0-62 in Auditory Comprehension and 0-68 for Expressive Communication in a 7 year old. Minimum range: 50 (lower language abilities) Maximum range: 150 (higher language abilities). The PLS use a play-based assessment to provide a comprehensive developmental language appraisal. Increase in raw score indicates improvement in the specific subdomain. These raw scores are standardized for analysis and comparison. Standardization does not impact the interpretation of the results (NCT01531582)
Timeframe: Baseline, 8 and 16 weeks

,,
InterventionScores on Scale (Mean)
Auditory ComprehensionExpressive CommunicationTotal Language Ability
16 Weeks-After 8 Week Washout20.4717.4838.83
8 Weeks After Treatment With Minocycline18.2516.6334.88
Baseline Measures17.66416.2834.20

[back to top]

Vineland Adaptive Behavior Scale, 4th Edition (Vineland-II)Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up

"This test is to measure the adaptive behaviors; the ability to adapt to changes in one's environment, learn new everyday skills and level of independence. It measures social and personal skills via five major domains: communication, daily living skills, socialization, motor skills, and a maladaptive behavioral index. These scales can be used to support the diagnosis of intellectual and developmental disability.~The score ranges for each subdomain are as follows: Receptive Communication, 0-108; Expressive Communication, 0-308; Fine Motor, 0-196; Gross Motor, 0-228; Personal Daily Living Skills, 0-268; Domestic Daily Living Skills, 0-184; Community Daily Living Skills, 0-348; Internalizing Maladaptive Behavior, 0-22; and Externalizing Maladaptive Behavior, 0-20. These raw scores are allocated into the five major domains, and standardized for analysis of results.Increase in raw score indicates improvement in the specific subdomain for each, except for Maladaptive Behavior Scales." (NCT01531582)
Timeframe: Baseline, 8 and 16 weeks

,,
InterventionScores on Scale (Mean)
Receptive CommunicationExpressive CommunicationFine Motor AbilityGross Motor AbilityDaily Living Skills - PersonalDaily Living Skills - DomesticDaily Living Skills - CommunityMaladaptive Behavior - InternalizingMaladaptive Behavior - Externalizing
16 Weeks-After 8 Week Washout33.8843.7995.3849.3856.382.677.085.716.00
8 Weeks After Treatment With Minocycline36.444.28101.248.9259.123.847.445.484.68
Baseline Measures30.2841.8498.9648.2853.82.66.046.685.64

[back to top]

Percentage of Osteoid Volume (OV)/Bone Volume (BV) in the CC of the Iliac Crest

OV is the percentage of a given volume of bone tissue that consists of new unmineralized bone matrix (osteoid). Percentage = (OV/BV) *100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

Interventionpercentage of BV (Median)
Teriparatide2.58
Denosumab0.39

[back to top]

Percentage of Single or Double Tetracycline Labels Per Bone Surface (sLS/BS or dLS/BS) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies

At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or NL suggested suppression of bone formation. Percentage = (Single or double TET labels / BS) *100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of TET label (Median)
sLS/BS, in CC (n=31, 35)dLS/BS, in CC (n=31, 35)sLS/BS, in EC (n=30, 35)dLS/BS, in EC (n=30, 35)sLS/BS, in IC (n=30, 35)dLS/BS, in IC (n=30, 35)sLS/BS, in PC (n=30, 35)dLS/BS, in PC (n=30, 35)
Denosumab1.280.227.181.684.660.830.000.00
Teriparatide15.4410.4424.2428.8415.2814.969.370.00

[back to top]

Wall Thickness (W.Th) in the CC, EC and IC of the Iliac Crest

W.Th is the distance from the cement line to the marrow space of completed trabecular bone packets. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionµm (Median)
CC (n=31, 35)EC (n=30, 35)IC (n=30, 35)
Denosumab24.0330.0837.80
Teriparatide26.2931.8838.25

[back to top]

Change From Baseline to 3 Months in Mineralizing Surface (MS) /Bone Surface (BS) in the Cancellous Compartment (CC) of the Iliac Crest Bone Biopsies

MS /BS is a measure of the proportion of BS on which new mineralized bone is deposited at the time of DEM or TET labeling, and calculated as the sum of the total extent of double label (DL) plus half the extent of single label (SL) divided by BS. At baseline (18 days prior to randomization / study drug administration), DEM was administered (3 days on, 12 days off, 3 days on). 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered (same dosing schedule as DEM). Both DEM and TET temporarily bind to new bone and fluoresce under UV light. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or no label (NL) suggested varying degrees of suppression of bone formation. (NCT01753856)
Timeframe: Baseline, 3 months post first dose of study drug

Interventionpercentage of BS (Median)
Teriparatide12.43
Denosumab-2.51

[back to top]

Activation Frequency (Ac.f) in the CC, EC and IC of the Iliac Crest

Ac.f is the probability of new remodeling cycles initiated on the BS per year. Ac.f = (BFR/BS) / wall thickness. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or NL suggests suppression of bone formation. SL cases were imputed to a value of 0.3 µm/day or counted as missing. NL cases were assigned a value of zero. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionnew cycles per year (Median)
DL Only, in CC (n=31, 26)DL and Imputed SL, in CC (n=31, 35)DL Only, in EC (n=30, 29)DL and Imputed SL, in EC (n=30, 35)DL Only, in IC (n=30, 25)DL and Imputed SL, in IC (n=30, 35)
Denosumab0.100.060.350.340.170.12
Teriparatide1.411.412.772.771.881.88

[back to top]

Adjusted Apposition Rate (Aj.AR) in the CC, EC and IC of the Iliac Crest

Aj.AR is MAR averaged over the entire osteoid surface and in a steady state is an estimate of the mean rate of matrix apposition. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or NL suggested suppression of bone formation. BFR = MAR * (MS/BS). SL cases were imputed to a value of 0.3 µm/day or counted as missing. NL cases were counted as missing. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionµm/day (Median)
DL Only, in CC (n=31, 24)DL and Imputed SL, in CC (n=31, 33)DL Only, in EC (n=30, 25)DL and Imputed SL, in EC (n=30, 30)DL Only, in IC (n=30, 24)DL and Imputed SL, in IC (n=30, 33)
Denosumab0.210.140.650.580.580.35
Teriparatide0.580.580.760.761.031.03

[back to top]

Average Length of DLs in the CC, EC, IC and PC of the Iliac Crest

The length of TET DLs is a measure of the extent of bone formation in each compartment within individual remodeling units and is measured in mm. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionmm (Mean)
DL, in CC (n=31, 24)DL, in EC (n=30, 25)DL, in IC (n=30, 24)DL, in PC (n=10, 1)
Denosumab0.310.350.270.32
Teriparatide0.400.480.430.38

[back to top]

Change From Baseline to 3 Months in Bone Formation Rate/Bone Surface (BFR/BS ) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies

BFR/BS is the volume of mineralized bone formed per unit surface of bone per unit of time [mm cubed per mm squared per year (mm³/mm²/year)]. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicates active bone formation, a SL or NL suggests suppression of bone formation. BFR = MAR * (MS/BS). SL cases were imputed to a value of 0.3 mcm/day or counted as missing. NL cases were assigned a value of zero. (NCT01753856)
Timeframe: Baseline, 3 months post first dose of study drug

,
Interventionmm³/mm²/year (Median)
DL Only, in CC (n=30, 26)DL and Imputed SL, in CC (n=31, 35)DL Only, in EC (n=29, 28)DL and Imputed SL, in EC (n=30, 35)DL Only, in IC (n=30, 25)DL and Imputed SL, in IC (n=30, 35)DL Only, in PC (n=6, 16)DL and Imputed SL, in PC (n=30, 35)
Denosumab-0.0056-0.0055-0.0069-0.0069-0.0184-0.01840.0000-0.0005
Teriparatide0.02800.02750.05090.05010.04550.04550.02310.0015

[back to top]

Change From Baseline to 3 Months in Label Length Within Each Basic Multicellular Unit (BMU) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies

BMUs are local groups of osteoblasts and osteoclasts that act in concert to complete a single remodeling cycle. The label length is a measure of the extent of the mineralization front within each BMU in the CC, EC, IC and PC. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation, and a SL or NL suggested suppression of bone formation. (NCT01753856)
Timeframe: Baseline, 3 months post first dose of study drug

,
Interventionmillimeters (mm) (Median)
CC (n=30, 24)EC (n=28, 25)IC (n=30, 24)PC (n=4, 1)
Denosumab0.050.030.020.10
Teriparatide0.190.250.180.12

[back to top]

Change From Baseline to 3 Months in Mineral Apposition Rate (MAR) in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies

MAR is a measure of the linear rate of production of mineralized bone matrix by osteoblasts and is measured by the mean distance between 2 consecutive labels divided by the time interval. At baseline (18 days prior to randomization / study drug administration), DEM was administered. 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation, and a SL or NL suggested suppression of bone formation. SL cases were imputed to a value of 0.3 micrometers per day (µm/day) or counted as missing. NL cases were reported as missing. (NCT01753856)
Timeframe: Baseline, 3 months post first dose of study drug

,
Interventionmcm/day (Median)
DL Only, in CC (n=30, 24)DL and Imputed SL, in CC (n=31, 33)DL Only, in EC (n=28, 25)DL and Imputed SL, in EC (n=29, 31)DL Only, in IC (n=30, 24)DL and Imputed SL, in IC (n=30, 34)DL Only, in PC (n=4, 1)DL and Imputed SL, in PC (n=19, 4)
Denosumab-0.04-0.06-0.07-0.09-0.18-0.22-0.04-0.04
Teriparatide0.000.010.030.030.200.200.050.00

[back to top]

Change From Baseline to 3 Months in MS/BS in the Endocortical Compartment (EC), Intracortical Compartment (IC), and Periosteal Compartment (PC) of the Iliac Crest Bone Biopsies

MS /BS is a measure of the proportion of BS on which new mineralized bone is deposited at the time of DEM or TET labeling and is calculated as the sum of the total extent of DL plus half the extent of SL divided by BS. At baseline (18 days prior to randomization / study drug administration), DEM was administered (3 days on, 12 days off, 3 days on). 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered (same dosing schedule as DEM). Both DEM and TET temporarily bind to new bone and fluoresce under UV light. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or NL suggested varying degrees of suppression of bone formation. (NCT01753856)
Timeframe: Baseline, 3 months post first dose of study drug

,
Interventionpercentage of BS (Median)
ECICPC
Denosumab-2.97-6.70-0.39
Teriparatide26.129.392.40

[back to top]

MS/BS in the CC, EC, IC and PC of the Iliac Crest Bone Biopsies 3 Months Post First Dose of Study Drug

MS /BS is a measure of the proportion of BS on which new mineralized bone is deposited at the time of DEM or TET labeling and is calculated as the sum of the total extent of DL plus half the extent of SL divided by BS. At baseline (18 days prior to randomization / study drug administration), DEM was administered (3 days on, 12 days off, 3 days on). 22 days prior to the biopsy procedure (biopsy obtained 3 months post first dose of study drug), TET was administered (same dosing schedule as DEM). Both DEM and TET temporarily bind to new bone and fluoresce under UV light. New bone in the biopsy was seen as the amount of bone between the 2 fluorescently DEM- or TET-labeled lines under a microscope. A DL indicated active bone formation and a SL or NL suggested varying degrees of suppression of bone formation. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of BS (Median)
CC (n=31, 35)EC (n=30, 35)IC (n=30, 35)PC (n=30, 35)
Denosumab0.965.423.050.00
Teriparatide18.7339.5021.694.69

[back to top]

Number of Samples With Single or Double Tetracycline Labels, SL and DL, or No Tetracycline Labels in the CC, Endocortical Compartment (EC), Intracortical Compartment (IC) and Periosteal Compartment (PC) of the Iliac Crest Bone Biopsies

(NCT01753856)
Timeframe: 3 months post first dose of study drug

,
InterventionSamples (Number)
DL and SL, in CC (n=31, 35)DL Only, in CC (n=31, 35)SL Only, in CC (n=31, 35)No Label, in CC (n=31, 35)DL and SL, in EC (n=30, 35)DL Only, in EC (n=30, 35)SL Only, in EC (n=30, 35)No Label, in EC (n=30, 35)DL and SL, in IC (n=30, 35)DL Only, in IC (n=30, 35)SL Only, in IC (n=30, 35)No Label, in IC (n=30, 35)DL and SL, in PC (n=30, 35)DL Only, in PC (n=30, 35)SL Only, in PC (n=30, 35)No Label, in PC (n=30, 35)
Denosumab240922506424010110430
Teriparatide310003000030000100191

[back to top]

Osteoid Thickness (O.Th) in the CC, EC and IC of the Iliac Crest

O.Th is a measure of the average thickness of osteoid seams. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionmicrometers (mcm) (Median)
CC (n= 31, 35)EC (n= 30, 35)IC (n= 30, 35)
Denosumab3.784.334.68
Teriparatide6.126.997.08

[back to top]

Percentage Change From Baseline to 1, 3, and 6 Months in Intact Parathyroid Hormone (PTH)

PTH regulates calcium and phosphate metabolism in bone and kidney, and is typically measured in serum using the intact PTH assay. Percentage = (PTH value at specified time points - PTH value at baseline) / PTH value at baseline * 100. (NCT01753856)
Timeframe: Baseline, 1, 3, and 6 months post first dose of study drug

,
Interventionpercentage change in PTH (Median)
1 month (n=28, 34)3 months (n=18, 28)6 months (n=27, 33)
Denosumab72.2446.6830.40
Teriparatide-26.89-32.16-40.18

[back to top]

Percentage Change From Baseline to 1, 3, and 6 Months in Serum Carboxyterminal Cross-Linking Telopeptide of Type I Collagen (CTX)

CTX is a marker of bone turnover and is a measure of bone resorption. Percentage = (CTX value at specified time points - CTX value at baseline) / (CTX value at baseline) * 100. (NCT01753856)
Timeframe: Baseline, 1, 3, and 6 months post first dose of study drug

,
Interventionpercentage change in CTX (Median)
1 month (n=31, 33)3 months (n=21, 29)6 months (n=29, 33)
Denosumab-90.70-90.77-82.50
Teriparatide6.0973.0489.13

[back to top]

Percentage Change From Baseline to 1, 3, and 6 Months in Serum Osteocalcin

Osteocalcin is a marker of bone turnover and a measure of osteoblast function. Percentage = (osteocalcin value at specified time points - osteocalcin value at baseline) / (osteocalcin value at baseline) * 100. (NCT01753856)
Timeframe: Baseline, 1, 3, and 6 months post first dose of study drug

,
Interventionpercentage change in osteocalcin (Median)
1 month (n=31, 33)3 months (n=20, 29)6 months (n=29, 31)
Denosumab-6.56-45.70-50.53
Teriparatide90.53123.66187.29

[back to top]

Percentage Change From Baseline to 1, 3, and 6 Months in Serum Procollagen Type I N-terminal Propeptide (P1NP)

P1NP is a marker of bone turnover and is a measure of bone formation. Percentage = (P1NP value at specified time points - P1NP value at baseline) / P1NP value at baseline * 100. (NCT01753856)
Timeframe: Baseline, 1, 3, and 6 months post first dose of study drug

,
Interventionpercentage change in P1NP (Median)
1 month (n=33, 34)3 months (n=22, 29)6 months (n=31, 32)
Denosumab-11.56-66.64-68.24
Teriparatide134.38213.15284.22

[back to top]

Percentage of Bone With Remodeling-Based and Modeling-Based Formations in the CC, EC and PC of the Iliac Crest Bone Biopsies

In this study, post-treatment DLs in the CC, EC, and PC were classified as remodeling-based or modeling-based bone formations which was determined by whether the underlying reversal line was scalloped or smooth and by the collagen fiber orientation. Percentage = (remodeling-based formation units or modeling-based formation units/ total bone formation units) * 100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of the total formation unit (Median)
Remodeling-Based Bone Formation in CC (n=31, 32)Modeling-Based Bone Formation in CC (n=31, 32)Remodeling-Based Bone Formation in EC (n=30, 29)Modeling-Based Bone Formation in EC (n=30, 29)Remodeling-Based Bone Formation in PC (n=29, 5)Modeling-Based Bone Formation in PC (n=29, 5)
Denosumab90.839.17100.000.000.00100.00
Teriparatide89.0210.9883.3316.670.00100.0

[back to top]

Percentage of Eroded Surface/Bone Surface (ES/BS) in the CC, EC and IC of the Iliac Crest

ES/BS is the fraction of the entire trabecular surface occupied by resorption bays, including both those with and without osteoclasts. It is an indicator of bone resorption. Percentage = (ES/BS) *100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of BS (Median)
CC (n=31, 35)EC (n=30, 35)IC (n=30, 35)
Denosumab1.521.651.27
Teriparatide3.733.7911.19

[back to top]

Percentage of Mineralizing Surface With Remodeling-Based Formation and Modeling-Based Formation in the CC, EC and PC of the Iliac Crest Bone Biopsies

"The percentage of mineralizing surface where post-treatment DLs in the CC, EC, and PC were classified as remodeling-based or modeling based bone formation based on collagen fiber orientation and whether the underlying reversal line was scalloped or smooth.~Percentage = percentage remodeling- or modeling-based formation units * MS/BS" (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of the total formation unit (Median)
Remodeling-Based Bone Formation in CC (n=31, 35)Modeling-Based Bone Formation in CC (n=31, 35)Remodeling-Based Bone Formation in EC (n=30, 35)Modeling-Based Bone Formation in EC (n=30, 35)Remodeling-Based Bone Formation in PC (n=30, 35)Modeling-Based Bone Formation in PC (n=30, 35)
Denosumab0.870.095.420.000.000.00
Teriparatide16.672.0632.926.580.004.69

[back to top]

Percentage of Osteoid Surface (OS)/Bone Surface (BS) in the CC, EC and IC of the Iliac Crest

OS is the percentage of the entire trabecular BS that is covered by osteoid. Percentage = (OS / BS) *100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of BS (Median)
CC (n=31, 35)EC (n=30, 35)IC (n=30, 35)
Denosumab3.466.954.34
Teriparatide20.5130.8517.81

[back to top]

Percentage of Overfilled Remodeling Sites in the CC, EC and PC of the Iliac Crest Bone Biopsies

The percentage of overfilled remodeling sites in the CC, EC, and PC were defined as the percentage of observed remodeling units in which the second DL (TET) extended beyond the limits of the scalloped reversal line and into the adjacent, previously unresorbed surface of the bone. Percentage = (overfilled remodeling bone formation unit / total bone formation unit) * 100. (NCT01753856)
Timeframe: 3 months post first dose of study drug

,
Interventionpercentage of overfilled remodeling site (Median)
CC (n=31, 32)EC (n=30, 29)PC (n=29, 5)
Denosumab0.000.000.00
Teriparatide17.7421.980.00

[back to top]

Frequency of Participants Who Experienced Any Grade of Rash As Characterized By The Common Toxicity Criteria for Adverse Effects (CTCAE) V4.0

Sum of participants who experienced any grade rash according to the Common Toxicity Criteria for Adverse Effects (CTCAE) V4.0, from the initiation of BIBW2992 compared to week 8. (NCT01880515)
Timeframe: Percentage of adverse events at week 8

InterventionPercentage of Patients w/any grade rash (Number)
Tetracycline44.5
No Tetracycline75.5

[back to top]

Progression Free Survival

From the start of consumption of BIBW 2992 to the date progression or last follow up (NCT01880515)
Timeframe: Participants will be followed for the duration of the treatment, an average of 8 weeks.

Interventionmonths (Median)
Tetracycline8.1
No Tetracycline12.3

[back to top]

Counts of Participants With Successful H. Pylori Eradication

(NCT02159976)
Timeframe: 4 weeks after termination of eradication therapy, up to 6 weeks

InterventionParticipants (Count of Participants)
Sequential Therapy146
Modified Bismuth Quadruple Therapy134

[back to top]

Functional Dyspepsia Symptom Responses Rate

(NCT02159976)
Timeframe: 1 year after termination of eradication therapy

,
InterventionParticipants (Count of Participants)
complete (≥75%)Satisfactory (50-74%)Partial (25-49%)Refractory (<25%)
In Eradication Failure Group0012
In Eradication Success Group44169

[back to top]

Counts of Participants Whose Drug Compliance is More Than 85%

(NCT02159976)
Timeframe: 4 weeks after termination of eradication therapy, up to 6 weeks

InterventionParticipants (Count of Participants)
Sequential Therapy165
Modified Bismuth Quadruple Therapy170

[back to top]

Counts of Participants With Adverse Event

(NCT02159976)
Timeframe: 4 weeks after termination of eradication therapy, up to 6 weeks

InterventionParticipants (Count of Participants)
Sequential Therapy93
Modified Bismuth Quadruple Therapy72

[back to top]

Ecological Momentary Assessments (EMA) - Craving

"Participants will be asked Are you craving heroin at this moment on seven-point Likert scales (1=strongly disagree to 7=strongly agree) 4 times per day outside of the laboratory (in their natural environment) using a personal digital assistant on days 8-14 of medication treatment. All scores were averaged to compute one score. Higher scores indicate more craving for heroin." (NCT02359006)
Timeframe: 4x/day for one week

Interventionscore on a scale (Mean)
Minocycline1.04
Placebo1.14

[back to top]

Ecological Momentary Assessments (EMA) - Pain

"Participants will be asked Do you feel any pain at this moment on seven-point Likert scales (1=strongly disagree to 7=strongly agree) 4 times per day outside of the laboratory (in their natural environment) using a personal digital assistant on days 8-14 of medication treatment. All scores were averaged to compute one score. Higher scores indicate more feelings of pain." (NCT02359006)
Timeframe: 4x/day for one week

Interventionscore on a scale (Mean)
Minocycline1.22
Placebo1.14

[back to top]

Ecological Momentary Assessments (EMA): SOWS

Self-report opioid withdrawal scale. Withdrawal symptoms are measured on a 7-point Likert scale (1=strongly disagree, 7=strongly agree). Participants complete these ratings 4 times per day on days 8-14 of medication treatment. All scores were averaged to compute one score. Higher scores indicate more withdrawal symptoms. (NCT02359006)
Timeframe: 4x/day over one week

Interventionscore on a scale (Mean)
Minocycline1.05
Placebo1.03

[back to top]

Brief Pain Inventory - Short Form: Interference

"Brief Pain Inventory - Short Form: BPI-SF is a self-report questionnaire that assesses 7 questions each rated on a scale of 0-10, which are added and divided by 7. This average score of 7 questions gives a pain interference with living score, with a minimum score of 0 and a maximum score of 10.~Higher scores indicate that pain interferes more with aspects of daily life." (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline0.930.900.630.670.52
Placebo0.971.331.041.491.2

[back to top]

Brief Pain Inventory - Short Form: Pain Severity

Brief Pain Inventory - Short Form: BPI-SF is a self-report questionnaire that assesses the impact of pain on daily function, location of pain, pain medications, and amount of pain relief in the past 24 hours or the past week. Each question is scored 0-10, and the scores are summed and then averaged to create a pain severity score. Minimum score is 0; maximum score is 10. Higher scores indicate more severely perceived pain. (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline1.280.880.780.801.10
Placebo1.100.951.001.181.28

[back to top]

Digit Symbol Substitution Test

The DSST is a test of psychomotor performance, which measures motor persistence, sustained attention, response speed and visuomotor coordination. The task is to fill in blank spaces with the symbols that are paired with the number above the blank space as fast as possible for 90 sec. The minimum score is 0 and the maximum score is 120. Higher numbers indicate better cognitive performance. (NCT02359006)
Timeframe: Baseline (Day 0), Pre- and 1-hour post-medication treatment on Test Days 8, 15 and 22, and at Follow-up (~Day 28

,
Interventionscore on a scale (Mean)
BaselineDay 8 Pre-medicationDay 8 Post-medicationDay 15 Pre-medicationDay 15 Post-medicationDay 22 Pre-medicationDay 22 Post-medication~Day 28 (Follow-up)
Minocycline37.1142.3341.7845.6743.2548.4446.5650.75
Placebo37.1140.8940.8943.3341.1143.0040.1146.67

[back to top]

Interleukin-1 Beta (IL-1β)

Serum cytokine analysis assayed using electrochemiluminescence multi-array technology (Meso Scale Discovery, Gaithersburg, MD). IL-1β is measured in pictograms per milliliter (pg/ml). Cytokines were assessed at screening (approximately 1 week prior to medication), and on the last day of medication treatment. Higher numbers indicate higher blood levels of this cytokine. (NCT02359006)
Timeframe: Pre/post : At Screening before medication, and on Day 22 of medication

,
Interventionpictograms per milliliter (Mean)
ScreeningDay 22
Minocycline0.800.67
Placebo0.720.62

[back to top]

Interleukin-6 (IL-6)

Serum cytokine analysis assayed using electrochemiluminescence multi-array technology (Meso Scale Discovery, Gaithersburg, MD). IL-6 is measured in pictograms per milliliter (pg/ml).Cytokines were assessed at screening (approximately 1 week prior to medication), and on the last day of medication treatment. Higher numbers indicate higher blood levels of this cytokine. (NCT02359006)
Timeframe: Pre/post : At Screening before medication, and on Day 22 of medication

,
Interventionpictograms per milliliter (Mean)
ScreeningDay 22
Minocycline1.642.14
Placebo1.111.99

[back to top]

Opioid Withdrawal Symptom Checklist (OWSC): Back Pain Item

"For safety reasons, withdrawal signs and symptoms were assessed using a 22-item withdrawal instrument that has been reliably used to assess opiate withdrawal. As an additional assessment of daily pain, the presence of back pain item was analyzed. This item has a minimum score of 0 and maximum score of 4, with higher scores indicates more agreement with statement/more back pain." (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline000.100.200.10
Placebo0.100.100.200.200.40

[back to top]

Pain Threshold

The Cold Pressor Test (CPT) measures pain threshold (in seconds). For this test, two water coolers filled with either warm (100.04ºF/37.8ºC) or cold water (32.9-34.7ºF/0.5-1.5ºC) are used. To begin the CPT, participants first immerse their hand into the warm-water bath for 2 min. Participants are then instructed to immerse their hand into the cold water bath and report the first time they experience pain (pain threshold). Lower scores indicate lower pain threshold. Minimum score is 0 seconds, and a maximum cut-off score of 300 seconds is used to prevent tissue damage. (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionseconds (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline18.7216.1616.1316.2117.59
Placebo24.7824.3718.4625.7521.92

[back to top]

Pain Tolerance

The Cold Pressor Test (CPT) measures pain threshold and pain tolerance (in seconds). For this test, two water coolers filled with either warm (100.04ºF/37.8ºC) or cold water (32.9-34.7ºF/0.5-1.5ºC) are used. To begin the CPT, participants first immerse their hand into the warm-water bath for 2 min. Participants are then instructed to immerse their hand into the cold water bath and report when the pain becomes unbearable (pain tolerance). Lower scores indicate lower pain tolerance. Minimum score is 0 seconds, and a maximum cut-off score of 300 seconds is used to prevent tissue damage. (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionseconds (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline40.8637.4234.4136.6131.58
Placebo59.7252.5648.4251.5243.14

[back to top]

Profile of Mood States (POMS) - Total Mood Disturbance

"The POMS is a 65-item scale that divides items amongst eight mood states (tension, depression, anger, fatigue, confusion, vigor) on a 5-point rating scale (0=not at all to 5=extremely). Total Mood Disturbance is calculated by adding the tension, depression, anger, fatigue, and confusion subscale scores and subtracting the vigor subscale score. This has a minimum of 0 and a maximum score of 210. Higher score indicate more mood disturbance." (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline43.144.750.343.440.7
Placebo47.441.8840.442.342.2

[back to top]

Profile of Mood States (POMS) Depression Subscale

"The POMS is a 65-item scale that divides items amongst eight mood states (tension, depression, anger, fatigue, confusion, vigor) on a 5-point rating scale (0=not at all to 5=extremely). We analyzed the 15-item Depression subscale, which has a minimum score of 0 and a maximum score of 75. Higher score indicate more agreement with the statement/more feelings of depression." (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline20.8018.921.0019.218.8
Placebo18.917.916.717.017.8

[back to top]

Short-Form McGill Pain Questionnaire (SF-MPQ): Affective Subscale

This measure is a subscale of the SF-MPQ, comprised of 4 of the 15 total items. The measure is completed immediately after the CPT, where participants describe their experience of CPT pain by choosing among a series of possible answers [none (score=0), mild (score=1), moderate (score=2), or severe (score=3)]. The items to describe the pain are 'Tiring-Exhausting', 'Sickening', 'Fearful', 'Punishing-Cruel'. The scores for these 4 items are summed as a measure of Affective pain, with a minimum score of 0 and a maximum score of 12. (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline2.01.71.92.41.89
Placebo1.51.72.22.02.3

[back to top]

Short-Form McGill Pain Questionnaire (SF-MPQ): Sensory Subscale

This measure is a subscale of the SF-MPQ, comprised of 11 of the 15 total items. The measure is completed immediately after the CPT, where participants describe their experience of CPT pain by choosing among a series of possible answers [none (score=0), mild (score=1), moderate (score=2), or severe (score=3)]. The items to describe the pain are 'Throbbing','Shooting', 'Stabbing', 'Sharp', 'Cramping', 'Gnawing', 'Hot/burning', 'Aching', 'Heavy', 'Tender', and 'Splitting'. The scores for these 11 items are summed as a measure of Sensory pain, with a minimum score of 0 and a maximum score of 33. (NCT02359006)
Timeframe: One measurement at each of 5 weekly sessions: Baseline, Day 8, Day 15, Day 22 and at Follow-up (~Day 28)

,
Interventionscore on a scale (Mean)
BaselineDay 8 (Test Day 1)Day 15 (Test Day 2)Day 22 (Test Day 3)~Day 28 (Follow-up)
Minocycline10.3310.910.811.312.5
Placebo12.913.114.213.310.7

[back to top]

Sustained Attention to Response Test (SART): Go Trials: Errors of Omission

"The SART is a Go No-Go task. It assesses the ability to withhold responses to an infrequently occurring target (No-Go trials).The SART is a Go No-Go task. It assesses the ability to withhold responses to an infrequently occurring target (No-Go trials). A total of 225 single digits (25 x 9 digits) are presented on a computer monitor for 250 ms each, immediately followed by a mask for 900 ms. Subjects must press a spacebar in response to every digit except the 3. Higher numbers indicate more errors of omission." (NCT02359006)
Timeframe: Baseline (Day 0), Pre- and 1-hour post-medication treatment on Test Days 8, 15 and 22, and at Follow-up (~Day 28

,
Interventionommission errors (Mean)
BaselineDay 8 Pre-medicationDay 8 Post-medicationDay 15 Pre-medicationDay 15 Post-medicationDay 22 Pre-medicationDay 22 Post-medication~Day 28 (Follow-up)
Minocycline10.99.116.8815.87.718.413.211.1
Placebo17.913.7813.44212725.422.3321.1

[back to top]

Sustained Attention to Response Test (SART): No-go Trials: Errors of Commission

"The SART is a Go No-Go task. It assesses the ability to withhold responses to an infrequently occurring target (No-Go trials). A total of 225 single digits (25 x 9 digits) are presented on a computer monitor for 250 ms each, immediately followed by a mask for 900 ms. Subjects must press a spacebar in response to every digit except the 3. Higher numbers indicate more errors of commission." (NCT02359006)
Timeframe: Baseline (Day 0), Pre- and 1-hour post-medication treatment on Test Days 8, 15 and 22, and at Follow-up (~Day 28

,
Interventioncommission errors (Mean)
BaselineDay 8 Pre-medicationDay 8 Post-medicationDay 15 Pre-medicationDay 15 Post-medicationDay 22 Pre-medicationDay 22 Post-medication~Day 28 (Follow-up)
Minocycline75.785.757.405.59.35.67.00
Placebo98.337.337.898.77.39.897.26

[back to top]

Tumor Necrosis Factor Alpha (TNF-α)

Serum cytokine analysis assayed using electrochemiluminescence multi-array technology (Meso Scale Discovery, Gaithersburg, MD). TNF-α is measured in pictograms per milliliter (pg/ml).Cytokines were assessed at screening (approximately 1 week prior to medication), and on the last day of medication treatment. Higher numbers indicate higher blood levels of this cytokine. (NCT02359006)
Timeframe: Pre/post : At Screening before medication, and on Day 22 of medication

,
Interventionpictograms per milliliter (Mean)
ScreeningDay 22
Minocycline2.862.66
Placebo2.662.53

[back to top]

Number of Participants in Which H. Pylori Was Eradicated

Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy

Interventionparticipants (Number)
Pantoprazole+Bismuth+Tetra+Metro154
Hybrid Therapy154

[back to top]

Number of Participants in Which H. Pylori Was Eradicated

Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.

Interventionparticipants (Number)
Esomeprazole+Amox+Levo+Tetra13
Esomeprazole+Amox+Levo21

[back to top]

Number of Participants in Which H. Pylori Was Eradicated

Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (Number of Participants With Complete Eradication of Helicobacter Pylori) (NCT02547038)
Timeframe: sixth week after the end of anti- H. pylori therapy

Interventionparticipants (Number)
Pantoprazole+Bismuth+Tetra+Metro169
(Panto+Amox+Clar+Metr)+(Panto+Amox)170

[back to top]

Remodeling-based Formation Units Including Overfilled Units in the Femoral Neck

"Femoral neck bone samples were prepared according to standard procedures for bone histology and bone histomorphometry at a central bone histomorphometry facility.~Remodeling based formation units in active bone-forming, tetracycline-labeled surfaces were identified by a scalloped cement line. The number of remodeling based formation units including overfilled units was evaluated at the cancellous, periosteal, and endocortical regions and is reported in units per mm of bone surface." (NCT02576652)
Timeframe: Days 22-58 (at the time of hip replacement surgery)

Interventionunits/mm (Mean)
Cancellous RegionEndocortical RegionPeriosteal Region
Osteoarthritis Participants0.02850.03230.0033

[back to top]

Overfilled Remodeling-based Formation Units in the Femoral Neck

"Femoral neck bone samples were prepared according to standard procedures for bone histology and bone histomorphometry at a central bone histomorphometry facility.~Remodeling-based formation units in active bone-forming, tetracycline-labeled surfaces were identified by a scalloped cement line. The number of overfilled remodeling-based formation units was evaluated at the cancellous, periosteal, and endocortical regions and is reported as units per mm of bone surface." (NCT02576652)
Timeframe: Days 22-58 (at the time of hip replacement surgery)

Interventionunits/mm (Mean)
Cancellous RegionEndocortical RegionPeriosteal Region
Osteoarthritis Participants0.00380.01080.0000

[back to top]

Modeling Based Formation Units in the Femoral Neck

"Femoral neck bone samples were prepared according to standard procedures for bone histology and bone histomorphometry at a central bone histomorphometry facility.~Modeling based formation units in active bone-forming, tetracycline-labeled surfaces were identified by a smooth cement line. The number of modeling based formation units was evaluated at the cancellous, periosteal, and endocortical regions and is reported in units per mm of bone surface." (NCT02576652)
Timeframe: Days 22-58 (at the time of hip replacement surgery)

Interventionunits/mm (Mean)
Cancellous RegionEndocortical RegionPeriosteal Region
Osteoarthritis Participants0.14550.22230.1990

[back to top]

Percentage of Participants With Modeling Based Bone Formation in the Femoral Neck

"Femoral neck bone samples were prepared according to standard procedures for bone histology and bone histomorphometry at a central bone histomorphometry facility.~Modeling based formation units in active bone-forming, tetracycline-labeled surfaces were identified by a smooth cement line.~The percentage of participants with fluorochrome labeling present in the cancellous or periosteal, or endocortical surfaces of the femoral neck indicative of modeling-based bone formation is reported." (NCT02576652)
Timeframe: Days 22-58 (at the time of hip replacement surgery)

Interventionpercentage of participants (Number)
Osteoarthritis Participants100

[back to top]

Number of Participants in Which H. Pylori Was Eradicated

Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.

Interventionparticipants (Number)
Esomeprazole+Amox+Levo36
Esomeprazole+Bismuth+Tetra+Levo49

[back to top]

Other Virus or Bacteria Contamination Rate.

Rate of how many people were infected with influenza or pneumonia over the course of the study in each group. (NCT04716426)
Timeframe: 22 days after randomization.

InterventionParticipants (Count of Participants)
Tetracycline Hydrochloride 3%0
Placebo0

[back to top]

Number of Participants With Adverse Events

Number of participants who presented adverse events. (NCT04716426)
Timeframe: 22 days after randomization.

Interventionparticipants (Number)
Tetracycline Hydrochloride 3%17
Placebo23

[back to top]

Days Over Which an Adverse Event Was Reported

Average days over which an adverse event was reported. (NCT04716426)
Timeframe: 22 days after randomization.

InterventionDays (Mean)
Tetracycline Hydrochloride 3%0.36
Placebo0.28

[back to top]

COVID-19 Contamination Rate.

Rate of how many people were infected with COVID-19 over the course of the study in each group. (NCT04716426)
Timeframe: 22 days after randomization.

InterventionParticipants (Count of Participants)
Tetracycline Hydrochloride 3%2
Placebo5

[back to top]

Average Number of Adverse Events

Average number of adverse events over the course of the study. (NCT04716426)
Timeframe: 22 days after randomization.

Interventionadverse events (Mean)
Tetracycline Hydrochloride 3%0.65
Placebo0.94

[back to top]